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ABSTRACT 
Past literature indicates that anxiety symptoms and disorders can manifest in older adults 
for the first time in late life, without a prior history of psychopathology, and that the 
experience of anxiety symptoms may vary amongst older adults according to the age at 
onset of anxiety. Research has yet to comprehensively address this issue. Accordingly, this 
thesis examined the implications of an age of onset distinction for the presentation and 
treatment of late-life generalised anxiety disorder (GAD). 
This thesis consists of three sections. The first section contains an overview of the thesis 
and three theoretical chapters which provided the basis for the empirical investigations set 
out in Sections Two and Three. The main aim of Study One, presented in Section Two of 
this thesis, was to provide empirical evidence of a bimodal distribution of age at onset of 
GAD and a method for determining an appropriate cut-off to distinguish these two 
subgroups. The subsequent investigations presented in Section Two aimed to investigate 
differences in the aetiology and phenomenology of early-onset (EO) and late-onset (LO) 
GAD. In addition, the relationship between the experience of negative life events and age at 
onset of GAD was examined. 
Participants included 76 older adults aged 55-84 years meeting diagnostic criteria for a 
current DSM-IV anxiety disorder, of which GAD was the most commonly diagnosed 
(96%). Information regarding the onset of current and past episode of psychiatric illness, 
the demographic and health characteristics of participants, and the experience of negative 
life events across the lifespan was assessed. As age at onset of GAD defined the groups to 
be compared, belonging to the EO vs. LO group represented the between subjects 
independent variable. The results confirmed a bimodal distribution for first lifetime onset of 
GAD. An·age of 34.4 years was identified as the cut-off point to distinguish between 
participants classified as having EO (n= 24) or LO (n = 56) GAD. EO participants reported 
significantly greater benzodiazepine and health supplement use; a longer history of anxiety 
since initial onset; a greater number of episodes of psychiatric illness; a greater family 
history of psychiatric illness; greater severity of the symptom 'restlessness and/or feeling 
keyed up;' a greater percentage of time spent worrying; greater distress, and; greater 
interviewer- rated severity of GAD than LO participants. On the other hand, LO 
V 
participants reported greater functional limitations, poorer perceptions of health , and greater 
frequency and severity of both health-related events and difficult financial circumstances 
preceding first onset of GAD, than those with EO GAD. The results also showed that LO 
GAD was associated with the experience and accumulation of greater levels of life stress 
thanEO GAD. 
The study presented in Section Three aimed to investigate the relationship between age at 
onset and the treatment of late-life GAD. Forty-one treatment-seeking participants (EO = 
1 .8 and LO = 23) from Study One completed a 12-week CBT program for GAD. Measures 
of anxiety, worry and depression were completed at five time-points: at pre-treatment (TO), 
following completion of relaxation training (Tl), cognitive skills (T2) and behavioural 
skills (T3) modules of therapy, and six months following treatment completion (T4). 
Participant-rated evaluations of symptom severity and treatment efficacy were completed 
from Tl through to T4. Measures of trait anxiety, anxiety sensitivity, se lf-efficacy and 
perceptions of anxiety control were assessed at TO and at T4. The results showed that 
treatment resulted in significant improvements on all outcome measures from pre- to post-
treatment and that these gains made from treatment were maintained at six-month follow-
up. Age of onset was not found to have a significant effect on treatment outcomes. With 
exception of the finding that LO participants reported significantly greater symptom 
severity following completion of the relaxation skills module than EO participants, onset 
groups did not differ in patterns of change over the course of treatment. 
Theoretically, the study emphasises the need to accurately conceptualise age of onset and to 
determine an empirically derived cut-off for distinguishing between early- and late- onset 
subsamples. Clinically, the study highlights the fact that participants with EO and LO GAD 
both respond equally well to a manualised CBT program for GAD and that age of onset is 
not a factor in treatment outcome. The theoretical and clinical implications of the results 
and the need for further development and refinement of the understanding of an onset 
distinction in the presentation and management of late-life GAD through future research are 
discussed. 
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SECTION I: GENERAL INTRODUCTION AND 
LITERATURE REVIEW 
CHAPTER ONE 
General Introduction and Overview 
Age at onset is considered an important index for syndrome distinction in aetiological 
studies of a number of psychiatric disorders of late-life (lketani et al. , 2004). Primarily, 
such research has focused on major depressive disorder (MOD) (Benazzi, 200 I; Brodaty et 
al., 2001; Holroyd & Duryee, 1997; Kovacs, Gastonis, Paulauskas, & Richards, 1989; 
Krishnan, Hays, Tupler, George, & Blazer, 1995; Van den Berg et al., 2001), dysthymic 
disorder (DD) (Barzega, Maina, Venturello, & Bogetto, 2001; Devanand et al. , 2004) and 
schizophrenia (Howard, Rabins, Seeman, Jeste, & Group. , 2000; Palmer, McClure, & Jeste, 
200 I; Sato, Bott lender, Schroter, & Moller, 2004). ln the depression literature in particular, 
age of onset is considered an important dimension in classifying mood disorders (Klein et 
al. , 1999). Specifically, early-onset (EO) and late-onset (LO) depression have been found 
to have a different aetiology (Brodaty, et al., 200 I ; Van den Berg, et al., 200 I), clinical 
presentation, treatment response and outcome (Benazzi , 2001; McMahon et al., 1994), 
suggesting that LO depression is often a different illness from EO depression. 
In recent years, interest has also grown in the relationship between age of onset and the 
clinical characteristics of late-life anxiety disorders such as panic disorder (PD), 
agoraphobia, and generalised anxiety disorder (GAD). GAD is of particular interest in light 
of prevalence data suggesting that it may be the most common anxiety disorder in old age 
(Bryant, Jackson, & Ames, 2008; Lenze & Wetherell , 20 I I). Given the important clinical 
implications of an onset distinction in the depression literature and the links between 
anxiety and depression in older adults (Bryant, et al., 2008; Manela, Katona, & Livingston, 
1996; Sable _& Jeste, 2001), this interest is clearly warranted as differences between early-
and late-onset of anxiety may have significance for the aetiology or clinical presentation of 
late-life anxiety disorder. Nevertheless, current knowledge of the relationship between age 
at onset and late-life anxiety is limited. A review of the existing empirical literature 
highlights an ad-hoc approach to research to date, often with little theoretical justification 
of inquiry. The purpose of this thesis is to provide a critical review and synthesis of the 
existing literature, both empirical and theoretical, before embarking on an empirical 
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investigation of the relationship between age at onset of late-life GAD and aetiological 
factors, phenomenology, and treatment response. A greater knowledge of these 
relationships may assist in both the identification of those at risk of developing GAD in 
later life, and the treatment and management of those with GAD in late-life. This 
introductory chapter serves to provide a general overview of the research contained in this 
thesis, including a synopsis of how the thesis will be structured to address the following 
research questions: 
Research Question 1: Is there an empirically identifiable cut-off age that differentiates 
EO GAD from LO GAD? 
Research Question 2: What are the aetiological differences between older adults with 
early- and late-onset GAD? 
Research Question 3: What are the phenomenological differences between older adu lts 
with early- and late-onset GAD? 
Research Question 4: What are the differences between older adults with early- and late-
onset GAD in the frequency and severity of stressful negative life events preceding the 
onset of anxiety? 
Research Question 5: What is the relationship between the experience of negative life 
events across the lifespan and symptoms of psychopathology in older adults with GAD? 
Research Question 6: What are the implications of an age at onset distinction for the 
treatment of late-life GAD? 
In order to address each of these six research questions it is important to first understand the 
nature and ·consequences of anxiety. Chapter Two begins this task by defining the 
experience of anxiety. A brief description of the specific anxiety disorders referred to in 
this thesis is then provided. GAD is specifically defined as an anxiety disorder which 
commonly occurs in late-life, and is highly prevalent in the sample of older adults 
investigated in this thesis. In order to understand the burden that anxiety in older persons 
presents for the healthcare system and the community, it then summarises the current and 
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projected rates of anxiety in older adults in Australia. This is followed by a review of the 
epidemiologic evidence outlining prevalence rates of anxiety disorders in geriatric 
populations, highlighting issues of comorbidity and the distinction between anxiety and 
depression. Finally, an overview of the social, biological and psychological risk factors 
associated with the onset and maintenance of anxiety in late-life is provided. 
Chapter Three reviews and summarises the findings of existing empirical literature relating 
to the clinical presentation of early- and late-onset anxiety. Late-life anxiety disorders 
considered in this chapter include PD, agoraphobia and GAD. This chapter then provides a 
critique of the methodological approaches of past research and discusses the consequent 
difficulties in drawing firm conclusions or generalising results due to the paucity of 
theoretically driven research. Chapter Four turns to the examination of a theoretical model 
that has been proposed to account for the age at onset distinction in late-life depression. 
Given that anxiety and depression are closely related disorders in late-life, Boyd, 
McKiernan and Waller' s (2000) cognitive model of early- and late-onset depression is 
considered as a model which may potentially be applied to distinguish the content and 
process of early- and late-onset anxiety. The relative strengths of this ·model are discussed 
with reference to supporting empirical evidence. 
Chapter Five outlines the aims and research questions to be addressed by the empirical 
investigations included in Section Two of this thesis, and the theoretical implications of 
these investigations. By referring to the literature review presented in earlier chapters, the 
first five research questions are outlined in greater depth. A number of specific and more 
detailed hypotheses and/or exploratory research questions are put forward for the purposes 
of comprehensively addressing each of these five primary research questions. The general 
methods for 'the empirical investigations, presented in Section Two, are set out in Chapter 
Six. 
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The broad aims of the empirical sections of this thesis then are to use the theoretical 
framework outlined in Chapter Four to address the six research questions outlined above. 
The first empirical study, as set out in Chapter Seven, was designed to determine whether 
there is evidence for the existence of two sub-populations of anxious older adults. Having 
established the existence of an early- and late-onset anxiety group, a secondary aim of the 
study was to determine a cut-off point for best deciding to which sub-population a given 
age of onset belongs (Research Question I). The meaning of the results in terms of 
empirical evidence of a bimodal distribution of onset of anxiety disorders is discussed . 
The studies presented in subsequent chapters of Section Two were designed to explore 
differences in the aetiology, phenomenology, and the experience of negative life events 
between of subgroups of anxious older adults. These adults were classified as having early-
or late-onset GAD according to the cut-off age identified in the previous chapter. 
Specifically, the study presented in Chapter Eight aimed to investigate differences between 
sub-groups of older adults with EO and LO GAD across various demographic and clinical 
variables identified as risk factors for anxiety in older persons (Research Question 2). 
Chapter Nine examines and presents the findings of a study investigating potential 
differences in the phenomenology of early- and late-onset GAD (Research Question 3). 
Chapter Ten aimed to examine Research Question 4 by testing the model put forth by Boyd 
et al. (2000). Chapter Ten also examines Research Question 5 by conducting an exploratory 
study investigating the relationship between the experience of negative life events across 
the lifespan and symptoms of anxiety and depression amongst older adults with early- and 
late-onset of GAD. 
Chapter Eleven, as set out in Section Three of this thesis, examines and presents the 
findings of a study designed to investigate the implications of an age at onset di stinction for 
the treatment of GAD in late-life (Research question 6). Finally, Chapter Twelve 
summarises the results of the present empirical investigations with reference to the 
theoretical framework, discusses their implications, limitations and directions for future 
research. Greater understanding of the impact of age at onset of anxiety in late-life has 
important clinical implications, particularly for the treatment and management of anxiety in 
older adults . 
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CHAPTER TWO 
An Introduction to Anxiety in Late-life: Definitions, Prevalence, 
Comorbidity and Risk Factors 
2.1 Definition of Anxiety 
Anxiety is an adaptive emotional reaction that helps prepare young and old for coping 
through resource mobilisation or avoidance, with an anticipated or ongoing event that is 
perceived as noxious or threatening (Sheikh, 2003). Such anxiety becomes pathologic 
when it becomes excessive or maladaptive, and can significantly interfere with an 
individual's ability to hold and fulfil multiple roles (e.g. occupational, family, and social) 
(Lauderdale & Sheikh, 2003). Clinically significant anxiety is manifested by a variety of 
symptoms including (i) cognitive symptoms (nervousness, worry, apprehension , 
fearfulness, irritability); (ii) behavioural symptoms (hyperkinesis, pressured speech, 
exaggerated startle response); and (iii) physical symptoms (muscle tension , chest tightness, 
palpitations, hyperventilation, paresthesias, and sweating) (American Psychiatric 
Association, 1994). 
The major physical symptoms of anxiety in older age groups include muscle tension, 
headaches, pressure in the chest, difficulty swallowing, heart palpitations, and 
gastrointestinal discomfort (Ayers, 2005). These physical symptoms of anxiety are 
reported at a higher rate among older adults than younger age groups. In addition , it has 
been found that older adults who are anxious tend to physically and behav iourally exhibit 
increased agitation and aggressiveness in addition to the typical anxiety symptoms (Leger 
et al., 2000}. Furthermore, sleep disturbance has been found to be one of the major 
distinguishing symptoms in older anxious people (Wetherell , Le Roux, & Gatz, 2003). 
Specific anxiety disorders defined in the Diagnostic and Statistical Manual of Mental 
Disorders (American Psychiatric Association, 2000) include; Panic Disorder (PD), which 
is characterised by recurrent or persistent panic attacks. A panic attack is a discrete period 
in which there is a sudden onset of intense apprehension, fearfulness, or terror, often 
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associated with feelings of doom. During such attacks, symptoms such as shortness of 
breath, chest pain or discomfort, choking or smothering sensations can be present. 
Agoraphobia is defined as anxiety about, or avoidance of places or situations from which 
escape might be difficult, or in which help may not be available in the event of a panic 
attack or panic like symptom. Panic di sorder may occur with or without agoraphobia, and 
agoraphobia without a history of panic di sorder may also occur. 
A Specific Phobia is characterised by clinically sign ificant anxiety provoked by exposure to 
a specific feared object or situation which often leads to avoidance behav iour. Social 
Phobia, on the other hand, is defined by cl inically significant anxiety resulting from 
exposure to certain types of social or performance situations, which simi larly leads to 
avoidance of such situations. Obsessive-Compulsive Disorder (OCD) describes a range of 
obsessions which can cause significant anxiety or distress, or by compulsions, which serve 
to neutrali se anxiety. Pas/traumatic Stress Disorder (PTSD) involves the re-experiencing 
of an extremely traumatic event accompanied by symptoms of increased 
arousal/hypervigilance and avoidance of stimuli associated w ith the trauma. Generalised 
Anxiety Disorder (GA D) is characterised by excess ive and uncontrolled worry of at least six 
months duration (American Psychiatric Association, 2000). This worry or apprehensive 
expectation is accompanied by at least three or more somatic or psychological symptoms. 
These include restlessness, fatigue, muscle tension, irritability, difficulty concentrating, and 
sleep disturbance (American Psychiatric Association, 2000), and there are often marked 
impairments in daily functioning (Wittchen, Zhao, Kessler, & Eaton, 1994). At present, 
GAD is poorly recognised and conse9.uently often undertreated (Keller, 2002). 
2.2 Population Ageing in Australia and its Impact on the Incidence of Anxiety 
2.2.1 Population estimates and projections of an ageing population 
According to the Austra lian Institute of Health and Welfare (AIHW) the number of 
Australians aged 65 years and older is expected to increase from 2.7 million in 2006 to 6.3 
million in 2036, representing 24% of the total population at that time (AIHW, 2007). 
Moreover, the number of older Australians aged 85 years and over requiring the need fo r 
services and assistance has doubled over the past 20 years. This age group is projected to 
7 
increase more rapidly than other age groups from 330 000 in 2006 to I.I million in 2036, 
that is, from 1.6% of the total population to 4.2% (AIHW, 2007). People aged 85 and older 
are also projected to increase their share of the total older population from 12% of older 
Australians in 2006 to 18% in 2036 (AlHW, 2007). 
2.2.2 Anxiety incidence and age 
In addition to the increase in the aged population, the projected figure of psychiatric 
di sorders amongst older adults is estimated as being at least 20% by 2036 (Koder & 
Ferguson, 1998). Results of the 2004-05 Australian Nationa l Health Survey (NHS) of 
mental hea lth (Australian Bureau of Statistics, 2006) revealed that although the majority of 
older people enjoyed good mental hea lth, a sign ificant number of older people (9.5%, or 
approximately 230 800 people) experienced one or more mental or behavioural disorder. 
The most commonly reported mental health problems were mood and anxiety related 
problems ( 4.6% and 4.2% respectively). Additionally, I 0.9% of older adults reported high 
levels of psychological distress, and 24% take medication for their psychologica l or mental 
well-being (AIHW, 2007). 
Research published by the Australian Bureau of Statistics (McLennan·, 1998) also report 
anxiety to be the most common mental disorder among older adults, despite being the most 
under-diagnosed and under-treated. The incidence of anxiety disorders in older adu lts may 
be underestimated due to the finding that older people are twice as likely to decline 
involvement in some surveys and studies (Snowdon, 2001). Thus, although the proportion 
of adults aged 65 and older experiencing anxiety symptoms appears to decline in 
comparison to younger and middle-aged groups, these rates are nonetheless significant 
when considering Australia's ageing population and projected figures for our ageing 
population in years to come. The following section reviews the epidemiologic evidence 
outlining prevalence rates of anxiety di sorders in ger iatric populations in both community 
and clinical settings. This further highlights the impact and importance of investigating the 
experience of anxiety symptoms and disorders in later life. 
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2.3 Prevalence of Anxiety Disorders in Older Adults 
Until recent years, there has been considerable consensus in the research literature that most 
anxiety disorders begin before young adulthood (Barlow, 1988), and that anxiety disorders 
rarely have onset in late-life (Burke, Burke, Regier, & Rae, 1990; Lindesay, 1991 a). This 
has led to the belief that most cases of anxiety disorders among older adults involve 
individuals who have experienced problems with anx iety for many years (Flint, 1994, 
1997; Stanley & Beck, 2000) and epidemiologic studies have generally reported that their 
prevalence declines in later life (Bland, Newman, & Orn, I 988; Regier et al., 1988). Based 
on the conclusions of these early epidemiological studies, anxiety disorders are reported to 
be less common in community-living older adu lts compared with younger adults. Despite 
such beliefs, the occurrence of anxiety symptoms without a prior history has been noted to 
occur in later life and epidemiologic stud ies that have had a strong focus in geriatric 
populations (Beekman, Bremmer, Deeg, van Balkom, & Smit, 1998; Flint, 1994; Lindesay, 
Briggs, & Murphy, 1989; Manela, et al. , 1996) indicate that anxiety disorders are quite 
prevalent amongst older persons. Rates of all anxiety disorders in later life are reported to 
range from 5.5% (Regier, et al., 1988) to 15% (Beekman, et al. , 1998; de Beurs, Beekman, 
Deeg, van Dyck, & van Tilburg, 2000; de Beurs et al. , 1999; Manela, et al. , 1996) 
depending on the characteri stics of the populations sampled (i.e., community-dwelling 
versus institutiona li sed), the diagnostic criteria employed, and the method of eliciting 
symptoms (Sable & Jeste, 2001). 
The Epidemiologic Catchment Area (ECA) survey, which evaluated lifetime and current 
prevalence-of psychiatric disorders in the community, documented a one-month prevalence 
rate of 5.5~ for all of the anxiety disorders in individuals aged 65 and older (Regier, et al. , 
1988; Regier et al. , 1984). This was lower than the rate of 8.3% found for those aged 
between 25-44 years of age, the age at which anxiety is cons idered at its peak prevalence. 
Whilst some have taken the above findings to indicate that anxiety disorders may not 
represent a significant mental health problem in later-life, anxiety disorders were in fact 
found to be more than twice as prevalent as affective disorders, and four to seven times as 
prevalent as major depression in the ECA study (Regier, et al., 1988). Furthermore, the 
prevalence of anxiety disorders amongst older adults in the ECA study is thought to have 
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been underestimated due to its inclusion of community dwelling residents only, and there is 
some suggestion that anxiety disorders appear to be more prevalent among institutionali sed 
older adults (Bland, et al. , 1988). Prevalence rates of anxiety symptoms in geriatric settings 
are reported to range from 19% of nursing home residents (Ouslander, Osterweil , & 
Morley, 1991 ; Parmelee, Katz, & Lawton, 1993) to as high as 44% (K vaal , Macijauskiene, 
Engedal, & Laake, 200 I). The findings suggest that the prevalence of anxiety, however 
variably defined, is much higher in clinical samples than in community samples. 
Prevalence rates of anxiety can further vary when looking at individual anxiety disorders. 
Phobic di so rders (i.e. , agoraphobia, simple phobia and social phobia) have been reported to 
be the most common anxiety disorders in people of a ll ages, including older age groups in 
some studies (Bland, et al. , 1988; Regier, et al. , 1988). Prevalence rates of phobic disorders 
across various studies range from 1 .4% to 25.6% using the Geriatric Mental State (GMS-
AGECA T: Copeland, Dewey, et al., 1987; Copeland, Gurland, et al., 1987), DSM 111 
criteria and the Phobic Disorders Screen (Lindesay & Banerjee, 1993). This variability is 
likely to reflect differences in both the instruments used, and application of hierarchical 
diagnostic rules. Of the phobias, social phobia appears to have a relative ly low prevalence, 
with some authors suggesting the reason being that it is easier for order people to avo id 
social situations (Bryant, et al. , 2008). With regard to prevalence of specific anx iety 
disorders, some studies reporting phobic di sorder to be the most common anxiety disorder 
in older adults (Bland, et al., 1988; Regier, et al. , 1988) did not include GAD in thei r 
surveys, even though GAD has been found to be more prevalent than phobic disorder in 
other studies (Beekman, et al. , 1998). 
When GAD is included as a diagnostic entity in prevalence studies, it is often fo und to be 
the most common anxiety disorder in older persons (Bryant, et al. , 2008), with prevalence 
rates much h·igher than the 4.6% found in the ECA study. Lower prevalence rates reported 
for GAD are in part due to the utilisation of the hierarchical diagnostic system of DSM-111-
R (American Psychiatric Association, 1987), which precludes a diagnosis of GAD if an 
individual has comorbid depression or other anxiety disorders. In Australia, the twelve -
month prevalence rates of non-hierarchical GAD in adults aged c: 65 years was reported to 
be 1.6% in a study of mental health and well being (Hunt, Issakidis, & Andrews, 2002) 
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compared with a peak prevalence rate of 4.9% in younger adults. Flint (1999) has reported 
prevalence rates of GAD to range from 0.7% to 7.1 %. In contrast to findings of studies 
using DSM-III-R hierarchical criteria for GAD, a review of the major community-based 
epidemiological studies reporting data on anxiety disorders in individuals 65 and over by 
Krasucki and colleagues (1998) found the prevalence of GAD to be around 4%. According 
to the Longitudinal Aging Study Amsterdam (LASA: Beekman, et al. , 1998) the rate of 
GAD in later life (7.3%) was more than three times the rate of major depression (2%). 
Panic disorder (PD) and obsessive-compulsive disorder (OCD) are less common in older 
persons, each with an estimated prevalence of I% or less (Beekman, et al. , 1998; Carmin, 
Wiegartz, & Scher, 2000; Regier, et al., 1988). Given the above findings, GAD appears to 
be the most common anxiety disorder in older adults (Blazer, George, & Hughes, 1991; 
Burke, et al. , 1990). 
2.3.1 Summary 
Although it is generally believed that anxiety disorders in older adults are less common 
than depression, epidemiological studies reveal that this is not the case (Beekman et al. , 
2000), and despite reports of a decline in prevalence of anxiety disor-ders among individuals 
aged 65 and over, they nevertheless occur at significant rates (Lynch, Compton, 
Mendelson, Robins, & Krishnan, 2000). About one fifth of older adults are estimated to 
experience clinically significant symptoms of anxiety at any given time (Hocking & 
Koenig, 1995; Manela, et al. , 1996; Sheikh & Salzman, 1995), while 34% are estimated to 
have had anxiety symptoms at some point in their lives (Blazer, Hughes, & George, 1991). 
In addition, anxiety disorders are estimated to occur more than twice as often as affective 
disorders and are four to eight times more frequent than MOD in individuals aged 65 and 
over (Regier, et al. , 1988; Weissman et al., 1985). As such, anxiety disorders are among 
the most common psychiatric illness to affect adults in late-life. Further, on examination of 
prevalence rates of specific anxiety disorders, findings of epidemiologic studies focusing on 
geriatric populations and those studies that do not use the DSM-III hierarchical system for 
assigning diagnoses indicate that GAD appears to be the most common anxiety disorder 
affecting older adults. The prevalence rates, combined with the pervasive and chronic 
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nature of anxiety suggest that there is a need for research on the experience of anxiety, in 
particular GAD, in late life. 
2.4 Impact of Anxiety on the Individual and the Community 
In light of the incidence and prevalence rates outlined in the foregoing sections it is 
apparent that anxiety symptoms can cause considerable suffering to the individual. In older 
adults anxiety is reported to cause considerable subjective distress and impairment (Ayers, 
Sorrell, Thorp, & Wetherell , 2007; Lynch, et al. , 2000), reduced life satisfaction (Brenes et 
al., 2005), and increased risk for the onset of disability, even in high-functioning older 
adults (Seeman et al. , 1995). In addition, GAD is associated with role impairments such as 
being divorced or separated and higher rates of unemployment. It is also associated with 
self-reported interference with daily activities (Wittchen, et al., 1994), more visits to 
primary care providers (Blazer, George, et al. , 1991 ; Kennedy & Schwab, 1997; Wetherell, 
Maser, & van Balkom, 2005), and increased average length of visit ( de Beurs, van Balkom, 
Van Dyck, & Lange, 1999). Anxiety symptoms and disorders also increase the risk of 
mortality as a result of both physical conditions such as cardiovascular disease (Sadavoy & 
LeClair, 1997; Van Hout et al. , 2004), and suicide (Allgulander & Lavoria, 1993). Sub-
threshold symptoms as well as full-blown disorders cause impairment in the psychosocial 
functioning of older adults in later life. 
Because of the adverse consequences of anxiety disorders in older adults in terms of both 
human suffering and excessive or inappropriate health service use, the treatment of geriatric 
anxiety, specifically of GAD, is an important issue (Wetherell , Sorrell, Thorp, & Patterson, 
2005). One follow-up study of older adults with untreated anxiety symptoms suggests that 
anxiety in this population generally does not remit spontaneously over the course of two to 
three years (Livingston, Watkin, Milne, Manela, & Katona, 1997). Further, the majority of 
older adults who receive treatment for anxiety symptoms are prescribed with medications. 
Epidemiological data suggest that the rate of benzodiazepine use among older persons is 
14% higher than rates for younger adults, and anxiety-related disorders have been noted to 
constitute the most frequent use for these drugs in both younger and older patients 
(Schneider, 1996). 
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Benzodiazepine users have been found to be more like ly than non-users to experience 
accidents requiring medical attention (Oster, Russell , Huse, Adams, & Imbimbo, I 987), 
and the use of long half-life benzodiazepines such as diazepam (valium) have been 
associated with increased risk of hip fracture (Ray, Griffin, & Downey, 1989). In addition 
to sedation, the toxic effects of benzodiazepines in older adults include unsteadiness, fa ll s, 
confusion and impairment in memory and other cognitive functions , even at low doses 
(Schneider, 1996; Wengel , Burke, Ranno, & Roccaforte, 1993). Schne ider notes that 
despite the ir di sadvantages and limitations in safe use for older patients, benzodiazepines 
remain the treatments of choice for acute or subacute anxiety symptoms amongst medical 
practitioners. 
2.5 Comorbidity of Anxiety and Depression 
Comorbidity is an important issue in the consideration of anxiety disorders in both the 
research literature and in clinical practice with o lder adults. According to Bryant et al. , 
(2008), the neglect of anxiety in its own ri ght may be a consequence of the view that 
anxiety di sorders rarel y occur in the absence of depressive symptoms. Indeed, empirica l 
evidence po ints to frequent co-occurrence of anxiety and depress ion , with literature 
reporting rates ranging from 30-70% in various populations of mixed age and older adults, 
including community dwelling, those in clinical settings (Alexopoulos, I 991; Blazer, 
Hughes, & George, 1987; Regier, Narrow, & Rae, 1990), and amongst institutiona lised 
older adults (Parmelee, et al. , 1993). Given that anxiety disorders and depression are 
closely re lated in late-life, models put forth in the depression literature may therefore have 
some explanatory value for understanding late- life anx iety. As such, an understanding of 
the relationship between anxiety and depress ion in late-life is necessary. The following 
sections provide an overview of this relationship w ith respect to specific anxiety di sorders, 
and of the temporal sequencing in the onset of comorbid anx iety and depress ion. 
Assessment of anxiety and depression at the syndromal or diagnostic level of caseness has 
shown the two to be highly correlated, even when categorical definitions and strict 
operational criteria are used (Angst, 1996; Kess ler et al., 1994). Furthermore, studies of 
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older adults suggest that both disorders often share common risk factors, and since some 
symptoms are common to both of these disorders (e.g. irritability, sleep and appetite 
disturbance, difficulty concentrating, poor memory), it may be difficult to distinguish 
between anxiety and depression. Further barriers to teasing out this relationship include the 
use of hierarchical case definition, whereby participants of studies using this criterion who 
are cases of depression are not deemed cases of anxiety. Under-reporting of anxiety 
symptoms to a greater extent than depression by older people, as well as under-recognition 
of symptoms by medical practitioners further add to this difficulty (Bryant, et al. , 2008). In 
any case, it is c lear that the prevalence of anxiety disorders in people with depression and 
vice versa is much higher than would be expected by chance. Lenze et al. (200 I) reported 
that approximately 85% of adults with depression have significant symptoms of anxiety, 
while Jeste, Hays and Steffens (2006) found that 42% of their depressed sample endorsed 
comorbid anx iety symptoms. In another study Maser and Cloninger (1990) reported that 
about one-th ird of older adults with an anxiety disorder meet the criteria for depression, and 
about two-thirds of depressive patients meet the diagnostic criteria for an anxiety disorder. 
Anxiety and depressive symptoms frequently coexist to varying degrees within MDD, DD, 
PD, and GAD (Beekman, et al., 2000; Katon & Roy-Byrne, f991). A study of the 
prevalence rates of anxiety and depression in a community-dwelling sample of older adults 
by Lindesay et al. ( 1989) found that 39% of phobic participants also had depression, 
compared to only 11 % of participants without phobias. Comorbidity was found to be 
highest in participants diagnosed with GAD, 91 % of whom also had a diagnosis of 
depression . In another study of anxiety prevalence Manela, et al. (1996) reported a high 
level of comorbidity between GAD and depress ion, reporting major depression to occur in 
up to 70% of older persons with GAD. In a more recent study Lenze et al. (2000) found that 
almost 28% of patients with major depression aged 60 and over had concurrent GAD. 
Further, up to 75% of older depressed patients have clin ically significant subsyndromal 
symptoms of generalised anxiety (Copeland, Davidson, & Dewey, 1987). 
In comparison with either depression or generalized anxiety, the co-occurrence of 
depression and general ized anxiety is reported to represent a more severe and more chronic 
psychopathology (Holwerda et al. , 2007). Moreover, remission rates for depression and co-
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existing generalized anxiety are lower in comparison with ' pure ' depression or ' pure ' 
GAD. Although high levels of comorbidity between depressive disorders and anxiety 
disorders have been found, anxiety disorders and depressive disorders merit separate study 
because risk factors reveal more differences than similarities (Beekman, et al. , 2000). 
Furthermore, different neurobiological mechanisms in generalized anxiety and depression 
indicate a biological distinction between generalized anxiety and depression (Nutt, 2001 ). 
Whilst the literature reviewed above demonstrates the evidence of substantial comorbidity 
between both anxiety and depressive disorders in people of all ages (Byrne, 2002), there is 
uncertainty about which disorder is likely to have developed first among older patients. A 
number of researchers have reported the onset of most anxiety disorders to precede that of 
MDD (Brown, Campbell, Lehman, Grisham, & Mancill , 2001 ; Mineka, Watson, & Clark, 
1998; Sanderson, Beck, & Beck, 1990; Schneier, Johnson, Hornig, Liebowwitz, & 
Weissman, 1992; Schoevers, Beekman, Deeg, Jonker, & Van Tilburg, 2003b; Schoevers, 
Deeg, van Tilburg, & Beekman, 2005 ; Stein, Tancer, Gelernter, Vittone, & Uhde, 1990; 
Wittchen, Carter, Pfister, Montgomery, & Kessler, 2000). In addition, the risk of depression 
in individuals with chronic anxiety disorders such as GAD is reported to be greater than the 
risk of anxiety in individuals with depressive disorders (Angst, 1996). Findings of the 
National Comorbidity Study (NCS: Kessler et al. , 1996) and a second population based 
study by Hettema, Kuhn, Prescott and Kendler (2006) indicate that prior existence of any 
anxiety disorder significantly increases the risk for subsequent development of MDD, with 
the strongest risk attributable to previous GAD. Of note was the finding of the NCS study 
that approximately 68% of participants reported the onset of MDD to have followed the 
onset of an anxiety disorder. This figure exceeded rates of substance use disorders (19.2%) 
and dysthymia (1.8%). Analyses further indicated that GAD was typically the temporally 
primary disorder in relation to depression among people with comorbid anxious depression 
(Kessler, Keller, & Wittchen, 200 I ; Kessler, et al. , 1996). Longitudinal studies 
investigating the issue of comorbidity between anxiety disorders and depression report 
similar conclusions to those of a cross-sectional nature (de Beurs et al. , 200 I; Schoevers, et 
al., 2005). Longitudinally, although not all individuals with anxiety symptoms or disorders 
develop depression, studies in all age groups typically find a pattern of progression from 
anxiety to depression (Schoevers, et al. , 2005). 
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2. 5 .1 Summary 
Evidence suggests that 38% to 46% of older adults with depression have comorbid anxiety 
disorders, most notably GAD (Beekman, et al., 2000; Lenze, et al., 2000), whereas 15% to 
30% of older adults with anxiety disorders have comorbid depression (Beekman, et al. , 
2000; van Balkom et al. , 2000). Although it is thought by many clinicians that most anxiety 
disorders in older adults are comorbid with depression, anxiety disorders without comorbid 
depression are much more common than depression without comorbid anxiety (Beekman, 
et al., 2000; Le Roux, Gatz, & Wetherell , 2005). With regard to the temporal sequence of 
onset, findings of two separate investigations have revea led that the most common lifetime 
pattern of comorbidity was GAD preceding depression (Lenze et al. , 2005 ; Schoevers, et 
al., 2005). 
Although there is considerable overlap between anxiety and depression, the distinctions still 
appear to be meaningful (Teachman, Siedlecki, & Magee, 2007). Clark and Watson (1991) 
note that findings of high comorbidi ty between the two disorders can be reversed to 
highlight the fact that approximately half of all persons diagnosed with depression do not 
have an anxiety diagnosis, suggesting that they are di stinct disorders, and as such, warrant 
separate investigation. In order to investigate the presentation and experience of anxiety 
disorders in old age, it is first necessary to gain an understanding of the risk factors 
associated with anxiety in later life. 
2.6 Risk Factors for Anxiety in Later Life 
The research conducted on older adults with anxiety di sorders has shown that the clinical 
experience of these disorders is complex. Fortunately, research in the area has gone some 
way to delineating the nature of thi s experience and previous investigations have identified 
a number of risk factors that may be associated with symptoms and clinically relevant 
levels of anxiety di sorders in older persons. These factors may be broadly categorised as 
social, biological, and psychological. Findings of these studies suggest that though 
longstanding vulnerability factors such as family and personal histories of anxiety may 
have a role in the risk profile of anxiety disorders in older persons, the prevalence of risk 
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factors such as deteriorating physical health, cognitive decline, and a diminishing social 
network, combined with medical advances allowing older adults to live longer, may 
contribute to or account for the increasing prevalence of anxiety disorders in later life. 
Knowledge of risk factors for anxiety in older persons may help increase the power of 
detecting this disorder in later life, and may contribute to the development of preventative 
measures. Risk factors known to contribute to the aetiology of anxiety in older adults will 
be outlined in the present section with a view to developing an understanding of the 
presentation of anxiety in late-life and investigating potential differences in the relationship 
of these risk factors with early-and late-onset of anxiety in subsequent chapters of this 
thesis. 
2. 6.1 Social Risk Factors 
Demographic characteristics 
Data from studies that have examined variables associated with the development of anxiety 
in late-life (Beekman, et al. , 1998; Beekman, et al. , 2000; de Beurs, et al. , 2000; de Beurs, 
et al., 2001; Flint, I 997, 2005b; Lenze, Shear, Mulsant, & Reynolds, 2002; Schaub & 
Linden, 2000) suggest that older women have a much greater chance of experiencing an 
anxiety disorder than older men. These findings are consistent with those of the ECA 
survey (Regier, et al., 1988; Weissman, et al. , 1985), in which older women were found to 
be at greater risk of experiencing an anxiety disorder relative to older men, with a reported 
ratio of 2: 1. Specifically, female sex and high neuroticism put one at risk for developing 
anxiety symptoms, and for remaining anxious as well (de Beurs, et al. , 2000). 
With regard to other demographic variables considered to be risk factors for anxiety, lower 
levels of education have been found to be significantly associated with GAD in late-life. 
(Beekman, et al., 1998; de Beurs, et al. , 2000). Differences found for marital status are in 
favour of married subjects, with separation, widowhood, or being divorced increasing the 
probability of suffering generalised anxiety (Beekman, et al., 1998; Beekman, et al. , 2000; 
Wittchen, et al. , 1994). In line with these findings , Schaub and Linden (2000) found 
separated, divorced, or single subjects to perceive more anxiety of the phobic and panic 
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type. This finding was independent of age group, further indicating that being married 
might exert a protective function against anxiety. 
Qualitative aspects of social network: Lack of social support, loneliness and negative life 
events 
Investigations of risk factors based on data from the Longitudinal Aging Study Amsterdam 
(LASA: Deeg, Knipscheer, & van Tilburg, I 993) have found a small social network and 
less exchange of emotional support to be significantly associated with phobic diso rders, 
whilst loneliness was found to be significantly associated with GAD. As such, social 
support has been reported to be a protective factor, with other investigations reporting 
social support to be associated with a lower likelihood of developing an anxiety disorder 
when exposed to stressful events (Beekman, et al. , 1998; de Beurs, et al. , 2001). In another 
study investigating predictors of change in anxiety symptoms over time, no social 
functioning risk factors were found to be associated with developing anxiety (de Beurs, et 
al., 2000). 
Regarding the role of negative life events, both recent losses in the family (widowhood) 
and suffering chronic physical illness have been found to be significantly associated with 
anxiety disorders (Beekman, et al., 1998; de Beurs, et al., 2000; Vink, Aartsen, & 
Schoevers, 2008). In particular, PD and OCD have been found to have the strongest 
associations with partner loss, chronic physical illness, and poor subjective health , whilst 
experiencing negative events in World War II (WWII) is significantly associated with GAD 
(Beekman, et al., 1998). Having experienced a traumatic event such as being a victim of 
crime is associated with phobic disorders among older adults (Lindesay, 1997). 
2. 6.2 Biological Risk Factors . 
Chronic disease and vascular factors 
Studies investigating the association between chronic disease and vascular factors with 
anxiety symptoms in late-life have found both cognitive impairment (Forsell & Winblad, 
1998) and high blood pressure (Paterniti et al., 1999) to be correlated with anxiety 
symptoms. With regard to investigation of chronic disease, Beekman et al. (] 998) found 
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chronic diseases to be weakly assoc iated with any anxiety disorder and strongly, but not 
significantly, associated with PD and OCD. In another study, van Zelst et al. (2003) found 
the number of chronic health conditions experienced by o lder adults to be correlated with 
anxiety disorders in late-life. 
Self-perceived health 
Poor self-perceived health has been found to be significantly associated with GAD 
(Beekman, et al. , 1998), and has been reported to be a better predictor of decline in mental 
health than chronic di seases (de Beurs, et al., 2001). De Beurs and colleagues findings are 
consistent with previous findings of Beekman et al. (1998), that subjective evaluations of 
physical hea lth were more strongly associated with anxiety disorders than more objective 
measures of physical health. Accordingly, how respondents experience their own health is 
reported to predict subsequent emotional functioning more strongly than their obj ective 
health status, consistent with findings reported by Bath and Morgan (1998; cited in de 
Beurs, et al., 200 l ). In another study investigating predictors of change in anx iety 
symptoms over time by de Beurs et al., (2000), those with a perception of poor health were 
also found to be more likely to become or remain anxious. Similarly, chronicity of anxiety 
symptoms was also associated with decreased subjective health and increased limitations in 
functioning. 
Disability 
Using data from the LASA (LASA: Deeg, et al. , 1993), Beekman et a l. (1998) found that 
suffering functional limitations, categorised as di sability, had the most consistent 
association with all anxiety disorders, including a significant association with GAD. These 
findings are consistent with research in which those with greater functi onal limitations and 
problems with hearing and/or eyes ight were more likely than those not suffering such 
problems to become or remain anxious (de Beurs, et al., 2000), and with later reports of a 
correlation between functional limitations and anxiety di sorders (Beekman, et a l. , 2000; 
Schoevers, et al. , 2003b; van Zelst, de Beurs, Beekman, Deeg, & van Dyck, 2003). 
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Genetic factors 
A family history of anxiety is a strong predictor of anxiety disorders (Rapee, 2002). There 
is a growing consensus in the research literature that some aspects of anxiety run in families 
and are almost certainly heritable (Barlow, 2002). However, what seems to be inherited is a 
' vulnerability' to develop an anxiety disorder, rather than a specific clinical syndrome itself 
(Malcarne & Hansdottir, 2001). This is consistent with findings that older adults with 
anxiety disorders have a family history (parents and/or s iblings and relatives) with an 
anxiety disorder (Beekman, et al. , 2000; de Beurs, et al., 2000). Several studies have also 
shown a strong link between anxiety disorders in an individual and their first-degree 
relatives (Crowe, Noyes, Pauls, & Slymen, 1983; Noyes, Clarkson, Crowe, Yates, & 
McChesney, 1987; Rapee, 2002). Other research focused specifically on parents has shown 
that anxious children and their parents are likely to be concordant for anxiety disorders 
(Beidel & Turner, 1997). 
2. 6. 3 Psychological Risk Factors 
In a study of which risk factors are most important for anxiety disorders amongst older 
persons, Beekman et al. (1998) investigated a range of personality factors and found an 
external locus of control to be significantly associated with GAD (Beekman, et al., 1998; 
Beekman, et al., 2000). In another study, again using data from the LASA study (LASA: 
Deeg, et al., 1993), de Beurs et al. (2000) found high neuroticism, low self-efficacy and low 
mastery all to be predictors of becoming anxious in later life. Overall, personality traits 
such as external locus of control (Beekman, et al. , 2000) and neuroticism (van Zelst, et al. , 
2003), dysfunctional coping (Coolidge, Segal , Hook, & Stewart, 2000) and 
psychopathology (de Beurs, et al., 2001; Forsell, 2000; Schoevers, et al. , 2003b; Schoevers, 
et al., 2005) are all found to be cross-sectionally and longitudinally associated with anxiety 
symptoms and disorders. 
2.6.4 Summary 
The reviewed studies reveal that longitudinally, female gender, low education, being single 
as well as personality traits, inadequate coping strategies, previous psychopathology and 
20 
qualitative aspects of one's social network are all risk factors associated with the incidence 
of anxiety disorders in older adults (Beekman, et al. , 1998; Beekman, et al. , 2000; de Beurs, 
et al., 2000; de Beurs, et al., 200 I ; Forsell , 2000; Schoevers, et al., 2005 ; van Zelst, et al. , 
2003; Vink, et al. , 2008). Anxiety complaints in late-life are closely linked with poor 
physical health and depression (Stanley & Beck, 2000), with generalised anxiety or panic 
symptoms being the usual presentations among these patients (Astrom, 1996; Sembi, 
Tarrier, O 'Neill , Burns, & Farragher, 1998). Chronic diseases and functional limitations 
showed only cross-sectional associations with anxiety disorders ; however, findings from 
cross-sectional and longitudinal studies were found to be similar. Of the stress-related 
factors associated with developing an anxiety disorder in late-life, poor self-perceived 
health is associated with the development of anxiety in older adults, as are functional 
limitations (i.e. limited ability to perform day to day activities) (Le Roux, et al., 2005), and 
distress due to negative life events (traumatic early experiences and recent losses) 
(Beekman, et al. , 1998; Iketani , et al. , 2004). Moreover, personality traits including high 
neuroticism, low se lf-efficacy, low mastery, and external locus of control are all associated 
with anxiety symptoms and disorders in older adults. 
2. 7 Conclusions 
Anxiety symptoms and disorders are a significant mental health concern facing older adults 
in Australia and abroad, and will continue to be so in the coming years. Despite reports of a 
decline in the prevalence of anxiety disorders in later life, epidemiological evidence 
suggests that anxiety disorders, in particular GAD, are in fact highly prevalent in older 
adults (Beekman, et al. , 1998; Manela, et al., 1996; Regier, et al., 1984). Furtheremore, the 
pervasive and chronic nature of anx iety poses a major problem in later life (Beekman, et al. , 
1998; de Beurs, et al. , 2000; de Beu rs, et al. , 200 I ; Deeg, et al., 1993 ). Evidence supporting 
a distinction between anxiety disorders and depression in later life and highlighting the 
negative consequences of this comorbidity in adult populations further indicate that the 
presentation and treatment of anxiety disorders in older adults warrants investigation in and 
of itself. 
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With regards to risk factors for anxiety in late-life, both cross-sectional (Forsell & Winblad , 
1998; Paterniti, et al., 1999; Stevens & Andersson, 1996) and longitudinal studies 
(Beekman, et al., 1998; Beekman, et al. , 2000; de Beurs, et al., 2000; de Beurs, et al. , 2001 ; 
Forsell, 2000; Schoevers , et al., 2005; van Zelst, et al. , 2003) have identified a number of 
risk factors associated with symptoms and clinically relevant levels of anxiety disorders in 
older persons. These include female gender, less education, functional limitations, fair or 
poor subjective health, external locus of control, low self-efficacy, neuroticism, traumatic 
early life experiences, and recent losses (Beekman, et al. , 1998; Beekman, et al. , 2000; de 
Beurs, Beekman, et al. , 1999). These findings are not however specific to an onset 
distinction. Accordingly, knowledge regarding the relationship between these biological, 
psychological and social risk factors and age of onset is as yet unknown. It will be seen in 
coming chapters that some of these risk factors are likely to be long-standing and therefore 
more relevant to an early age of onset, for example personality traits, early trauma 
experiences (e.g. experiencing WWII) and genetic factors. Others are events or 
circumstances which are particularly likely to occur in later life and with increasing 
frequency. These include bereavement, declining physical health and strength, loss of 
cognitive capacity and increasingly restricted social network. In itself, this is an argument 
for investigating whether there is a qualitatively different late-onset subtype of anxiety 
disorders. 
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CHAPTER THREE 
Empirical Evidence of a Distinction in the Aetiology and Clinical 
Experience of Early- and Late-onset Anxiety 
Whilst knowledge regarding the importance and implications of age at onset for anxiety 
disorders is limited, there is some empirical support for a distinction in the aetiology and 
phenomenology of early- and late-onset anxiety disorders. Amongst the anxiety literature, 
preliminary evidence of these differences exists for panic disorder (PD), and to a lesser 
degree, PD with agoraphobia. More recently, generalised anxiety disorder (GAD), 
previously highlighted as a disorder commonly known to occur in later life, has been a 
focus of interest regarding an onset distinction. The present chapter reviews this literature 
with a view to outlining our current understanding of the relationship between age of onset 
and the experience of these anxiety disorders in late-life. Firstly, it provides a definition of 
'late-onset' as defined in the depression literature, in which onset research was first 
established. A review of the empirical evidence of an onset distinction in the aetiology and 
phenomenology of anxiety disorders including panic disorder, agoraphobia and GAD 
follows. Finally, this chapter discusses limitations in the current literature with regard to 
definitions of ' age of onset ' and highlights the gaps in our current knowledge regarding an 
onset distinction in late-life anxiety disorders. 
3.1 Definition of 'Late-onset' 
In the depression literature, there is no standard age for ' early onset ' (EO) depression 
(Benazzi, 200 l ), and according to Devanand et al. (2004), a consensus on an age cut-off for 
defining late onset (LO) depression does not exist. As such, LO depression has typically 
been defined as that which starts at an advanced age (Van den Berg, et al. , 200 l ). Based on 
this definition , cut-off points for LO depression have ranged from 50 to 65 years in the 
research literature (Baldwin & Tomenson, 1995; Krishnan, et al., 1995; Reynolds et al. , 
1998; Van den Berg, et al., 2001). Consequently, an onset prior to this age range has been 
variably defined as ' early-onset ', depending on the study and the cut-off selected to 
represent the LO group. For research purposes this method of defining EO and LO has 
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carried through to preliminary investigations of age at onset and late- life anxiety, as 
reflected in the literature reviewed in the following sections. 
3.2. Empirical Support for an Onset Distinction in the Aetiology of Panic 
Disorder (PD) in Late-life 
PD in both younger and older adults has primarily been the focus of onset research amongst 
anxiety disorders (Barzega, et al. , 200 I; Goldstein, Wickramaratne, Horwarth, & 
Weissman, 1997; Hassan & Pollard, I 994; lketani , et al., 2004; Raj , Corvea, & Dagon, 
1993; Sheikh, King, & Taylor, 1991 ; Sheikh, Swales, Carlson, & Lindley, 2004; 
Venturello, Barzega, Maina, & Bogetto, 2002). Studies amongst young adult populations 
report an association between an early age at onset of panic and increased familial risk 
(Battaglia, Bertella, Bajo, Politi, & Bellodi, 1998; Battaglia et al., 1995 ; lketani, et al., 
2004), suggesting that a high genetic loading may be involved in EO PD (Battaglia, et al., 
1995) and that EO PD may be a special clinical subcategory with a distinct biological basis 
(Segui et a l. , 1999). Findings amongst older adult samples are similar. For example, in a 
study of adults aged 60 and over identified as having early- or late-onset PD based on a cut-
off of 35 years, Sheikh et al. (2004) found that 63% of older adults with EO PD had a 
family history of anxiety, versus only 39% of LO PD participants. Though this finding of 
difference was non-significant, it indicates a strong trend towards EO PD having a greater 
association with a positive family history of anxiety, in line with previous investigations of 
age at onset of PD in young adult samples (Venturello, et al., 2002). 
On the other hand, LO cases of PD have been found to be associated with, and/or preceded 
by another psychiatric condition such as other anxiety disorders and mood disorders (Flint, 
1997; Starcevic, Uhlenhuth, Kellner, & Pathak, 1993), alcoholism (Merikangas et al. , I 998) 
certain medical conditions (Flint, 1997; Raj , et al. , 1993), or other life events (Raj, et al., 
1993; Sheikh, et al., 2004; Venturello, et al., 2002). For example, using a cut-off age of 60 
years to distinguish early- from late-onset participants, Raj et al. (1993) found 29% of the 
EO sample and 10% of the LO sample to have mitral valve prolapse (MVP). Thi s was well 
above the rate of 1.4% that is found in the general population for people by their eighth 
decade. As such, Raj et al. propose that MVP may be seen as a clinical marker for the 
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presence of PD. Parkinson ' s disease and chronic obstructive pulmonary disease (COPD) 
were also found to be highly prevalent among LO PD cases. In another study, Hassan and 
Pollard (1994) found that 85% of individuals with LO PD (i.e. onset of PD after the age of 
60 years) had concurrent medical problems, particularly cardiovascular, gastro-intestinal 
(GI), and chronic pulmonary diseases. Furthermore, in 39% of these cases, the panic attacks 
began at the time of an acute medical illness (Flint, 1997). Comparisons with an EO sample 
were not made in this study. 
In a study of EO and LO PD in a young adult sample identified using a cut-off age of 18 
years, Venturello et al. (2002) found a significantly higher number of adult onset patients to 
report a greater mean number of life events than patients in the EO group. The number of 
LO PD patients who experienced at least one severe event was also higher. Their data 
indicates that the role of precipitating events in PD is significantly higher in the LO group, 
and that environmental factors are perhaps less relevant in the development of PD in EO 
patients. In line with this, in an earlier investigation in a sample of older adults, Raj et al. 
(1993) found a trend for subjects with LO PD (onset 2'. 60 years) to report a higher level of 
stress at the time of evaluation, with medical events and finan cial and interpersonal 
problems cited as stressors occurring prior to episode onset. These findings are not 
supported by those of Sheikh et al. (2004) who, using a cut-off of 35 years and older to 
distinguish LO PD from EO PD, found no difference between early- and late-onset groups 
of adults with late-life PD on number of life stressors experienced in the year prior to onset 
of PD, as assessed by the Psychiatric Epidemiology Research Interview Life Events Scale 
(PERJ: Dohrenwend, Krasnoff, Askenasy et a l. , 1978; cited in Sheikh, et al. , 2004). 
3.3 Empirical Support for an Onset Distinction in the Phenomenology of Panic 
Disorder in Late-life 
Preliminary studies (Sheikh, et al. , 199 1; Sheikh, et al. , 2004 ; Sheikh, Swales, King, 
Sazima, & Bail, 1998) suggest poss ible age-related differences in the phenomenology, 
history and course of PD. Initial data suggests that among older PD patients, those with 
onset later in life (onset> age 55) are less symptomatic in some panic-associated domains, 
report less anxiety and arousal, report higher levels of functioning, present with less 
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avoidance behav iour compared to EO patients, and in general , have less severe PD 
(Hocking & Koenig, 1995; Segui, et al. , 1999; Sheikh, et al. , 1991 ). These findings are 
supported by those of Segui et al. ( 1999) w ho found LO PD patients with an onset age of 
60 years and older to report less severity of PD than those with EO. Similarly, Katerndahl 
and Talamantes (2000) found that those with LO panic attacks (onset 2: 50 years of age) 
typically represent a less severe form of disorder, with lower levels of comorbidity, less 
mental hea lth services utilisation and a greater number of positive coping behaviours than 
those with EO panic attacks (onset < 50 years). 
By contrast, a study of early versus late onset PD in a young adult sample by Tketani et a l. 
(2004) revea led no significant differences between onset groups in number of DSM-111-R 
panic symptoms, frequency of panic attacks, prevalence of agoraphobia, or in scores on the 
Spielberger State-Trait Anxiety Inventory (STAI: Spielberger, Gorsuch, Lushene, Vagg, & 
Jacobs, I 983) for patients whose onset of PD occurred before or after 25 years of age. 
Similarly, in a sample of older adults, Raj et al. ( 1993) reported that although LO (onset 2: 
60 years) participants were found to experience significantly more shortness of breath, with 
a trend towards reporting more chest pain or pressure, overall the symptoms experienced by 
both EO and LO patients during panic attacks were similar. Based cin the ir findings, Raj et 
al. (1993) concluded that the data showed few differences bel\veen EO and LO panic in 
terms of phenomenology, suggesting that the two subtypes are not different di sorders. 
These finding are consistent with those of Sheikh et a l. (2004), who found that the number 
of panic symptoms endorsed on the Structured C linica l Interview (SCID-I/P : F irst, Spitzer, 
Gibbon, & Williams, 1995; SCID-P: Spitzer, Williams, G ibbon, & First, 1990) and severity 
of panic did not differ between onset groups di st inguished by a cut-off of 35 years, in line 
with prev ious findings (Battaglia, et al. , I 995 ; Goldstein, et al. , 1997; Segui, et al. , 1999) 
and consistent w ith findings of Iketani et al (2004). Sheikh et al. (2004) also fo und that 
older adults w ith early- and late-onset PD did not di ffer w ith respect to scores on the Beck 
Anxiety Inventory (BAI: Beck, Epstein , Brown, & Steer, 1988), the Agoraphobic 
Cognitions Questionnaire (ACQ: Chambless, Caputo, Bright, & Gallagher, l 984), and the 
Beck Depression Inventory (Beck, Ward, Mendelson, Mock, & Erbaugh, 196 1 ). As such, 
the re lationship bel\veen age of onset and the phenomenology of late life PD remains 
unclear. 
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3.4 Empirical Support for an Onset Distinction in the Aetiology and 
Phenomenology of Agoraphobia in Late-life 
In contrast to other anxiety disorders, studies that have examined the incidence and age at 
onset of phobias have found that many cases of agoraphobia in late life are a new onset 
(Eaton et al., 1989; Lindesay, 1991 b). Lindesay ( 1991 b) found that many older subjects 
with LO agoraphobia (onset~ 60 years of age) attributed the start of their fears to negative 
health events such as acute physical illness, falls , or to traumatic events such as muggings. 
Lindesay ( 1991 b) also found an association between phobic disorders and early parental 
loss due to separation or death , suggesting that these early life experiences may confer a 
vulnerability to the development of phobias in old age (Flint, 1997). 
In a study of risk factors and illness characteristics of agoraphobia in older adults, McCabe, 
Cairney, Veldbuizen, Herrmann, and Streiner (2006) found no differences in the proportion 
of individuals who reported early (onset :S 54 years) versus LO (onset ~ 55 years) across 
age groups, marital status, education, first language, major depression, or panic attacks. In 
another study by Lindesay et al. ( 1989), agoraphobia was found to be more prevalent 
among women than men and this gender difference was found to decrease with increas ing 
age, in line with findings ofKrasucki, Howard , and Mann (1999). Older people who were 
widowed or divorced/separated were at higher risk of agoraphobia, whilst individual s who 
were married were at lowest risk. A sizeable proportion of agoraphobia cases in older 
persons reported LO, and thus McCabe et al. (2006) proposed that LO cases may have been 
precipitated by the loss of a spouse who may have acted as a protective factor for a 
vulnerable individual. 
Regarding the hypothesis put forward by Lindesay (1991 b), that the aetiology of 
agoraphobia in older adults may be more related to their health status, McCabe et al. (2006) 
found a higher prevalence of agoraphobia among individuals reporting at least one chronic 
health problem at the bivariate level, but no effect of chronic health problems in the 
multivariate model. Although the direction of the observed relationship is consistent with a 
possible increased risk of agoraphobia among those with medical illness, given the cross-
27 
sectional nature of the study, it is possible that the causal direction is reversed and those 
with agoraphobia are more prone to health problems. 
3.5 Empirical Support for an Onset Distinction in the Aetiology of Generalised 
Anxiety Disorder (GAD) in Late-life 
Available data from older epidemiologic surveys suggest that approximately 50% of 
respondents aged 65 and older report an onset of GAD during childhood or early adulthood, 
and as having symptoms for most of their lives. The remaining respondents report 
developing GAD symptoms within the last five years (Blazer, Hughes, et al. , 1991), 
indicating a bimodal distribution for age at onset of GAD (Beck, Stanley, & Zebb, I 996). 
Despite these findings, very little research has focused on onset differences in GAD in late-
life. An early investigation of differences in the clinical symptoms of GAD by Hoehn-
Saric, Hazlett and McLeod (1993) compared middle-aged adults with a childhood or 
adolescent onset of GAD to those w ith onset after the age of 20, in a samp le aged between 
23 and 60 years. The researchers found that difficulties in marital or sexual relationships, a 
past hi story of psychiatric illness, a disturbed home environment in childhood, symptoms 
of anxiety in childhood, inhibited or avoidant behaviour, and difficulties in social 
interactions during childhood differentiated the two onset groups. In particular, the EO 
group showed significantly greater dysfunction or severity on all of these variables. The 
samples investigated by Hoehn-Saric et al. (1993) did not include older adults however, 
limiting the genera lisabilty of their findings to samples of older patients with GAD. Aside 
from this early study, only one other study had investigated the role of age at onset in the 
presentation of late-life GAD (Beck, et al. , I 996) in over a decade, until a study by Le 
Roux et a l. (2005). This gap in knowledge highlights the fact that despite its prevalence and 
potentially serious consequences, GAD in older adults has received relatively little research 
attention. 
In an effort to ga in more information on an age of onset distinction Le Roux et al. (2005) 
examined the distribution of age at onset and correlates of late-life GAD in a sample of 
older adu lts recruited for a psychotherapy study. Part icipants were distinguished as having 
early- or late-onset using a threshold of 50 years. No differences were found between onset 
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groups for age, gender, marital status or education. These findings are consistent with those 
of Beck et al. (1996) who, using an age cut-off of fifteen years or less to define EO and 39 
years or greater to identify those with LO GAD in a sample of older adults, found onset 
groups to be simi lar with respect to age, education, gender, ethnicity, and amount of time 
spent worrying. EO and LO groups of older adu lts were also found to be alike with regard 
to gender, ethnicity, marital status, and employment status in an investigation of late-life 
GAD by Chou (2009). In contrast to previous findings however, Chou found respondents in 
the LO group (onset :C: 50 years) to be significantly older than EO participants (age < 50 
years) and to have a significantly lower level of education than those in the EO group. 
Regarding health characteristics, Chou (2009) found that onset groups were similar with 
regard to rates of various cardiac conditions, stomach conditions and arthritis. Among those 
with lifetime GAD (at least one episode of GAD), those with a LO were significantly more 
likely to report hypertension, poor role functioning, bodily pain and poor self-rated health 
than those with an EO. On the other hand , among those with current GAD (episode onset in 
the year preceding interview), EO and LO groups of older adults were not found to differ 
on these factors. In a study by Le Roux et al. (2005) EO patients were found to be taking 
psychotropic medications at a higher rate than LO patients, to have higher rates of a hi story 
of counselling and/or psychotherapy and to be significantly more likely to report 
psychiatric comorbidity. No significant differences were found between groups for number 
of medical cond itions, self-rated health, or physical disability (Le Roux, et al. , 2005). LO 
patients, however, reported significantly more limitations in role functioning due to 
physical problems. Based on these findings, Le Roux et al. (2005) suggest that role 
disability, as opposed to physical disability, may be a risk factor for the development of 
GAD in late life, consistent with findings from the LASA suggesting that functional 
impairment is strongly associated with anxiety (Beekman, et al. , 1998). These findings are 
not however supported by those of Lenze et al. (2005), who found no differences between 
early- and late-onset groups of GAD patients in activities of daily living (AOL) score, and 
cite no support for hypothesised differences in disability as being greater in LO cases (i.e. 
those with onset of GAD at 60 years of age or older). 
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With regard to stressful life events, Le Roux et al (2005) did not find participants with LO 
symptoms of GAD to be more likely to have experienced negative life events such as 
widowhood, poor health or cognitive impairment than those with EO GAD. These findings 
are consistent with those of Lenze et al. (2005), who found no differences between the EO 
and LO GAD groups in age, mini-mental state examination (MMSE) score, rates of 
cardiovascular illness, and rates of cerebrovascular illness. Both Lenze et al. (2005) and Le 
Roux et al. (2005) note that findings of no difference in physical health, cognitive 
impairment and other negative events may be a result of lack of sensitivity of the measures 
selected. 
The role of psychological risk factors such as locus of control and self-efficacy has not 
previously been examined in investigations of an onset distinction in late-life anxiety 
disorders. In a previous study by Hoehn-Saric et al., (1993), the Eysenck Personality 
Inventory (EPI: Eysenck & Eysenck, 1975) was used to assess personality traits of 
introversion, extraversion, and neuroticism. Analyses revealed that the EO group scored 
significantly higher on the neurotic ism scale of the EPI than the LO group. These findings, 
along with higher scores on a measure of trait anxiety and a more obsessive personality as 
rated by the Psychiatric History Rating Scale (PHRS) for the EO grciup, led the authors to 
conclude that EO patients differ from those with LO GAD with respect to vulnerability to 
anxiety (Hoehn-Saric, et al., 1993). 
3.6 Empirical support for an Onset Distinction in the Phenomenology of Late-
life G_AD 
In a review of patients with GAD in a middle-aged sample, Hoehn-Saric et al (1993) found 
that patient~ with an onset in childhood or adolescence (onset< 20 years of age) did not 
differ with regards to symptoms of anxiety from those who had an onset after 20 years of 
age. Based on their findings , Hoehn-Saric and colleagues concluded that once GAD is 
developed, the anxiety symptoms become similar in the two groups. That is, if patients 
were assessed solely by DSM-III-R criteria for GAD, one would not find a difference in the 
two sub-groups. In line with these findings, Beck et al. (1996) compared a sample of older 
adults with EO GAD (onset:". 15 years of age) to those with LO GAD (onset::> 39 years) 
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and found no significant differences between groups on the STAI State -Scale (STAI-S: 
Spielberger, et al., 1983), the Hamilton Anxiety Scale (HAM-A: Hamilton, 1959), the Penn 
State Worry Questionnaire (PSWQ: Meyer, Miller, Metzger, & Borkovec, 1990) or on the 
BDI (Beck, et al., 1961 ). Early-and late-onset groups were also found to be similar with 
regards to the severity of worry about finances, health, and social concerns using the Worry 
Scale (WS: Wisocki, Handen, & Morse, 1986) to assess the severity of worry in these three 
domains. Participants with EO GAD were however found to report significantly higher trait 
anxiety on the STAI Trait -Scale (STAI-T: Spielberger, et al. , 1983). They were also rated 
as more depressed on the Hamilton Rating Scale for Depression (HRSD: Hamilton, 1960) 
and were found to have a higher level of clinician-rated severity of GAD as compared to 
the LO sample, though this trend was noted to be marginally significant (p < .055). As a 
result of their findings, Beck and colleagues (1996) concluded that examination of age of 
onset suggested few differences between those adults reporting worry onset during 
childhood and adolescence versus adulthood. 
On the other hand, Le Roux et al. (2005) found partial support for their hypothesis that EO 
patients would experience more severe symptoms than LO patients and that the clinical 
presentation of GAD differs between those with EO and LO. Specifically, they found that 
EO patients had significantly higher scores on the PSWQ (PSWQ: Meyer, et al. , 1990), 
and had greater interviewer-rated GAD than LO patients. Findings of Le Roux et al. , 
(2005) also indicated that pathological worry appears to be more prominent relative to 
somatic anxiety symptoms or depressive symptoms in adults with an EO of GAD. 
However, no significant differences were found between groups in overall anxiety or 
depressive symptoms on scales that assessed anxiety or depression more broadly, for 
example, the Beck Anxiety Inventory (BAI: Beck & Steer, 1993), the BDI (Beck, Steer, 
Ball, & Ranieri, 1996) or the HAM-A (Hamilton, 1959). 
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3.7 Summary of Empirical Support for an Onset Distinction in Late-life 
Anxiety Disorders 
The literature reviewed in the preceding section indicates that the risk factors associated 
with early- and late-age of onset in a variety of anxiety disorders may differ, and may 
contribute to differences in the aetiology and phenomenology of anxiety in late-life. Overall 
the evidence suggests greater psychiatric comorbidity, family history of anxiety, and 
increased clinical severity of symptoms in those with EO of an anxiety disorder. In contrast, 
LO anxiety disorders appear to be associated with greater experiences of life stress, such as 
physical and/or medical illness, and experiences of loss and traumatic events leading up to 
the onset of anxiety. Findings of differences relating to the phenomenology of late-life 
anxiety disorders are mixed however. 
With regard to panic-related symptoms, there is some support for greater severity of clinical 
symptoms and increased comorbidity in patients with EO PD as compared to those with LO 
PD (Goldstein, et al., 1997; Iketani, et al., 2004; Sheikh, et al. , 1991 ; Sheikh, et al. , 2004). 
On the other hand, other studies report no difference in clinical severity of symptoms 
(Battaglia, et al., 1995; Segui, et al., 1999). Mixed findings are similarly reported for GAD, 
with Le Roux et al. (2005) reporting EO ·patients to experience more severe symptoms than 
LO patients with respect to worry and interviewer-rated GAD, consistent with the findings 
of Shores et al. (1992). Alternatively, the findings of Beck et al. (1996) suggest few 
differences in psychopathology between those adults reporting worry onset during 
childhood and adolescence vs. adulthood. As such, the literature is unclear as to whether 
there is an onset distinction in aetiology and phenomenology of late-life anxiety disorders. 
3.8 Limitations in Age of Onset Research in Late-life Anxiety Disorders 
Whilst the_ literature reviewed in the foregoing sections of this chapter indicates that early-
and late-onset anxiety disorders may differ with regard to aetiology and phenomenology, 
findings in support of such differences are mixed. There are a number of limitations in 
onset research that may contribute to this variability in findings. Specifically, there is a lack 
of consistency as to the thresholds used to define and distinguish early- and late onset 
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groups in the study of geriatric disorders. Accordingly, cut-off points selected for defining 
early- and late-onset vary widely between studies. This variability in cut-off age and lack of 
evidence to support the choice of a specific cut-off, in addition to differences in measures 
used to elicit and identify age of onset, may be significant factors as to the mixed findings 
of difference between early- and late-onset anxiety disorders. 
Despite evidence of initial onset of PD in later life (Frances & Flaherty, 1989; Hassan & 
Pollard, 1990; Luchins & Rose, 1989), there is generally no accepted cut-off age for 
distinguishing early- versus late-onset in late-life PD. Age cut-offs for defining "late-onset" 
in studies of PD in older adults have ranged from 20 to 60 years (Katerndahl & Talamantes, 
2000; Segui, et al., 1999; Sheikh, et al. , 2004). In a study investigating differences in the 
phenomenology and course of PD relating to age of onset in older adults, Sheikh et al. 
(2004) report that their decision to use a cut-off of 35 years was based on findings of the 
Epidemiological Catchment Area (ECA) study, according to which onset of most cases of 
PD is between ages 25-29, followed by age 30-34, after which the numbers fall 
precipitously. Similarly, in a study ofEO and LO PD in Japan, Iketani et al. , (2004) defined 
EO as :S 25 years, and LO as over 25 years, according to the distribution of age at onset in 
the sample, a median age of24 years in the ECA study (Burke, et at,· 1990), and the cut-off 
age typically used in previous research (Sheehan, Sheehan, & Minichiello, 1981 ). 
These studies appear to have selected the chosen cut-offs to differentiate early- from late-
onset based on observation of the distribution of onset in a large scale epidemiological 
study (ECA; (Burke, et al. , 1990), and are in line with the theoretical understanding that 
onset of psychiatric illness typically occurs early in life (Barlow, 1988). On the other 
hand, in an investigation of the clinical characteristics of panic disorder in a sample of older 
adults (Raj, et al., 1993), clinical records of all inpatients and outpatients of a geriatric 
service were retrospectively reviewed for a diagnosis of PD with or without agoraphobia at 
discharge. For the purposes of investigation these patients were assigned to the EO group if 
onset of PD occurred at 59 years or earlier, and to the LO group if onset occurred at age 60 
years or later. This latter study by Raj et al. (1993) and previous investigations of age at 
onset and late-life PD (Segui , et al., 1999; Sheikh, et al. , 1991) have used a much later cut-
off to distinguish early-from late-onset groups (i.e., 55-60 years). Moreover, given that 
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analyses were performed on data not initially collected for the purposes of onset research, 
Raj et al. (1993) did not outline a procedure for how age at onset was identified. As such, it 
is also unclear as to whether individuals identified as having a diagnosis of PD were 
experiencing their first episode of PD, or whether their diagnoses at discharge represented a 
recurring disorder. 
In a study investigating the risk factors and illness characteristics of agoraphobia in older 
adults, McCabe et al. (2006) used data from the Canadian Community Health Survey -
Mental Health and Well Being (CCHS 1.2) in order to determine the proportion of 
agoraphobics in their sample who experienced an initial onset after the age of 54, defined as 
LO in their study. The CCHS 1.2 incorporated the use of the World Mental Health 
Composite International Diagnostic Interview (WMH-CIDI), a structured, lay-administered 
diagnostic interview generating International Classification of Diseases (ICD-10) and 
DSM-IV diagnoses. The WMH-CIDI allows for retrospective age-of-onset reports to be 
obtained, with an emphasis on the importance of accurate responses to questions, for 
example, "Can you remember your exact age the very first time you (had the syndrome)? 
Respondents who answer 'no ' can be further probed for a bound of uncertainty by moving 
up the age range incrementally (e.g. , "was it before you started school?" "Was it before you 
became a teenager?"). Despite the wealth of information that is gathered about age at onset 
using the WMH-CIDI, it appears that McCabe and Colleagues did not use this information 
to inform selection of a cut-off for distinguishing between early- and late-onset groups, 
which would be reflective of the distribution of age at onset in their sample. Rather, 
McCabe et al. selected a cut-off point of 55 and older to represent those with LO; whilst 
adults aged · 15-54 represented the EO group. The researchers ' selection of this particular 
cut-off was based on reasoning that many large-scale surveys of psychiatric disorders in the 
general population such as the National Comorbidity Study (NCS: Kessler, et al. , 1994); 
NCS, 1994) exclude adults over 54 years. 
The study by McCabe et al. (2006), together with cut-offs used to define 'LO' in 
investigations of late-life PD points to the fact that selection of a cut-off age for 'LO' across 
onset research appears to be based on theoretical grounds of what defines old age and age 
of onset, though this age in itself can vary between studies. Further, there appears to be 
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little consideration of the distribution of age at onset ascertained in any given sample in 
informing a cut-off that might distinguish samples according to age at onset. Reporting on 
onset distributions in such studies would not only establish a knowledge base allowing for 
identification of patterns or trends in distribution of onset, but would allow for thresholds to 
be based on such a distribution rather than arbitrarily selected cut-offs . Unlike other 
anxiety disorders that show mixed findings, a bimodal distribution in age of onset is fairly 
well documented for GAD (Blazer, George, et al., 1991; Regier, et al., 1988). As such, 
older adults suffering GAD may represent a heterogeneous group consisting of those with 
an onset of symptoms at an early age with a chronic course, and those who appear to 
develop a disorder later in life following a stressful life event (Hoehn-Saric, et al., 1993). 
According to Beck et al. (1996), one of the major problems in making comparisons 
between findings of onset differences and in replicating these findings is the selection of an 
arbitrary cut-off age for the determination of GAD onset. Beck et al. (1996) note that this 
approach does not take into account the current age of the patient in relation to GAD 
duration. As illustrated by Beck and colleagues, if a cut-off age of 21 is selected, this 
strategy would result in both a 25-year-old having GAD for one year and a 50 year-old with 
a 30 year history of GAD being categorised as having LO. To addres-s this limitation, Beck 
et al.'s (1996) investigation of age at onset included a group of older GAD patients whose 
excessive worry began before the age of fifteen, identified as the EO group, and those with 
excessive worry beginning after the age of 39; identified as the LO group. The authors ' 
rationale for selection of the respective age-cut-offs was to form two discrete groups with 
clearly differing recollections of the onset and duration of excessive worry, and to reflect 
the bimodal distribution of age at onset in their sample. Contrary to expectations about the 
impact of GAD duration on selection of cut-off points for identifying early- and late-onset 
groups, findings of few differences between the two groups led Beck et al. (1996) to 
conclude tliat, given both the EO and LO samples in their study had experienced GAD 
symptomatology for a number of years, it was unlikely that the duration of the disorder was 
central in their findings. 
Despite highlighting the problem of onset research as being related to the selection of 
arbitrary cut-off ages (Beck, et al., 1996), the cut-offs selected by Beck and colleagues to 
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distinguish early- and late-onset groups appear to be equally arbitrary. According to their 
classification of EO and LO groups, patients with an onset occurring between the ages of 
16-38 years (i.e. over a 23-year period) were unaccounted for, despite this age range being 
the period during which the onset of anxiety disorders is typically thought to occur 
(Barlow, 1988; Flint, 1994), and at which anxiety disorders are considered to be at peak 
prevalence (Regier, et al. , 1984). The failure to consider onset of GAD within this age-
range further contributes to the current difficulties in drawing conclusions about find ings of 
difference between early- and late-onset GAD in later life. 
An investigation of age at onset of late-life GAD by Le Roux et al. (2005) included 
participants aged 55 and over who were categorised as having early-or late-onset GAD 
based on onset of symptoms occurring before or after the age of 50. Diagnostic interviews 
were conducted using the Anxiety and Depression Interview Schedule for DSM-IV (Di 
Nardo, Brown, & Barlow, 1994). The researchers note that this version was used as 
opposed to the lifetime version (ADIS-IV-L: Brown, Di Nardo, & Barlow, 2004) in order 
to reduce the time and burden of the assessment process for participants. As a result, onset 
information was only collected on participants ' presenting episode and not lifetime 
episodes. Given that the course of GAD can wax and wane with periods of wellness 
between onsets, it remains unclear as to whether the LO sample in their study consisted of 
participants whose first onset was after the age of 50, or whether this group included a 
proportion of participants with recurring disorders, many of whom may have had an initial 
onset much earlier in life. 
3.9 Summary of Limitations in Onset Research 
Although interest in research of an onset distinction amongst geriatric anx iety disorders is 
increasing, the literature reviewed in the foregoing sections of this chapter points to an 
inconsistency across the onset literature with regards to definitions of LO, the thresholds 
used to determine early and late-onset groups, and the methodology utilised in eliciting age 
of onset across studies. In reviewing studies of late-life anxiety, a failure to assess lifetime 
episodes of illness onset has led to a lack of clarity as to whether ' LO ' refers to the onset of 
a disorder for the first time in late life without a prior history of illness, or merely the first 
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onset to occur in later life after a threshold selected by the researcher. The implication of 
failing to assess lifetime episodes using interview schedules that only allow for 
measurement of a patients ' presenting disorder is that patients classified as having a LO 
disorder may be misclassified as earlier remitted episodes of illness go unassessed, as is the 
case in previous research (Beck, et al. , 1996; Le Roux, et al., 2005). This variability across 
the research literature has implications for drawing conclusions about differences between 
older adults with early- and late-onset anxiety. 
Measures used to elicit and identify onset in the studies reviewed vary from semi-structured 
to structured, with some being lay-administered, whilst others are clinician-rated . As a 
result of these approaches to onset research, there is the potential for data to be 
compromised by inadequate or inappropriate measures of anxiety, lack of clarity about 
definitions of 'age at onset,' inconsistent cut-offs selected to determine onset groups, and 
methodology that is not necessarily suited to the research question. In investigations of 
onset differences, cut-off points have ranged from as early as fifteen years in studies of 
GAD in older adults (Beck, et al. , 1996) to 60 years in studies of late-life GAD, 
agoraphobia and PD (Chou, 2009; Le Roux, et al. , 2005 ; McCabe, et al. , 2006; Raj , et al., 
1993). This further makes comparisons of findings between studies of onset difficult, and 
highlights the need for some methodological agreement as to cut-off selection for studies of 
onset. In addition, many of these studies do not report the distribution of onset in the ir 
samples, rather reporting on means and medians of the distribution instead. Reporting on 
these distributions would allow for the observation and/or establishment of trends or 
patterns in onset, which may better_ inform appropriate thresholds to distinguish between 
sub-groups of anxiety with onset across the lifespan. 
A related concern with regards to anxiety research in general, as highlighted by Flint 
(2005a), is the need for hypothesis-driven research, where late-life anxiety disorders are the 
a priori focus. Flint notes that much of the existing literature relating to anxiety in older 
adults is based on secondary analyses of data from studies that did not set out to investigate 
anxiety. This is also evident in research relating to an onset distinction amongst anxiety 
disorders, where secondary analyses have been conducted on data from studies that did not 
initially set out to investigate the existence of differences in onset, as seen in the PD 
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literature (Raj , et al., 1993), and research relating to onset differences in GAD (Hoehn-
Saric, et al., 1993; Le Roux, et al., 2005; Lenze, et a l. , 2005). This appears to be more 
evident in onset literature relating to anxiety disorders than in the depression literature, 
reflecting the fact that anxiety as a construct, particularly in later life, is less well studied 
than depression (Flint, 2005a). 
3.10 Conclusions 
Despite preliminary evidence suggesting that early- and late-onset anxiety di sorders can be 
considered as two distinct subgroups and that these subgroups may be distinguished by 
aetiological and phenomenological factors , the limitations in current research outlined in 
the foregoing sections of this chapter highlight the need for research that will clarify and 
extend the existing knowledge regarding such differences. Specifically, there is a need for 
theoretical clarity regarding this distinction. Cognitive theories of anxiety postulate that 
certain cognitive styles (such as the tendency to respond anxiously to stress, and the 
perception that events are out of one ' s control) provide a predisposition to anxiety. These 
theories predict that anxious behaviour develops when negative life stressors interact w ith 
these predisposing cognitive styles. Accordingly, anxiety is a product of an interaction 
between environmental conditions and internal vulnerabilities (diathesis-stress models). 
The applicability of such models has been investigated in older adults, but has not yet been 
applied to the early-versus late-onset anxiety distinction. The applicability of a diathesis-
stress model of anxiety will be di scussed in the following chapter, with a view to 
investigating a model that might distinguish the content and process of early- and late-onset 
anxiety. 
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CHAPTER FOUR 
A Theoretical Explanation to Account for a Distinction in Early- and 
Late-onset Anxiety in Late-life 
In light of the fact that empirical investigations of an age at onset distinction amongst the 
anxiety disorders is a relatively recent phenomenon, no model has yet been put forward to 
account for this distinction amongst anxiety disorders in late-life. Moreover, although there 
exists a well-established body of literature investigating an age of onset distinction in late-
life depression, until a review of psychological perspectives of early- and late-onset 
depression in older adults by Boyd et al. (2000), no theories had been put forward or tested 
to account for this distinction in depression. In their review, Boyd and colleagues focus on 
psychological perspectives of the early-versus late-onset depression distinction, and 
consider this distinction within the context of theories of aging. 
Beck's (1987) cognitive theory of depression developed to account for depression in 
younger adults is highlighted as having potential utility in developing theories of late-life 
depression, and as being particularly pertinent to the early-versus late onset distinction. 
Boyd et al. (2000) therefore develop a cognitive model of early- and late-onset depression 
based on theoretical underpinnings of this theory. Since anxiety and depression are closely 
related disorders (Barlow, 1988; Barlow & Campbell, 2000; Mineka, et al., 1998), 
including in late-life (Beekman, et al. , 2000; de Beurs, et al., 2001; Flint, 1997), and there is 
a need for- theoretical clarity regarding this distinction amongst anxiety disorders in older 
adults, the model put forward by Boyd ·and colleagues will be outlined in this chapter with a 
view to empirically investigating its applicability in accounting for an age of onset 
distinction' in late-life anxiety. 
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4.1 A Cognitive Model to Account for Late-life Depression 
According to Boyd et al. (2000), accounts of late-life depression based on theories of aging 
(Brandstadter & Renner, 1990; Cumming & Henry, 1961 ; Erickson, 1950, 1980, 1997; 
Erickson, Erickson, & Kivnick, 1986; Havighurst, 1963; Labouvie-Vief, DeVoe, & Bulka, 
1989) emphasise factors that are specific to late life. Accordingly, these theories of aging 
do not allow for the possibility that mechanisms involved in late-life depression may be 
re.lated to those involved in depressive episodes earlier in the lifespan. An alternative 
perspective proposed by Boyd et al. (2000) posits the aetiological mechanisms responsible 
for early and late-life depression to be similar, noting that " although factors unique to late 
life would be important, theoretical models of early-life depression would also have 
valuable contributions to make to the understanding of late-life depression" (Boyd, et al., 
2000, p. 154). 
4.2 Development of a Cognitive (diathesis-stress) Model to Account for Early-
and Late-onset Depression 
According to cognitive theories of psychopathology, certain cognitive (thinking) styles 
provide a predisposition to psychopathology. Consequently, anxiety or depression arises as 
the result of an interaction between negative life stressors (environmental conditions) and 
these predisposing cognitive styles (internal vulnerability) , described as diathesis-stress 
models. The. stress-diathesis models of illness propose that most psychiatric disorders arise 
as a result of environmental adversity experienced by predisposed individuals. Since old 
age can be a period of chronic stress and significant loss (Brandstadter, Rothermund, & 
Schmitz, 1_997), diathesis-stress models such as Beck's (1987) cognitive theory of 
depression may have particular utility in explaining the anxiety experienced by older adult 
populations. Abramson, Metalsky & Alloy (1989) propose that diathesis-stress models can 
be viewed as 'titration models,' whereby the less maladaptive a person's cognitive style and 
thus initial vulnerability, the more negative an event must be to interact with that style and 
induce depression (Boyd, et al., 2000). 
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Drawing on diathesis-stress models, Boyd et al. (2000) propose that some older adults 
remain free of depression until late-life because although they have some cognitive 
vulnerability to psychopathology, they do not experience significant life stressors until old 
age. Boyd and colleagues also put forward an alternative hypothesis that proposes LO 
depression to be triggered by stressors that are specific to late life, e.g. those of an 
uncontrollable or irreversible nature (Seligman & Elder, 1986). Drawing on a titration 
perspective as previously defined (Abramson et al. , 1989), a third explanation is that in 
older adults EO depression may be associated with greater vulnerability to depression than 
LO cases, and consequently, depression in EO cases may be triggered by lesser degrees of 
stress or fewer stressful events/experiences. In contrast, adults with LO are posited to have 
less dysfunctional thinking styles and lower levels of cognitive vulnerability, but a late life 
that is extremely stressful (Boyd, et al. , 2000). 
This latter view is consistent with the argument put forth by Kendler, Myers and Prescott 
(2002). According to Kendler et al. , the stress-diathesis model predicts that among affected 
individuals, an inverse relationship exists between the level of the diathesis (or liability) 
and the level of onset-related environme"ntal trauma. As such, affected individuals whose 
onset was associated with high levels of trauma should, on average, have lower levels of 
disease liability than affected individuals with little or no trauma associated with onset. 
Boyd et al. (2000) report that although none of these hypotheses have been investigated by 
direct empirical examination, there· is some evidence to support the third hypothesis, 
presented diagrammatically in Figure 4.1. As outlined in the following section, this is 
considered to be the most plausible model of EO and LO depression by Boyd and 
colleagues. • 
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High cognitive vulnerabilities 
High level of dysfunctional 
assumptions 
Low or normal stress events 
Hassles and life events 
Low cognitive vulnerability 
Low level of dysfunctional 
assumptions 
High Stress events 
Hassles and life events 
Early-onset 
(i.e., previous episodes of 
depression prior to old age) 
Late-onset 
(i.e., no episodes of 
depression prior to old age) 
Figure 4.1. Cognitive model of early- and late-onset depression (cited in Boyd, et al. , 2000) 
4.3 Evidence Supporting a Cognitive Model of an Early- and Late-onset 
Distinction 
Drawing on the cognitive vulnerability model proposed, Boyd et al. (2000) cite some 
evidence for the proposition that EO depression is associated with a greater internal 
vulnerability to depression, whilst LO depression is associated with greater levels of life 
stress. For example, Boyd et al. report that a number of studies have found EO depression 
to be associated with a fragile personality style while LO depression is associated with a 
more robust personality style (Abrams, Alexopoulos, & Young, 1987; Brodaty et al. , 1991 ; 
Roth, 1955), providing support for the hypothesis that EO depression is associated with 
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greater internal vulnerability than LO depression. Furthermore, in a study of life stressors 
and depression, Musetti et al. (1989; cited in Boyd, et al., 2000) found LO depression to be 
associated with more life stressors in the six months leading up to the onset of clinical 
depression than EO depression. 
Consistent with the cognitive model of early- and late-onset depression, there is some 
evidence to support the proposition that EO anxiety is associated with a greater internal 
vulnerability to anxiety, while LO disorders are associated with greater levels of life stress. 
For example, Lindesay (1991b) found that older subjects with LO agoraphobia attribute the 
start of their fears to traumatic events such as acute physical illness, falls , or muggings. On 
the other hand, Keller (2002) reported that the incidence of LO anxiety disorders was 
associated with more life stressors in the twelve months leading up to the onset of clinical 
anxiety. Although further studies are needed to confirm these findings , they are consistent 
with a diathesis-stress model of early- and late-onset anxiety, proposing that environmental 
precipitants appear to play a more important role in the onset of LO than in EO anxiety 
among older adults. 
4.3.1 Summary 
A review of the literature suggests that consideration of stress-diathesis models in 
accounting for an onset distinction in late-life psychopathology can help further our 
understanding of the experience of anxiety in older adults. Stress-diathesis mode ls are able 
to outline the way in which people come to develop anxiety, and propose a variety of 
factors that contribute to the onset and maintenance of anxiety as people age. It is proposed 
that when anxiety begins early in life, social , psychological and biological processes that 
characteri~e early life (for example, experiencing adverse events, genetic factors , and 
personality traits) will be most important to understanding the development of anxiety. 
Conversely, if onset occurs in late life, developmental processes important in late life (e.g. 
increasing experiences of negative life events and declines in physical/medical health) may 
play an essential role in both the onset and maintenance of the disorder. A review of the 
literature indicates that adverse events can occur at a relatively high rate in older adults, 
which can be serious in nature ( e.g. death of a loved one, reduced finances, or personal 
illness) (Hughes, George, & Blazer, 1988). Furthermore, support has been found for the 
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proposition that there is a positive relationship between such stressors and psychological 
symptoms (Beekman, et al., 1998; Lenze, et al. , 2002). Despite the association between 
adverse life-events and anxiety, not everyone who experiences an adverse event develops 
an anxiety disorder. The psychological variables that are well established as vulnerability 
factors for anxiety in late-life, in addition to the stress-related events considered to play a 
role in the distinction of early and late-onset anxiety in older persons are thus outlined in 
the following subsection of the present chapter, with a view to investigating the 
contribution of these factors to an age of onset distinction in late-life anxiety in subsequent 
chapters of this thesis. 
4.4 Psychological Vulnerabilities Contributing to an Age of Onset Distinction in 
Late-life Anxiety 
4.4.1 Trait anxiety 
Trait anxiety, defined as a vulnerability to respond anxiously to stress and psychological 
threat, has been found to be elevated in anxious patients. Spielberger (1975, 1985) holds 
that people with high trait anxiety are more vulnerable to stress and interpret a wider range 
of situations as being dangerous. Furthermore, the frequency and intensity of anxiety states 
that have been experienced in the past is posited to provide a basis for predicting the 
probability that anxiety reactions will be manifes.ted in the future (Spielberger, 1985). Trait 
anxiety has previously been utilised as a measure of psychopathology in investigations of 
an onset distinction in late-life GAD (Beck, et al., 1996; Le Roux, et al., 2005) and may 
have some explanatory value in the cognitive model ofEO and LO anxiety with regards to 
measuring an individuals' tendency to respond to anxiety. 
4.4.2 Anxiety sensitivity 
Anxiety sensitivity (AS) is an individual difference variable that refers to the fear of anxiety 
symptoms as they are believed to have harmful somatic, psychological, or social 
consequences (Reiss, 1991; Reiss & McNally, 1985). Examples include the belief that a 
rapid heart rate is a sign of an impending heart attack and that nervous shaking is a sign of 
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mental illness. AS has been found to be elevated in anxious patients generally. There also 
exists converging evidence that anxiety sensitivity acts as a specific risk factor in the 
development of anxiety pathology (Schmidt, Santiago, & Wernicke, 2001). PD is 
specifically linked with heightened AS (Watkins, Grossman, Krishnan, & Blumenthal, 
1999). 
For older adults with a long history of panic symptomatology, AS may be acquired like 
other fears through a variety of psychosocial experiences, and may function to increase the 
individual's vulnerability for panic attacks and/or disorder for the first time in late life . 
Late-life increases in AS may occur, or pre-existing AS may interact with life stressors 
specific to this developmental period. As older adults experience an increasing number of 
physical illnesses, for example cardiovascular disease, they may become more concerned 
about related bodily sensations, and more reactive to anxiety symptoms that involve these 
bodily sensations. For thesJ individuals, elevation in AS may develop as a complication of 
deteriorating physical health and place the individual at greater risk for panic symptoms 
and panic disorder. Alternatively, longstanding minor elevations in AS may interact with 
the myriad of life stressors occurring in later life (e.g. retirement,. death of a spouse), 
causing such individuals to react catastrophically to stress precipitated increases in anxiety. 
4.4.3 Worry 
Worry in its relation to anxiety problems is regarded as pathological and an important 
clinical phenomenon. The cognitive phenomenon of worry is thought to be central to the 
experience of anxious affect (Diefenbach, Stanley, & Beck, 2001). Worry also seems to be 
at least pa!'llY independent o·f somatic arousal, which could render it a specific cognitive 
process distinguishable from any broader construct of anxiety (Gladstone & Parker, 2003). 
Thus, worry may be an important ' process' factor in distinguishing between early- and late-
onset anxieties. 
Based on increased stressors associated with ageing such as loss and declining health, 
research indicates that older adults are more inclined to worry. In a study with older adults 
who self-identified as chronic worriers, Wisocki, Hunt, and Souza (1998: cited in Hunt, 
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Wisocki, & Yanko, 2003) found participants to report that their worries grew in intensity 
over the lifespan and that in general 'worries are deeper, more morbid , and stronger in the 
later years' (p. 12) when compared with the worries of a younger population. Furthermore, 
one's sense of control or mastery over life events is thought to be relevant in the assessment 
of worry-proneness, as increased levels of worry have been found to be associated with 
decreases in perceived control, due to real or perceived declines in physical health 
(Diefenbach, et al., 2001). As such, worry may be considered amongst the cognitive 
vulnerabilities that are exacerbated in late life due to experiences of stressors, consistent 
with the findings of Le Roux et al. (2005) who reported significantly higher scores on a 
measure of pathological worry in those with late-onset GAD, than in those with an early-
onset 
4.4.4 Perceived control/locus of control 
Perceived control (PC: Lefcourt, 1980; Phares, 1976; Rotter, 1966), defined as one' s 
personal influence over outcomes or events in the environment, has consistently been found 
to relate to general health, health-related behaviours, and longevity (Chipperfield, 
Campbell, & Perry, 2004; Krause & Shaw, 2000 ; Prendant & Lachman, 2001). Research 
indicates that a lack of perceived control can result in subjective, behavioural, and 
physiological indications of distress (Rapee & Barlow, 1989; cited in Rapee, Craske, 
Brown, & Barlow, 1996). Moreover, it has been demonstrated that repeated experience 
with uncontrollable, aversive events can lead to chronic pathological emotional states, 
including anxiety and depression, in some individuals (Abramson, Seligman, & Teasdale, 
1978; Barlow, 1988). These aversive events may be external threats and stressors, or 
internally generated sensations. A sense of lack of control over emotional and bodily 
reactions is viewed as a crucial element in some emotional disorders. Specifically, Barlow 
(1988) suggests that the unexpected experience of bursts of focal or discrete emotions may 
lead to anxiety or affective disorders in vulnerable individuals. This is because they view 
their own .emotions or bodily reactions as out of control. For example, in PD, vulnerable 
individuals who unexpectedly experience an intense, short-lived burst of the discrete 
emotion of fear then develop "anxiety" over the possibility of the reoccurrence of this 
response in an uncontrollable manner. 
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Based on these findings, it appears that the degree to which people view events as within 
their control can become a dispositional characteristic. As such, this trait may be a 
fundamental mediator of motivation and psychopathology (Barlow, 1988; Rotter, 1966, 
1975). According to Rotter (1966), individuals differ in the degree to which they perceive 
reinforcement as being contingent on their behaviour. Accordingly, an individual who 
believes that reinforcement is a result of his or her own actions is described as having a 
high belief in 'internal control ' . 'External locus of control ' is the perception that an event is 
not entirely contingent on one ' s own actions, but is the result of luck, chance, fate, or 
powerful others (Rotter, 1966). As a personality dimension, it has been construed as a 
relatively broad, generalized expectancy (Rotter, 1966, 1975), as well as more specific 
expectancies regarding control over limited areas of one ' s experiences. 
Johnson and Samson (1979) suggest that locus of control (LOC) may mediate the effect of 
life change, and have found significant positive correlations between anxiety, depression, 
and negative life change for those with external LOC, but not for internal LOC. Empirical 
evidence from clinical samples conclude that a loss of control and greater extemality (i.e. , 
attribution of control to sources outside oneself) are associated with elevations in anxiety 
symptoms in older adults (Hoehn-Saric & McLeod, 1985; Rapee, et al. , 1996). Older adults 
are considered ' doubly vulnerable' to the deleterious effects of uncontrollability, as their 
sense of control can be diminished by age-related declines in physiology ( e.g., diminishing 
functional capacity) and losses in their social environment (e.g. , death of loved ones). In 
general, studies of institutionalised and community-dwelling samples support the 
interpretation that having a greater sense of personal control is associated with better health 
among older adults (Arbuckle, Pushkar, Chaikelson, & Andres, 1999). 
4. 4. 5 Self-efficacy 
Self-efficacy expectancies are characterizec) as beliefs about one ' s ability to carry out 
specific behaviours or behavioural sequences (Stanley, Novy, Hopko, Beck, Averill, & 
Swann, 2002). Although the majority of self-efficacy research has been conducted with 
young and middle aged adults (Bandura, 1997; Maddux, 1995), some data have 
47 
documented correlations of expectancies with affective and behavioural responses in older 
individuals. In this age group, perceptions of efficacy and control have been suggested to be 
even more important predictors of behaviour, health, and adjustment than for younger 
individuals (Rodin, 1986; Welch & West, 1995). In fact, research with older adults has 
indicated significant relationships between expectancies and health risk status 
(Grembowski, Patrick, Diehr, Durham, Beresford et al. , 1993), fear of falling and 
associated behaviours (Tinetti , Richman, & Powell, 1990), changes in functional status 
(Mendes de Leon, Seeman, Baker, Richardson , & Tinetti , 1996), cognitive performance 
(Seeman, Rodin, & Albert, 1993), and various measures of adjustment, physical and health 
status, and affect (Waller & Bates, 1992). Whilst there is some evidence to suggest lower 
levels of self-efficacy in older adults with GAD relative to published data from younger 
adult control samples (Stanley, Novy, Hopko et al., 2002), to date, no studies have reported 
on the relationship between self-efficacy and an age of onset distinction in late-life anxiety. 
4.5 Stress-related Factors 
An extensive literature has been put forth on the relationship between life events and 
mental disorders over the past three decades (Newman & Bland, 1994). According to 
Davies (1996), an " event" is historically seen as a discrete incident (such as a death or an 
accident), which is distinguished from chronic problems such as disablement, and from the 
more minor but frequent irritations of daily life. The relationship between stressful life 
events and the onset of major depression has been demonstrated in the research literature 
(Costello, 1982; Paykel, 1978). Despite research indicating that stressful life events also 
precede episodes of anxiety disorders (Faravelli & Pallanti, 1989; F inlay-Jones & Brown, 
1981), relatively little is known about the relationship between stressful life events and 
anxiety, and even less so about this relationship in older adults. 
In a study of the association between life events and anxiety in adult populations, a 
comparison of PD patients with normal controls by Faravelli and Pallanti (1989) revealed 
more life events in the patient group before the onset of the disorder. A study of community 
residents who were followed up over the course of a year by Blazer et al. (1987) found an 
increased risk of GAD when the respondents experienced life events classified as 
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"negative," "unexpected," or "very important." In another study of stressful life events and 
the onset of anxiety and depressive disorders , Finlay-Jones and Brown (1981) found that 
life events characterised by 'loss ' were more prominent in patients with a depressive 
disorder, whereas patients with · anxiety reported life events described as 'dangerous.' 
Findings of these studies indicate that for certain categories of life events, there is a 
correlation between excessive events and the type of disorder that develops as a result of 
such experiences. In addition, concurrent events are thought to affect well-being negatively, 
even though each event separately may cause relatively little stress (Kraaij , Arensman, & 
Spinhoven, 2002). Life events can have a cumulative negative impact on well-being, as it 
is not uncommon for older adults to experience several different events over a short period 
of time. 
As people age, events may disturb the course of one ' s' life more frequently, and because 
losses become more frequent than gains, they can decrease a person's sense of control of 
the external environment (Clemence, Karmaniola, Green, & Spini, 2007). Health events are 
reported to be the most common negative events to affect older persons, occurring in over a 
quarter of a community sample during a twelve-month period (Davies, 1996). The 
prevalence of anxiety and depression is higher in physically ill oliier people (Beekman, 
Pennix, Deeg et al., 1997; Bryant, Jackson and Ames, 2007). The illnesses of old age tend 
to have a chronic course, fluctuating severity of symptoms (Hickey & Stilwell, 1992), and 
recent onset of disablement is known to pose particular adjustment problems (Reich, 
Zautra, & Guamaccia, 1989). Older people with disability have many adaptive tasks to 
achieve and reduced resources at their disposal. In addition, they may have to deal with 
pain, fatigue and incapacity, as well as having to learn to detect and manage their 
symptoms. 
The psycho'logical response to physical illness in older adults is influenced by a number of 
factors, including the organ and functional system affected, severity of impairment, and the 
rapidity of onset and decline (Davies, 1996). In general , acute-onset events such as a stroke, 
which entail sudden loss of function, will be harder to adapt to than gradual disability 
imposed by a slower onset condition such as arthritis, where adjustments can be made in a 
relatively private way over a period of time (Davies, 1996). Prior lifestyle and previous 
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experience of illness and treatment also influence adjustment. People who have greatly 
valued autonomy are more likely to suffer drops in self-esteem and to become agitated and 
hostile when forced to become dependent on others for services. Environmental factors 
such as degree of social support and the extent to which significant aspects of personal 
activities are disrupted will also affect well-being. Whether the experience, type, or number 
of adverse life events associated with early- and late-onset anxiety differs is as yet 
unknown. Moreover, whether cognitive/personality styles are differentially associated with 
negative events in older people and can thus account for a distinction in onset of late-life 
anxiety disorders has not been investigated to date. 
4.5.1 Summa,y 
The variables outlined above have been associated with the development of anxiety in late-
life, and preliminary findings regarding an onset di stinction indicate that some of these 
variables are differentially associated with anxiety according to age at onset. The extent of 
this knowledge is limited however and to date, there are no studies that have investigated 
the role of life stressors and psychologica l vulnerabilities in an age of onset distinction in 
late-life GAD. Drawing on the cognitive mode l proposed (see section 4.2), Boyd et a l. 
(2000) suggest that the roles of psychological vulnerabi lities and stressful life events might 
be differently weighted in early- and late-onset depression , but that the diathesis-stress 
interaction may be significant in both cases (presented diagrammatically in Figure I , 
Section 5.2) (Boyd, et al. , 2000). Given that anx iety and depression are closely related 
disorders in late-life, the same may be true of early- and late-onset GAD. As such, further 
research is required to clarify the theori sed relationships between both early- and late-onset 
GAD in late life and the various psychological vulnerabilities and stress-related factors 
thought to account for an onset distinction. 
4.6 Conclusions 
The research reviewed in the previous chapters indicates that age at onset of anxiety 
amongst older adults is clearly an important concept for investigation. Research concerning 
early- and late-onset of anxiety demonstrates that age at onset is able to account, in part, for 
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the variation in the clinical experience of late life anxiety, in addition to treatment outcome. 
The theory and past research suggests that older adults with an early-onset and thus long 
history of anxiety are more likely to experience greater psychiatric comorbidity, have a 
family history of anxiety, and have greater clinical severity of anxiety symptoms. On the 
other hand, older adults with onset of anxiety for the first time in late life (LO) are reported 
to experience less clinical severity of symptoms, and greater experiences of life stress, such 
as physical and/or medical illness, and traumatic events leading up to the onset of anxiety. 
Although research has gone some way to explaining the variations in the aetiology, 
phenomenology and treatment outcome of early- and late-onset anxiety in older persons, 
further research is needed to clarify a number of issues (see Chapter Three). Given that 
much of the current knowledge regarding such differences is the result of investigations in 
which samples of older adu lts are distinguished by onset retrospectively based on arbitrary 
thresholds selected by the researcher, research is needed determine whether there exists two 
subgroups of older adu lts with EO and LO anxiety using a reliable assessment of age at 
onset. Furthermore, research is needed to identify a method for determining a cut-off to 
distinguish these subgroups in order to gain information regarding the age at which LO 
anxiety is likely to develop. 
In addition, research is needed to investigate the relationship between age at onset and both 
the aetio logical and phenomenological correlates ofEO and LO anxiety in order to clarify 
the variables considered to be important in classifying these two subgroups. Clarification of 
these variables may therefore assist in identifying factors that might be addressed in early 
intervention and prevention programs for anxiety. It is also necessary to clarify the 
theorised relationship between the experience of negative life events and age at onset of 
anxiety. Despite reference to such a relationship in diathesis-stress models put forth to 
account for a distinction in the onset of depression (Boyd et al. , 2000), little empirical 
evidence has been conducted to date, and no such model has been put forth to account for a 
distinction in early- and late-onset anxiety disorders. 
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SECTION II: 
AN INVESTIGATION OF A BIMODAL DISTRIBUTION OF 
AGE AT ONSET FOR GAD AND THE RELATIONSHIP 
BETWEEN AGE AT ONSET AND THE AETIOLOGY AND 
PHENOMENOLOGY OF LATE-LIFE GAD 
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CHAPTER FIVE 
Aims, Research Questions and Hypotheses 
5.1 Aims and General Overview of the Research Questions 
The aim of the empirical research presented in subsequent chapters of thi s thesis is to 
provide an original extension of the previous literature, fo r the purpose of understanding the 
role of age at onset in the clinical experience and management of GAD in late-life. An 
understanding of the potential differences in the experience of late-life GAD according to 
age at onset of psychopathology is long overdue. Past literature indicates that GAD can 
manifest in older ad ults for the first time in late li fe, without a prior hi story of 
psychopathology, and that the experience of anxiety symptoms may vary amongst older 
adults. Despite thi s, research has yet to comprehensively address thi s issue . The research 
reported in subsequent chapters of thi s thesis thus provides some hope of a better, 
empirically driven understanding of the experience and treatment implications of EO and 
LO GAD. The primary aim of this sect ion of the thesis is to examine the fo llowing 
research questions: 
Research Question 1: Is there an empirically identifiable cut-off age that differentiates 
EO GAD from LO GAD? 
Research Question 2: What are the aetiological differences between older adults with 
early- and late-onset GAD? 
Research Question 3: What are the phenomenological differences between older adults 
with early- and late-onset GAD? 
Research Question 4: What are the differences between older ad ults with early- and late-
onset GAD in the frequency and severity of stressful negative life events preceding the 
onset of anxiety? 
Research Question 5: What is the relationship between the experience of negative life 
events across the lifespan and symptoms of psychopathology in late-li fe GAD? 
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Drawing on previous literature summarised in chapter Three, the intensive nature of the 
present study allows for the exploration of several specific relationships which stem from 
these six broader research questions. These research questions and the hypotheses 
pertaining to each of these questions are outlined in further detail in the following 
subsections. 
5.2 Research Questions and Hypotheses 
5. 2.1 Research Question 1: Is there an empirically identifiable cut-off age that 
differentiates EO GAD Ji-om LO GAD? (Chapter Seven) 
Chapter Seven examines whether the existence of two subpopulations of anxious treatment-
seeking older adults; one with an onset earlier in life (EO) and the other with an onset 
occurring in late-life (LO), can be empirically established. Furthermore, Chapter Seven 
exp lores whether it is possible to empirically identi fy a cut-off point for best deciding to 
which subpopulation a given age of onset belongs. If the age of onset for anxious 
treatment-seeking older adults demonstrates a bimodal distribution , this would provide 
evidence of the existence of two subpopulations. As the thesis p.roposes that anxiety in 
older adults can be differentiated according to age of onset, it was hypothesised that: 
Hypothesis I : There would be a bimodal distribution for age at onset of late-life GAD. 
If age at onset of late-life GAD does demonstrate a bimodal distribution, then it will be 
possible to empirically identify an age of onset cut-off point based upon the local minima in 
the probability density function. 
5.2. 2 Research Question 2: What are the aetiological differences between older 
adults with early- and late-onset GAD? (Chapter Eight) 
Chapter Eight presents the findings of an investigation aimed at examining aetiological 
differences between EO and LO GAD. A sample of o lder adults with EO and LO GAD 
were compared in a cross-sectional analysis across a number of aetiological factors. In 
particular, a series of between-groups comparisons were performed on participants' 
demographic and hea lth characteristics. These health characteristics included indices of 
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chronic disease in later life, the use of prescription/non-prescription medication, treatment 
history and genetic risk factors. The proposed hypotheses relating to the associations 
between age of onset and these aetiological factors are outlined in Table 5.1. The following 
relationships are specifically addressed in Chapter Eight: 
I. The association between age at onset of GAD and demographic characteristics such as 
gender, socioeconomic status, and level of education. A number of empirical studies 
reviewed in Chapter Three (Beck et al. , 1996; Le Roux et al. , 2005; Lenze et al. , 2005) 
concluded that the demographic characteristics of late-life GAD is not distinguished by 
age at onset. Accordingly, it was hypothesised that early-and late-onset participants 
would be similar with respect to their demographic characteristics. 
2. The relationship between age at onset of GAD and indices of chronic disease in later 
life. The literature pertaining to GAD reviewed in Chapter Three (Chou, 2009; Le 
Roux, et al., 2005) concluded that age of onset does not seem to be a significant factor 
with regard to medical comorbidity in late-life. On the other hand, studies of PD 
(Hassan & Pollard, 1994; Raj , et al. , 1993) indicate that LO PD is associated with 
greater medical comorbidity than EO PD. A goal of this chapter, therefore, was to 
clarify whether there is a significant relationship between age at onset and the health 
characteristics of older adults with late-life GAD. Drawing upon previous research that 
has directly explored this relationship it was hypothesised that EO and LO groups 
would be similar with regards to medical comorbidity, in particular, in the frequency of 
specific health conditions reported and in the total number of medical conditions 
overall. 
3. The relationship between age at onset of GAD and the current use of prescription and 
non-prescription medication. The literature reviewed in Chapter Three (Le Roux, et al. , 
2005) suggests that patients with EO GAD use psychotropic medication at significantly 
higher rates than those with LO GAD. It was therefore hypothesised that EO 
participants would use psychotropic medications (i.e. antidepressants and/or 
benzodiazepines) at a higher rate than LO participants. The use of prescription and 
non-prescription medication as well as alcohol use has not previously been examined in 
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invest igations of age at onset of GAD. An aim of this chapter therefore was to explore 
the relationships between age at onset and both medication use and the use of alcohol. 
In light of previous findings of similarity in the medical comorbidity of EO and LO 
GAD, it was hypothesised that onset groups would be simi lar with regards to 
prescription and non-prescription medication use. Previous research suggests that 
amongst individuals with longstanding mental illness, alcohol and substance use are 
common comorbid conditions (Merikangas, et al. , 1998) . Accordingly, it was 
hypothesised that EO GAD would be associated with greater alcohol use than LO GAD. 
4. The relationship between age at onset of GAD and participants' treatment history, 
including help-seeking behaviour and history of treatment sought. The literature review 
(Le Roux, et al. , 2005) suggested that EO GAD is associated with higher rates of past 
treatment utili sation (past psychotropic medication use and a history of counselling 
and/or psychotherapy) than LO GAD. Age at which older adults first sought help for a 
psychiatric illness has not specifically been investigated and was included for the 
purpose of exploring other aspects of help-seeking. It was hypothesised that EO 
participants would have a significantly younger mean age at help-seeking than LO 
participants. Specific hypotheses regarding the relationship between age at onset of 
GAD and treatment history to be examined in Chapter Eight are set out in Table 5.1 
(see hypotheses Sa - 5d). 
5. The relationship between early- and late age at onset of GAD and genetic factors. The 
relationship between age at onset of GAD and a family history of anxiety disorders has 
not previously been investigated. Based upon the PD literature reviewed (Battaglia, et 
al. , 1998; Battaglia, et al. , 1995; Goldstein, et al., 1997; Segui, et al. , 1999; Sheikh, et 
al. , 2004), however, it was hypothesised that a family history of mood and/or affective 
disorder would be more common in the relatives of older adults with EO GAD. 
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Table 5.1 
Summa,y of Hypotheses Examined in the Investigation of Aetiological Differences between 
EOandLOGAD 
Hypotheses 2 - 6: Chapter Eight 
Age of onset and demographics 
Hypot/resis 2: EO and LO participants will be similar with respect to their demographic 
characteristics. 
Age of onset and chronic disease in later life 
1lypot/resis 3: EO and LO groups will be similar with regards to medical comorbidity as 
indicated by the frequency of spec ific conditions reported and in the total number of medical 
conditions reported. 
Age of onset and the use of prescription and non-prescription medication 
Hypot/resis 4a: EO participants will use psychotropic medications 
(i.e. antidepressants and/or benzodiazepines) at a higher rate than LO participants. 
Hypothesis 4b: EO participants will not differ in the use of other prescription and non-
prescription medications from LO participants. 
Hypothesis 4c: EO participants will have higher rates of alcohol use than LO participants. 
Age of onset and treatment history 
Hypot/resis Sa: EO participants wi ll have a significantly younger mean age at help-seeking than 
LO participants. 
Hypot/resis Sb: EO participants will have more anxiety episodes than LO participants. 
Hypot/resis Sc: EO participants will have a longer history of anxiety as refl ected in a greater 
period of time since onset of the first episode of GAD than LO participants. 
Hypot/resis Sd: Older adults with EO GAD will have a history of greater psychotropic 
medication use and hi story of psychotherapy and/or counselling at higher rates than those with 
LO of GAD. 
Age of onset and genetic or predisposing/actors 
Hypot/resis 6: A family history of mood and/or affective disorder wi ll be more common 
among the relatives of older adults with EO GAD than those with LO GAD. 
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5.2.3 Research Question 3: What are the phenomenological differences between 
older adults with early- and late-onset GAD? (Chapter Nine) 
Chapter Nine presents the findings of a study aimed at exploring differences between early-
and late-onset groups across a number of phenomenological factors. In particular, a series 
of between-groups comparisons were performed in order to investigate differences between 
onset groups in rates of psychiatric comorbidity, indices of GAD-related symptom severity, 
including responses to psychometric measures of pathology, and on measures of health and 
functioning. The proposed hypotheses regarding the relationship between age of onset and 
these phenomenological factors are outlined in Table 5.2. The following relationships are 
specifically addressed in this Chapter Nine: 
I. The relationship between age at onset of GAD and psychiatric comorbidity. The 
literature reviewed in Chapter Three (Chou, 2009; Le Roux, et al., 2005) suggests that 
EO GAD is associated with greater psychiatric comorbidity. It was therefore predicted 
that the EO group would have higher rates of psych iatric comorbidity than the LO 
group. 
The relationship between age at onset of GAD and indices of GAD phenomenology. 
These included the frequency and severity of GAD- related worries, the frequency acnd 
severity of GAD- related symptoms, interference and distress associated with worry, 
percentage of time spent worrying, interviewer-rated severity of GAD and responses on 
self-report measures of psychopathology. Interference, distress and percentage of time 
spent worrying have not previously been examined as indices of GAD severity. As 
such, an aim of this chapter was to explore the relationship between age at onset of 
GAD and these aspects of phenomenology. With the exception of interviewer-rated 
severity of GAD, which has been found to be greater amongst those with EO GAD 
(Beck, et al., 1996; Le Roux, et al., 2005), drawing on previous literature suggesting 
that early- and late-onset anxiety disorders are not differentiated phenomenologically 
(Beck, et al., 1996; Hoehn-Saric, et al. , 1993; Raj, et al. , 1993; Sheikh, et al. , 2004), it 
was hypothesised that onset groups would be similar with regard to these variables (see 
hypotheses Sa - Se). 
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2. The relationship between early-and late-onset GAD and measures of health and 
functioning, including self-perceived health and functional limitations. Measures of 
health and functioning have previously been examined as indices of the severity of 
psychopathology, and are thought to be differentially associated with disorders of late-
life. In line with recent findings of se lf-perceived health (Chou, 2009) and previous 
literature suggesting that onset of anxiety later in life may be associated with negative 
health-related changes (Lindesay, 1991 b), it was hypothesised that LO participants 
would have poorer perception of their own health as compared to participants with EO 
of GAD (see hypothesis 9a). With regard to functional limitations, the literature 
suggests that LO GAD is associated with greater functional limitations than EO GAD 
(Chou, 2009; Le Roux, et al. , 2005). Therefore, it was predicted that older adu lts with 
LO GAD would report greater functional limitations than participants with EO GAD 
(hypothesis 9b). 
Table 5.2 
Summary of Hypotheses Examined in the Investigation of Phenomenological Differences 
between EO and LO GAD 
Hypothesis 7: Chapter Nine 
Age of onset and psychiatric comorbidity 
Hypothesis 7a: EO participants will have higher rates of psychiatric comorbidity than LO 
participants at time of evaluation (i.e. the presenting disorder). 
Hypothesis 7b: EO participants will have higher rates of psychiatric comorbidity than 
those with LO GAD at onset of first DSM-IV disorder of any kind. 
Hypothesis 7c: EO participants will have higher rates of psychiatric comorbidity than 
those with LO GAD at onset of first DSM-IV anxiety di sorder. 
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Table 5 .2 - continued 
Summary of Hypotheses Examined in the Investigation of Phenomenological Differences 
between EO and LO GAD 
Hypotheses 8 - 9: Chapter Nine 
Age of onset and indices of GAD phenomenology 
Hypothesis Ba: EO and LO participants will be similar with regard to the frequency and 
severity of GAD -related worries. 
Hypothesis Bb: EO and LO participants will be similar with regard to the frequency and 
severity of GAD symptoms. 
Hypothesis Be: EO and LO participants will be similar in the experience of interference, 
distress and percentage of time spent worrying daily as a result of GAD symptoms. 
Hypothesis Bd: EO participants will have significantly higher interviewer-rated GAD 
severity than those with LO GAD. 
Hypothesis Be: EO and LO participants will be simi lar with regards to symptoms of 
pathology as assessed by self-report measures of depression, anxiety, worry, trait anxiety, 
anxiety sensitivity, self efficacy and locus of control. 
Age of onset and measures of health and functioning 
Hypothesis 9a: Participants with LO GAD will have poorer perceptions of their health 
compared to participants with EO of GAD. 
Hypothesis 9b: Older adults with LO GAD will have greater functional limitations than 
those with EO GAD. 
5.2.4 Research Question 4: What are the differences between older adults with 
early- and /ate-onset GAD in the frequency and severity of stressful negative life 
events preceding the onset of psychopathology? (Chapter Ten) 
Drawing on the cognitive model proposed in Chapter Four (see section 4.2), Boyd et al. 
(2000) suggest that the roles of both cognitive vulnerabilities and stress (negative events) 
might be differentially weighted in early-and late-onset depression, but that the diathesis-
stress interaction may be significant in both cases. Given that anxiety and depression are 
closely related disorders in late-life, the same may be true of early-and late-onset anxiety. 
Accordingly, consideration of this stress-diathesis model in accounting for an onset 
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distinction in late-life GAD may be important in further understanding this distinction . 
Available data support the proposition that LO GAD is associated with greater levels of life 
stress. For example, in the ECA data, the occurrence of one or more negative events has 
been noted to increase the risk of developing GAD by threefold in the 12-month period 
following negative life events (Blazer, et al. , 1987). In line with this, increased incidence of 
GAD has been reported in the 20 months following a catastrophic financial loss in a sample 
of older adults (Ganzini, McFarland, & Cutler, 1990). Thus, although there is some 
evidence that environmental precipitants may play a more important role in LO GAD than 
in EO GAD among older adults, further investigation is needed to confirm these findings . 
Research question 4 is therefore specifically aimed at investigating the relationship between 
age at onset of GAD and stressful life events preceding the onset of the presenting episode 
of GAD and past episodes of clinically significant anxiety disorders. The hypotheses put 
forward to examine this relationship (hypotheses I0a - I0e) are outlined in Table 5.3 and 
are addressed in Chapter Ten. 
Table 5.3 
Summary of Hypotheses Examined in the Investigation of the Relatir_mship between Age at 
Onset and Stressful Life Events Preceding the Onset of Psychopathology 
Hypotheses 'IOa - lOe: Chapter Ten 
Hypothesis 10a: LO participants will experience higher rates of health-related events 
preceding the onset of the presenting episode of GAD. 
Hypothesis I Ob: LO participants will experience health-related events of greater severity 
preceding the onset of the presentin-g episode of GAD. 
Hypothesis 1 Oc: LO anxiety will be associated with a higher frequency of stressful life 
events preceding first onset of a DSM-IV anxiety disorder of any kind. 
Hypothesis 10d: LO anxiety will be associated with life events of greater severity 
preceding first onset of a DSM-IV anxiety disorder of any kind than EO anxiety. 
Hypothesis JOe: LO participants will experience a greater number of negative/stressful life 
events preceding the onset of each episode than EO participants. 
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5.2.5 Research Question 5: What is the relationship between the experience of 
negative life events across the lifespan and symptoms of psychopathology in /ate-life 
amongst those with EO and LO GAD? (Chapter Ten) 
In the depression literature, research has found catastrophic events experienced early in 
childhood and early life experiences during WWII to be associated with depression in later 
life (Beekman et al., 1995). In addition, negative socio-economic circumstances during 
childhood and adulthood, severe illness of significant others and negative experiences of 
relationships in adulthood appear to be related to depressive symptoms in late life (Kraaij, 
Kremers, & Arensman, 1997). In studies of young and middle-aged adults, the experience 
of physical , sexual and emotional abuse are found to have a significant and long lasting 
impact on emotional wellbeing (Beitchman et al., 1992; Bifulco, Harris, & Brown, 1992; 
Brown & Harris, J 993). Despite these preliminary findings in the depression literature, 
there is little knowledge about negative events experienced early in the life of older adults. 
Kraaij and de Wilde (2001) note that this is all the more surprising given that older people 
constitute the age group with the highest possible accumulation of negative life events. 
Similarly, not only is there a paucity of research investigating the relationship between 
negative events and anxiety in later life, but also of the relationship between current 
anxiety, specifically GAD, in older adults and negative life events experienced across the 
lifespan. Consequently, whether the experience, type, or number of adverse life events 
associated with early- and late-onset GAD differs is as yet unknown. The literature 
reviewed in Chapter Four and summarised above highlights the need for investigation of 
the negative stress-related factors (life events) associated with EO and LO GAD. 
Research Question 5 therefore aimed to ·investigate the relationship between the experience 
of negative life events across the lifespan and symptoms of psychopathology in later life, 
with respect to an age of onset distinction. Due to a lack of previous research regarding this 
relationship, a number of specific exploratory research questions were put forward to 
further examine this broader research question in detail. Using a measure of negative life 
events, a series of between-groups comparisons and examination of correlation coefficients 
were performed to examine these questions. The research questions explored in Chapter 
Ten are listed in Table 5.4. 
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Table 5.4 
Summa,y of the Exploratory Research Questions Examined in the Investigation of the 
Relationship between Age al Onset of GAD and the Experience of Negative Life Events 
across the Lifespan 
Exploratory research questions 1 - 6: Chapter Ten 
Exploratory Research Question 1: What is the prevalence of negative life events 
experienced by EO and LO participants at different developmental periods across the 
lifespan. 
Exploratory Research Question 2: What is the relationship between the total number of 
negative life events of each type experienced throughout life and symptoms of 
psychopathology in later life amongst participants with EO and LO GAD. 
Exploratory Research Question 3: What is the relationship between the experience of 
specific negative life events during each developmental period and symptoms of 
psychopathology in later life amongst participants with EO and LO GAD. 
Exploratory Research Question 4: What is the relationship between the total number of 
negative life events of all types experienced per developmental period and symptoms of 
psychopathology in late life. 
Exploratory Research Question 5: Are there differences between onset groups in the 
mean number of specific negative life events experienced per developmental period and 
throughout life. 
Exploratory Research Question 6: Are there differences between onset groups in the 
mean number of total life events expe_rienced per developmental period and throughout life. 
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5.3 Theoretical and Clinical Implications 
This investigation is one of the first of its kind in the area of age at onset of GAD in 
late-life and will provide a number of crucial theoretical and practical implications. In 
terms of the theoretical benefits, the study will outline an empirical method for 
identifying the existence of two subgroups of older adults with early-and late-onset 
GAD and determine a cut-off point for best deciding to which subpopulation a given 
age of onset belongs. Such a method may then be used in future onset research, rather 
than the se lection of arbitrary cut-offs chosen by the investigator, as has been done in 
the past. The present study will further aim to reveal fundamental information about the 
aetiology and phenomenology of early- and late-onset GAD. Aetiological and 
phenomenological variables will be examined in a moderately large clinical sample, a 
subsample of which undergoes CBT for GAD and long-term follow-up . The 
hypothesised relationships between age of onset and aetio logical factors such as 
demographic characteristics, indices of chronic disease and medical comorbidity and 
genetic factors, in addition to phenomenological factors such as symptom frequency and 
severity, psychiatric comorbidity, disability, distress , interference and symptoms of 
psychopathology will be explored. This will in turn serve to enhance our understanding 
of the aetiology and phenomenology of EO and LO GAD in older adults and the nature 
of the theory of a distinction in early- and late-onset GAD in late-life. 
The current study also examines the re lationship between age at onset of GAD and the 
experience of negative life events preceding episode onset. By investigating the role of 
the stress-diathesis interaction in the onset of GAD, this study will provide a greater 
understanding of the environmental precipitants to the onset of GAD, which will help to 
inform early-intervention and the treatment of late-life GAD. Furthermore, the current 
study examines the relationship between negative life events in key developmental 
periods across the lifespan and symptoms of anxiety, worry and depression in the 
context of an onset distinction in late-life GAD. Evidence of meaningful patterns 
regarding this relationship may inform future research in this area. 
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CHAPTER SIX 
Method 
6.1 Participants 
Participants included individuals aged 55 and over who were seeking help for 
symptoms of anxiety and worry. Although definitions of old age commonly use an age 
of 65 as a starting point, previous investigations of anxiety in older adults have utilized 
participants aged 55 and over (McCabe, et al. , 2006 ; Wetherell, Gatz, & Pedersen, 
2001 ). The lower age cut-off of 55 , as opposed to the commonly used sample of 65 and 
over (Flint, 1994; Mehlman et al., 2004; Stanley, Beck, et al. , 2003 ; Stanley, Hopko, et 
al., 2003), was used here in order to provide access to a wider pool of potential 
participants. This cut-off further allowed for the inclusion of interested participants 
between the ages of 55-64 who identified themselves as 'older adults' and otherwise 
identified with inclusion criteria . 
Eligible participants had a principal or co-principal diagnosis of GAD as establi shed by 
the Anxiety Disorders Interview Schedule for DSM-N- Lifetime version (ADIS-IV-L: 
DiNardo, Brown, & Barlow, 1994). Exclusion criteria included age under 55 ; a history 
of mania or psychosis; cognitive impairment as indicated by a score of less than 83 on 
the Addenbrooke's Cognitive Exam (ACE: Mathuranath, Nestor, Berrios, Rakowicz, & 
Hodges, 2000) (see Appendix A) or a reported diagnosis of dementia; current 
participation in psychotherapy; current alcohol or other substance abuse, and; 
commencement of psychotropic medication within two months of commencement of 
the study. Individuals with comorbid depression, dysthymia, or other anxiety disorders 
were not excluded from participation. Individuals currently stabilised on psychotropic 
medication for at least two months were included, though were asked to refrain from 
changing their dose or type of medication for the duration of the study. 
To recruit participants, a media release was written and released through the ANU 
Media Office (Appendix B). Following its release the study was advertised in both the 
state paper and a local community newspaper in Canberra, on a local ABC radio station 
on the AM band, and via the Australian National University (ANU) Psychology Clinic, 
where clients are able to self refer for the treatment of anxiety and depression. A flyer 
describing the study was also distributed among Canberra community services specific 
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to older adults (Appendix C). These services included the Council of the Ageing 
(COTA), the Belconnen and Hughes Senior's Centre's, and the ACT Health Promotion 
Website. Interested volunteers were asked to contact the primary investigator with their 
contact details. Volunteers were subsequently contacted by telephone by the 
investigator to discuss the aim and nature of the study. Following a brief initial 
telephone screening to assess suitability for the study, potential participants were invited 
to attend the Australian National University for comprehensive clinical assessment 
interviews with the primary investigator. 
From an original response of 119 community-dwelling individuals residing in the 
Australian Capital Territory (ACT), 96 (81 %) volunteered to participate in this study. 
Of the 96 participants initially recruited, all completed the clinical interview. Of those 
participants, 76 met the diagnostic criteria for a current DSM-IV anxiety disorder. A 
further nine participants reported significant past episodes of anxiety but did not meet 
the diagnostic criteria for a current anxiety disorder at evaluation. Eleven individua ls 
without psychiatric disturbance who volunteered were not included in the current 
investigation. The 85 older adults meeting diagnostic criteria for either a current or past 
episode of anxiety were included in the investigation of a bimodaJ distinction of age at 
onset (Chapter Seven) and included 27 males (31.8%) and 58 females (68.2%). 
Participants were aged between 55 and 85 years of age, with a mean age of 64.67 for 
males (SD= 7.43) and 63.21 for females (SD= 6.24). 
The nine participants reporting significant past episodes of anxiety who did not meet 
diagnostic criteria for a current anxiety disorder were excluded from subsequent 
investigations. The remaining 76 participants included in the investigations presented in 
Chapters Eight through Ten were 22 males (29%) and 54 females (71%). Of these 76 
participants, seven were unable to return for a second appointment to complete the 
Negative Life Events Questionnaire interview due to factors such as caring for a 
terminally ill partner, work commitments, moving interstate and overseas travel. The 69 
older adults included in investigation of the relationship between negative life events 
across the lifespan and late-life GAD included twenty-two males (31.9%) and forty-
seven females (68.1%). The mean age of males included in this investigation was 63 .91 
(SD = 6.62) and 62.76 for females (SD = 6.39). A flowchart depicting participant 
inclusion in the current investigation is presente:d in Figure 6.1. 
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Initial response to 
recruitment: 
119 volunteers 
Suitable 
participants 
N = 85 
Unsuitable 
N=ll 
Figure 6.1. Flowchart of participants recruited to Study One 
Current Diagnosis 
of Anxiety 
N = 76 
Past diagnosis of 
Anxiety 
N =9 
Early- onset 
N = 24 
Late- onset 
N = 52 
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6.2 Design 
The studies presented in chapters Seven through Ten were of a cross-sectional, 
observational design. Since age at onset defined the groups to be compared, belonging 
to the "early-onset" (EO) or " late-onset" (LO) group represented the between subjects 
independent variable. Age and gender were not included as covariates, as descriptive 
analyses revealed that onset groups were similar in terms of age and gender. The 
dependent variables analysed in the investigation of the aetiological correlates of EO 
and LO GAD (Chapter Eight) were age of onset characteristics, demographic 
characteristics, health characteristics and genetic factors. Demographic variables 
included marital status, level of education, employment status, employment intensity, 
occupation, and social support. Health variables included number and type of chronic 
illnesses, current use of prescription and non-prescription medication and treatment 
history, including past psychotherapy and psychotropic medication use. Genetic factors 
included a family history of psychiatric illness. 
The dependent variables examined in the investigation of phenomenological 
comparisons of EO and LO GAD (Chapter Nine) were psychiatric comorbidity, indices 
of GAD-related phenomenology, measures of perceived health and functional 
limitations, and scores on psychometric measures of psychopathology. Psychiatric 
comorbidity included diagnostic comorbidity at time of evaluation, at first onset of a 
DSM-TV anxiety disorder of any kind, and at first onset of a DSM-TV-L disorder of any 
kind. Indices of GAD-related phenomenology included the frequency and severity of 
GAD-related worries, the frequency and severity of GAD-related symptoms, percentage 
of time spent worrying, level of interference and distress experienced due to GAD 
symptoms, and overall interviewer-rated severity of GAD. Psychopathology variables 
included scores on self-report measures of anxiety, worry, depression, trait anxiety, 
anxiety sensitivity, a measure of locus of control and on a measure of self-efficacy. 
The dependent variab les examined in investigation of the re lationship between negative 
life events and symptoms of psychopathology in EO and LO late-life GAD (Chapter 
Ten) were negative life circumstances preceding episode onset, negative life events as 
measured by the negative Life Events Questionnaire, and scores on psychometric 
measures of pathology. Negative life circumstances preceding episode onset included 
difficulty and/or changes in fami ly or relationships, in occupation or education, in 
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financial circumstances, in health , and in 'other' life events. Negative life event clusters 
included death of significant others, significant illness (personal and in significant 
others), socio-economic circumstances, abuse (sexual , physical and emotional), 
crime/disaster/war events (CDW), negative relationships with others and problem 
behaviours of significant others. Measures of psychopathology included all those 
examined in chapter Nine, listed above. 
6.3 Materials 
6.3.1 The Addenbrooke 's Cognitive Examination 
The Addenbrooke's Cognitive Examination (ACE: Mathuranath, et al., 2000) was used 
as a screen ing tool to examine the suitability of interested candidates for the study. The 
ACE is considered a reliable and valid instrument for the assessment of cognitive 
functioning. The ACE assesses cognitive status (Appendix A) by evaluating six separate 
cognitive domains (orientation, attention and concentration, memory, verbal fluency, 
language, and visuospatial abilities). The ACE surveys these key aspects of cognition 
without the use of specialised equipment. The ACE is administered by the investigator 
and is scored out of 100. The ACE is a bed-side or clinic-based schedule that 
incorporates the Mini-Mental State Examination (MMSE), though expands on its 
assessment of memory, language and visuospatial components, as well as adding tests 
of verbal fluency. The MMSE is the most widely used and validated bedside instrument 
for mental status evaluation, but has certain limitations. These include insensitivity to 
early stages of Alzheimer's disease and to isolated frontal or linguistic deficits found in 
early Fronto-Temporal Dementia. The ACE has high internal consistency (78%) (ACE: 
Mathuranath, et al., 2000), indicating that all its component scores contribute to the 
measurement of cognitive functions and correlate well with the composite score. At a 
cut-off of 88, the ACE offers a high sensitivity of 93%, and a specificity of 71 % for 
identifying dementia. The lower cut-off score of 83 , which is recommended as more 
appropriate for research studies requiring a high specificity or when screening 
populations with a low base rate of dementia, has a sensitivity of 82% and a specific ity 
of 96%. Participants with an ACE score :S 83 were excluded from participating in the 
study. 
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6.3.2 Psychiatric diagnoses, psychiatric comorbidity and age at onset of 
psychiatric illness 
Because of the importance of identifying age at onset of current and lifetime disorders 
in the present study, the Anxiety Disorders Interview Schedule for DSM-IV Lifetime 
version (ADIS-IV-L: DiNardo, et al. , 1994) was used to assess psychiatric diagnoses 
and age at onset. The ADIS-IV-L is a semi-structured clinical interview administered by 
the investigator and provides an in-depth, full diagnostic assessment of a broad range of 
conditions (e.g., anxiety disorders , mood disorders, somatoform disorders, and 
substance use disorders) , as well as permitting differential diagnosis amongst these 
disorders according to DSM-IV criteria. The Interview Schedule is designed to 
detennine the onset and precipitants to current and past episodes of these conditions, 
using a diagnostic timeline that fosters accurate determination of the onset, remission 
and temporal sequence of these conditions (Grisham, Brown, & Campbe ll , 2004). The 
review of lifetime data allows the investigator to determine if and when a client had 
previously been diagnosed with a DSM-IV disorder, and to assess major clinical 
dimensions of past episodes of psychopathology. If participants are vague as to the date 
of onset, the interviewer is prompted to ascertain the time period by asking questions 
that link onset to objective life events (e.g., "can you recall anything that might have led 
to this problem," and "what was happening in your life at the time?"). A series of 
questions are asked to establish the level of interference and distress associated with 
symptoms of each given disorder, to rule out medication side effects and medical 
conditions as causes for the symptoms, and to clarify the life circumstances that were 
present at the onset of symptoms (Antony & Barlow, 2002). The detailed inquiry into 
key symptoms, inclusion of items fostering differential diagnosis with neighbouring 
conditions, inquiry on precipitants and life stressors at time of disorder onset, as well as 
reasons for remission, exceeds that found in other popular instruments such as the 
Structured Clinical Interview for DSM-IV (SCID: First, Spitzer, Gibbon, & Williams, 
1997). 
As part of the interview, the clinician (investigator) assigns a 0-8 clinical severity rating 
(CSR) to indicate the degree of distress and interference in functioning associated with 
each current and lifetime diagnosis. In instances where the participants met criteria for 
two or more current diagnoses, the principal diagnosis was the one receiving the highest 
CSR. In instances where an individual present_ed with two distinct emotional disorders 
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of equal severity, co-principal diagnoses were given. As such, assessment of psychiatric 
comorbidity was conducted at the dimensional level where symptoms were evaluated on 
a continuum, rather than imposing DSM hierarchical rules. Psychiatric comorbidity thus 
described whether a participant had at least one co-principal DSM-IV diagnosis at 
evaluation, at first onset of a DSM-V disorder of any kind and at first onset of a DSM-
IV anxiety disorder of any kind, and consisted of two categories ; yes and no. 
6.3.3 .INC Digital Concepts Digital Recorder (USB 350) 
Assessment and diagnostic interviews were recorded using a JNC digital recorder USB -
350. Given the complexity and depth of interviews, recordings allowed for a review of 
all interviews to ensure that all the relevant details were documented. Recordings also 
provided an independent rater with audio of the interviews, for inter-rater reliability of 
the principal diagnosis and of age at onset. 
6.3.4 Demographic characteristics 
Demographic characteristics were collected during participants' initial assessment 
interview using both the ADIS-IV-L (DiNardo, et al. , 1994), and a semi-structured 
interview schedule constructed to obtain detailed information about the pa1ticipants ' 
personal history. This included detail s about their upbringing, relationsh ip with parents 
and siblings, marital/relationship history and family constellation, and fami lial 
psychiatric history. The interview schedule also asked questions about educational and 
vocational history, and social networks (See Appendix D for a copy of the complete 
interview schedule). Demographic characteristics collected included gender, marital 
status, cultural/ethnic background, religious background, level of education, 
employment status, employment intensity, occupation, and social demographics. 
Marital status consisted of four categories; single/never married, married or cohabiting 
(de facto) , separated or divorced, and widowed. Level of education indicated the highest 
level of education attained. Education consisted of seven categories; primary school, 
high school for less than 4 years, graduated from high school, completed some technical 
training or university education, undergraduate degree, completed some post-graduate 
education, and postgraduate qualifications. Employment status described whether the 
participants were currently employed with thre<? categories; employed, unemployed, and 
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retired. Employment intensity described the amount of hours spent in employment, and 
consisted of two categories; part-time and full time. Occupation consisted of e leven 
categories; medical profession, scientific background, academic profess ion, military 
profession, tradespersons, labourers and related workers, clerical and service workers, 
intermediate and elementary workers in production and transport, clerical positions, 
sales and marketing, and ' other', which included positions such as sewing and 
dressmaking, and homemaking. Social support items were assessed using the semi-
structured interview schedule constructed for the present study, and consisted of 
questions about the receipt of social support from participants' friends , children, and 
partner. Quality of social contact from friendship networks consisted of two categories, 
acquaintances only and confiding relationships. 
6.3.5 Health characteristics 
Information on chronic health conditions was collected during the initial assessment 
interv iew, using the semi-structured interview schedule as previously described 
(Appendix D). The schedule comprised of a section assessing health-related 
characteristics of participants including their current medical/physical conditions and 
asked questions regarding current medication use, including use of recreational 
substances. Participants were also asked questions about past treatment, as well as 
questions to ascertain se lf-perceived health and self-reported limitations in activity due 
to current phys ical health. Medical conditions assessed included diseases of the nervous 
system, cardiovascular conditions, respiratory di sease, neoplasms, endocrine conditions, 
cholesterol, digestive and gastro-intestinal conditions, genitouri nary conditions, ear/eye 
conditions (problems with perception), ear, nose and throat conditions , pain syndrome, 
and musculoskeleta l/connective tissue conditions. 
Medications taken by participants were categori sed as prescription or non-prescription. 
Prescription medications included antidepressants, anxiolytics (benzodiazepines), anti-
hypertensives, anticoagulants, anticonvulsives, anti-inflammatory, sedatives, 
hypothyroid medication, hypolipidaemics, hypoglycaemic medications, and nicotinic 
analgesics. Non-prescription medications included anti-reflux agents, anti-diarrhoeal 
medications, simple analgesics, vitamins, minerals, and fish oil. The use of medications 
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described whether the participant was regularly taking this medication throughout 
participation in the study and consisted of two categories; yes and no. 
Information collected about participants ' treatment history included the age at which 
participants first sought help for a psychiatric problem, measured in years , and the type 
of treatment sought or received. The type of treatment described whether the participant 
had sought or received psychotropic treatment, counselling and/or psychotherapy, or 
both psychotropic and psychotherapeutic treatment, and consisted of two categories; yes 
and no. Other variables assessed as part of treatment history included the number of 
episodes of psychiatric illness and duration of mental health history with respect to 
number of years since onset of first episode. 
Functional limitations were assessed using one item which enquired as to whether 
participants ' current health limited their ability to do any of a number of daily activities. 
These activities included ; vigorous activities such as jogging or running, lifting heavy 
objects, or participating in sports; moderate activities such as pushing a vacuum cleaner, 
moving furniture or playing golf; light activities such as walking; climbing stairs; 
bending, kneeling or stooping; bathing or dressing oneself, and; other. Items were 
scored on a 3-point scale where 1 = not at all limited, 2 = limited a little, and 3 = limited 
a lot. 
Self perceived health was assessed using a single item that has been used extensively in 
past research (Chipperfield, I 993; Idler & Kasi , 1991 ; Wolinsky & Johnson, 1992), and 
is reported to predict mortality beyond seemingly more "objective" health measures 
(Menec, Chipperfield, & Perry, 1999; Mossey & Shapiro, 1982). This item asked 
participants to rate their health considering their age on a 5-point scale where I= 
excellent, and 5 = poor. A second item was included, asking participants how they 
would rate their current health compared to one year ago. This item was also rated on a 
5-pont scale where I = much better than one year ago, and 5 = much worse than one 
year ago. Ratings for both items were subsequently reverse coded such that high scores 
reflected excellent health/better than one yeiir ago, and low scores reflected poor health/ 
worse than one year ago. 
73 
6. 3. 6 Genetic factors 
Info1mation on the presence of current or past affective disorders, anxiety disorders, and 
other DSM-IV disorders in the relatives of participants was collected during the semi-
structured assessment interview, as described above. A family history of psychiatric 
illness described whether the immediate family members of participants including their 
mother, father, and children currently have, or have had a diagnosis of a psychiatric 
disorder in the past. This variable consisted of two categories; yes and no. 
6.3. 7 Indices of GAD-related phenomenology 
Indices of GAD-related phenomenology including the frequency and severity of GAD-
related worries, as well as the frequency and severity of GAD-related symptoms were 
assessed using the ADIS-IV-L (Di Nardo, et al., 1994). The ADIS-IY-L, administered at 
the initial assessment interview by the principal investigator as previously described in 
section 6.3.2, elicits dimensional clinician ratings of the essential features of each 
disorder. Clinicians rate the excessiveness of each worry area on a scale from 0-8, 
where 0 = no worry/tension and 8 = constantly worried/extreme tension. The rating 
reflects a combination of the frequency, appropriateness, and tension associated with 
that worry sphere. In addition, the clinician makes a separate rating that reflects the 
person's ability to control the worry about that aspect of their lives, where 0 = no 
difficulty, and 8 = extreme difficulty. Symptoms are also rated dimensionally on a 0-8 
scale, where 0 = none, and 8 = very severe. This allows for judgment of the degree to 
which an individual experiences symptoms like restlessness or irritability. 
Participants were also asked to estimate the percentage of time spent worrying about 
their particular areas of worry, and a series of questions were asked to establish the level 
of interference and distress associated with GAD symptoms. The various dimensional 
ratings faci litate the assignment of an overall clinical severity rating (CSR) for the 
diagnosis. A scale of 0 to 8 is also used for this clinician rating (0 = none to 8 = very 
severely disturbing/disabling). In general , a CSR of 4 or higher is judged to reflect the 
presence of a clinical level of psychopathology, whereas a CSR of 3 or lower represents 
a subclinical disorder. 
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6.3.8 Anxiety 
In addition to the assessment of anxiety symptoms using the ADIS-IV-L, anxiety 
symptoms were assessed using the Geriatric Anxiety Inventory (GAI: Pachana et al., 
2007) (Appendix E). The GAi is a 20-item self-report inventory des igned specifically to 
assess anxiety in older adults in a range of settings. Participants completed the GA i as 
part of a series of questionnaires provided at the initial interview, during treatment, and 
six-months following completion of CBT treatment. The inventory has a dichotomous 
response format (agree/disagree) for ease of use in the context of mild cognitive 
impairment or poor education. Relative to other inventories assess ing anxiety, the GAI 
places less focus on somatic symptoms, so as to reduce overlap with the symptoms of 
general medical conditions. Responses to the 20-item scale are summed to yield an 
overall scale score, with higher scores indicating greater severity of anxiety symptoms. 
All 20 items of the GAI have item-total correlations of 0.39 or above, with most above 
0.5 0. The Cronbach's alpha coefficient of 0.9 l for the 20-item inventory amongst 
normal older adults and 0.93 in a psychogeriatric sample suggests a high degree of 
internal consistency for the GAI. Test-retest reliability for a one-week period was 
reported as 0.91 and concurrent validity with a variety of other measures has been 
demonstrated in both the normal and psychogeriatric populations. ln the development 
and testing of the GAI, Pachana et al. (2007) reported the optimum cut-off point in 
di stinguishing geriatric patients with DSM-IV GAD from those w ithout GAD to be 
10/ 11 , which correctly classified 83% of patients with a sensitivity of 75% and a 
specificity of 84%. A cut-off of 8/9 was reported to identi fy patients with any anxiety 
disorder, and was noted to correctly class ify 78% of patients with a sensitivity of 73% 
and specificity of 80%. The GAi was considered to be the most appropriate and valid 
measure of assessing symptom severity across a range of anxiety disorders and 
symptoms in the present sample. 
6.3.9 Worry 
The Penn State Worry Questionnaire (PSWQ: Meyer, et al., 1990) is a 16-item self-
report instrument used for the assessment of clinically significant pathological worry. 
The items of the PSWQ (Appendix F) provide a measurement of a person 's tendency to 
engage in excessive worry, irrespective of the worry content, and associated ability to 
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control worry. The PSWQ was completed as part of a battery of questionnaires provided 
before, during, and six-months following completion of CBT treatment. Each item is 
rated on a 5-point sca le from 1 = "not at all typical of me" to 5 = "very typical of me." 
Items are summed to obtain a total score out of 80 for the scale, with higher scores 
indicating a greater tendency to worry. 
The PSWQ has been validated amongst a sample of mixed anxiety disorders (a= 0.93) 
and GAD clients (a= 0.86) (Brown, Antony, & Barlow, 1995) and has good internal 
consistency and adequate convergent validity in older adults with GAD, as well as in 
those without psychiatric diagnoses (Beck, Stanley, & Zebb, 1995; Stanley, Novy, 
Bourland, Beck, & Averill , 200 I). In young adult samples, a cut-off score of 45 out of 
80 has been reported to accurately identify GAD participants with 99% sensitivity and 
98% specificity (Behar, Aclaine, Zuellig, & Borkovec, 2003). This cut-off is 
recommended when an investigator has advertised for individuals with worry-related 
problems, or when non-anxious/non-depressed individuals have had an initial screening. 
If screening for GAD participants from an unselected sample, a cut-off of 62 is 
recommended, and is reported to accurately identify non-cases of GAD from cases with 
86% specificity and 98% negative predictive power. Molina and Borkovec (1994) 
reported on PSWQ means and standard deviations compiled from all existing data sets 
available within a two-year period after the PSWQ was available in its published form. 
Mean scores of between 63.24 (SD= 9.33) and 67.66 (SD= 8.86) were reported across 
a number of clinical samples diagnosed with GAD (Molina & Borkovec, 1994), and 
between 30.98 (SD = 8.13) and 44.27 (SD= 11.44) for non-anxious samples. 
6.3.10 Depression 
Depressive symptoms were measured using the Geriatric Depression Scale (GDS-15: 
Sheikh & Yesavage, 1986a), a 15 item self-report scale answered in a yes/no format , 
designed specifically to assess depression in older adults. The GDS-15 (Appendix G) 
was completed by participants as part of a battery of questionnaires provided at the 
initial assessment interview before treatment, during treatment, and six-months 
following completion of CBT treatment. The scale focuses on the unique cognitive 
complaints of older persons and places less emphasis on somatic symptoms than 
traditionally found in measures of depression, due to the high incidence of somatic 
complaints in non-depressed older adults. A cut-off of 6/7 correlates significantly with 
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that of the 30-itern parent scale. In addition, the parent scale has been shown to 
correlate well with the number of research diagnostic criteria symptoms for depression. 
Sensitivity of the GDS-15 ranges from 79%-100% and specificity from 67%-80% 
(Friedman, Heise l, & Delavan, 2005; Kurlowicz & Greenberg, 2007). There is debate as 
to which cut off score gives the best specificity and sensitivity (i.e. 5 or 6), but 6 is 
recommended, as it is associated with higher sensitivity. The GDS-15 has been fo und to 
have a high degree of internal consistency, and higher than that of the Hamilton Rating 
Scale for Depress ion (HRS-D) and the Zung Self Rating Depression Scale (SDS: 
Yesavage et al., 1982-1983). 
6.3. 11 Trait anxiety 
Trait anxiety was assessed using the Spielberger State-Trait Anxiety Inventory-Trait 
scale (STAI-T: Spielberger, et al. , 1983). The STA]-T was completed as part of the 
initial assessment and again six months fo llowing completion of CBT treatment. The 
STAI-T is a 20-itern self-report scale consisting of a number of statements used to 
describe oneself and provides a score indicating an indi vidual ' s general tendency to be 
anxious. E leven of the items enquire about negative characteristics (e.g., fee ling 
"nervous," " inadequate," or "tense"), whilst nine are anxiety-absent positive items (e.g. , 
"I feel cairn"). Items are rated on a 4-point scale with the following categories : (I) 
'Almost Never' , (2) 'Sometimes ' , (3) 'Often' , and (4) 'Almost always'. Individuals 
were asked to indicate how they 'generally' felt with regards to each statement. Scoring 
weights for the anxiety-absent items were reversed, such that responses marked I, 2, 3, 
or 4 were scored 4, 3, 2, or I respectively, and weighted scores for the 20 items were 
summed to obtain a total score out of 80 for the scale. Higher scores indicate a greater 
tendency to be generally anxious. 
Investigations of reliability have demonstrated high internal consistency of the STAI-T 
(Spielberger, et al. , 1983), with the median Cronbach 's a lpha coefficient for the STAI-T 
across a range of participant samples reported as 0.90. Spielberger et al. also reported 
evidence of good construct validity, as did Stanley, Beck and Zebb (1996), who 
investigated the psychometric properties of the STAI in older adults w ith and without 
anxiety complaints. A cut-off of 39/40 on the sum score is recommended by Sp ielberger 
et al. Recent studies investigating the psychometric properties of the STAI-Tin younger 
and older populations without a psychiatric diagnosis (Fuentes & Cox, 2000) reported 
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mean scores of 39.3 and 33.8 in older females and males respectively, and a mean of 
38.9 in a younger adult population, consistent with Spiel berger et al. 's original norms 
which ranged from 34.79 (SD = 9.22) to 40.40 (SD= 10.15) in samples of working 
adults, students, and military recruits. Investigation of the psychometric properties of 
the STAI-Tin an older adult population (Stanley, Beck, & Zebb, 1996) found older 
adults meeting DSM-III-R criteria for GAD to have a mean of 48.0 (SD= 11 .9). 
6.3.12 Anxiety Sensitivity 
Anxiety Sensitivity refers to the fear of anxiety symptoms, as they are believed to have 
harmful somatic, psychological, or social consequences, and was assessed using the 
Anxiety Sensitivity Index (ASI: Peterson & Reiss, I 987). The AS! is a 16-item self-
report inventory which was included to provide information relevant to the diagnosis 
and treatment of people with anxiety disorders. The ASI was completed as part of a 
battery of questionnaires provided at the initial assessment interview and six-months 
post completion of the CBT treatment program. Examples of items include " It scares 
me when my heart beats rapidly" and " When my stomach is upset, l worry that I might 
be seriously ill." Each item of the ASI is scored on a 5-point scale with the categories of 
' very little', 'A little ', ' Some' , ' Much' , and ' Very much ' . Individuals were asked to 
circle the category that best represents the extent to which they agree with the item. The 
ASI was scored by summing the points for all sixteen items, which was then used for 
comparison with the norms. The official norms were constructed from twelve studies, 
with the average total score for a non-clinical population reported as 19.01 , and a 
standard deviation of 9.11. The mean score reported for a clinical population is 35.9, 
more than two standard deviations above the ASI norm, with mean scores reported for 
each anxiety condition varying between 0.5 and 1.0 standard deviation above the AS! 
norm. The mean score reported for GAD is 26.1. 
A number of published studies investigating internal reliability (Peterson & 
Heilbronner, 1987; Reiss, Peterson, Gursky, & McNally, 1986; Taylor, Koch, & 
Crockett, 1991) have reported alpha coefficients in the range of 0.8 to 0.9, indicating a 
high degree of internal consistency for items on the ASL Reiss et al., (1986) further 
reported a two-week test-retest reliability of 0.75, reported to be satisfactory for an 
anxiety measure, and Maller & Reiss (1992) reported a three-year test-retest correlation 
of 0.71 , which has been interpreted as evidence that the ASI measures a stable 
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personality trait. The authors report findin gs that differentiate the AS! from the STAI-T, 
and indicate strong support for construct va lidity of the ASI (Peterson & Reiss, 1992). 
6. 3.13 Self - efficacy 
Self-efficacy was measured using the Self Efficacy Scale (SES: Sherer et al. , 1982). The 
SES (Appendix H) was also completed as part of a battery of questi onnaires provided at 
the initial assessment interview and again six months fo llowing CBT for late- li fe GAD. 
The SES is a 30-item scale designed to assess generalized self-efficacy (17 items), and 
social self-efficacy (6 items), leav ing a total of23 scored items and 7 "fill er" questions. 
Items are rated from A to E with respect to degree of agreement with the statements 
about personal attitudes and traits, from "disagree strongly" to "agree strongly," and 
answers are converted to scores of 1 to 5. The items were summed to produce a General 
Self-efficacy subscale score and a Social Self-efficacy score, with higher total scores 
reflecting greater self-efficacy. The subscale scores are not summed to give an overall 
score. 
In construction and validation of the scale reliability coefficients obtained for the 
General and Social self-efficacy subscales were 0.86 and 0.71 r~spectively (Sherer et 
al., 1982), and the authors reported evidence of construct and criterion valid ity of the 
Self-Efficacy Scale. Evidence of psychometric support for the SES in older adults is 
limited, however, in an investigation of the psychometric properties of the SES in a 
sample of older adults with generalised anx iety, Stanley et al. (2002) found strong 
internal consistency for both General and Social subscales (a lpha = 0.91 an 0.78 
respectively) and evidence fo r adequate validity of this measure. Previous investigations 
of the SES in a sample of anxious older adults (Stanley, et al. , 2002) indicate lower 
levels of self-efficacy and outcome expectancies in older adults with GAD (SES 
Genera l; M = 54.4, SD= 11.09; SES Social ; M = 18.04, SD= 4.17) relat ive to published 
data from younger adult control samples and older adult samples (SES General ; M = 
64.3, SD = 8.58; SES Social ; M= 2 1.2, SD= 3.63). 
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6.3.14 Locus of Control Beliefs 
Perceptions of control over anxiety- related events 
The Anxiety Control Questionnaire (ACQ: Rapee, et al., 1996) was used to assess 
perceived control over anxiety-related events (Appendix I). The ACQ is a 30-item 
inventory including beliefs regarding perceived control over a variety of potentially 
threatening internal events and situations. These include mental or physical reactions, 
disasters, and control over other people. The ACQ was completed as part of a battery of 
questionnaires provided at the initial assessment interview and again by those 
participants who took part in treatment, at six-month follow-up. Participants responded 
to the 30 propositions (e.g., "l am usually able to avoid threat quite easily") by rating 
their agreement on a 6-point scale from 0 = "strongly disagree" to 5 = "strongly agree." 
A 6-point scale was used to force respondents to select either end of the scale and 
minimise response bias. Scoring consisted of totalling the values such that higher scores 
indicate greater perceived control. Early investigations of validity amongst young adults 
populations revealed anxious populations to score in the low to mid 70s on average, 
whilst non-clinical samples score in the mid to high 90s (Rapee, et al. , 1996). 
The Cronbach ' s alpha for the overall scale was 0.87 in a _clinically disordered 
population, and 0.89 with a non-clinical population, indicating that the items in the 
questionnaire have a high degree of internal consistency. The internal consistency of the 
ACQ has been found to be higher than that found for Rotters ' (1966) Locus of Control 
questionnaire, suggesting that the ACQ contains more homogeneous items than the 
previous scale, and is also reported to predict anxiety more strongly (Rapee, et al. , 
1996). ln addition, the authors report strong test-retest reliability of the ACQ over a 
month, indicating utility for treatment outcome studies and measuring change across 
time, and is reported to show good convergent and discriminate validity. 
6.3.15 Measures of negative life events 
Stressful life events preceding onset of DSM-IV-L disorders 
Information on the occurrence of stressful life events preceding the onset of anxiety, 
depression and other DSM-IV disorders was collected during the initial assessment 
interview using the ADIS-IV-L (Di Nardo, et al., 1994), as previously described in 
section 6.3.1. As part of the interview, participants were asked whether they were under 
any stress during the period of time at which !hey reported symptoms to have begun, 
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and were questioned about difficulties or changes in i) family and/or relationships; ii) 
work and/or school; iii) finances; iv) legal matters; v) the health of themselves or others, 
and; vi) 'other'. The occurrence of changes or difficulties in any of these areas was 
answered 'yes' or 'no, ' and participants were able to provide further detail as to the 
type of difficulties and/or change experienced. 
Types of stressful life changes or difficulties reported to be experienced by participants 
in each of the six domains assessed, (i.e., family or relationships, occupation or 
education, finances , legal difficulties, health , and other) were collated and coded from 0 
to 6, where higher scores reflect greater disruption or life change. Coding was based on 
events listed in the Social Readjustment Rating Scale (SRRS: Holmes & Rahe, 1967). 
The SSRS contains 43 events which are assigned a value ranging from 11 (minor 
violations of the law) to 100 (death of a spouse) to reflect the level of life-change 
brought about by this event. Events reported by participants were thus classified in 
order of increasing severity to reflect the level of life change brought about, based on 
events listed in the SSRS and their corresponding rating. For example, events relating to 
changes in family relationships as reported by participants ranged in severity from I = 
"estrangement from a family member' to 6 = 'death of a spouse. ' Changes in finances 
included items such as 'owing on a mortgage or debt ', and ·'change in financial 
situation ', whilst work related events included items ranging from ' beginning or ending 
school', to 'being fired'. Health events included items such as ' change in the health of a 
family member ' and 'major personal illness or injury' and events classified as ' other' 
included 'change in residence and/or relocation ' , 'children leaving home ', and 'war-
time experiences ' . 
Negative life events 
Negative life events were measured using the Negative Life events Questionnaire 
(Kraaij & de Wilde, 2001) (see Appendix J), an adaptation of the Life Events 
Questionnaire used in the World Health Organisation multicentre study on parasuicide 
(Kerkhof, Schmidke, Bille-Brahe, De Leo, & Lonnqvist, 1994). The adapted version 
was extended to include questions relating to the experience of negative life events 
specific to older adults, for example, the occurrence of dementia in ones partner. In 
addition, questions are asked for an additional developmental period, late adulthood, 
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defined as the period spanning 50 years of age and onwards. The Negative Life Events 
Questionnaire consists of 107 items which ask questions about negative life events 
concerning oneself and significant others (i.e. , parents, siblings, partners, children, and 
other people considered to be important to the interviewee). The questionnaire is a 
li fet ime instrument as the occurrence of events is questioned across four different 
developmental periods ranging from childhood to the year prior to the interview, i.e. 
'chi Id hood' (0-15 years of age), ' adulthood' ( 16-49 years), ' late adulthood ' (50 years of 
age to I year prior to the interview), and '12 months prior to interview'. Positively 
answered items were fo llowed by questions concerning the time period(s) in which the 
event occurred. 
Items on the Negative Life Events questionnaire were classified as belonging to one of 
ten negative life event clusters: death of significant others (e.g., a parent, partner, or 
chi ld); severe illness of self; severe illness of a significant other; negative socio-
economic circumstances (e.g. , financial problems with self or partner); sexual abuse; 
physical abuse; emotional abuse and neglect; crime, di saster and war (CDW) events; 
relational stress, and; problem behaviour of significant others. Scores for all ten 
categories were obtained for the four different developmental periods identified, and for 
the whole life span overall. The number of events in each of the ten categories 
experienced within each developmental period was also calculated to give a period 
score. Four types of scores were obtained; (I) reflecting the experience of an event 
within the li fe event categories (a dichotomous category score); (2) a quantity cluster 
score, to reflect the quantity of events experienced within the life event category; (3) a 
dichotomy period score, reflecting the experience of some event within the 
developmental period; and (4) a quantity period score, reflecting the quantity of events 
experienced within the developmental period. 
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6.4 Procedure 
Prior to the commencement of the study, ethical approval was granted by the Australian 
National University ' s Human Research Ethics Committee . All participants were 
provided with a written information sheet out lining the aims of the research and an 
overview of what participation involved (Appendix K) , and signed a consent form 
(Appendix L) prior to their participation. Participants recruited to the study as described 
above (Section 6.1) were screened for eligibility and then invited to take part in clinical 
assessment interviews. All appointments were conducted at The School of Psychology 
at the Australian National University (ANU), with the exception of one interview, 
which was conducted in the participant's home due to difficulties with mobility. 
Interviews conducted at the ANU were held in a quiet, soundproof room. Participants 
were told that the interview would take two to three hours, or could be conducted over 
two meetings if they preferred. ln order to minimise participant fatigue, the investigator 
provided participants with breaks as needed, and water, tea and coffee were readily 
available. Participants were advised that they could refuse to answer any questions that 
they were not comfortable answering, and that they could withdraw from the study at 
any time. Any questions regarding participation were addressed both prior to and 
following completion of the assessment. 
The first component of the interview involved an assessment of cognitive functioning to 
determine eligi bility for the study. To this end, participants were first administered the 
Addenbrooke ' s Cognitive Examination (ACE: Mathuranath, et al., 2000). This was 
followed by clinical assessment and diagnosis of both current and past (lifetime) 
episodes of DSM-IV anxiety and mood disorders using the ADIS-IV-L (Di Nardo et al. , 
1994). All diagnostic interviews were conducted by the principal investigator, who had 
been trained to criteria on the ADIS:IV-L by supervisors with expertise in the diagnosis 
and treatment of anxiety. Inter-rater reliabi lity for principal diagnoses and age at onset 
was assessed by having an independent post-graduate student who had completed 
Master' s level coursework in clinical psychology, was trained in ADIS-IV-L 
administration and blind to the study aims and design , review 22 randomly selected 
audio recordings of the diagnostic interview (See Appendix M for inter-rater reliability 
forms). Following administration of the ADIS-IV-L, participants were asked questions 
about themselves, their family, and their medical history in further detail. This sub-
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section of the initial interview was conducted as a semi-structured interview and 
consisted of both closed and open-ended questi ons, as set out in Appendix D. 
On completion of the diagnostic assessment interview participants were offered a break 
of fifteen minutes by the investigator before proceeding to the assessment of negative 
life events. Alternatively, participants were given the option of returning for a second 
appointment to complete this stage of the interview. For those participants opting to 
return to complete the interview, a date and time was scheduled at the participant 's 
convenience, within two weeks of their initial assessment. Participants were then 
debriefed, and any questions they had were addressed. Participants continuing on were 
info rmed that for this part of the interview, they would be asked specific questions 
about various life events involving themselves, their parents, their si blings (brothers and 
sisters) , their partner/s, and their children. For each question answered positively, 
participants were asked to indicate the period in their life during which particular events 
were experienced. These periods were classified as i)"Childhood" (from Oto age 15); ii) 
"Early and middle adulthood" (from age 16 to age 49) ; iii) "Late life" (from age 50 
onwards), and; iv) " In the last 12 months" (the year prior to interview). Time periods, 
including the specified age ranges, were provided to the respondent on a sheet of paper 
to refer to throughout the interview. Participants were asked to answer ' yes ' or ' no ' to 
questions, and to let the investigator know of any questions that did not apply to them or 
their circumstances. At completion of thi s final stage of the interview, participants were 
debriefed, and any questions they had were addressed. 
Participants were also asked to complete a battery of self-report psychometric scales 
which were given to participants following completion of the initial interview. This 
comprised the Geriatric Depress ion Scale - 15 (GDS-15), the Geriatric Anxiety 
Inventory (GAI), the Spielberger State-Trait Anxiety Inventory - Trait scale (STAI-T), 
the Penn State Worry Questionnaire (PSWQ), the Anxiety Sensitivity Index (ASI), the 
Self Efficacy Scale (SES) and the Anxiety Control Questionnaire (ACQ) (See 
Appendices E through to J). Participants were instructed to complete the questionnaires 
within one-week of the initial interview and to return the questionnaires to the 
investigator in the stamped, self-addressed envelope provided. Participants were 
informed they could contact the primary investigator if they required help, or had any 
questions regarding completion of the questionnaires. In order to protect the anonymity 
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and confidentiality of participants, completed questionnaires were de-identified and 
stored separately from signed consent forms. 
Treatment- seeking participants interested in taking part in a study involving a twelve-
week CBT program for anxiety were infonned that that they would be contacted once 
their questionnaires had been returned to discuss eligibility and commencement of 
participation in the second phase of the present study (outlined in Section Three of this 
thesis). Those participants who were either unsuitable to take part in the treatment study 
(Chapter Eleven), or required urgent help and/or treatment were provided with onwards 
referrals as necessary to private psychologists, general practitioners, or to the Older 
Person ' s Community Mental Health team. 
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CHAPTER SEVEN 
Initial Data Screening and Establishment of a Bimodal Distribution of 
Onset in late-life Anxiety disorders 
7.1 Data Analysis 
7. 1.1 Analysis plan 
Analysis of age at onset 
In order to address the research questions of whether there exists two subpopulations of 
older adults ("early onset" and "late onset") with GAD, and secondary to this; if there 
are two subpopulations , what cut-off best determines to which subpopulation a given 
age of onset belongs (Chapter Seven), a single-distribution model of the data was 
compared with one allowing for a mixture of the two distributions (McLachlan & Peel, 
2000). The distributions used in this study are Gamma probability density functions 
(pdfs) because they are defined on the nonnegative real line (i.e., [0, oo ]). The single-
distribution model may be written as Y ~ f (a, b) , where f is a Gamma pdf with 
parameters a and b. The tilde symbol (~) denotes " is distributed as." The mixture-
distribution model may be written as Y ~ qf (a, b) + (I - q) g(c, d), where f and g are 
Gamma distributions and q is a mixture parameter taking a value in the [0, J] interval. 
Maximum-likelihood estimation is feasible for fitting both models, and was the 
estimation procedure used for this analysis. Although age at onset of GAD was of 
primary interest in this investigation, data was also collected on age at onset of the 
presenting disorder at assessment, and of first lifetime onset of any DSM-IV di sorder. 
Distributions of onset for DSM-IY-L anxiety disorders, primarily GAD, and DSM-IV-L 
disorders of any kind were both tested using gamma pdfs, and the results for both of 
these are reported. An interrater reliability analysis using the Kappa statistic was 
performed to determine consistency among raters. 
Comparison of early- and late-onset groups 
Independent-samples !-tests and Chi-square (x2) analyses were conducted to determine 
whether early-and late-onset groups statistically differed on demographic variables of 
age, gender, marital status, education, occupation and employment status, and social 
support (See Chapter Eight). In addition, the relationship between age at onset of GAD 
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and health characteristics such as indices of chronic disease, medication use, treatment 
history, self-perceived health, and functional limitations were examined using x2 
analyses and independent-samples t-tests. Genetic factors (i.e. family history of 
psychiatric illness) were also compared for between group differences. Calculation oft 
was based on the assumption of equal variances; t-values, degrees of freedom and 
significance based on Levene's test for equality of variances are reported for variables 
found to have unequal variances. These variables included age at first onset of a DSM-
IY-L disorder of any kind and ofa DSM-IV-L anxiety disorder, duration of illness since 
first episode onset, number of non-prescription medications, and functional limitations. 
Inspection of these variables indicates that in general, EO participants appear to be more 
similar to one another, whereas LO participants appear to vary from one another to a 
greater degree. 
Independent-samples t-tests and x2 analyses were conducted to determine differences 
between onset groups in psychiatric comorbidity, the severity of GAD-related worries 
and symptoms, the percentage of participant's day spent worrying, interference and 
distress associated with GAD symptoms, interviewer-rated severity of GAD and 
symptoms of anxiety, worry and depression (Chapter Nine). Differences in the 
frequency and severity of stressful life events reported to precede onset of current and 
past DSM-IV disorders assessed were also investigated using x2 analyses and 
independent-samples t-tests (Chapter Ten). No participants reported problems with the 
law/legal difficulties to occur prior to onset of current or past episode of 
psychopathology and therefore this variable was not analysed. Negative life events data 
were analysed to determine the frequencies of the different clusters of negative life 
events for both EO and LO groups. The bivariate relationship between the various 
clusters ?f negative life events and symptoms of psychopathology in older adults with 
EO and LO GAD were examined using Pearson's correlations. It was expected that 
correlations between negative life events and scores on measures of anxiety, worry and 
depression would be positive, indicating that the experience of one or more negative life 
event was related to higher scores on psychometric measures of pathology. 
Independent-samples t-tests were also conducted to investigate whether early- and late-
onset groups differed with regard to the quantity of specific events experienced in each 
developmental period and across the lifespan, in addition to whether onset groups 
differed with regard to the quantity of total life events experienced in each 
developmental period and throughout life. 
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7. 1.2 Data preparation and screening 
All data collected were entered and analysed using the Statistical Package for the Social 
Sciences version 14 (SPSS 14: SPSS Inc, 2005), and version 16 (SPSS 16: SPSS Inc, 
2008) when it became available. Three participants had missing data on assessment of 
cognitive status, and were therefore omitted from this analysis. Component scores were 
summed to calculate overall scores on the Addenbrooke's Cognitive Examination 
(ACE: Mathuranath, et al. , 2000) and the Mini Mental Status Examination (MMSE). 
Inspection of the distribution of scores indicated that three participants scored below the 
cut-off of 83 on the ACE, used to identify cognitive decline. One of these participants ' 
scored 79, whilst the other two participants had a score of 82 on the ACE. Given that 
these scores were just below the cut-off of 83 , the fact that anxiety and depression can 
affect memory and concentration considerably, and that these participants reported no 
concerns of memory loss, a decisi on was made not to exclude these part icipants from 
subsequent investigations. 
Five participants did not return any psychometric measures and of the 76 participants 
who completed the initial assessment interview, seven participants did not complete the 
Negative Life Events Questionnaire. These participants were th?refore omitted from 
analyses pertaining to these measures (Chapters Nine and Ten, respectively). Of the 
remaining 71 participants who returned the battery of questionnaires, all items were 
returned complete. Scores on the relevant item s of the Geriatric Depression Scale 
(GDS-15: Sheikh & Yesavage, 19866), the Penn State Worry Questionnaire (PWSQ: 
Meyer, et al. , 1990), the Spiel berger State-Trait Anxiety Inventory- Trait scale (ST AI-T: 
Spielberger, et al. , 1983) and relevant subscale items of the Self Efficacy Scale (SES: 
Sherer, et al. , 1982), and Anxiety Control Questionnaire (ACQ: Rapee, et al. , 1996) 
were reversed. Item scores were summed to calculate the relevant overall and/or 
subscale scores on the Geriatric Anxiety Inventory (GAI: Pachana, et al. , 2007), the 
PWSQ, the GDS-15, the STAI-T, the Anxiety Sensitivity Inventory (AS[ : Peterson & 
Heilbronner, 1987; Peterson & Reiss, 1987), the SES, and the ACQ. Internal reliabilities 
were calculated for all of these scales and are presented in Table 7.1. The SSE subscale 
was found to have low internal reliability that was not further improved by item 
deletion. Reliabilities for each of the remaining scales and subscales range from good to 
excellent. 
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Table7 . I 
Internal Reliabilities of Psychometric Scale Scores 
Scale 
The Geriatric Anxiety Inventory (GAl) 
The Penn State Worry Questionnaire (PSWQ) 
The Geriatric Depress ion Scale -1 5 (GDS-15) 
The State-Trait Anxiety Inventory - Trait scale (STA!-T) 
The Anxiety Sensitivity Index (AS!) 
The Self Efficacy Scale (SES) 
General Self Efficacy (GSE) 
Social Self Efficacy (SSE) 
The Anxiety Control Questionnaire (ACQ) 
Cronbach's a 
0.86 
0.86 
0.78 
0.90 
0.92 
0.86 
0.63 
0.83 
Prior to data analys is, data were screened for accuracy of data entry, missing va lues, 
univariate outliers, and fit between their di stributions and the assumptions of analys is 
(normality, linearity, homoscedas ity). Inspection of the scale distributions revealed that 
all scales and subscales were normally distributed . The distribution fo r the GDS-1 5 
illustrated a slight positive skew and kurtos is, indicating that most participants reported 
lower levels of depress ion as measured by the GDS-15. This is not surprising given that 
the majority of participants had a principal or co-principal (i .e., most severe) diagnosis 
of GAD according to DSM-IV-TR criteria and reported symptoms of anx iety rather than 
depress ion to be their primary problem of concern. For this reason, a decision was made 
not to transform this variable. No univariate outliers were identified. 
Data Reduction 
In order to max imise the power of anal yses, the number of categories of most of the 
demographic variables were collapsed into two categories. These variables and their 
revised categories included ethnicity, marital status (s ingle or partnered), level of 
education (secondary or tertiary) , employment status (employed or unemployed/retired) 
and occupation (non-professionals or profess ionals). Individual medical conditions were 
also further collapsed into categories reflecting the type of condition. 
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The two marital status categories were formed by combining the single, separated or 
divorced, and widowed categories into one single category and maintaining the 
married/in a relationship category. Given that all participants had above primary level 
education, levels of education categories were formed by removing the primary 
education category. The high school for less than 4 years ('intermediate certificate) and 
graduated high schoo l (matriculation) categories were combined to form the secondary 
education category, and the college or some technical education, undergraduate and 
postgraduate degree categories were combined to fonn one tertiary education category. 
The employment status categories were formed by combining the retired and 
unemployed categories and maintaining those in the employed category. 
Due to the range of occupational categories participants fell into, the occupation 
categories were formed by combining those from a medical, academic and scientist 
background, those with a military background (army, navy, air force) having advanced 
training and education through the Australian Defence Force Academy (ADF A), and 
those with occupations requiring university qualificat ions into one professional/skilled 
category. Tradespersons, labourers and related workers, clerical and service workers , 
intermediate and elementary workers in production, transport, clerical positions, sales 
and marketing, in addition to positions such as security, sewing ·and dressmaking and 
homemaking were combined to form one non-professional category. Occupation was 
coded into these two categories according to the Australian Standard Classifications of 
Occupations (Australian Bureau of Statistics, 1997). 
As a group, participants had 42 different current medical disorders. The categories or 
types of medical conditions were fmmed by combining conditions identified as 
belonging to the same illness groups based on DSM-IV-TR (APA, 1994) classification . 
Accordingly, the experience of headaches and migraines were combined to form the 
diseases of the nervous system category. Congestive heart failure, pulmonary embolism, 
cardiac disease, sub-ventricular tachycardia, enlarged heart, angina, and hypertension 
were all combined to form one category reflecting a cardiac condition. Asthma and 
pneumonia were combined to form one category representing respiratory disease. 
Diabetes and thyroid conditions were combined under one category representing 
endocrine/metabolic conditions. The category digestive and gastrointestinal conditions 
was formed by combining constipation, diarrhoea, irritable bowel syndrome, reflux, and 
stomach aches, pains and spasms. The category.eye and ear conditions was formed by 
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combining cataract, eye disease, and hearing loss. Arthritis, osteoporosis, and 
degenerative conditions of the spine were combined to form the category 
musculoskeletal/connective tissue conditions. Due to expected cell counts of less than 
five for some groups of non-prescription medications, these medications were also 
further collapsed. Vitamins, minerals , folate , and fish oil were combined to form the 
category of health supplements. 
7.2 Descriptive Analysis 
7.2. 1 Cognitive status 
Descriptive statistics were conducted to examine the cognitive status of participants. 
The current sample of participants were found to be cognitively intact, with 
participants ' , on average, scoring well above the cut-off scores indicative of cognitive 
decline, on both the MMSE (M = 29.10, SD = 1.08) and the ACE (M = 93.04, SD = 
4.48). 
7.2.2 Psychiatric diagnoses and co morbid psychiatric conditions of the 
presenting episode 
Descriptive statistics were conducted to investigate the diagnostic characteristics of 
participants ' presenting episode of psychiatric illness. Current and comorbid psychiatric 
conditions at time of evaluation are presented in Table 7.2. Overall , a total of 59.2% of 
the sample had at least one co-existing diagnosis at time of evaluation. Based on a 
review of 22 audiotapes by an independent rater, raw percent agreement on primary 
diagnoses between the investigator and independent rater was l 00%, Kappa = 1.00 (p < 
.001). 
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Table 7.2 
Psychiatric Diagnoses and Comorbid Psychiatric Conditions at Evaluation (N = 76) 
Variable /(%) (n) 
Primary/principal diagnosis 
Generalised anxiety disorder 96.0 (73) 
Panic disorder 2.8 (2) 
Phobias (social , specific, agoraphobia) 1.4 (I) 
Secondary comorbid diagnosis 
Generalised anxiety disorder 4.2 (3) 
Panic disorder 8.5 (6) 
Phobias 9.9 (7) 
Obsessive-compulsive disorder 1.4 (I) 
Post-traumatic stress disorder 2.8 (2) 
Major depressive disorder, single 4.2 (3) 
Major depressive disorder, recurrent 15.5 (11) 
Panic symptomatology (subsyndromal) 12.7 (9) 
Tertiary comorbid diagnosis 
Phobias (social , simple, agoraphobia) 1.4 (I) 
Obsessive-compulsive disorder 2.8 (2) 
Post-traumatic stress disorder 1.4 (1) 
Major depressive disorder, recurrent 5.6 (4) 
Panic symptomatology (subsyndromal) 2.8 (2) 
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7. 2. 3 Age at onset of the current episode of psychiatric illness 
Descriptive statistics were conducted to investigate the age at onset of participants ' 
presenting episode of psychiatric illness, as identified from the ADIS-IV-L (Di Nardo et 
al. , 1994). Participants ' mean age at onset of the presenting episode was 63.67 (SD = 
6.6) years, with an age range from 55 to 84 years. Participants' mean age at onset of 
their current DSM-[V disorder was 59.0 (SD = 6.6) years, with a range from 40 to 78 
years of age. The distribution for age at onset of the presenting disorder at evaluation is 
shown in Figure 7.1. Raw percent agreement on age at onset of the presenting disorders 
was 97%. The interrater reliabi lity was found to be Kappa= 0.83 (p < .00 I). Of the four 
participants on whom assessment of age at onset differed, raters were found to be within 
twelve months of each other for age at onset. 
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Figure 7.1. Distribution of age at onset of the presenting (current) disorder (N = 76) 
7. 2. 4 Psychiatric diagnoses and comorbid psychiatric conditions at first onset of a 
DSM-JV-L anxiety disorder 
Descriptive statistics were conducted to investigate the diagnostic characteristics of 
participants at onset of first lifetime DSM-TV anxiety disorder. Psychiatric diagnoses 
and comorbid conditions assigned to first lifetime onset of an anxiety disorder are 
presented in Table 7.3. Over four fifths of participants ' met criteria for a principal 
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diagnosis of GAD. Just under half of the sample had at least one co-existing diagnosis 
in addition to a principal diagnosis of GAD, PD, or a phobic di sorder, also presented in 
Table 7.3. Based on a review of22 randomly selected diagnostic audio recordings, raw 
percent agreement on primary diagnoses, which included GAD, PD and social phobia, 
was 92%. The inter-rater reliability was found to be Kappa= 0.84 (p < .001). Diagnoses 
made by the investigator and rater differed for one of the reviewed interviews, whereby 
the investigator made a diagnosis of GAD and the rater PD. For this patient, the 
investigator had also made a diagnosis of PD in addition to GAD, though this was 
assigned as a secondary condition. 
Table 7.3 . 
Principal Diagnoses and Comorbid Psychiatric Conditions of Participants at First 
Onset of an Anxiety Disorder (N = 85) 
Variable f(%) (n) 
Primary/principal diagnosis 
Generalised anxiety disorder 83.7 (72) 
Panic disorder 9.3 (9) 
Phobias (social, specific, agoraphobia) 2.3 (2) 
Secondary comorbid diagnosis 
Generalised anxiety disorder 10.6 (9) 
Panic disorder 4.7 (4) 
Phobias 8.2 (7) 
Obsessive-compulsive disorder 1.2 (I) 
Post-traumatic stress disorder 1.2 (I) 
Major depressive disorder, single 14.1 (12) 
Major depressive disorder, recurrent 1.2 (I) 
Panic symptomatology (subsyndromal) 7.1 (6) 
Tertiary comorbid diagnosis 
Major depressive disorder, recurrent 2.4 (2) 
Panic symptomatology (subsyndromal) 1.2 (1) 
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7.2. 5 Age at onset of first DSM-IV-L anxiety disorder 
Descriptive statistics were conducted to investigate the age at onset characteristics of 
participants at first onset of a DSM-IV anxiety disorder of any kind. Pai1icipants' mean 
age at onset of first DSM-IV anxiety disorder, primarily GAD (83.7%), was 40.22 (SD 
= 19.5) years, with age at onset ranging from 4 to 72 years. The distribution for age at 
first onset of a DSM-IV anxiety disorder is shown in Figure 7.2. Raw percent 
agreement on age at first onset of an anxiety disorder was 99%, Kappa = 0.77 (p < 
.001). Of the participants on whom assessment of age at onset differed, raters were 
found to be within twelve months of each other for age at onset. 
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Figure 7.2. Distribution of age at onset of first lifetime DSM-IV anxiety disorder 
(N=85) 
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7.2. 6 Psychiatric diagnoses and co morbid psychiatric conditions at first onset of 
a DSM-JV-L disorder of any kind 
Psychiatric diagnoses and comorbid psychiatric conditions assigned to first lifetime 
onset of a DSM-IV disorder of any kind are presented in Table 7.4. As seen in Table 
7.4, the majority of participants' had a primary diagnosis of GAD at first onset of a 
psychiatric condition of any kind. A total of 49.4% of the sample had at least one co-
existing diagnosis. 
Table 7.4. 
Principal Diagnoses and Comorbid Psychiatric Conditions of Participants at First 
Onset of a DSM-IV Disorder of Any Kind (N = 85) 
Variable / {%) (n) 
Primary/principal diagnosis 
Generalised anxiety disorder 75.3 (64) 
Panic disorder 5.9 (5) 
Phobias (social , specific, agoraphobia) 2.4 (2) 
Obsessive-compulsive disorder 2.4 (2) 
Post-traumatic stress disorder 1.2 (I) 
Major depressive disorder, single 11.8 ( I 0) 
Other 1.2 (I) 
Secondary comorbid diagnosis 
Generalised anxiety disorder 10.6 (9) 
Panic disorder 4.7 (4) 
Phobias 8.2 (7) 
Obsessive-compulsive di sorder 1.2 (I) 
Post-traumatic stress disorder 1.2 (I) 
Major depressive disorder, single 15 .3 (13) 
Major depressive disorder, recurrent 1.2 (I) 
Panic symptomatology (subsyndromal) 5.9 (5) 
Other 1.2 (I) 
Tertiary comorbid diagnosis 
Generalised anxiety disorder 1.2 ( I ) 
Panic symptomatology (subsyndromal) 1.2 (I) 
96 
7.2. 7 Age at onset of first lifetime DSM-IV disorder of any kind 
Descriptive statistics were conducted to investigate the age at onset characteristics of 
participants at first onset of a DSM-IV disorder of any kind. Participants' mean age at 
onset of first DSM-IV disorder of any kind was 38.20 (SD= 19.8) years, with a range 
from 4 to 72 years. The distribution for age at onset of first DSM-IV disorder of any 
kind is shown in Figure 7.3 . As seen in Figure 7.3, the distribution for age of onset 
appears flat from 'childhood' to the '30's ' , with a large number of participants reporting 
the onset ofa psychiatric illness in their 40 ' s and 50's. 
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Figure 7.3. Distribution of age at onset of first lifetime DSM-IV disorder of any kind 
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7.3. Identification of a Bimodal Distribution of Onset 
7.3.1 Distribution of age at onset of first DSM-IV-L anxiety disorder 
A single distribution model of the data was compared with one allowing for a mixture 
of two distributions to determine whether there exists two sub-populations of older 
adults with GAD or one, based on age at onset of first lifetime DSM-N anxiety disorder 
data, presented above in section 7.2.5. Using a maximum-likelihood estimation 
procedure, the log-likelihood of the single-distribution model was LLJ = 381.39, 
whereas the log-likelihood of the mixture-distribution model was LL2 = 358.69. The x_2 
statistic for improvement in model fit was x2 (3) = 2(LLJ - LL2) = 45.39, p < .0001. The 
mixture-distribution model was found to be significantly better fitting than the single-
distribution model. The mixture-model ' s component Gamma probability density 
functions (pdfs) are depicted in Figure 7.4. The left-hand distribution is f (3.16, 0.19) 
with a mean of 16.77 years and the right-hand distribution is g (21.70, 0.51) with a 
mean of 52.85 years. The two distributions are well-separated. The mixture parameter q 
= .35 , implying that about 35% of the sample belong to the EO subpopulation and about 
65% belong to the LO subpopulation. 
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Figure 7.4. Gamma probability density function (pdf) distribution applied to the 
distribution of age at onset of first lifetime anxiety disorder 
98 
7.3.2 Distribution of age at onset for first DSM-IV-L disorder of any kind 
To determine whether there exists two sub-populations of treatment-seeking older adults 
with a DSM-IV mood or anxiety disorder based on age at onset of first lifetime DSM-
IV disorder of any kind, a single distribution model of the data was compared with one 
allowing for a mixture of two distributions. The log-likelihood of the single-distribution 
model for this data was found to be LLJ = 377.16, whereas the log-likelihood of the 
mixture-distribution model was LL2 = 361.81. The x2 statistic for improvement in model 
fit was x2 (3) = 30.71, p < .0001. As with findings for onset of anxiety, the mixture-
distribution model was found to fit the data significantly better than the single-
distribution model. The left-hand distribution is f (2.98, 0.15) with a mean of 19.73 
years and the right-hand distribution is g (26.12, 0.49) with a mean of 52.90 years. The 
mixture parameter q = .44, implying that about 44% of the sample belong to the EO 
subpopulation and about 56% belong to the LO subpopulation. As such, the results for 
the onset of any disorder were quite similar to the foregoing because in the majority of 
instances the age of onset for any disorder was identical to that for anxiety; the main 
difference being due to several cases whose age of onset for any disorder (primarily 
major depressive disorder) was earlier. 
7. 3.3 Determination of a threshold for best distinguishing "early-onset " fro m 
"late-onset " anxiety 
The cut-off point identified to distinguish the EO group from the LO group was the age 
at which the pdf curves intersect, as this was the point at which the probability that a 
given age of onset belonged to either subpopulation was identical. This point was fo und 
by standard numerical root-finding methods, and the resulting cut-off was found to be 
34.4 years. The estimated probabilities of misclass ification are the areas under the right-
hand tail of the "early onset" pdf and under the left-hand tail of the " late onset" pdf 
beyond the cut-off-age (see Figure 7.4). These are as follows: Pr (false "early onset") = 
. 0225 ; Pr (false " late onset") = .0517. Given the 35%-65% mixture, the estimated 
misclassification rate for the entire population is .35*.0517 + .65* .0225 = .0372 . 
Accordingly, it is expected that about 96. 7% of the cases would be correctly classified. 
Figure 7.5 shows the mixture-distribution fitted to a histogram of the data. The mixture-
distribution model accurately captures the mean (40.33) and overall shape of the 
distribution. 
99 
Mixture Model 
"' ('-J 
= ci 
= ('-J 
= ci 
"' 0 
ci 
~ 
= 0 
ci 
"' = = ci 
= = = ci 
0 20 40 60 80 
age 
Figure 7. 5. Mixture distribution fitted to age at onset of first anxiety disorder data 
The shape of the distribution and the observation that a proportion of the sample 
reported an onset of anxiety in their 30 ' s and 40 's raised the question as to whether 
there might be more than two subpopulations distinguished by onset. This was tested by 
fitting a three-distribution model to the data to ascertain whether its fit was significantly 
better than the two-distribution model. The x2 statistic for improvement in model fit was 
x2 (3) = 7.20, p = 0.066. The improvement was not significant. Based on the identified 
cut-off of 34.4 years, 32 .94% (28) of the sample was identified as having EO anxiety, 
and 59.06% (57) was identified as having a LO anxiety disorder. 
100 
7.4 Discussion 
Current and lifetime onset of clinically significant symptoms of DSM-IV anxiety 
disorders were assessed in the present study in order to investigate whether there exists 
two sub-populations of older adults representing a group with "early onset," and "late 
onset" of anxiety, or just one population of anxious older adults. Using a Maximum-
likelihood estimation procedure to apply gamma probability density function (pdf) 
distributions to the data, the present study tested both a single and mixed-distribution 
model to determine which distribution fit the data best. Results revealed a bimodal 
distribution for first lifetime onset of a DSM-IV anxiety disorder, of which the majority 
was found to be GAD, with the mixture-distribution model being found to be 
significantly better fitting than the single distribution model. 
According to the mixed-model distribution, the mean age at onset of participants ' 
identified as belonging to the EO sub-group was 16. 77 years, and mean age at onset of 
participants identified as having LO anxiety was 52.85 years. As with findings for first 
onset of an anxiety disorder, the mixture-distribution model fit the data for first onset of 
any DSM-IV psychiatric disorder significantly better than the single distribution model. 
Accordingly, the mean age at onset of participants' identified ~s belonging to the EO 
group was 19.73 years . Participants identified as having LO of any disorder had a mean 
age at onset of 52 .90 years. 
Given support for a bimodal distribution was found, a secondary aim of the present 
study was to establish a cut-off point that best determines to which subpopulation a 
given age of onset belongs. Using standard numerical root-finding methods, a cut-off of 
34.4 years was identified as the point at which the pdf curves intersect, and at which the 
probability that a given age of onset belonged to either subpopulation would be 
identical_. Based on this cut-off, participants reporting onset of an anxiety disorder prior 
to and including 34 years of age in the present study were classified as having an EO 
disorder. Participants with an onset of anxiety at 35 years or later were identified as part 
of the LO group. 
Despite previous investigations reporting the observation of a bimodal distribution for 
age at onset of anxiety (Hoehn-Saric, et al. , 1993 ; Le Roux, et al., 2005; Raj, et al. , 
1993), the use of a maximum-likelihood estimation procedure to test the fit of a single 
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or two-distribution model to the current data and thus determine modality of the attained 
distribution of onset represents a significant advancement on previous research. An 
advantage of this procedure is that the threshold used to identify both early- and late-
onset groups are determined by empirical means. Previous investigations of an onset 
distinction in both the depression and anxiety literature have looked at age of onset 
categorically, according to a pre-determined cut-off. As previously highlighted, in 
samples of mixed age, the median age at onset of a distribution has generally been used 
as the cut-off (Brodaty, et al. , 2001 ). This cut-off can range from 20 to 60 years in 
studies across the anxiety literature (Lenze, et al. , 2005; McCabe, et al. , 2006; Raj, et 
al. , 1993). The current study did not use the mean or median age at onset of the 
distribution, but derived the cut-off based on application of a statistical model to 
identify the point at which the probability of falling on either side of the distribution 
was equal. Using numerical root-findings methods, the resulting cut-off identified to 
distinguish participants classified as having an early-or late-onset anxiety disorder was 
34.4 years . 
A further advantage of the statistical procedure used in the present study is that it allows 
for the calculation of an estimated probability of misclassification . Based on the 
identified cut-off of 34.4 years, it is expected that 96.7% of cases from this sample 
would be correctly classified as being EO or LO. That is, only 3.3% of cases are likely 
to be misclassified. Accordingly, aside from limitations associated with retrospective 
recall of onset of an episode of illness, this methodology presents a means of identify ing 
a cut-off specific to the sample which is highly accurate and minimises the probability 
of misclassification that may result when arbitrary cut-off points are selected by the 
researcher. 
By eliciting the age at onset of participants ' earliest episode of an anxiety disorder, in 
addition to all subsequent episodes recalled by participants ', the current study makes a 
distinction between age at onset of the presenting disorder at time of evaluation, and age 
at onset of first lifetime episode of anxiety and other DSM-IV psychiatric disorders. In 
doing so, the term "late-onset" in the present study referred to those participants whose 
first onset of an anxiety disorder occurred after the age of 34. This distinction is not 
clear in previous research (Le Roux, et al. , 2005 ; Raj , et al. , 1993 ; Sheikh, et al. , 2004), 
whereby the term "late-onset" has been variably referred to as i) the onset of anxiety 
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occurring in late-life based on theoretical definitions of"old age" (i.e. from 50-65 years 
and older), and does not preclude onset of illness earlier in life; ii) the onset of an 
anxiety disorder occurring for the first time in old age, without a prior history of 
psychiatric illness, or; iii) the onset of anxiety occurring for the first time after 
adolescence or young adulthood, defined as the period in which onset of psychiatric 
illness is typically thought to occur. Although the first definition appears to refer to a 
late-life episode as opposed to specifically being a LO episode in late life , the 
distinction is not often clear in the research literature, as previously outlined in section 
3.8 . 
This lack of clarity as to definitions of "LO" in the investigation of late-life anxiety, and 
failure to assess lifetime episodes of onset contributes to the ambiguity that exists as to 
the occurrence of "LO" disorders (Barlow, 1988; Flint, 1994, 1997). In the present 
study, participants identified as having LO GAD represent a population of older adults 
whose first onset of anxiety occurs after the age of 34 based on statistical fit of multiple 
models to the attained distribution of onset. The mean age at onset for this sub-group 
was identified as 52.85 years indicating that there are indeed a number of anxious older 
adults who report having their first episode of clinically significant anxiety after the age 
of 50. By identifying lifetime episodes of psychiatric illness and using a statistically 
derived age cut-off to distinguish early- and late-onset subgroups, the present study 
aimed to highlight a methodology that may address this lack of clarity in future 
research. Though this methodology may result in varying thresholds across studies 
depending on the sample population, it would allow researchers to build a picture of the 
age at which LO disorders are likely to occur in a given population, and what is known 
about LO disorders based on the age-cut-off identified, as distinct from disorders 
occurring after a pre-selected age reflective of a particular developmental period of life. 
In summary, the present data provide evidence for the existence of two sub-populations 
of community dwelling anxious older adults representing an EO group whose onset of 
an anxiety disorder occurs at or prior to the age of 34, and a LO group for whom 
episode onset occurs at 35 years of age or later. Having established a cut-off age to 
distinguish these subgroups of anxious older adults, the studies reported in subsequent 
chapters were designed to explore potential differences in the aetiology, 
phenomenology and response to psychological treatment of these groups. 
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CHAPTER EIGHT 
A Cross-sectional Study of Differences in the Aetiological Correlates of 
Early- and Late-onset Anxiety 
8.1 Introduction 
The current chapter presents the findings of an investigation aimed at examining 
whether there are aetiological differences between early- onset (EO) and late-onset (LO) 
Generalised Anxiety Disorder (GAD). An empirical comparison of these two onset 
groups across a range of aetiological factors has the potential to clarify and extend the 
existing knowledge regarding such differences, which are considered to be important 
dimensions in classifying and/or differentiating EO and LO anxiety. Whilst participants 
were assessed for all DSM-IV anxiety disorders in the previous chapter, GAD was 
found to be the most commonly diagnosed disorder at evaluation (i.e. the presenting 
disorder) , and at first onset of an anxiety di sorder of any kind in the present sample. 
Accordingly, GAD will be the focus of research presented in the current chapter and 
subsequent investigations presented in this thesis. 
Due to limited knowledge about the aetiological differences between early-and late-
onset GAD, the study presented in this chapter undertook an exploratory approach. 
Whilst hypotheses were put forward based upon the literature review outlined in 
Chapter Three, a combination of both mixed findings concerning the aetiological 
differences between EO and LO GAD and the methodological limitations of previous 
investigations (outlined in Sections 3.7 and 3.8) suggest that more evidence is required 
to substantiate any differences thus far proposed in the literature. Having addressed 
some of the methodological limitations of previous onset research, as discussed in 
section 3.9, the present investigation compared participants with EO and LO GAD 
across a number of demographic characteristics and bio logical ri sk factors. The specific 
relationships and hypotheses addressed in this chapter were previously outlined in 
section 5.2.2 (see Table 5.1). 
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8.2 Classification of Anxiety Sub-groups 
Participants were classified into two age of onset groups based upon the optimal cut-off 
procedure for EO and LO GAD, as described in the previous chapter. This optimal cut-
off age was found to be 34.4 years. Criteria for this classification was based on the 
finding that this cut-off age accurately predicted that the probability of a given age at 
onset for belonging to either sub-population (that is, before or after this cut-off) would 
be identical (see section 7.3 .3). Based on the identified cut-off of 34.4 years, 31.6% (n 
= 24) of the sample were classified as having EO GAD, and 68.4% (n = 52) were 
classified as having LO GAD. 
All analyses reported in the present and subsequent studies were conducted using a cut-
off age of 34.4 to distinguish between EO and LO groups. A decision was made to also 
conduct all investigations using a cut-off of 50 years in order to ensure that the current 
research would be directly comparable to previous investigations that have used this 
cut-off point (Chou, 2009; Le Roux, et al., 2005). Using a cut-off of 50 years, 55.3% 
(42) of the sample was categorised as belonging to the EO group, and 44.7% (34) was 
identified as belonging to the LO group. As the primary focus of investigations 
presented in this thesis was to compare participants using the empirically derived cut-off 
of 34.4 years and due to word limitations, findings using a cut-off of 50 years were 
reported only where they differed from those using the cut-off of 34 years . 
8.3 Sample Characteristics 
8. 3.1 Age of onset characteristics 
Descriptive statistics for mean age at evaluation and age at onset of current and past 
episodes·of psychiatric illness are presented in Table 8.1. Comparison of means using 
independent-samples t-tests were performed to examine the differences in age at 
evaluation and age at onset of current and past episodes of psychiatric illness between 
EO and LO groups. The findings revealed that onset groups did not differ in mean age 
at evaluation or in age at onset of the presenting episode. Comparison of onset groups 
revealed that, on average, participants in the EO group were significantly younger at 
first onset of a DSM-IV anxiety disorder of any kind than those in the LO group. 
Similarly, participants in the EO group were found to be significantly younger, on 
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average, than those in the LO group at age of first onset of a DSM-IV disorder of any 
kind. Levene ' s test for equality of variances was highl y significant for these two 
variables, indicating non-equal variances for groups on these two variab les. 
Accordi ngly, t va lues, degrees of freedom, and p va lues reported for these variables are 
based on Levene ' s test of equa li ty. 
Table 8.1 
Descriptive Statistics of Current Age and Age of Onset Characteristics for EO and LO 
Participants 
Variable 
Age at evaluation (years) 
Age at onset of presenting 
episode (years) 
Age at first onset of any 
DSM-IV disorder (years) 
Age at onset of first anxiety 
disorder (years) 
Early Onset 
(n = 24) 
M SD 
61.8 5.6 
58.5 7.2 
15.0 6.7 
15.0 6.7 
* p S: 0.05 ; **p S: 0.0 I; ***p :S 0.00 I 
Late Onset 
(n = 52) 
M SD 
63 .9 6.4 
59.6 6.2 
49.5 13.1 
52 .9 9.8 
t equality of variances not assumed (Levene 's test significant) 
Significance test 
l [dD 
1.37[74] 
0.65 [74] 
15.16[73 19J***t 
19.70[633l] ***t 
A comparison of group differences using a cut-off of 50 years also revealed significant 
differences. In contrast to the findings using a cut-off of 34.4 years, the LO group was 
found to be significantly older than the EO group at assessment (t (74) = 2.04, p < .05) 
and at onset of the presenting episode (1 (74) = 2 .30, p < .05) at the p < .05 level. 
Consistent with findings using a cut-off of 34.4 years, those in the EO group were, on 
average, found to be significantly younger than those in the LO group at first onset of a 
DSM-IV anxiety disorder (I (57.39) = 12.7 15, p < .001) and at first onset of a DSM-IV 
disorder of any kind (I (73.10) = 8.554, p < .001), equal variances not assumed. 
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8.3.2 Demographic characteristics 
Descriptive statistics for the demographic characteristics of participants are presented in 
Tables 8.2 through to Table 8.4. Chi-square(/) analyses were conducted to investigate 
differences in the demographic characteristics of EO and LO participants. The findings 
of these analyses are also presented in Tables 8.2 through 8.4. Descriptive statistics for 
gender, ethnicity and marital status are presented in Table 8.2. Females outnumbered 
males in both EO and LO groups 2: I. The majority of participants were non-indigenous 
Australians, with a similar proportion of European, Asian and South American 
participants in each group. The majority of participants were married or in a 
relationship. A greater proportion of LO participants were single or separated and/or 
divorced and equivalent amounts were widowed. Analyses revealed no significant 
differences between onset groups in gender, ethnicity or marital status. 
Table 8.2 
Gender, Ethnicity and Marital Status of EO and LO Participants 
Early Onset Late Onset Significance 
(N = 24) (N= 52) test 
Variable /(%) (n) /(%) - (n) 7[dfj 
Gender 0.001 [1 ] 
Male 29.2 (7) 28.8 (15) 
Female 70.8 (17) 71.2 (37) 
Ethnicity 1.49[3] 
Non-indigenous Australian 75.0 (18) 80.7 (42) 
European 16.7 (4) 7.7 (4) 
Asian 4.2 (1) 5.8 (3) 
South American 4.2 (1) 5.8 (3) 
Marital status 1.88[!] 
Single 4.2 (I) 5.8 (3) 
Married/in a relationship 79.2 (19) 63.5 (33) 
Separated or divorced 12.5 (3) 25.0 ( 13) 
Widowed 4.2 (I) 5.8 (3) 
* p:S0.05; **p:S0.01; ***p:S0.001 
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The educational and occupational characterist ics of EO and LO participants are 
presented in Table 8.3. The majority of participants were highly educated, with about 
one third of both EO and LO participants having completed secondary education, and 
two-thirds of participants in each group having completed tertiary education and/or 
qualifications. Of those participants who were employed, the majority of early-and late-
onset participants were employed in a part-time as opposed to full-time capacity. 
Employment intens ity is likely to be a reflection of the age of the sa mple, with more 
than half of the participants in both early-and late-onset groups being retired. The 
occupations of participants also reflected the hi gh level of education achieved by many 
participants, with half of the EO group and just over half of the LO group working in 
professional and/or skilled appointments. The x2 analyses revealed no significant 
differences between EO and LO groups in education, occupation, employment status or 
employment intens ity. 
Table 8.3 
Education and Occupational Characteristics of EO and LO Participants 
Early Onset Late Onset Significance 
(N = 24) (N =. 52) test 
Variable f(%) (n) f(%) (n) X [dfj 
Level of education 0.05p] 
Year 8 - ' intermediate ' 16.7 (4) 15.4 (8) 
Year 10 - 'matriculation ' 16.7 (4) 15.4 (8) 
Tafe/trade qualification 20.8 (5) 40.4 (21) 
University degree 41.7 (I 0) 15.4 (8) 
Post-graduate degree 4.2 ( I) 13.4 (7) 
Occupation 0.1 0pJ 
Professional or assoc iate 50.0 ( 12) 50.0 (26) 
professional 
Higher administrative or clerical 37.5 (9) 42.3 (22) 
Tradesperson 8.3 (2) 1.9 ( I) 
Non-professional 4.2 ( I) 5.8 (3) 
* p~0.05; ••p~0.01 ; ·••p~0.001 
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Table 8.3 - continued 
Education and Occupational Characteristics of EO and LO Participants 
Early Onsel Late Onset Significance 
(N = 24) (N = 52) lest 
Variable /(%) (n) /(%) (n) i [dQ 
Employment status 0.18[1] 
Employed 41.7 (I 0) 36.5 (I 9) 
Unemployed 12.5 (3) 7.7 (4) 
Retired 45 .8 (II) 55.8 (29) 
Employment intensity 0.6l r2J 
Part-time 29.2 (7) 21.2 ( II ) 
Full-time 12.5 (3) I 5.4 (8) 
n/a 58 .3 (14) 63.5 (33) 
Table 8.4 presents the social network characteri stics of participants. The majority of 
both EO and LO participants reported that they considered their children, spouse, and 
friends to be a source of social support. Three-quarters of EO participants and just over 
one-half of LO participants reported that they considered their children to be a source of 
social support. Three-quarters of EO participants and just over two-fifths of LO 
participants reported that their spouse or partner was a source of social support. Over 
four-fifths of both early- and late-on.set participants reported that their friendships were 
supportive. Regarding the quality of friendships , just under two-thirds of both early and 
late-onset participants described their friendships as confiding, whilst about one-third of 
EO and LO participants described their friends as being more like acquaintances as 
opposed to having close, confiding relationships with friends. Analysis of social 
demographics revealed that participants with EO GAD report receiving greater social 
support by their children than do those with LO GAD. Onset groups were not found to 
differ with regard to social support provided by partners/spouses or by friends, nor in 
the quality of friendships maintained. 
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Table 8.4 
Social Support Characteristics of EO and LO participants 
Early Onset late Onset Significance 
(N = 24) (N = 52) test 
Variable f(%) (n) f(%) (n) X [dD 
Social support 
Children 79.2 (I 9) 55.8 (29) 3.861q* 
Spouse/partners 75.0 (18) 80.4 (41) 0.28[1] 
Friends 87.5 (21) 84.6 (44) 0.1111] 
Quality of friendships 0.31 [! ] 
Acquaintances 37.5 (9) 44.2 (23) 
Confiding 62.5 ( 15) 55.8 (29) 
* p :e: 0.05; **p :e: 0.0l ; ***p :e: 0.001 
8.3.3 Health Characteristics 
Age of onset and chronic disease in later life 
As a group, 42 different current medical conditions were reported by participants. 
Descriptive statistics for the more commonly reported conditions are listed in Table 8.5 . 
The most common medical conditions for both EO and LO groups included a pain 
syndrome, arthritis, high blood pressure, high cholesterol , and irritable bowel syndrome. 
A high percentage of both EO and LO groups reported wearing glasses for reading 
and/or long-distance vision. A series of x2 analyses were conducted to determine 
whether early-and late-onset groups differed with regards to medical comorbidity. 
Analyses were not performed between groups for conditions where there was a cell size 
of less than five (i.e. respiratory and endocrine/metabolic problems). Overall , EO and 
LO groups were found to be similar with respect to the frequency of current health 
conditions experienced by adults with late-life GAD. EO and LO participants reported 
an average of 3.7 (S.D = 2.6) and 4.5 (SD = 2.8) medical conditions each. An 
independent-samples t-test revealed that, on average, onset groups did not differ in the 
total number of conditions reported (t(74) = 1.23, p > .05). 
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Table 8.5 
Frequency of Current Medical Conditions Reported by EO and LO Participanls 
Early onset Late onset Significance 
(N=24) (N = 52) test 
f(%) (n) f(%) (n) X [d~ 
Diseases of the nervous system 25.0 (6) 19.2 (I 0) 0.33[1] 
Headache 16.7 (4) 17.3 (9) 
Migraine 8.3 (2) 1.9 (I) 
Cardiac conditions 16.7 (4) 19.2 (I 0) 0.07[1 ] 
Congestive heart failure 4.2 (I) 3.8 (2) 
Pulmonary embolism 0.0 (0) 1.9 ( I) 
Cardiac disease 8.3 (2) 3.8 (2) 
Sub-ventricular tachycardia 0.0 (0) 3.8 (2) 
(SVT) 
Enlarged heart 0.0 (0) 1.9 ( I) 
Angina 8.3 (2) 3.8 (2) 
Hypertension 12.5 (3) 11.5 (6) 
High blood pressure 50.0 (12) 40.4 (21) 0.62[!] 
Respiratory disease 12.5 (3) 19.2 (I 0) 
Asthma 8.3 (2) 11.5 (6) 
Pneumonia 4.2 (I) 7.7 (4) 
Neoplasms 8.·3 (2) 3.8 (2) 
Endocrine/ metabolic conditions 4.2 ( I) 15.4 (8) 
Diabetes Type II 0.0 (0) 9.6 (5) 
Hypothyroidism 4.2 (I) 5.8 (3) 
High cholesterol 37.5 (9) 42.3 (22) 0 .16[1 ] 
Digestive and gastrointestinal 33.3 (8) 40.4 (21) 0.35[1] 
conditions 
Constipation 4.2 (I) 7.7 (4) 
Irritable bowel syndrome 
25.0 (6) 15.4 (8) (IBS) 
Reflux, oesophageal 4.2 (I) 23.1 ( 12) 
Stomach aches, pains and 8.3 (2) 11.5 (6) 
spasms 
Genito-urinary problems ( urinary 
4.2 (I) 7.7 (4) 
tract infection) 
* p:S0.05; **p:S0.01; ***p:S0.001 
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Table 8.5 - Continued 
Frequency of Current Medical Conditions Reported by EO and LO Participants 
Early onset Late onse/ Significance 
(N=24) (N = 52) test 
f(%) (n) f(%) (n) X [dD 
Any eye/ear conditions 12.5 (3) 19.2 (I 0) 0.52[1] 
Cataract 8.3 (2) 7.7 (4) 
Eye disease 8.3 (2) 13 .5 (7) 
Problems with vision 
( use of glasses) 95.8 (23) 88.5 (46) 
Hearing loss 8.3 (2) 7.7 (4) 
M usculoske letal/ connective 50.0 ( 12) 61.5 (32) 0.90[! ] 
tissue conditions 
Arthritis 41.7 (10) 51.9 (27) 
Osteoporosis 12.5 (3) 7.7 (4) 
Back or spine issues 
(Including disc disorder, 4.2 (1) 17.3 (9) 
degenerat ion) 
Pain syndrome 41.7 (I 0) 63.5 (33) 3.17[1 ] 
Age of onset and current medication use 
Frequency of current prescription and non-prescription medications used by early- and 
late-onset participants are presented in Table 8.6. A series of x2 frequency analyses 
were conducted to determine whether EO and LO groups differed with regards to use of 
prescription and non-prescription medications. Analyses were not performed between 
groups for conditions where there was a cell size of less than five (i.e . ant iconvulsants 
and anti-inflammatory medications). The most commonly used prescription 
medications by both EO and LO groups were antidepressants, antihypertensives, 
anticoagulants, and hypolipidaemics, consistent w ith the most commonly reported 
medical conditions listed in Table 8.5. With regard to the use of psychotropic 
medications , rates of current antidepressant and/or anxiolytic use, excluding the use of 
benzodiazepines, were not found to significantly differ between onset groups. A 
significant x2 was however found for benzodiazepines at the .05 level, with 
benzodiazepine use being significantly greater amongst EO participants than LO 
participants. Onset groups were not found to s ignificantly differ in the use of any other 
prescriptions medication. 
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The most commonly used non-prescription medications by both early-and late-onset 
participants were health supplements. A I frequency analysis found that EO 
participants were more likely than LO participants to use health supplements at the .05 
significance level. Anti-reflux agents were used by about one-fifth of LO participants, 
though were not used by any EO participants. Whilst a I frequency analysis was not 
performed due to an expected cell count of less than 5 for the EO group, thi s result 
suggests that LO participants are more likely to use anti-reflux agents and thi s result 
should be considered as being potentially significant. 
Table 8.6 
Frequency of Current Prescription and Non-prescription Medications Used by EO and 
LO Participants 
Early onset Late onset Significance 
(N=24) (N = 52) test 
Variable / (%) (n) /(%) (n) K[dfj 
Prescription medications 
Antidepressants 20.8 (5) 30.8 ( 16) 0.81 [ ! ] 
Benzodiazpines 29.2 (7) 9.6 (5) 4.72r 1i * 
Antihypertensives 20.8 (5) 40.4 . (21) 2.79[1 I 
Anticoagulants 25.0 (6) 34.6 ( 18) 0.7011 1 
Anticonvulsants 4.2 ( 1) 9.6 (5) 
Anti-inflammatory 4.2 ( 1) 9.6 (5) 
Hypothyroid medications 4.2 (I) 5.8 (3) 
Hypolipidaemic 20.8 (5) 25.0 (13) 0.16(1 ] 
Hypoglycaemics 0 (0) 9.6 (5) 
N icotinic analgesics 16.7 (4) 15.4 (8) 
Non-prescription medications 
Anti-reflux agents 0.0 (0) 21.2 ( I 1) 
Anti-diarrhoeal 4.2 ( 1) 3.8 (2) 
Simple analgesics 8.3 (2) 13.5 (7) 
Health supplements 50.0 ( 12) 26.9 (14) 3.89r1i * 
Vitamins 29.2 (7) 19.2 (10) 
Minerals 16.7 ( 4) 15.4 (8) 
Folate 10.7 (3) 1.8 ( 1) 
Fish oil 33.3 (8) 5.8 (3) 
* p-:,0.05; **p -:, 0.01 ; ***p-:,0.001 
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Table 8.7 presents the total number of prescription and non-prescription medications 
used by participants per day. The mean alcohol consumption ofEO and LO groups (i .e. 
number of drinks) per week is also presented in Table 8.7. Independent-samples I-tests 
revealed that onset groups did not differ in the number of prescription, non-prescription, 
or total number of medications (prescription and non-prescription) used. The EO group 
showed a trend towards greater substance (alcohol) use than the LO group however this 
difference was not found to be significant. 
Table 8.7 
Descriplive Statistics of Prescription and Non-prescription Medication Use by EO and 
LO Participants 
Early onset Late onset Significance 
(N=24) (N = 52) test 
Variable M SD M SD t1ctn 
Prescription medication use 1.5 1.2 2.0 1.6 1.23[74] 
Non-prescription medications use 1.0 1.2 0.9 1.0 0.69[74] 
Total number of medications used 
2 .5 2.1 2.8 2.0 0.56[74] (prescription and non-prescription) 
A lcohol use 7.3 9.7 3.9 6.3 l.86174J 
* p :S 0.05; **p :S 0.01; ***p :S 0.001 
Age of onset and treatment history 
Descriptive statistics for mean age at help-seeking, number of episodes and time since 
initial onset of anxiety for EO and LO groups are presented in Table 8.8. Table 8.8 also 
presents the resu lts of independent-samples t-tests comparing onset groups on these 
variables. Levene's test for equality of variances was significant for the age at help-
seeking and duration of illness variables. Accordingly, the t-values, degrees of freedom 
and p values reported for these variables were adjusted to account for heterogeneous 
variance. Independent-samples t-test revealed that onset groups did not differ in mean 
age at which they first sought help for a psychiatric problem. A significant difference 
was found between onset groups for mean number of episodes of psychiatric illness, 
with EO participants reporting a greater number of episodes on average. A significant 
difference was also found for time (in years) since onset of first OM-IV anxiety 
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disorder, with EO participants, on average, having a significantly longer history of 
anxiety than LO participants. 
Significant differences were also found using a cut-off of 50 years. A significant 
between-group difference was found for mean age at help seeking (t (74) = 3.40, p < 
.00 I), with EO patients on average seeking help at 47.76 years (S.D = 15 .0) , and LO 
participants seeking help at 59.12 years (SD = 13. 7). As with findings using a cut-off of 
34, significant differences in the mean number of episodes of illness (t (74) = 5.95, p < 
.00 1) and duration of illness (t (73.99) = 7.7 1, p < .001) were also found. 
Table 8.8 
Help-seeking and Illness Characteristics of EO and LO Participants 
Early onset Late onset Significance 
(N=24) (N= 52) test 
Variable M (SD) M (SD) l[dfj 
Age at help seeking 48 .3 (18.7) 54.9 (13.4) 1.57[344] t 
Number of episodes 4.0 (1.2) 2.2 (1_.2) 6.031741 *** 
Time since onset of first episode 
46.8 (8. 1) 14.5 (12.5) l 3.46[655SJ* **j· 
of anxiety (years) 
* p::o0.05; **p ::o 0.0l; ***p::o0.00J 
"t equality of variances not assumed (Levene 's test significant) 
Descriptive statistics for psychiatric treatment variables for EO and LO participants are 
presented in Table 8.9. Differences in the frequency of psychiatric treatment previously 
sought were investigated using J frequency ana lyses. Overall, the two groups were 
similar with regard to psychiatric treatment history. No significant differences were 
found between the two onset groups in the proportion of participants who reported a 
history of counselling or psychotherapy, past psychotropic medication use, nor with 
regard to previous treatment of any kind . 
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Table 8.9 
Descriptive Statistics of Psychiatric Treatment History for EO and LO Participants 
Early onset Late onset Significance 
(N=24) (N= 52) test 
Variable f ("/o) (n) f (%) (n) J ;(° [dD 
Treatment history 
History of counselling/ psychotherapy 29.2 (7) 17.3 (9) 1.3911] 
History of psychotropic medication use 70.8 (1 7) 57.7 (30) 1.20[1] 
History of any treatment (therapy and/or 79.2 (19) 63.5 (33) 1.87(1 ] 
medications) 
* p:S0.05; **p :S 0.01; ***p :S 0.001 
8.3.4 Age of onset and genetic or predisposing factors 
Descriptive statistics for family history of a psychiatric illness for EO and LO 
participants are presented in Table 8.10. Investigation of differences between onset 
groups for a positive family history of a mood and/or affective di sorder using J 
analyses revealed that EO participants were significantly more likely to have mothers 
with a history of psychiatric illness than LO participants. Onset groups did not differ 
with regard to frequency of psychiatric illness reported in the fathers of participants. 
EO participants were also found to report a family history of psychiatric illness in their 
' parents ' (mother and father combined) at a significantly higher rate than LO 
participants. Investigation of a famil y history of mental illness in the offspring of 
participants revealed no significant difference between onset groups. 
Table 8.10 
Frequency of EO and LO Participants Reporting a Family History of Psychiatric Illness 
Early Onset Late Onset Significance 
(N = 24) (N = 52) test 
/ (%) (n) / (%) (n) / [dD 
Family history of emotional 
disorders 
Mother 75.0 (18) 34.6 (18) 10.74[1]*** 
Father 20.8 (5) 15.4 (8) 0.34(1] 
Parents (mother and/or father) 83.3 (20) 36.5 (19) 14.39[1]*** 
Children 45.8 (11) 42.3 (22) 0.08p] 
* p :S 0.05; **p:S 0.01 ; ***p:S0.001 
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8.4 Discussion 
Chapter Eight aimed to provide an overall description of the nature of the sample 
recruited, as well as to acquire an understanding of the aetiology late-life GAD in a 
group of community-dwelling anxious older adults distinguished by age at onset. 
Accordingly, potential differences in the demographic characteristics, health 
characteristics and genetic factors of a sample of older adults with EO and LO GAD 
were examined in the present chapter. Given the relationship between GAD and 
depression in late-life, and the observation that PD and panic symptomatology 
commonly co-occurred in a proportion of participants, the findings of the current 
investigation are discussed with reference to previous investigations of an onset 
distinction in late-life in the GAD, PD and MDD literature. 
An examination of the age at onset characteristics revealed that participants reported a 
wide range of ages of onset, from young-old to old-old, indicative of the full range of 
ages at which generalized anxiety appears to be a problem in older Australian adults . An 
initial analysis of the age of onset characteristics revealed no differences between early-
and late-onset groups in mean age at evaluation, or in age at onset of the presenting 
episode. This finding suggests that it was appropriate to compare the EO and LO 
samples, as they were of a similar age and had been suffering the current episode for an 
equivalent period of time. These findings are also consistent with previous 
investigations of late-life GAD (Beck, et al. , 1996; Le Roux, et al. , 2005; Lenze, et al. , 
2005) in which EO and LO groups of older adults were found to be similar with regard 
to current. age and age at onset of the presenting disorder. By definition, the EO 
participants should have experienced their first anxiety disorder at a younger age than 
the LO participants. As expected, a significant between-group difference was found for 
age at on~et of first DSM-IV disorder of any kind and for age at onset of first DSM-IV 
anxiety disorder, with mean age at onset of EO participants being significantly younger 
than that of LO participants at these time points. 
It was hypothesised that early- and late-onset participants would be similar with respect 
to their demographic characteristics. The current findings revealed that the demographic 
characteristics of the two sub-samples of older adults did not found to differ from one 
another with respect to age, gender or marital status, nor in terms of education, 
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occupation, employment status, or employment intensity. These findings are in line 
with previous investigations of age at onset of GAD in later life (Beck, et al. , I 996; 
Chou, 2009; Le Roux, et al., 2005 ; Lenze, et al. , 2005) in that participants were 
typically female, married, and well-educated (i.e. had completed high school level 
education). Participants reported high levels of ed ucation and professional employment, 
which is in line with the available data of ACT residents (AIHW, 2003). 
Analysis of social demographics revealed that EO and LO onset groups did not differ 
with regard to social support provided by participants' partner/spouse or by friends , nor 
in the quality of friendships mainta ined. A higher proportion of EO participants were 
however found to receive social support from their children than LO participants, 
although this finding was significant only at the .05 level. One explanation for this 
finding is that the children of older adults with EO GAD may have been raised in an 
environment in which one or both parents had a psychiatric illness and therefore they 
provided a supportive role from an ear ly age which continues on throughout life. In 
contrast, o lder adults with LO GAD may previously have been independent and 
therefore did not use their children as a source of support when they were young. 
Furthermore, for many LO participants problems w ith anxiety may have developed after 
their children left home. As a result, the children of LO participants may not be as aware 
of their parents need for support, or be around to provide it. Aspects of social 
demographics have not previously been investigated in onset research and further 
research is required to investigate this relationship given the role of social support as a 
protective factor in the development of anxiety when exposed to stressful events (de 
Beurs, et al. , 2000). 
The hypothes is that EO and LO groups would be similar with regards to medical 
comorbidity as indicated by both the frequency of specific conditions reported and the 
total number of medical conditions overa ll was supported by the present data. The 
current findings are consistent with those of Chou (2009), who found simi lar rates of 
various cardiac conditions, stomach conditions and arthritis in a sample of older adu lts 
with early-and late onset GAD in late-life. The current findings are al so in line with 
previous findings of Le Roux et al. (2005), who found no difference between groups of 
older adults with EO and LO GAD in mean number of medical conditions or in physical 
disability. 
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Although approximately 50% of the sample reported having one of a few conditions 
known to be common in later life (i .e. pain, cholesterol, high B.P, and musculoskeletal 
conditions), an overview of the frequency of other medical conditions reported by 
participants indicate that a relatively small proportion of the sample (i.e. about 25% or 
less) endorsed having any given condition, including those commonly associated with 
anxiety disorders . Similarly, the current sample of both EO and LO participants were 
overall not found to be high users of medication (see sections 7.2.3). Therefore, it may 
be that the sample of help-seeking older adults who volunteered for the present 
investigation had relatively good medical/physical health, raising the question as to 
whether healthier adults are more likely to self-refer to this kind of study. Although 
chronic health conditions are associated with anxiety in later life (van Zelst, 2003), the 
earlier finding that both EO and LO participants were similar in mean age at time of 
evaluation and at onset of the presenting episode suggests that the number of concurrent 
medical conditions reported is associated with the aging process itself, as opposed to 
age at onset and duration of anxiety. 
The hypothesis that EO participants would be using psychotropic medications such as 
antidepressant medications and/or benzodiazepines at a higher rate than LO participants 
(hypothesis 4a) was partially supported by the current findings . Whilst current 
psychotropic medication use, excluding benzodiazepines, was not found to differ 
between onset groups, a significantly greater proportion of EO participants were found 
to be taking benzodiazepines than LO participants at the .05 significance level. These 
findings are in contrast to previous research by Le Roux et al. (2005) who found current 
psychotropic medication use by participants with EO GAD to be double that of LO 
GAD patients. In particular Le Roux et al. found that a higher proportion of LO patients 
were using benzodiazepines when compared to the EO group. Although the findings of 
Le Roux et al. led them to conclude that individuals who develop GAD in late life may 
receive less effective treatment for their illness than those with a longer history of 
anxiety, the current findings suggest that it is those with a longer history of anxiety that 
continue to use these less effective medications, whilst those with a more recent history 
are more likely to be prescribed newer SSRI treatments rather than benzodiazepines. 
The cut-off age used to compare onset groups does not appear to be a factor as to the 
difference between the present data and the findings of Le Roux et al. (2005), with the 
frequency of antidepressant use by EO and LO groups remaining similar when 
compared using a cut-off of 50 years. The finding that EO and LO groups were similar 
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in mean age at help-seeking for an emotional disorder (see section 8.2.3) may also 
account for the similar rates in use of mood stabilising medications in the current 
sample. 
Hypothesis 4b proposed that EO participants would not differ from LO participants in 
their use of prescription and non-prescription medications. This hypothesis was partially 
supported by the current data. Although LO participants were observed to use the 
majority of prescription medications cited by the sample at higher rates than EO 
participants and to use a greater number of prescription medications overall , this finding 
was not significant. The finding that onset groups were similar with regard to 
prescription medication use is consistent with the finding of similar rates of significant 
medical conditions for which these medications were prescribed, including cardiac 
conditions, hypertension and cholesterol problems . 
A comparison of non-prescription medication use revealed that early- and late-onset 
groups significantly differed in their use of health supplements at the .05 level , with a 
greater proportion of EO participants using health supplements than those with LO 
GAD. The use of anti-reflux agents was not statistically examined due to an expected 
cell count of less than five for the EO group. An analysis of the frequencies however 
suggests that LO participants (21.2%).are more likely to use anti-reflux agents than EO 
participants (0%), and that this result may warrant further investigation . 
It is unknown why the frequency of health supplement use by participants in the EO 
group nearly doubled that of the_ LO group. Given that on average, EO participants 
delayed help-seeking until their late 40 ' s despite a considerably earlier age of onset in 
most cases, and the relatively good physical health and low rates of medication use in 
general for this sample, it is possible that a proportion of participants primarily looked 
to alterna'tive or 'natural' remedies to maintain good health and to address anxiety and 
other emotional problems. On the other hand, those people that develop health and 
emotional difficulties in later life may be more geared towards the medical model for 
solutions to health and emotional problems, and therefore less likely to consider 
'natural' or ' herbal' remedies. Further investigation is required to establish this in future 
studies. 
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The hypothesis that EO participants would have higher rates of alcohol use than LO 
participants (Hypothesis 4c) was not supported by the current data. On average, 
although participants in the EO group consumed more alcohol per week than LO 
participants, this difference did not reach significance. Alcohol and substance use are 
common comorbid conditions in individuals with longstanding mental illness, and 
studies have shown that anxiety disorders are frequently preceded by another 
psychiatric condition such as mood disorders, or alcoholism (Merikangas, et al., 1998; 
Starcevic & Bogojevic, 1999; Starcevic, et al. , 1993). As such, it is possible that alcohol 
may be used as a means to self-medicate by those with a long and chronic history of 
anxiety, which may account for the greater use of alcohol in the EO group. This is 
reflected in a statement by one participant identified as having EO anxiety who reported 
that "my panic attacks have reduced because I use alcohol to 'blunt' my feelings," and 
"I carry a coke bottle with a beer and brandy mix in my pocket ... when I feel stressed or 
nervous, I have a nip of brandy and beer." The use of alcohol to manage problems with 
anxiety by some individuals in the EO group, along with increased alcohol use by this 
group on average may be a factor as to the delayed age at help-seeking for participants 
in the EO group (see Section 7.2.3) and similar rates in use of mood stabilisers between 
groups. Taken together, these findings suggest that the relationship between age of onset 
and alcohol use may warrant further investigation. 
The hypothesis that EO participants would, on average, seek treatment at a younger age 
than LO participants (Sa) was not supported by findings of the current investigation. On 
average, mean age at help-seeking for the EO group was 6.6 years earlier than 
participants in the LO group, though this difference was not significant. In contrast, 
using a cut-off 50 to compare onset groups, the EO group were found to seek help for 
emotional problems at a significantly younger age than those in the LO group. This 
finding may in part be due to the fact that those participants who were identified as 
belonging to the LO group based on a cut-off of 50 years had a much more recent onset 
relative to mean age at evaluation, and consequently had not previously sought help. On 
the other hand, those in the EO group had a greater number of episodes of psychiatric 
illness and lifetime history of anxiety in terms of time since onset of first episode, 
therefore prompting help-seeking at a much earlier age. 
EO participants reported a significantly greater number of discrete episodes of anxiety 
and/or depression than LO participants, and til)1e since onset of first anxiety episode in 
121 
the EO sample was also significantly greater than that of the LO group. These findings 
remained significant when groups were compared using a cut-off age of 50 years to 
di stingui sh onset groups, and are in support of hypotheses Sb and Sc, respectively. 
Findings of difference between EO and LO groups in duration since onset of illness and 
number of illness episodes are as expected given the much younger mean age at onset of 
first anxiety episode for EO participants, and are consistent with previous findings of 
late-life PD (Raj, et al. , 1993) and GAD (Beck, et al. , 1996; Le Roux, et al. , 2005). 
Hypothesis (Sd) proposed that participants with EO GAD would report a history of both 
psychotropic use and counselling or psychotherapy at higher rates than those with LO 
GAD. This hypothesis was not supported by the data. Although a greater proportion of 
EO participants had a history of psychotropic treatment, had previously engaged in 
psychotherapy and had received treatment of either kind than LO parti cipants, onset 
groups were not found to differ with regard to history of treatment sought fo r emot ional 
problems. These findings are in line with previous findings of Le Roux et al. (2005), 
who found patients with EO GAD to have non-significantly higher rates of both a 
history of psychotropic medication use and a history of counselling or psychotherapy 
than those with LO GAD . 
Invest igation of genetic factors confirmed a higher prevalence of a positive family 
history of psychiatric illness in participants with EO GAD and is in partial support of 
Hypothesis 6. Specifically, a significantly higher proportion ofEO participants reported 
their mothers to have a history of psychiatric illness than LO participants. Onset groups 
were not, however, found to differ with regard to the proportion of fathers or children 
reported to have a history of psychiatric illness. The relationship between genetic 
factors and age at onset of GAD has not previously been invest igated however an 
association between EO of anxiety and increased familial risk for PD has been reported 
in previous investigations (Battaglia, et al. , 1998; Battaglia, et al. , 1995 ; Goldste in, et 
al. , 1997; Segui, et al., 1999), in line with the current findings . Similarly, in a study of 
aging and panic disorder by Sheikh et al. (2004), 63% of older adults with EO PD were 
found to have a family history of anxiety, versus 39% of LO participants. This finding 
of difference was non-significant, however, is in support of findings of a greater 
association between EO GAD and a positive family history of anxiety in the present 
study and as reported in previous research. 
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In summary, the present data were in partial support of the hypotheses put forward . 
Ear ly-and late-onset groups were homogenous in terms of demographic and health 
characteri stics including both the type and number of health conditions reported , as 
predicted. As expected, EO participants were significantly younger at first onset of any 
DSM-IV disorder and first onset of a DSM-IV anxiety disorder. There was a small but 
significant finding for greater receipt of social support by the children of those with EO 
GAD. Hypothesised differences in participants' use of psychotropic medication were 
partially confinned by the present data. Participants were found to be similar with 
regard to antidepressant use, however there was a small but significant finding for 
greater benzodiazepine use and the use of health supplements amongst those with EO 
GAD. Of note were the findings suggesting that participants with EO GAD tend to 
have a significantly longer course of illness characterised by a greater number of 
ep isodes of psychiatric illness, and that EO anxiety is related to a longstanding 
psychobiological (genetic) vulnerability to anxiety, as indicated by a positive family 
history of psychiatric disorders. Table 8.11 presents the variables on which onset groups 
were found to significantly differ in the investigation of the aetiological correlates of 
EO and LO GAD. 
Table 8. 11 
Summary of Variables Found to Significantly Differ in the Aetiological Comparison of 
EO and LO Participants 
Variables 
Age at first onset of any disorder (years) 
Age at onset of first anxiety disorder (years) 
Social support - Children 
Benzodiazepine use 
Health supplement use 
Anti - reflux medication use 
Time since onset of first episode of anxiety 
(years) 
N umber of episodes 
Family history of emotional disorders 
* p:C::0 .05; **p:C:: 0.01 ; ***p:C::0.00 1 
' Large difference, but x' not performed 
Direction of significance 
EO < LO*** 
EO < LO*** 
EO > LO* 
EO >LO* 
EO > LO* 
LO > EO a 
EO> LO*** 
EO > LO*** 
EO > LO*** 
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CHAPTER NINE 
Phenomenological Comparisons of Early-onset and Late-onset GAD in 
Late-life 
9.1 Introduction 
As with previous findings regarding the aetiology of EO and LO anxiety disorders, 
findings relating to differences in the phenomenology of EO and LO anxiety disorders 
have also been mixed (Battaglia, et al. , 1995 ; Goldstein, et al., 1997; Segui, et al., 1999; 
Sheikh, et al. , 2004). Specifically, there is some literature suggesting differences 
between onset groups on subjective measures of GAD (Beck, et al. , 1996; Le Roux, et 
al. , 2005), whilst others suggest similarities on objective measures of GAD severity 
(Beck, et al., 1996; Hoehn-Saric, et al., 1993 ; Le Roux, et al., 2005). Limitations in past 
research as outlined in Chapter Three, as well as a lack of information regard ing the 
relationship between age at onset and the phenomenology of GAD in older adults 
suggests the need for research that will add to our current understanding of this 
relationship. The current chapter therefore presents the findings of a study set out to 
empirically investigate the phenomenology of EO and LO-·GAD. Establ ishing 
phenomenological differences between EO and LO GAD patients could potentially have 
important treatment implications, and could also provide insights as to whether age of 
onset can influence an individuals' response to treatment. 
The study presented in this chapte_r aimed to explore differences between onset groups 
across a number of phenomenological factors. These factors included rates of 
psychiat_ric comorbidity, indices of GAD-related symptom severity including responses 
on measures of psychopathology, and measures of health and functioning. The specific 
hypotheses examined in this investigation (hypotheses seven to nine) were previously 
outlined _in Section 5.2.3 and Table 5.2 (see page 59). 
9.2 Age of Onset and Psychiatric Co morbidity 
Tables 9.1 through to 9.5 present the descriptive statistics for the primary and secondary 
( comorbid) psychiatric conditions of participants at assessment, at first onset of a DSM-
IV disorder of any kind and first onset of a DSM-IV anxiety disorder of any kind . 
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9. 2. I Descriptive analysis of current psychiatric comorbidity 
Psychiatric comorbidity at evaluation for both EO and LO participants is presented in 
Table 9.1. All EO participants met the criteria for a primary or principal diagnosis of 
GAD, whilst 94.2% of LO participants had a principal diagnosis of GAD. Of the LO 
participants not meeting criteria for a principal diagnosis of GAD, two had a principal 
diagnosis of PD and co-principal diagnosis of GAD, whilst one participant had a 
principal diagnosis of a phobic disorder (agoraphobia without a history of panic 
disorder) and a co-principal diagnosis of GAD. Over one-third of EO participants and 
approximately one-half of LO participants had a primary diagnosis of GAD without 
· psychiatric comorbidity, with remaining participants meeting criteria for at least one 
other comorbid psychiatric condition. 
Table 9.1 
Frequency of Current and Comorbid Psychiatric Conditions for EO and LO 
Participants at Evaluation 
Primary Diagnosis 
Early-Onset (N=24) late Onset (N= 52) 
GAD 
(n = 24) 
No Diagnosis 37.5% (9) 
GAD 
V) 
·;;; 
PD 4.2% (1) 0 
C: 
on 
"' Phobias 20.8% (5) 5 
c OCD 4.2%(1) 
"' -a
C: PTSD 8.3% (2) 0 
u 
<1) 
MOD single if! 
MOD recurrent 16.7%(4) 
PD symptomatology 8.3% (2) 
GAD 
(n=49) 
49.0% (24) 
10.2% (5) 
4.1%(2) 
6.1% (3) 
16.3% (8) 
14.3% (7) 
PD Phobias 
(n=2) (n= l) 
3.8% (2) 1.9% (I) 
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9.2.2 Descriptive analysis of psychiatric comorbidity at first onset of a DSM-IV 
disorder of any kind 
Descriptive statistics for primary and secondary comorbid psychiatric conditions at first 
onset of a DSM-IV disorder of any kind for EO and LO participants are presented in 
Tables 9.2 and 9.3, respectively. The majority of EO participants met criteria for a 
primary diagnosis of GAD, with just over one-half of these participants meeting criteria 
for one or more comorbid psychiatric condition . Two participants met criteria for a 
primary diagnosis of both GAD and major depressive disorder (MDD) and one met 
criteria for both obsessive-compulsive disorder (OCD) and GAD . One EO participant 
had a primary diagnosis of post-traumatic stress disorder (PTSD), and did not meet 
criteria for any other disorder at that time. 
Table 9.2 
Frequency of Principal and Comorbid Psychiatric Conditions at First Onset of a DSM-
IV Disorder of any kind for EO Participants (N = 24) 
Primary Diagnosis 
GAD OCD PTSD MOD single 
(n = 20) (n = I) (n = I) (n = 2) 
No diagnosis 45.0% (9) 100% (l) 
en GAD I 00% (1) 100% (2) 
·;; 
0 
C: PD 5.0%(1) bJl 
" Q Phobias 30.0% (6) 
c 
PTSD 
" 
5.0% (1) 
-0 
C: 
0 MDD single 10.0% (2) u 
" C/J 
PD symptomatology 5.0% (I) 
Three-quarters of LO participants had a primary diagnosis of GAD, whilst three LO 
participants had a primary diagnosis of PD. Furthermore, one participant each had a 
primary diagnosis of a phobia, recurrent MDD, and ' other, ' respectively. Seven LO 
participants had a primary diagnosis of MDD, single episode. Of the LO participants 
meeting criteria for a primary diagnosis of GAD, just over one-half did not meet criteria 
for an additional DSM-IV diagnosis. The remaining LO participants met criteria for one 
or more comorbid psychiatric condition, the most common being a single episode of 
MDD, followed by panic symptomatology. Participants with primary diagnoses of PD, 
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phobias and MDD 'single episode ' also met criteria for GAD, whilst those with a 
recurrent episode ofMDD and 'other', did not meet criteria for any other disorder. 
Table 9.3 
Frequency of Principal and Comorbid Psychiatric Conditions at First Onset of a DSM-
IV Disorder of any kind for LO Participants (N = 52) 
u, 
u, 
0 
C 
bl) 
"' i5 
c 
"' "'Cl 
C 
0 
u 
OJ 
VJ 
Primary Diagnosis 
GAD PD Phobias MDD MDD Other 
(n = 39) (n = 3) (n = 1) single recurrent (n = I) 
(n = 7) (n = 1) 
No 56.4% 66.7% 57.1% 100% 100% 
Diagnosis (22) (2) (4) (1) (I) 
GAD 33.3% 100% 14.3% (1) (1) (1) 
PD 5.1% 14.3% (2) (1) 
Phobias 2.6% 
(1) 
OCD 2.6% 
(1) 
MDD single 23.1% (9) 
PD 10.3% 
symptoms (4) 
Other 14.3% (1) 
9.2.3 Descriptive analysis of psychiatric comorbidity at first onset of a DSM-IV 
anxiety disorder 
Descriptive statistics for primary and secondary comorbid psychiatric conditions for EO 
and LO participants at first onset of a DSM-IV anxiety disorder are presented in Tables 
9.4 and 9.5 respectively. Nearly all of the EO participants met the criteria for GAD as 
the primary concern. One participant each met criteria for OCD and PTSD as the issue 
of primary concern, although both of these participants additionally met criteria for 
GAD. Of the participants with a primary diagnosis of GAD, nine did not meet criteria 
for any other disorder, with remaining participants meeting criteria for one or more 
comorbid psychiatric condition, the most common being a major depressive episode. 
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Table 9.4. 
Frequency of Principal and Comorbid Psychiatric Conditions for EO participants at 
First Onset of a DSM-IV Anxiety Disorder (N = 24) 
Primar~ Diagnosis 
GAD OCD PTSD 
(n = 22) (n = 1) (n = 1) 
No diagnosis 40.9% (9) 
-~ GAD 100% (1) I 00% (1) 
"' 0 
Panic Disorder 4.5% (1) = bO 
"' 6 Phobias 27.3% (6) 
c 
PTSD 4.5% (1) "' "O
= 0 MDD Single 18.2%(4) (.) 
Q) 
VJ 
PD symptomatology 4.5% (I) 
The majority of LO participants also had a principal diagnosis of GAD, with almost 
two-thirds of these participants not meeting criteria for an additional DSM-IV diagnosis. 
As with the frequency of comorbid conditions at first onset of a DSM-IV disorder of 
any kind, MDD was the most common comorbid psychiatric condition among 
participants with a primary diagnosis of GAD. Six participants had principal diagnoses 
of PD, four of whom also met criteria for GAD and one met ·criteria for a primary 
diagnosis of both a phobic disorder and GAD. 
Table 9.5 . 
Frequency of Principal and Comorbid Psychiatric Conditions at First Onset of a DSM-
IV Anxiety Disorder for LO Participants (N = 52) 
"' 
·;;; 
0 
= bO 
"' 6 
c 
"' "O
= 0 
(.) 
Q) 
VJ 
No. Diagnosis 
GAD 
PD 
Phobias 
OCD 
MDD Single 
PD symptomatology 
Primary Diagnosis 
GAD 
· (n = 45) 
64.4% (29) 
6.7% (3) 
2.2% (1) 
2.2% (1) 
13.3% (8) 
11.1%(5) 
PD 
(n = 6) 
33.3% (2) 
66.7% (4) 
Phobias 
(n = 1) 
100% (I) 
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Descriptive statistics for participants meeting diagnostic criteria for one or more 
comorbid psychiatric condition at time of evaluation, at first onset of a DSM-N 
disorder of any kind, and at first onset of a DSM-IV anxiety disorder are presented in 
Table 9.6. A x2 frequency analysis revealed that onset groups presented with similar 
rates of psychiatric comorbidity at all three time periods, with over one-half of EO 
participants and about one-third of LO participants presenting with psychiatric 
comorbidity at each of these assessment points. 
Table 9.6 
Descriptive Statistics for Psychiatric Co morbidity at Current and Past Episodes of 
Illness Onset for EO and LO participants 
Variable 
Comorbid psychiatric condition at 
presentation 
Comorbid psychiatric condition at 
time of 1st DSM-N diagnosis 
Comorbid psychiatric condition at 
time of 1st onset of GAD 
* p :S 0.05; **p :S 0.01; ***p :S 0.001 
Early Onset 
(N = 24) 
f(%) (n) 
54.2 (13) 
54.2 (13) 
58.3 (14) 
Late Onset 
(N = 52) 
f(%) (n) 
40.4 (21) 
34.6 (18) 
36.5 (19) 
Significance 
Test 
X [dfj 
1.26[!] 
2.60[1] 
3.17[1] 
In contrast to the findings presented in Table 9.6, an investigation of differences in 
psychiatric comorbidity using a cut-off of 50 revealed a significant difference between 
onset groups, presented in Table 9.7. Based on this cut-off to distinguish onset groups, 
EO participants were found to be significantly more likely to present with psychiatric 
comorbidity than LO participants at evaluation, at first onset of a DSM-IV disorder of 
any kind, and at first onset of a DSM-IV anxiety disorder. 
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Table 9.7 
Descriptive Statistics for Psychiatric Comorbidity at Current and Past Episodes of 
Illness Onset for EO and LO Participants Using a Cut-off Age of 50 Years (N = 76) 
Early Onset Late Onset Significance 
(N = 42) (N= 34) Test 
Variable /(%) (n) /(%) (n) ?[dfj 
Comorbid psychiatric condition at 
57.1 (24) 
presentation 
29.4 (10) 5.84[1]* 
Comorbid psychiatric condition at time 
57.1 (24) 20.6 (7) 10.40[1J** * 
of l st DSM-IV diagnosis 
Com orb id psychiatric condition at 1st 
57.1 (24) 
onset of GAD 
26.5 (9) 7.1911i** 
* p :S 0.05; **p :S 0.01; ***p :S 0.001 
9.3 Age of Onset and Indices of GAD Phenomenology 
9. 3.1 Frequency of GAD-related worries 
Descriptive statistics for the frequency of current worries reported by EO and LO 
participants are presented in Table 9 .8. A series of x2 frequency analyses were 
conducted to determine whether EO and LO groups differed with regard to topics of 
current worry. Analyses revealed that onset groups were similar with regard to 
frequency of worry about timeliness , work, family, finances , social interactions, the 
health of themselves and others, and community and world affairs. 
Table 9.8 
Frequency of Current GAD-related Worries Reported by EO and LO Participants 
Early-Onset Late-Onset Significance 
(N = 24) (N = 52) test 
Variable /(%) (n) /(%) (n) ? [d fj 
Timeliness, punctuality 75.0 (18) 78.8 (41) 0.14[1] 
Work/ Education 41.7 (10) 28.8 (15) 1.2211] 
Family 95.8 (23) 92.3 (48) 0.33[1] 
Finance 54.2 (13) 51.9 (27) 0.03[1] 
Social/ interpersonal interactions 70.8 (17) 50.0 (26) 2.90p] 
Health (self) 66.7 (16) 82.7 (43) 2.43 [1] 
Health (significant others) 79.2 (19) 76.9 (40) 0.05[1] 
Community/ world affairs 50.0 (12) 50.0 (26) 0.00[1] 
* p:S0.05; **p:S0.01; ***p:S0.001 
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9.3.2 Severity of GAD-related worries 
Descriptive statistics for mean severity of current worries as rated on a nine-point scale 
from zero to eight for EO and LO participants are presented in Table 9.9. Overall the 
two groups appear similar with respect to severity of worry for each of the worry 
domains. Comparison of means using independent-samples t-tests were performed to 
investigate differences between early- and late-onset groups on mean ratings of worry 
severity. Analyses revealed no significant differences between groups in severity of 
worry about timeliness, work, family, finances, or social interactions, nor were groups 
found to differ in severity of worry about their own health, the health of significant 
others, or about community/world affairs. 
Table 9.9 
Mean Severity of GAD-related Worries for EO and LO Participants 
Early-Onset Late-Onset Significance 
(N = 24) (N = 52) test 
Variable M SD M SD t[ctn 
Timeliness/ punctuality 4.9 3.2 5.1 2.9 - 0.35[74] 
Work/ Education 2.8 3.4 2.1 3.4 0.76[74] 
Family 6.5 2.2 6.12 2.2 0.50[74] 
Finances 3.3 3.3 3.0 3.2 - 0.32[74] 
Social/ interpersonal interactions 4.3 3.0 3.1 3.2 1.45[74] 
Health (self) 3.8 3.1 5.1 2.8 - 1.74[74] 
Health (significant others) 5.2 3.0 5.0 3.1 0.33[74] 
Community/ world affairs 3.6 3.7 3.0 3.2 0.77[3940] t 
* p:<=0.05; **p:<=0.01; ***p:<=0.001 
t equality of variances not assumed (Levene's test significant) 
9.3.3 Frequency of GAD-related symptoms 
Descriptive statistics for the frequency of current GAD symptoms reported by EO and 
LO participants are presented in Table 9.10. The majority of both EO and LO 
participants reported experiencing all symptoms, consistent with a current diagnosis of 
GAD. x2 frequency analyses conducted to investigate differences between EO and LO 
participants' experience of GAD symptoms revealed onset groups to be similar with 
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respect to the experience of GAD symptomatology. Although a greater proportion of 
EO participants reported feelings of irritability, this difference was not found to be 
significant. No significant differences were found between EO and LO participants in 
the frequency of symptoms including restlessness, fatigue, difficulty concentrating, or 
muscle tension, nor was there a significant difference in reports of sleep disturbance. 
Table 9.10 
Frequency of Current GAD Symptoms Reported by EO and LO Participants 
Early-Onset Late-Onset Significance 
(N = 24) (N = 52) test 
Variable /(%) (n) /(%) (n) X [dQ 
Irritability 79.2 (19) 65.4 (34) I .48[1J 
Restlessness, feeling keyed up 
100.0 (24) 96.2 (50) 0.95 [1 ] 
or on edge 
Being easily fatigued 83.3 (20) 84.6 (44) 0.02[1] 
Difficulty concentrating or mind 
87.5 (21) 94.2 (49) 1.02[1 ] 
going blank 
Muscle tension 91.7 (22) 90.4 (47) 0.03[1] 
Difficulty falling asleep/ staying 
91.7 (22) 82.7 (43) 1.07[1] 
asleep/ unsatisfying sleep 
* pS0.05; **pS0.01 ; ***pS0.001 
9. 3. 4 Severity of current GAD-related symptoms 
Descriptive statistics for mean severity of current GAD symptoms for EO and LO 
participants are presented in Table 9.11. On average, EO participants rated the 
experience of symptoms of restlessness and/or feelings of being keyed up or on edge as 
significantly more severe than those with LO GAD at a .0 I level. Comparison of means 
using independent-samples t-tests revealed no significant differences between onset 
groups in the severity of other symptoms including irritability, fatigue, difficulty with 
concentration, muscle tension, or sleep disturbance. 
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Table 9.11 
Mean Severity of GAD -related Symptoms for EO and LO Participants 
Early-Onset Late-Onset Significance 
(N = 24) (N = 52) test 
Variable M SD M SD f[dfj 
Irritability 4.7 2.7 4.4 3.0 0.39[74] 
Restlessness, feeling keyed up or 
6.9 1.1 
on edge 
6.0 1.5 2.75[74]** 
Being easily fatigued 5.2 2.6 5.2 2.5 - 0.07[74] 
Difficulty concentrating or mind 
5.5 2.4 5.6 1.9 - 0.35[74] 
going blank 
Muscle tension 6.2 2.2 6.2 1.9 0.03[74] 
Difficulty falling asleep/ staying 
6.0 2.2 5.6 2.5 0.61[74] 
asleep/ unsatisfying sleep 
* p :S 0.05 ; **p :S 0.01; ***p :S 0.001 
9.3.5 Jnterference and distress associated with GAD-related symptoms, 
percentage of time spent worrying and interviewer-rated severity of GAD 
Descriptive statistics for mean severity of GAD-related interference, distress, mean 
percentage of time spent worrying each day, and mean interviewer-rated severity of 
GAD for EO and LO participants are presented in Table 9.12 . Both the level of 
interference in participants lives due to symptoms of GAD and distress associated with 
current symptoms of GAD were rated on a scale of zero to eight (0 = "no 
interference/no distress"; 8 = "very severe interference/distress."). A comparison of 
means using independent-samples t-tests revealed that EO and LO groups did not differ 
with regard to interference ratings , with interference due to GAD symptoms being rated 
as "moderate to severe" by both EO and LO participants. On average, distress 
associated with current GAD-related symptoms significantly differed between onset 
groups at the .01 level, with EO participants rated as being significantly more distressed 
than LO participants, equal variance not assumed. Independent-samples t-tests also 
revealed that on average, participants in the EO group spent a significantly greater 
percentage of time worrying each day than those in the LO group at the .05 level. As 
with findings using a cut-off of 34 years, investigation of time spent worrying using a 
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cut-off of 50 years revealed that participants with EO GAD spent a significantly greater 
percentage of time worrying per day, on average, than those in the LO group (51 .8% 
vs. 46% respectively) (t (74) = 2.63 , p < .05). Interviewer-rated severity of GAD was 
also rated using a 9-point scale (where O = "none" and 8 = "very severely 
disturbing/disabling"). With regard to overall severity of GAD, those in the EO group 
had a significantly greater interviewer-rated severity score of GAD than those with LO 
GAD at a .001 level. 
Table 9.12 
Descriptive Statistics for Percentage of Time Spent Worrying, Interference, Distress 
and Interviewer-rated Severity of GAD for EO and LO participants 
Early-Onset Late-Onset Significance 
(N = 24) (N = 52) test 
Variable M SD M SD t[dfj 
Interference due to current 
5.7 1.3 5.2 1.4 1.40[74] 
symptoms/worry 
Distress associated with current 
7.1 0.8 6.4 l.2 2.71[6235J**t 
symptoms/worry 
Percentage of day spent worrying (%) 57.9 18.7 45_2 · 22.7 2.40[74]* 
Interviewer-rated severity of GAD 6.8 1.0 5.9 1.0 3.99[74]*** 
* p S 0.05 ; **p S 0.01 ; ***p S 0.001 
t Equality of variances not assumed (Levene' s test significant) 
9.3.6 Measures ofpsychopathology 
Descriptive statistics for scores on self-report measures of pathology for EO and LO 
participants are presented in Table 9.13. Comparison of means using independent-
samples ·t-tests were performed to examine the differences in scores on these scales 
between EO and LO groups. No difference was found between groups on a measure of 
anxiety as assessed by the GAi, nor in the severity of symptoms of depression, as 
measured by the GDS-15. Onset groups were also found to be similar with respect to 
scores on measures of pathological worry, trait anxiety, anxiety sensitivity, perceived 
control over anxiety-related events, and both general and social self-efficacy. 
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Table 9.13 
Descriptive Statistics for Scores on Measures of Anxiety, Worry, Depression, Trait 
Anxiety, Anxiety Sensitivity, Perceptions of Anxiety Control and Self-efficacy for EO 
and LO participants (N = 71) 
Early-Onset Late-Onset Significance 
( n= 21) (n = 50) test 
Variable M SD M SD t[dfj 
The Geriatric Anxiety Inventory 12.48 4.80 12.66 5.07 0.14[69] 
The Penn State Worry 
62 .14 59.56 9.87 11.05 0.97[69] Questionnaire 
The Geriatric Depression Scale -15 4.71 3.47 4.79 3.23 0.10[74] 
The State-Trait Anxiety Inventory -
49.71 50.26 9.32 0.22[69] 10.05 
Trait scale 
The Anxiety Sensitivity Index 32.10 12.46 29.62 13.75 0. 71 [69] 
The Anxiety Control Questionnaire 71.00 17.24 70.51 17.63 0.11[69] 
The Self Efficacy Scale (SES) 
Generalised self-efficacy (GSE) 54.76 13.94 53.06 9.77 0.59[69] 
Social self-efficacy (SSE) 18.14 5.04 18.54 3.80 0.36[69] 
9.4. Age of Onset and Measures of Health and Functioning 
9.4.1 Age of onset and Self perceived health 
Descriptiv_e statistics for mean ratings of self-perceived health for early-and late-onset 
groups are presented in Table 9.14. Independent-samples-t-tests were conducted to 
compare early- and late-onset groups on self-perceived health ratings. On average, 
based on a 5-point scale (1 = poor health; 5 = excellent heath), EO participants rated 
their general health to be better than those with LO GAD at a .05 level of significance. 
When asked to rate their current health as compared to one year ago on a 5-point scale 
(1 = ' much worse'; 3 = about the same' ; 5 = 'much better'), there was no significant 
difference between onset groups, with both EO and LO participants rating their health to 
be "about the same," on average. 
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Table 9.14 
Descriptive Statistics of Self-perceived Health for EO and LO Participants 
Early onset Late onset Significance 
(N=24) (N = 52) test 
Variable M SD M SD t[df] 
Self perceived health 
General health 3.6 0.9 3.1 1.0 2.14[74]* 
Current health compared to 
2.9 0.9 0.66[74] 3.1 0.7 
12 months ago 
* pS0.05; **pS0.01; ***pS0.001 
9.4.2. Functional limitations 
Descriptive statistics for functional limitations reported by EO and LO participants 
across a range of activities of daily living are presented in Tables 9.15 and 9.16 
respectively. The majority ofEO participants reported 'no limitations at all ' in vigorous, 
moderate or light activity, as well as in activities of daily living such as stair climbing, 
bending or kneeling, and bathing and dressing. One-fifth of EO participants reported to 
be ' limited a little' in vigorous activities. Just under one- tenth of EO participants 
reported being ' limited a little' in moderate activities, in climbing stairs, and in kneeling 
or bending. 
Table 9.15 
Frequency of Functional LimitatiQns in Activities of Daily Living for EO Participants 
Early Onset (N = 24) 
Functioryal limitations Not at all Limited Limited 
limited a little a lot 
f%(n) /% (n) f%(n) 
Vigorous activity 70.8 (I 7) 20.8 (5) 8.3 (2) 
Moderate activity 91.7 (22) 8.3 (2) 0.0 
Light activity 100.0 (24) 
Limitations in climbing stairs 91.7 (22) 8.3 (2) 
Limitations in bending or 91.7(22) 8.3 (2) 
kneeling 
Limitations in bathing, dressing 100.0 (24) 
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In Table 9.16 it can be seen that just under one-half of the LO participants reported no 
limitations in vigorous or moderate activity, and about one-third reported to be ' limited 
a little'. About one-quarter of LO participants reported to be ' limited a lot' in vigorous 
activities due to their current health and physical condition. The majority of LO 
participants reported no limitations at all in light activities, whilst just under two-fifths 
reported being ' limited a little ' by light activities. Three-quarters of LO participants 
reported no limitations in stair climbing and two-thirds reported no limitations in 
bending or kneeling, whi lst around one-fifth reported being ' limited a little ' in these 
activities. A small proportion reported being ' limited a lot' in performing these 
activities. The majority of LO participants had no limitations in activities of daily living 
such as bathing and dressing. 
Table 9.16 
Frequency of Functional Limitations in Activities of Daily Living for LO Participants 
Late Onset (N = 52) 
Functional limitations Not at all Limited Limited 
limited a little a lot 
f%(n) /% (n) /% (n) 
Vigorous activity 42.3 (22) 34.6 (18) 23.1 (12) 
Moderate activity 50.0 (26) 40.4 (21) 9.6 (5) 
Light activity 82.7 (43) 17.3 (9) 
Limitations in climbing stairs 75.0 (39) 19.2(10) 5.8 (3) 
Limitations in bending or 65.4 (34) 23.1 (12) 11.5 (6) 
kneeling 
Limitations in bathing, dressing 92.3 ( 48) 7.7 (4) 
A Principal Component Analysis (PCA) was run with the six variables measuring 
functional limitations. Prior to performing PCA, the suitability of data for factor 
analysis was assessed. Although the overall sample size is considered to be small , it is 
in keeping with the recommended ratio of ten cases per item to be factor analysed 
(Nunnally, 1978; Tabachnick & Fidell , 2007), which is considered to be adequate for 
this analysis . Inspection of the correlation matrix revealed all coefficients to be above 
0.3. The Kaiser-Meyer-Olkin value was 0.84, exceeding the recommended value of 0.6 
(Kaiser, 1970, 1974: cited in Pallant, 2011) aµd Bartlett' s Test of Sphericity (Bartlett, 
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1954: cited in Pallant, 2011) reached statistical significance, supporting the factorability 
of the correlation matrix. 
Principal components analysis revealed a one factor solution with an eigenvalue of 4.19, 
accounting for 69 .9% of the variance. An inspection of the screeplot revealed a clear 
break after the first component. Using Catell ' s (1966) scree test, a decision was made to 
retain this component for further investigation. Table 3 7 displays the factor loadings for 
each item. Reliability analysis of these variables yielded a Cronbach ' s alpha of 0.89. 
This finding was not surprising in that it indicated that participants reporting a limitation 
in one type of activity were likely to report some limitation in others. Similarly, 
participants who reported 'no limitations ' in a given activity were in general also likely 
to report not having limitations in other types of activities. Following findings of a one 
factor solution for items measuring functional limitations and high reliability amongst 
these items, these variables were combined to form one ' functional limitations ' score. 
An independent-samples t-test comparing means was run using this new score to 
investigate whether early-and late-onset groups differed with regard to functional 
disability. Analyses revealed a significant difference between EO and LO groups, with 
participants in the LO group reporting greater functional limitations than EO 
participants, using Levene ' s Test for equality of variance (I (73.77) = 3.78, p < .00 l ). 
Table 9.17 
Rotated Components Matrix for Functional Limitations for EO and LO Participants 
Functional limitation 
Vigorous activity 
Moderate activity 
Light activity 
Limitations in climbing stairs 
Limitations in bending or kneeling 
Limitations in bathing and dressing 
Component 1 
.813 
.8~ 
.838 
.857 
.913 
.719 
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9.5 Discussion 
Indices of GAD- related phenomena and measures of psychopathology were assessed in 
the present study in order to investigate the phenomenology of early- and late-onset 
GAD in late-life. The present study firstly aimed to examine the relationsh ip between 
EO and LO GAD and psychiatric comorbidity. Second, it sought to investigate the 
relationship between age at onset and GAD severity by examining differences in both 
the frequency and severity of GAD-related worries reported by EO and LO participants, 
and the frequency and severity of GAD-related symptoms endorsed by participants. The 
study further aimed to determine the severity of interference and distress associated with 
the experience of current GAD symptoms amongst EO and LO participants, in addition 
to time (percentage of day) spent worrying by early-and late-onset groups. The study 
additionally sought to determine whether EO and LO groups of older adults with a 
principal or co-principal diagnosis of GAD differed in response to clinical measures of 
depression, general anxiety, worry, trait anxiety, anxiety sensitivity, self efficacy and 
locus of control , and intended to confirm previous findings of interviewer-rated severity 
of GAD by examining the overall interviewer-rated severity of GAD. Finally, the study 
aimed to investigate the relationship between age at onset of GAD and both self-
perceived health and functional limitations. 
The hypotheses that EO participants would have higher rates of psychiatric comorbidity 
than LO participants at evaluation (7a); at first onset of a DSM-IV disorder of any kind 
(76 ); and at first onset of a DSM-IV anxiety disorder were not supported by the current 
data. These findings are consistent with those of Sheikh et al. (2004) who, using a cut-
off of 35 years to distinguish between onset groups, found no difference between groups 
of older adults with EO and LO PD for comorbidity with current major depression and 
dysthymia or past major depression, social phobia, simple phobia, GAD, and 
agorapho~ia. Based on a cut-off of 34 years, the current findings are in contrast to 
previous findings of age at onset of GAD and psychiatric comorbidity (Chou, 2009; Le 
Roux, et al. , 2005). Group comparisons of the current data using a cut-off age of 50, 
however, revealed that a significantly greater proportion of the EO group met criteria 
for one or more comorbid psychiatric conditions at evaluation, at first onset of a DSM-
IV disorder of any kind, and at first onset of a DSM-IV anxiety disorder. Although the 
findings of Le Roux et al. (2005) are limited to the assessment of current rather than 
lifetime psychiatric comorbidity, the current findings using a cut-off age of 50 support 
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the previous findings of Le Roux and colleagues who, also using a cut-off of 50 to 
distinguish onset groups, found that EO GAD patients were significantly more likely to 
report psychiatric comorbidity than LO patients. Similarly, using a cut-off of 50, Chou 
(2009) found those with EO GAD to be significantly more likely to report comorbidity 
than those with LO GAD. 
This difference in findings of comorbidity based on the different cut-off ages used may 
in part be due to the fact that when using a cut-off of 50, those participants who were 
identified as belonging to the LO group had a much more recent onset of a psychiatric 
illness, with the presenting episode also being the first episode of psychiatric illness for 
many of these participants. On the other hand, those in the EO group had a greater 
number of episodes of psychiatric illness and a greater lifetime history of anxiety in 
terms of time since the onset of their first episode (see Chapter Eight). Previous studies 
of comorbidity have found that the prior existence of any anxiety disorder increases the 
risk for subsequent development of MOD and other comorbid conditions, with the 
strongest risk attributable to previous GAD (Hettema, et al. , 2006; Kessler, et al. , 1996). 
As such, the fact that EO participants ' have had a longer history of anxiety than LO 
participants, with more subsequent episodes of psychiatric illness when distinguished by 
a cut-off of 50 years rather than the 34-year cut-off, may account for the finding that EO 
participants are significantly more likely to present with comorbidity when using th is 
later cut-off age. 
The current data revealed that EO and LO groups of older adults with either a principal 
or co-principal diagnosis of GAD did not differ with respect to the frequency or severity 
of GAD-related worries reported, supporting hypothesis Sa. These results are supported 
by previous research (Beck, et al. , 1996) in which older adults with early-and late-onset 
GAD were found to be similar with regards to severity of worry about finances , health, 
and social concerns. The observation of a trend towards greater frequency and severity 
of worry about social interactions amongst EO participants in the current sample, in line 
with previous findings (Beck et al , 1996) that older adults with EO GAD scored non-
significantly higher than those with LO GAD on the social subscale of the worry scale 
(WS: Wisocki , et al. , 1986), suggests that worry about social interactions may be a 
particular concern for older adults whose onset of GAD occurs earlier in life. 
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The finding that, on average, those in the LO group rated worry about health as more 
severe than those in the EO subgroup is in contrast to previous findings of Beck et al. 
(1996), who found a trend towards greater severity of worries about health in the EO vs. 
LO group, though this difference was not significant. Apart from this early investigation 
of the characteristics of GAD in older adults by Beck and Colleagues (1996), no other 
investigation has examined differences in the frequency or severity of GAD-related 
worries in older adults with early- and late-onset anxiety with which to compare the 
current findings. Overall, the current findings are in support of previous research 
indicating that EO and LO groups of older adults do not differ with regard to the 
frequency or severity of GAD-related worries. 
Hypothesis Sb proposed that there would be no difference between early-and late-onset 
participants in the frequency and severity of GAD symptoms reported. With the 
exception of significantly greater severity of "restlessness and/or feelings of being 
keyed up or on edge" for EO participants, onset groups were not found to differ in the 
frequency or severity of GAD symptoms outlined in Criterion C of the DSM-IV. 
Although differences in the frequency and/or severity of GAD-related symptoms in EO 
and LO groups of older adults has not been previously examined, the current findings 
are consistent with a previous investigation of age at onset of GAD in a middle aged 
sample (Hoehn-Saric, et al. , 1993), . in which patients with onset in childhood or 
adolescence were not found to differ with regards to symptoms of anxiety from those 
who had an onset after 20 years of age. Based on their findings Hoehn-Saric and 
colleagues (1993) concluded that once GAD is developed, the anxiety symptoms 
become similar in the two groups. 
Previous investigations of an onset distinction in late-life (PD) further lend support to 
the current findings. For example, in an investigation of the clinical characteristics of 
PD in a sample of older adults, Raj and colleagues (1993) found that the symptoms 
experienced during panic attacks were similar for both EO and LO patients. Based on 
their findings , Raj and colleagues (I 993) concluded that the data showed few 
differences between EO and LO panic in terms of phenomenology, suggesting that the 
two subtypes are not different disorders. This finding is consistent with those of Sheikh 
et al. (2004), who found that the number of panic symptoms endorsed and the severity 
of panic did not differ between onset groups in a sample of older adults with PD. 
Overall, the current findings are consistent with previous investigations of symptom 
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severity in older adults with early-and late-onset anxiety. In line with the above 
conclusions of Hoehn-Saric et al. (1993), given that participants in both the early-and 
late-onset subgroups had GAD symptomatology for a number of years, it is unlikely 
that age at onset is central to symptom severity in older adults with clinical levels of 
anxiety. 
The hypothesis that EO and LO participants would be similar in their experience of 
interference, distress or percentage of time spent worrying as a result of GAD symptoms 
(Sc) was only partially supported by the current findings. Onset groups were not found 
to differ in the severity of interference associated with GAD symptoms, with both onset 
groups rating interference, on average, to be "moderately severe." The find ing that 
early-and late-onset groups were similar with regard to severity of interference is in line 
with the findings reported in Chapter Eight that onset groups were similar with regard to 
current rates of employment and the level of education attained. Although onset groups 
were similar in their experience of interference to daily life as a result of GAD, EO 
participants were found to be significantly more distressed as a result of GAD than 
those with LO GAD. 
Distress due to symptoms of GAD has not previously been examined in investigations 
of an onset distinction; however, the current findings are consistent with previous 
investigation of onset and late-life anxiety in the panic literature. In an investigation of 
late-life PD, Sheikh et al. (2004) found patients with EO PD to have significantly 
greater distress in response to cognitions and feelings during panic attacks for those 
with EO PD. It is unclear as to why participants with EO GAD in late life experience 
greater distress due to symptoms of GAD than those with LO, despite both onset groups 
being similar with regard to symptom severity for the majority of GAD-related 
symptoms. It is possible that distress may be related to participants ' history of GAD 
with respect to duration of anxiety since initial onset and the number of clinically 
significant episodes experienced, both of which are greater for the EO group. 
Consequently, it may be that a history of untreated or recurring GAD fo r which there 
may seem to be no reprieve for those with EO of anxiety may contribute to the 
increased distress observed in the EO group. Further investigation is required to 
establish this however. 
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Group comparisons of the percentage of time spent worrying each day revealed that on 
average, participants with EO anxiety spent a significantly greater amount of time 
worrying than those in the LO group. As with levels of ' distress ' due to GAD, although 
there are no previous investigations with which to compare the current findings, it may 
be that percentage of time spent worrying is also related to the duration of anxiety. As 
such, those with a longer history of anxiety may tend to worry more than those with a 
more recent history, as observed . It may also be that this increased worry amongst EO 
participants contributes to the increased distress they experience. 
EO participants were found to have significantly greater interviewer-rated severity of 
GAD than those with LO GAD, as predicted (hypothesis 8d). This finding is supported 
by previous findings (Beck, et al. , 1996; Le Roux, et al. , 2005). It is interesting to note 
that this has been consistently found across past research (Beck et al., 1996; Le Roux et 
al., 2005), despite differences in the cut-off age used to distinguish onset groups. As 
with distress associated with GAD, it may be that a lifelong history of anxiety 
symptoms that may wax and wane over time though have not subsided, in addition to a 
greater number of clinically significant episodes of anxiety for those with EO of anxiety 
(see Chapter Eight) may contribute to the increased severity of GAD observed in these 
individuals, and the subsequent rating of this. 
The hypothesis that EO and LO participants would not differ in mean scores on self-
reported measures of anxiety, worry, depression, trait anxiety, anxiety sensitivity, 
perceptions of control over anxiety-related events and self-efficacy (hypothesis 8e), was 
supported by the current findini;s. The current findings are partially supported by 
previous research (Beck et al. , 1996; Le Roux et al. , 2005). Although Beck and 
colleagues found EO GAD patients to have significantly higher trait anxiety scores on 
the STAI-T, and .were rated as more depressed on the Hamilton Rating Scale for 
Depression (HRSD: Hamilton, 1960) compared with those in the LO sample, onset 
groups were found to be similar with regard to scores on the STAI-S, PSWQ, HARS, 
and the BDI. Similarly, whilst Le Roux and colleagues found older adults with EO 
GAD to report more excessive and uncontrollable worry than those with LO GAD as 
measured by the PSWQ (Meyer, et al., 1990), early-and late-onset groups did not differ 
on scales that assessed anxiety more broadly and included somatic symptoms such as 
the Beck Anxiety Inventory (BAI: Beck, et al., 1988) or the Hamilton Rating Scale for 
Anxiety (HAM-A: Hamilton, 1959), nor did_ they differ on a measure of depressive 
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symptoms (BDI: Beck, et al., 1961). Findings of similarity between onset groups in the 
phenomenology of late-life anxiety are further supported by the PD literature (Sheikh et 
al., 2004), which has found older adults with early- and late-onset PD to be similar with 
respect to scores on the BAI, the Agoraphobic Cognitions Questionnaire (ACQ) and the 
BDI. It is interesting to note that although the EO group were found to report a 
significantly greater percentage of time spent worrying than those in the LO group, 
onset groups were not found to differ on the PSWQ, an overall measure of pathological 
worry. This finding is in line with that of Barlow, Rapee, & Brown (1992), who found 
the PSWQ to be unrelated to reported percentage of the day spent worrying in a clinical 
GAD sample. 
Hypothesis 9a, that perceptions of health would be significantly worse amongst those 
with LO GAD than those with EO GAD was supported by the current findings. When 
asked about perceptions of ' current health compared to one year ago ' , both onset groups 
reported their health to be 'about the same, ' on average. Perceptions of general health, 
however, were found to significantly differ. On average, self-perceived health at 
assessment was found to be significantly worse for LO participants than for those in the 
EO group. The current research is in line with recent findings of Chou (2009), who 
found that amongst those with lifetime GAD, LO participants were significantly more 
likely to report poor self-rated health than those with EO GAD. The current findings are 
not supported by those of Le Roux et al. (2005) who found early-and late-onset groups 
with late-life GAD to be similar with respect to self-rated health. 
Aside from the investigation by Le Roux and colleagues (2005) and more recently Chou 
(2009) , no ·other investigation of an onset distinction has examined self-perceived health 
as a measure of health and functioning. As previously noted, anecdotally a number of 
LO participants experienced changes in physical health such as a knee replacement for 
one participant, and recovery from a broken foot for another prior to the onset of their 
current episode of GAD. Accordingly, it is possible that such changes in one ' s physical 
health that require lengthy recovery or that may alter one ' s health condition and 
subsequent functioning may contribute to the poorer perception of current health 
observed in the LO group as compared to the EO group. 
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A significant difference between groups was found on a measure of functional 
limitations, with participants in the LO group reporting greater limitations in activity 
due to physical health than those with EO anxiety. The current data is in support of the 
hypothesis that LO anxiety is associated with greater functional limitations (Hypothesis 
96 ), and is consistent with previous investigations of late-life anxiety (Chou, 2009; Le 
Roux et al., 2005) that have found individuals with LO of GAD to report significantly 
more limitations/poorer role functioning due to physical problems than those with EO 
GAD. This finding led Le Roux and colleagues (2005) to suggest that disability may be 
a risk factor for the development of GAD in later life. 
The current findings, in line with those of Le Roux et al. , (2005) and Chou (2009) are 
consistent with those of Beekman et al. (1998), who suggest that functional impairment 
is more strongly associated with anxiety than disease. Further, in a review of the 
relationship between late-life anxiety, depression and physical disability, Lenze, et al. 
(2001) draw a distinction between physical disability, or impairment in the performance 
of basic or instrumental activities of daily living, and role disability, or inabil ity to carry 
out important social or occupational functions . Accordingly, Le Roux et al. (2005) 
conclude that their results suggest that LO GAD is associated with role disability, but 
not necessarily with physical disability. The present data appear·to be in line with this 
distinction and the suggestion by Le_ Roux and colleagues that LO anxiety may be 
associated with role disability but not physical disability given that the present 
investigation revealed no differences between onset groups on a number of health 
conditions (see Chapter Eight) ; the overall prevalence of each medical condition was 
relatively low; and that onset groups did not differ in the severity of ' interference' to 
daily life ·as a result of GAD, despite the LO group being found to report greater 
functional limitations. 
9.6 Conclusions 
In summary, the present data suggest that there are some phenomenological aspects of 
late-life GAD that are distinguished by age of onset. Table 9.18 summarises the 
phenomenological differences that were found between onset groups. Expected 
differences in psychiatric comorbidity were not supported by the current data using a 
cut-off of 34 years of age, but were confirmed using a cut-off of 50, in line with 
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previous research. The severity of the symptom 'restlessness and/or feelings of being 
keyed up or on edge' was found to be significantly greater for participants with EO 
GAD than for those with LO GAD. Participants with EO of GAD were also found to 
experience greater distress due to symptoms of GAD, to spend a significantly greater 
proportion of the day worrying and to have greater interviewer-rated severity of GAD 
than LO participants, whilst those with LO GAD were found to have poorer self-
perceived health and to report greater functional limitations than those with EO GAD . 
Percentage of time spent worrying and distress are indices of phenomenology that have 
not previously been examined in the onset literature and may represent different facets 
of phenomenology that require further investigation. Findings regarding interviewer 
rated-severity, on the other hand, have consistently been found across previous research . 
As such, it may be that whilst onset groups cannot be discerned with respect to the 
frequency and severity of specific GAD symptoms, they can be with respect to overall 
GAD severity and in measures of health and functioning. 
Table 9.18 
Summary of Variables found to significantly differ in the Phenomenological 
Comparison of EO and LO Participants 
Variables Direction of Significance 
GAD symptom severity - Restlessness/keyed up 
Percentage of day spent worrying(%) 
Distress associated with current GAD symptoms/worry 
Interviewer-rated severity of GAD 
Self-perceived health - General health 
Functional limitations 
* p '.S 0.05 ; **p :S 0.01; ***p :S 0.001 
EO > LO** 
EO>LO* 
EO > LO** 
EO > LO*** 
LO>EO* 
LO> EO*** 
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CHAPTER TEN 
An Investigation of the Relationship between Negative Life Events and 
Symptoms of Anxiety and Depression in Older adults with Early-and 
Late-onset GAD 
10.1 Introduction 
Chapter Ten presents the investigation of Research Questions (RQ) 4 and 5, both of 
which sought to examine the relationship between age of onset and negative life events. 
Previous literature indicates that adverse life events can occur at a relatively high rate in 
older adults and can be serious in nature (e.g., death of a loved one, reduced finances, 
personal illness, or legal difficulties) (Hughes, et al., 1988). These and other such 
experiences including experiences of loss, severe illness of self or others, relational 
stress and experiences of sudden unexpected events have been found to be related to the 
onset of depression in later life (Kendi er, Hettema, Butera, Gardner, & Prescott, 2003; 
Kraaij, et al., 2002; Kraaij & de Wilde, 2001; Orrell & Davies, 1994). Despite research 
indicating that stressful life events also precede episodes of anxiety disorders (Faravelli, 
1985; Faravelli & Pallanti, 1989; Finlay-Jones & Brown, 19ll_l), relatively little is 
known about the relationship between stressful life events and anxiety, and even less so 
about this relationship in older adults (Kendler, et al. , 2003). Drawing upon the 
diathesis-stress model outlined in Chapter Four (See Section 4.2) and previous empirical 
evidence suggesting that environmental precipitants may play a more important role in 
the onset of LO GAD than in EO GAD, Research Question 4 aimed to investigate the 
relationship between age of onset and the frequency and severity of stressful life events 
preceding the onset of anxiety amongst older adults with EO and LO GAD. The 
hypothe~es put forward to investigate this relationship are outline in Table 5.3 (See 
Chapter five). Section I 0.2 of this chapter therefore presents the empirical examination 
of hypotheses 1 0a - 1 0e. 
Research Question 5 aimed to explore the relationship between age of onset and the 
experience of negative life events across the lifespan and symptoms of psychopathology 
amongst older adults with early- and late- onset GAD. As outlined in Chapter Four, 
whilst there is some literature regarding the relationship between negative life events 
and depressive symptoms, knowledge about the relationship between negative life 
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events and late-life anxiety, particularly in relation to an onset distinction represents a 
gap in the research literature. As such, it was not possible to put forward informed 
hypotheses regarding this research question. Rather, a number of exploratory research 
questions were put forward in Table 5.4 (see Section 5.2 .5), that were designed to 
investigate this relationship. Sections 10.3 - 10.8 therefore present the findings of this 
investigation. 
10.2 Frequency and Severity of Stressful Negative Life Events Preceding the 
Onset of Psychopathology in Older Adults with Early- and Late-onset GAD 
10. 2.1 Examination of hypothesis 1 0a: The frequency of stressful life events 
preceding the onset of the presenting episode of GAD 
Descriptive statistics for the frequency of stressful life events reported to precede the 
onset of the presenting episode of GAD by EO and LO participants are presented in 
Table 10.1. A series of i frequency analyses were conducted to investigate differences 
between EO and LO groups in the frequency of stressful life events preceding the onset 
of the presenting episode of GAD. No significant differences were found between onset 
groups in the frequency of stressful events involving family and/or relationships, 
occupation and/or education, finances , personal health and/or the health of significant 
others, or with regard to the experience of ' other' stressful events preceding onset of the 
presenting episode. 
Table 10.1 
Frequency of Stressful Life Events Preceding Onset of the Presenting Episode of GAD 
for EO and LO Participants 
Early onset Late onset Significance 
(N=24) (N= 52) test 
! (%) (n) f(%) (n) ? [dj] 
Difficulty in family or relationships 45.8 (II) 42.3 (22) 0.08[1 ] 
Difficulty in occupation or education 41.7 (10) 50.0 (26) 0.46[1] 
Difficulty with finances 16.7 (4) 36.5 (19) 3.07[1] 
Difficulty or changes in health of self 
70.8 (17) 57.7 (30) 1.20[1] 
or others 
a Other stressful events 50.0 (12) 42.3 (22) 0.39[!] 
a Includes changes in residence/relocation, changes in living conditions, changes in recreation or 
social activities, and children leaving the home 
* p :S 0.05; **p :S 0.01; ***p :S 0.001 
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10.2.2 Examination of hypothesis 1 Ob: The severity of stressful life events 
preceding the onset of the presenting episode of GAD 
Descriptive statist ics for the mean severity of stressful life events experienced by EO 
and LO participants preceding the onset of the presenting episode of GAD are presented 
in Table I 0.2. Comparison of means using independent-samples t-tests revealed that 
onset groups did not significantly differ in the mean severity of events experienced 
involving family or other significant relationships, education or occupation, financial 
circumstances, health-related events, or in the severity of 'other' stressfu l events. On 
average, onset groups were also found to be simi lar with regard to the total number of 
stressfu l events reported to precede the onset of the presenting episode of GAD. 
Table 10.2 
Mean Severity of Stressful Life Events Preceding the Onset of the Presenting Episode of 
GAD by EO and LO Participants 
Early Onset Late Significance 
(N = 24) Onset Test 
(N = 52) 
Variable M S.1 SD M SD t[d~ 
Difficulty in family or relationships 1.4 2.0 1.4 1.9 0.06[74] 
Difficulty in occupation or 
0.9 1.4 1.3 1.5 1.09[74] 
education 
Difficulty with finances 0.3 0.8 0.7 1.0 l .85rssAsJ t 
Difficulty or changes in health of 
1.0 0.8 0.9 0.9 0.26[74] 
self or others 
Other stressful events 1.3 1.5 1.0 1.3 0.96[74] 
Total number of life events 
2.1 0.8 2.3 1.2 0.71[6354] t 
preceding onset of current episode 
* p :S 0.05; **p :S 0.01; ***p :S 0.001 
t equality of variances not assumed (Levene's test significant) 
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J 0.2. 3 Examination of hypothesis 1 0c: The frequency of stressful life events 
preceding first onset of GA D 
Descriptive statistics for the frequency of stressfu l life events reported to precede first 
onset of GAD for EO and LO participants are presented in Table I 0.3. x2 frequency 
analyses conducted to investigate differences between early-and late-onset participants 
revealed that onset groups did not significantly differ with regard to the frequency of 
stressful events involving family or significant relationships, occupation and/or 
education, or 'other' stressful event prior to episode onset. A significant difference was 
found between groups in the frequency of events invo lving financial circumstances at a 
.05 level and health-related events at a .0 I level, with a significantly greater proportion 
of LO participants reporting these events to precede first onset of GAD than EO 
participants. 
Table 10.3 
Frequency of Stressful Life Events Preceding First Onset of GAD EO and LO 
Participants 
Early onset Late onset Significance 
(N=24) (N = 52) test 
f(%) (n) f(%) (n) X {df] 
Difficulty in family or relationships 50.0 (12) 48.1 (25) 0.02[!] 
Difficulty in occupation or education 54.2 (13) 48.1 (25) 0.24[\J 
Difficulty with finances 8.3 (2) 28.8 (15) 3.98[11* 
Difficulty or changes in health of self 
16.7 (4) 48.1 (25) 6.8711J** 
or others 
Other stressful events 37.5 (9) 36.5 (19) 0.0 1[! ] 
* p S 0.05; **p S 0.01; ***p S 0.00 1 
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10.2.4 Examination of hypothesis J0d: The severity of life events preceding first 
onset of GAD 
Descriptive statistics for the mean severity of stressful life events experienced by EO 
and LO participants preceding first onset of GAD are presented in Table 10.4. 
Comparison of means using independent-samples t-tests were performed to examine 
between-group differences in the mean severity of stressful events preceding first onset 
of GAD. Levene's test for equality of variances was highly significant for the difficulty 
in occupation or education variable, the difficulty with finances variable and the 
difficulty or changes in the health of self or others variable. Accordingly, t-values, 
degrees of freedom, and significance values reported for these variables are based on 
Levene's test of equality. A significant difference was found between onset groups in 
the severity of events relating to education or occupation, and for health-related events 
at the .01 level. A significant difference was also found between onset groups for 
financial circumstance at the .05 level. No significant differences were found between 
onset groups in the severity of stressful events involving family and/or significant 
relationships, or in 'other' events, nor were onset groups found not to differ with regard 
to the total number of stressful life events reported to precede first onset of GAD. 
Table 10.4 
Mean Severity of Stressful Life Events Preceding First Onset of GAD for EO and LO 
Participants 
Early Onset Late Onset Significance 
(N = 24) (N = 52) test 
Variable M SD M SD f[d f] 
Difficulty in family or relationships 1.3 1.8 1.7 2.1 0.91[74] 
Difficulty in occupation or education 0.6 0.7 1.5 1.8 3.14[7312]** t 
Difficulty with finances 0.2 0.6 0.6 0.9 2.31[6676]* t 
Difficulty"or changes in health of 
0.2 0.6 0.7 0.8 2.73 [59 34]** t 
self or others 
Other stressful events 1.1 1.6 0.9 1.4 0.45[74] 
Total number of life events 
1.7 0.9 2.1 1.1 1.65[74] 
preceding onset of anxiety episode 
* p :S 0.05; **p :S 0.01; ***p :S 0.001 
t Equality of variances not assumed (Levene' s test significant) 
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10.3 Examination of Exploratory Research Question 1: The Prevalence of 
Negative Life Events in Older Adults with Early-and Late-onset GAD 
The percentage of EO and LO participants who experienced one or more event per 
cluster, in each of the four developmental periods and across the life span are presented 
in Tables 10.5 and 10.6, respectively. Ninety-five percent of both EO and LO 
respondents experienced at least one negative life event during childhood . During 
adulthood and late-adulthood, all participants in both onset groups experienced one or 
more negative life event. In the year prior to the interview, the majority of both EO and 
LO participants experienced at least one negative event. 
All older adults with EO GAD had experienced the death of a significant other, as did 
all but one participant with LO GAD. Approximately one-fifth of both EO and LO 
participants reported the death of a significant other during childhood and in the year 
prior to the interview, with the majority of participants reporting the death of a 
significant other in adulthood or late-adulthood. Over four-fifths of both early-and late-
onset participants reported that they had had a severe illness at some point in their life, 
with the highest percentage of participants reporting this to have occurred in adulthood 
and late adulthood respectively. The majority of EO and -LO participants had 
experienced a significant other having a severe illness at some point throughout life , 
with a high percentage of EO participants having experienced a severe illness of 
someone close in all four developmental periods. Again, the highest percentage of 
participants reported this experience to occur during adulthood and late adulthood. 
Negative socio-economic circumstances were reported mainly during childhood and 
adulthood for both EO and LO participants. Few financial problems were reported by 
EO participants in the later stages of their life, although about one-third of LO 
participants still reported such difficulties in late-adulthood. Approximately nine percent 
of EO participants and eight percent of LO participants reported that they had been 
sexually abused during their life. Approximately one-half of older adults with early-and 
late-onset anxiety reported that they had been victims of physical abuse. Participants of 
both onset groups primarily experienced physical abuse in childhood and adulthood . 
Emotional abuse and neglect was reported by over four-fifths of EO participants, and 
three-quarters of LO participants. This form of abuse was mainly reported to occur 
during childhood and middle adulthood. 
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Just over one-half of EO participants had experienced events related to 
crime/disaster/war (CDW). These were mainly reported in adulthood and late 
adu lthood, represented by the periods of World War II and the Vietnam War. Over two-
thirds of LO participants experienced events related to CDW. These were mainly 
reported to occur in adulthood and late adulthood for LO participants. Throughout life, 
stress associated with relationships with friends , family and significant others were 
reported by all participants. Relational stress was reported at high rates in all 
developmental periods by both EO and LO respondents . Finally, the majority ofEO and 
LO participants reported experiencing problem behaviours of significant others 
throughout life. Most of the older adu lts reported experiencing these difficulties during 
adu lthood and late-adulthood, particularly those with EO of GAD. 
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Table 10.5 
Percentage of Participants with EO GAD who Experienced One or more Event per Negative life Event Cluster (N = 21) 
Chi ldhood Adulthood Late adulthood 12 months prior to Throughout life 
(0 - 15 years) (16 - 49 years) (50 years to past interview 
year) (past year) 
Event cluster % (n) % (n) % (n) % (n) % (n) 
Death of significant others 19.0 (4) 76.2 (16) 61.9 (13) 19.0 (4) 100.0 (21) 
Severe illness - self 28.6 (6) 61.9 (13) 71.4 (15) 33.3 (7) 90.5 (19) 
Severe illness - others 76.2 (16) 95.2 (20) 90.5 (19) 76.2 (16) 100.0 (21) 
Socio-economic circumstances 38. 1 (8) 61.9 (13) 23 .8 (5) 14.3 (3) 61.9 (13) 
Sexual abuse 4.8 (3) 9.5 (2) 0.0 (0) 0.0 (0) 9.5 (2) 
Physical abuse 52.4 (11) 38.1 (8) 4.8 (I) 4.8 (I) 52.4 ( 11) 
Emotional abuse/neglect 80.9 (17) 6 1.9 ( 13) 33.3 (7) 23.8 (5) 85.7 ( I 8) 
Crime/disaster/war 9.5 (2) 38.1 (8) 28.6 (6) 0.0 (0) 52.4 ( 11) 
Stress with relationships 81.0 (I 7) 100.0 (2 1) 90.5 (19) 61.9 (13) 100.0 (21) 
Problem behaviour of significant 38.1 (8) 85.7 ( 18) 71.4 (15) 52.4 (11) 85 .7 (18) 
others 
Total 95.2 (20) 100.0 (2 1) 100.0 (21) 95 .2 (20) 100.0 (2 1) 
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Table 10.6 
Percentage of Participants with LO GAD who Experienced One or more Event per Negative Life Event Cluster (N = 48) 
Chi ldhood Adu lthood Late adu lthood 12 months prior to Throughout life 
(0-15years) (16-49 years) (50 years to past interview 
year) (past year) 
Event cluster % (n) % (n) % (n) % (n) % (n) 
Death of significant others 18.8 (9) 77.1 (37) 79.2 (38) 20.8 (I 0) 97.9 (47) 
Severe illness - self 14.6 (7) 50.0 (24) 60.4 (29) 45.8 (22) 83.3 (40) 
Severe illness - others 50.0 (24) 87.5 (42) 81.2 (39) 64.6 (31) 93.8 (45) 
Socio-economic circumstances 37.5 (18) 56.2 (27) 31.2 (15) 18.8 (9) 66.7 (32) 
Sexual abuse 4.2 (2) 4.2 (2) 2.1 (1) 2.1 (1) 8.3 (4) 
Physical abuse 45.8 (22) 27.1 (13) 0.0 (0) 0.0 (0) 45.8 (22) 
Emotional abuse/neglect 56.2 (27) 56.2 (27) 31.2 (15) 16.7 (8) 75 .0 (36) 
Crime/disaster/war 18.8 (9) 41.7 (20) 25.0 (12) 2.1 (1) 70.8 (34) 
Stress with relationships 68.8 (33) 97.9 (47) 77.l (37) 56.2 (27) 100.0 (0) 
Problem behaviour of significant 29.2 (14) 58 .3 (28) 56.2 (27) 20.8 (10) 70.8 (34) 
others 
Total 95 .8 (46) 100.0 (48) 100.0 (48) 87.5 (42) 100.0 (0) 
155 
10.4. Examination of Exploratory Research Question 2: 
The Relationship between Negative Life Events per Developmental Period 
and Symptoms of Psychopathology in Late-life amongst Participants with 
EOandLOGAD 
Pearson product-moment correlation coefficients were computed using the 
dichotomy cluster scores to assess the relationship between negative life events in 
each of the four developmental periods and symptoms of psychopathology in late-
life. The relationships between negative life events (as measured by the Negative 
Life Events Questionnaire) and scores on measures of anxiety, worry and depression 
for participants with EO and LO GAD are presented in Tables 10.7 and 10.8, 
respectively. Due to the sample size of the LO group being larger than that of the EO 
sample, correlations for the LO sample were not required to be as large as those for 
the EO group to reach significance. The .05 significance level for the EO sample (n = 
21) was reached at r = .42, and at r = .29 for the larger LO sample (n = 48). 
Therefore, correlations in the EO sample that would be considered significant with a 
sample size of 48 were also noted in Table 10.7 for comparability purposes. 
I 0. 4.1 The relationship between negative life events per developmental 
period and symptoms of psychopathology in late-life amongst EO 
participants 
A strong, negative correlation was found between the experience of CDW events in 
childhood ·and scores on both measures of pathological worry and trait anxiety in 
late-life. Strong negative correlations were also found between the experience of 
severe illness of a significant other in late adulthood and scores on measures of 
depression and anxiety sensitivity in late-life. Negative socio-economic 
circumstances and CDW events in late adulthood both correlated positively with trait 
anxiety in late-life. There was a moderately strong correlation between problem 
behaviour of significant others in late adulthood and anxiety symptoms in late-life, as 
measured by the GAL The experience of negative life events in adulthood and in the 
year prior to the interview were not correlated with any symptoms of 
psychopathology in late life for participants with EO GAD. 
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Table 10.7 
Relationship between Negative Life Events per Developmental Period (dichotomy score) and Symptoms of Psychopathology amongst 
Participants with EO GAD (N "'.' 21) 
Event cluster per developmental period Measures of psychopathology 
GDS GAi PSWQ STAI-T ASI 
Death of significant others - childhood -.087 -.345" -.195 -.023 -.307" 
Death of significant others - adulthood -.197 .184 .063 .128 .201 
Death of significant others - late adu lthood .163 -.006 .084 -.126 .183 
Death of significant others - 12 months prior to interview .082 -.111 -.246 -.234 -.149 
Severe illness (self) - childhood -.153 -.134 -.116 .247 -.338" 
Severe illness (self) - adulthood -.093 .030 -.146 .071 -.093 
Severe illness (self) - late adulthood -.051 .253 .064 .215 -.331" 
Severe illness (self) - 12 months prior to interview -.126 .057 .012 .063 -.029 
Severe illness (others) - childhood -.160 -.264 -.276 -. I 06 -.275 
Severe illness (others) - adulthood -.167 .348" .237 .351" .216 
Severe illness (others) - late adulthood 
-.50 r'* -.143 -.136 .046 -.490* 
Severe illness (others)- 12 months prior to interview -.193 .076 .090 .254 -.083 
* p <0.05; ** p < 0.01; ***p < 0.001 
"Correlation considered significant with a sample size ofN = 48 
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Table I 0.7 - continued 
Relationship between Negative Life Events per Developmental Period (dichotomy score) and Symptoms of Psychopathology in Participants with 
EO GAD (N = 21) 
Event cluster per developmental period 
Socio-economic circumstances - childhood 
Socio-economic circumstances - adulthood 
Socio-economic circumstances - late adulthood 
Socio-economic circumstances - 12 months prior to interview 
Sexual abuse - childhood 
Sexual abuse - adulthood 
Sexual abuse - late adulthood 
Sexual abuse - 12 months prior to interview 
Physical abuse - childhood 
Physical abuse - adu lthood 
Physical abuse - late adulthood 
Physical abuse - 12 months prior to interview 
* p <0.05; ** p < 0.0 l ; ***p < 0.00 1 
" Correlation considered significant with a sample size ofN = 48 
Measures of psychopathology 
GOS 
-.208 
-.283 
-.094 
-.118 
.022 
-.030 
-.21 3 
-.165 
·:022 
.022 
GAI 
.056 
-.295" 
.210 
.084 
-.015 
-.153 
-.364" 
-.098 
-.015 
-.015 
PSWQ 
.147 
-.056 
.348" 
.23 1 
. 117 
.027 
-.003 
.240 
. 117 
. II 7 
STAI-T 
.309" 
.271 
.521 * 
.391" 
.007 
.093 
.028 
.080 
.007 
.007 
AS! 
.200 
-.098 
-.012 
-.072 
-.002 
.039 
-.369" 
-.073 
-.05 9 
-.059 
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Table 10.7 
Relationship between Negative Life Events per Developmental Period and Symptoms of Psychopathology in EO Participants 
Event cluster per developmental period Measures of psychopathology 
GDS GAI PSWQ STAI-T ASI 
Emotional abuse/neglect - childhood -.285 .154 .174 .104 -.149 
Emotional abuse/neglect - adulthood -.053 -.021 .032 .226 -.033 
Emotional abuse/neglect - late adulthood -.209 -.006 -.029 .IOI -.137 
Emotional abuse/neglect - 12 months prior to interview -.173 .127 .221 .264 -.088 
Crime/disaster/war - childhood .01 I -.015 -.517* -.621 ** -.059 
Crime/disaster/war - adulthood .327" .290 .117 .007 .245 
Crime/disaster/war - late adulthood .092 -.088 .371 .469* .200 
Crime/disaster/war - 12 months prior to interview -.203 -.046 
Relational stress - childhood -.329" -.351" -.215 -.109 -.003 
Relational stress - adulthood -.402" -.149 -.141 -.041 .200 
Relational stress - late adulthood -.177 .178 .339" .019 .039 
Relational stress - 12 months prior to interview -.205 -.016 -.020 .250 .233 
Problem behaviour of significant others - childhood -.123 -.091 .212 -.051 -.222 
Problem behaviour of significant others - adulthood -.397" -.357" -.355" -.203 -.273 
Problem behaviour of significant others - late adulthood -.037 -.445* -.188 -.234 -.092 
Problem behaviour of significant others - 12 months prior to interview .148 -.179 .087 .216 .1 14 
* p <0.05; ** p < 0.01 ; ***p < 0.001 
"Correlation considered significant with a sample size ofN = 48 
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10.4.2 The relationship between negative life events per developmental 
period and symptoms of psychopathology in late-life for LO participants. 
Moderately strong correlations were found between sexual abuse events in childhood 
and high scores on measures of trait anxiety and anxiety sensitivity in late-life. In 
addition, a moderately strong, positive correlation was found between problem 
behaviours of significant others experienced in childhood and trait anxiety in late-
life. Negative socio-economic circumstances and sexual abuse in adulthood were 
positively correlated with trait anxiety and anxiety sensitivity in late-life amongst 
participants with LO GAD. CDW events and relational stress in adulthood were 
significantly correlated with symptoms of worry and depression, respectively. 
Severe personal illness and negative socio-economic circumstances in late adulthood 
were both positively correlated with trait anxiety in late-life. Significant positive 
correlations were found between the experience of severe personal illness in the year 
prior to the interview and symptoms of anxiety, depression, trait apxiety and anxiety 
sensitivity amongst LO participants in late-life. Negative socio-economic 
circumstances in the year prior to interview were positively correlated with 
depressive symptoms in late-life, whilst CDW events in the year prior to interview 
were positively associated with anxiety sensitivity in late-life. Finally, a positive 
correlation was found between experiences of problem behaviour of significant 
others in the year prior to interview and anxiety symptoms in late-life. 
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Table I 0.8 
Relationship between Negative Life Events per Developmental Period (dichotomy score) and Symptoms of Psychopathology amongst Participants with 
LO GAD (N = 48) 
Event cluster per developmental period Measures of psychopathology 
GDS GAi PSWQ STAI-T AS! 
Death of significant others - childhood .261 .l26 .046 .094 .210 
Death of significant others - adulthood .039 .028 .023 -. I I I .150 
Death of significant others - late adu lthood -.260 -.046 -.084 -.110 -.020 
Death of significant others - I 2 months prior to interview -.028 .010 .015 .023 .091 
Severe illness (self) - childhood -.234 .050 -.03 I .034 .022 
Severe illness (self) - adulthood .183 .061 .052 .250 .15 I 
Severe illness (self) - late adu lthood .285 .184 .077 .431** .265 
Severe illness (self)- I 2 months prior to interview .479** .316* .117 .44 I** .338* 
Severe illness (others)- childhood .064 .156 -.021 .241 .146 
Severe illness (others) - adulthood .104 -.091 -.073 .108 .122 
Severe illness (others) - late adulthood .145 .192 -.075 .098 .209 
Severe illness (others)- 12 months prior to interview -.045 -.055 -. 136 -.062 -.047 
* p:S:0.05; ** p:S:0.01 ; ***p :S: 0.001 
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Table 10.8- continued 
Relationship between Negative Life Events per Developmental Period (dichotomy score) and Symptoms of Psychopathology amongst Participants with 
LO GAD (N = 48) 
Event cluster per developmental period Measures of psychopatho logy 
GDS GAI PSWQ STAI-T AST 
Socio-economic circumstances - childhood .02 1 .057 .035 .187 .050 
Socio-economic circumstances - adulthood .04 1 .231 .068 .307* .362* 
Socio-economic ci rcumstances - late adu lthood .217 .020 .069 .394** .283 
Socio-economic circumstances - 12 months prior to interview .297* .122 .159 .28 1 .277 
Sexual abuse - childhood -.048 .207 .262 .361 * .363* 
Sexual abuse - adulthood -.063 .207 .211 .324* .308* 
Sexual abuse - late adulthood -.083 .206 .105 .217 .095 
Sexual abuse - 12 months prior to interview -.216 .00 1 -.154 -.117 -.242 
Physical abuse - chi ldhood .105 .019 .043 .264 .225 
Physical abuse - adulthood -.126 .088 .073 .229 -.162 
Physical abuse - late adu lthood 
Physical abuse - 12 months prior to interview 
* p:<=0.05; ** p:<'.0.0 1; ***p:<=0.001 
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Table 10.8 
Relationships between Negative Life Events per Developmental Period and Symptoms of Psychopathology amongst LO Participants 
Event cluster per developmental p~riod Measures of psychopathology 
GOS GAi PSWQ STAI-T AS! 
Emotional abuse/neglect - childhood .212 -.081 -.049 -.043 -.170 
Emotional abuse/neglect - adulthood .078 -.1 14 -.071 .033 -.017 
Emotional abuse/neglect - late adulthood .283 -.010 -.121 .061 -.036 
Emotional abuse/neglect - 12 months prior to interview .276 -.201 -.206 -.026 -.014 
Crime/disaster/war - childhood .019 .049 .108 .195 .138 
Crime/disaster/war - adulthood -.086 .283 .291 * .112 .134 
Crime/disaster/war - late adulthood -.268 -.202 -.109 -.200 -.030 
C~ime/disaster/war - 12 months prior to interview -.038 .147 .186 .267 .291 * 
Relational stress - childhood -.027 .036 .079 .190 .166 
Relational stress - adulthood .357* -.233 -.143 -.012 -.080 
Relational stress - late adulthood .213 -.121 -.156 .111 .114 
Relational stress - 12 months prior to interview .201 .02 1 -.016 .062 .151 
Problem behaviour of significant others - childhood .027 .170 .129 .399* .126 
Problem behaviour of significant others - adulthood .033 .052 -.076 .090 .076 
Problem behaviour of significant others - late adulthood .131 -.] 51 -.200 -.011 -.015 
Problem behaviour of significant others - 12 months prior to interview .132 .342* .239 .249 .215 
* p :S 0.05; ** p :S 0.01 ; ***p :S 0.001 
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10.5. Examination of Exploratory Research Question 3: 
The Relationship between the Total Number of Negative Life Events 
(from each event cluster) throughout Life and Symptoms of 
Psychopathology in Late-life amongst Participants with EO and LO GAD 
Pearson product-moment correlation coefficients were computed using the quantity 
cluster scores to investigate the bivariate relationship between the occurrence of 
negative life events from each event cluster throughout life and symptoms of 
psychopathology in late-life. The relationship between the total number of life 
events experienced throughout life and symptoms of psychopathology for EO and 
LO participants are presented in Tables 10.9 and 10.10 respectively. Once again, due 
to the LO sample being larger than the EO sample, correlations in the EO sample that 
would be considered significant with a sample size of 48 were noted in Table 10.9 
for comparability purposes. 
10.5.l The relationship between the total number of negative events 
throughout life and symptoms of psychopathology amongst _older adults with 
EOGAD 
Findings for the EO group revealed only one event cluster to be significantly 
correlated with scores on a measure of psychopathology in late-life. Specifically, a 
moderately strong, positive correlation was found between the experience of negative 
socio-economic circumstances throughout life and trait anxiety in late-life. Three 
negative correlations were. noted that would have been deemed significant had the 
EO sample size (n = 21) been the same as the LO sample size (n = 48). These related 
to severe · illness of others and relational stress with the GDS-15 and problem 
behaviour of significant others with the GAL 
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Table 10.9 
Relationship between the Total Number of Life Events throughout Life (quantity score) and Symptoms of Psychopathology amongst Participants 
with EO GAD (N = 21) 
Event cluster (throughout life) Measures of psychopatho logy 
GDS GAI PSWQ STAl-T ASI 
Death of significant others -.040 -.026 -.031 -.066 .118 
Severe illness - self -. 150 .143 -.059 .259 -.281 
Severe illness - others -.352" .062 .021 .229 -.179 
Socio- economic circumstances -.229 -.017 .186 .462* -.006 
Sexual abuse .000 -.086 .093 .051 .089 
Physical abuse -.167 -.216 .147 .052 -.223 
Emotional abuse/ neglect -.204 .040 .060 .176 -.122 
Crime/disaster/war .127 .058 .179 .139 .059 
Relational stress -.393" -.114 -.027 .026 -.220 
Problem behaviour of significant others -.204 -.441" -.190 -.128 -.188 
Total number of events -330" -.096 .051 .210 .-.208 
* pS0.05; ** p S 0.01 ; ***p S 0.001 
"Correlation considered significant at.05 level with a sample size ofN = 48 
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10.5.2 The relationship between the total number of negative events 
throughout life and symptoms of psychopathology amongst older adults with 
LOGAD 
Amongst the LO group, there was a strong and significant positive correlation 
between experiences of severe personal illness throughout life and trait anxiety in 
late-life, and moderate, positive correlations between severe personal illness and both 
anxiety sensitivity and depression in late-life. Negative socio-economic 
circumstances throughout life were positively correlated with trait anxiety and 
anxiety sensitivity in late-life. There was a moderate, positive correlation between 
experiences of sexual abuse throughout life and both trait anxiety and anxiety 
sensitivity in late-life. There was also a significant positive correlation between 
relational stress throughout life and depression in late-life. The remaining six event 
clusters were not found to correlate significantly with any symptoms of 
psychopathology in late-life. The total number of events of all types throughout life 
was significantly correlated with both trait anxiety and anxiety sensitivity in late-life. 
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Table IO.IO 
Relationship between the Total Number of Life Events throughout life (quantity score) and Symptoms of Psychopathology amongst Participants 
with LO GAD (N = 48) 
Event cluster (throughout life) Measures of psychopathology 
GDS GAi PSWQ STAI-T AS! 
Death of significant others -.022 .049 -.010 -.090 .204 
Severe illness - self .337* .255 .100 .495*** .331 * 
Severe i II ness - others .056 .021 -.147 .058 .093 
Socio- economic circumstances .202 .176 .119 .441*** .390** 
Sexual abuse -.102 .236 .225 .353* .307* 
Physical abuse -.008 .056 .061 .264 .270 
Emotional abuse/ neglect .259 -.074 -.108 .029 -.087 
Crime/disaster/war -1.03 .214 .287 .214 .220 
Relational stress .286* -.138 -.070 .099 .085 
Problem behaviour of significant others .105 .090 -.029 .195 .114 
Total number of events .271 .100 -.004 .349* .325* 
* p :S 0.05; ** p :o 0.01; ***p :S 0.001 
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10.6. Examination of Exploratory Research Question 4: 
The Relationship between the Total Number of Negative Life Events 
Experienced per Developmental Period and Symptoms of 
Psychopathology in Late life 
Pearson product-moment correlation coefficients were computed using the quantity 
period scores to examine the bivariate relationships between the total number of all 
life events experienced in each developmental period and symptoms of 
psychopathology in late-life. The relationship between the total quantity of negative 
life events experienced in each of the developmental periods and symptoms of 
psychopathology for EO and LO groups is presented in Tables 10.11 and 10.12 
respectively. As with the above investigations, correlations in the EO sample that 
would be considered significant with a sample size of 48 were noted for 
comparability purposes in Table I 0.11 
No significant correlations were found between the total number of negative life 
events experienced in any of the four developmental periods and symptoms of 
psychopathology in late-life amongst EO participants. A moderately large, positive 
correlation was found between the total quantity of negative life events in childhood 
and trait anxiety in late-life amongst LO participants . A moderate, positive 
correlation was also found between the total number of negative life events 
experienced in adulthood and anxiety sensitivity in late-life. No correlations were 
found between the total number of life events experienced in either late adulthood or 
in the year prior to the interview and symptoms of psychopathology in late-life for 
the LO group. 
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Table I 0.11 
Relationship between the Total Quantity of Negat ive Life Events per Developmental Period (quantity score) and Symptoms of Psychopathology 
in Participants with EO GAD (N = 21) 
Developmental Period Measures of psychopathology 
GDS GAI PSWQ STAI-T ASI 
Childhood (0-15) -.199 -.154 .029 .037 -.269 
Adu lthood (16 - 49) -.331 " -.044 .000 .235 -.029 
Late adulthood ( 50 to past year) -.322" -.022 .133 .130 -.270 
Year prior to interview -.159 -.007 .090 .317 -.088 
* p S 0.05; ** p S 0.01; ***p S 0.00 I; " Correlation considered significant with a sample size of N = 48 
Table 10.12 
Relationship between the Total Quantity of Negative Life Events per Developmental Period (quantity score) and Symptoms of Psychopathology 
in Participants with LO GAD (N = 48) 
Developmental Period Measures of psychopatho logy 
GDS GAi PSWQ STAI-T AS! 
Childhood (0 - 15) .122 . 152 .142 .423** .282 
Adulthood (16 - 49) .222 .066 .050 .254 .294* 
Late adulthood ( 50 to past year) .218 -.002 -.116 .208 .2 17 
Year prior to interview .172 .066 -.059 .122 .140 
*p S 0.05 ; **pS0.01; ***p S 0.001 
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10.7. Examination of Exploratory Research Question 5: 
The Mean Number of Specific Negative Life Events Experienced per 
Developmental Period and throughout Life by Older Adults with EO and LO 
GAD 
Descriptive statistics for the mean number of specific life events experienced in each of the 
four developmental periods and across the lifespan for EO and LO participants are 
presented in Table I 0.13. Comparison of means using independent-samples t-tests were 
performed to examine differences between EO and LO participants in the mean number of 
specific events experienced in each developmental period and throughout life. On average, 
participants were not found to differ with regard to the number of events involving the 
death of significant others across the lifespan. Analyses revealed no significant difference 
between onset groups in mean number of events involving the death of significant others 
across the lifespan or within any of the four developmental periods. Onset groups were also 
found to be similar with regard to the mean number of events involving significant illness 
of self and others, negative socio-economic circumstances, sexual abuse, physical abuse, 
and CDW events experienced in each of the respective developmental periods and across 
the lifespan. 
EO participants were found to have experienced a significantly greater number of events 
involving emotional abuse and neglect in childhood than LO participants at the .05 level. 
Groups did not differ with regard to the mean number of events involving emotional abuse 
in adulthood, late adulthood, in the year prior to interview, or across the lifespan. On 
average, EO participants reported significantly more events involving relational stress in 
adu lthood than LO participants at the .05 level. Regarding experiences involving problem 
behaviour of significant others, those with EO GAD reported a significantly greater number 
of events in adu lthood at the .01 level, in the year prior to interview at the .05 level, equal 
variances not assumed, and throughout life at the .0 I level than LO participants. Onset 
groups were similar with regards to the number of events involving problem behaviours of 
significant others experienced in childhood. 
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Table 10.13 
Mean Number of Specific Life Events Experienced per Developmental Period and Across 
the Lifespan for EO and LO Participants (N = 69) 
Early Onset Late Onset Significance 
(N = 21) (N = 48) test 
Life event cluster M SD M SD t[ctn 
Death of significant others 2.95 1.53 3.42 1.76 1.05 [67] 
Childhood 0.24 0.54 0.31 0.72 0.42 [67] 
Adulthood 1.48 1.12 1.42 1.15 0.20[67] 
Late adulthood 1.05 1.07 1.44 0.99 1.47[67] 
Year prior to interview 0 .19 0.40 0.25 0.53 0.46[67] 
Significant illness - Self 2.57 1.89 2.08 1.67 1.07[67] 
Childhood 0.29 0.46 0.15 0.36 1.23[3085Jt 
Adulthood 0.81 0.81 0.60 0.68 1.09[67] 
Late adu lthood 1.00 0.84 0.77 0.78 l.1 0[67] 
Year prior to interview 0.48 0.75 0.56 0.71 0.46[67] 
Significant illness - Others 6.57 3.25 6.25 4.74 0,28[67] 
Childhood 1.00 0.71 0.65 0.76 1.82[67] 
Adulthood 2.05 1.32 1.96 --us 0.24[67] 
Late adulthood 2.00 1.18 2.00 1.56 0.00[67] 
Year prior to interv iew 1.52 1.12 1.65 3.37 0.16[67] 
Socio-economic circumstances 1.81 1.99 1.82 1.92 0.21[67] 
Childhood 0.38 0.50 0.38 0.49 0.05[67] 
Adulthood 0.90 0.83 0.88 0.96 0 ,12[67] 
Late adulthood 0.38 0.80 0.42 0.74 0 .18[67] 
Year prior to interview 0.14 0.36 0.25 0.60 0 .76[67] 
Sexual abuse 0.29 0.96 0.21 0.92 0.32[67] 
Childhood 0.14 0.65 0.08 0.45 0.46[67] 
Adulthood 0.14 0.48 0.08 0.45 0.49[67] 
Late adulthood 0.00 0.0 0.02 0.14 0.66[67] 
Year prior to interview 0.00 0.0 0.02 0.14 0.66[67] 
* p < 0.05; ** p < 0.01 ; ***p < 0.001 
t Equality of variances not assumed (Levene' s test significant) 
171 
Table I 0.13- continued 
Mean Number of Specific Life Events Experienced per Developmental Period and Across 
the lifespan for EO and LO Participants (N = 69) 
Early Onset Late Onset Significance 
(N = 21) (N = 48) test 
Life event cluster M SD M SD tld8 
Physical abuse I.IO 1.30 0.81 1.07 0.95 [67] 
Chi ldhood 0.57 0.60 0.50 0.58 0.46[67] 
Adu lthood 0.43 0.60 0.31 0.55 0.78 167] 
Late adulthood 0.05 0.22 0.00 0.00 1.00 12011 
Year prior to interview 0 .05 0.22 0.00 0.00 1.00 12011 
Emotional abuse 3.71 3.32 2.50 2.50 l .50[3o37JI 
Chi ldhood 1.48 1.12 0.88 0.91 2.34[67)* 
Adulthood 1.38 1.43 0.79 0.87 1.75 [26 76Jt 
Late adulthood 0.43 0.68 0.42 0.68 0.07 [67] 
Year prior to interview 0.24 0.44 0.17 0.38 0.69[67] 
Crime/disaster/war events 1.29 2.45 1.75 2.24 0.77[67) 
Childhood 0.52 2.18 0.60 1.77 0.16[67) 
Adu lthood 0.48 0.75 0.88 --1.63 1.07[67) 
Late adulthood 0.29 0.46 0.25 0.44 0.31[67) 
Year prior to interview 0 .00 0.00 0.02 0.14 0.66[67] 
Negative relationships with others 8.11 3.51 7.04 4.46 0.97(67] 
Childhood 1.29 0.90 1.19 1.10 0.36[67] 
Adulthood 4.01 1.73 2.94 1.99 2.14[67] * 
Late adulthood 1.90 1.09 2.00 1.85 0.27[6083Jt 
Year prior to interview 0.90 0.94 0.92 I.OJ 0.05[67] 
Problem behaviours of significant 4.05 2.40 2 .32 2 .20 2 .931 67]** 
others 
Childhood 0.38 0.5 0.31 0.51 0.51[67) 
Adu lthood 1.81 1.33 0.98 1.12 2.66[67] •• 
Late adulthood I.IO 0.89 0.77 0.86 1.43[67] 
Year prior to interview 0.76 0.89 0.25 0.53 2.46[2633J* t 
*p < 0.05; **p < 0.01; ***p<0.001 
t Equality of variances not assumed (Levene's test significant) 
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10.8. Examination of Exploratory Research Question 6: 
The Mean Number of Total Life Events Experienced per Developmental Period 
and throughout Life 
Descriptive statistics for the mean number of total life events experienced in each of the 
four developmental periods and throughout life for EO and LO participants are presented in 
Table I 0.14. Overall, the two groups appeared similar with respect to the total number of 
negative life events experienced in each developmental period and throughout life. 
Independent-samples t-tests were performed to compare early-and late-onset groups on 
mean number of life events experienced in each developmental period and throughout life. 
No difference was found between groups in mean number of li fe events experienced in 
childhood. On average, the EO group experienced a greater number of negative life events 
during adulthood than those in the LO group, which was significant at the .05 level. Onset 
groups did not differ in mean number of negative life events experienced in late adulthood, 
nor were they found to differ in the mean number of negative life events experienced in the 
year prior to the interview. On average, participants in the EO group were found to 
experience a greater number of negative life events throughout life than those in the LO 
group, however this difference was non-significant. 
Table 10.14 
Mean number of Total Life Events Experienced per Developmental Period and throughout 
Life for EO and LO Participants (N = 69) 
Early Onset Late Onset Significance 
(N = 21) (N= 48) test 
Developmental period M SD M SD t[dQ 
Childhood 6.29 5.53 5.04 3.38 1.15 [67] 
Adulthood 13.49 5.80 10.84 4.17 2.14[67] * 
Late adulthood 8. 19 2.66 8.08 4.04 0.11 [67] 
Year prior to interview 4.29 2.85 4.08 4.03 0.21 [67] 
Lifespan - total events 32.44 13.32 28.30 11.09 1.34 [67] 
* p '.S 0.05; ** p '.S 0.01 ; ***p '.S 0.001 
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10.9 Discussion 
Chapter Ten sought to explore the relationship between negative life events and late-life 
psychopathology amongst older adults with early-and late- onset GAD by investigating 
research questions 4 and 5. Research question 4 addressed the question of whether older 
adults with early- and late-onset GAD differ in the frequency and severity of stressful life 
events preceding the onset of psychopathology, and was interested in examining the 
hypothesis that environmental precipitants play a more important role in LO GAD than in 
EO GAD. The hypotheses that onset groups would differ with regard to the frequency and 
severity health-related events preceding the onset of both present and past episodes of 
clinically significant anxiety and/or mental illness were partially supported by the present 
data. 
Hypothesis 10a and !Ob were not supported by the current data, which revealed that EO 
and LO groups of older adults did not differ with respect to the frequency or severity of 
health-related events preceding the onset of the presenting episode of GAD. This finding is 
in line with those of Le Roux et al. (2005), who found no support for the hypothesis that 
older adults with LO of GAD symptoms were more likely to have experienced negative life 
events such as widowhood or poor health than those with EO of anxiety. Le Roux et al. 
(2005), however, noted that the measures used to assess negative life events in their study 
(i.e. current marital status, total number of medical conditions and MMSE) were fairly 
insensitive and that they did not collect data on other negative life events associated with 
aging. It is possible that the similarity in ages ofEO and LO participants at onset of the 
presenting disorder (58.5 vs. 59.6 years) may account for the findings ofno difference in 
the frequ c:ncy and severity of negative health-related events as at that age, both groups of 
participants would have experienced similar changes and/or losses in their health or the 
health of significant others. 
There was some evidence to support hypotheses· [0c and 10d. Specifically, investigation of 
the frequency of stressful life events experienced prior to first onset of an anxiety disorder 
of any kind (GAD) confirmed a higher prevalence of both health-related events and 
negative financial circumstances to precede the onset of psychopathology in the LO group 
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(hypothesis 10c). Furthermore, the current findings revealed significant relationships 
between the first onset of GAD amongst LO participants and the severity of health-related 
events, events involving negative financial circumstances, and events involving changes in 
education and/or occupation (hypothesis I Od). These findings are in line with the model 
put forth by Boyd et al. (2001) proposing that LO of psychopathology is associated with the 
experience of more environmental/life stressors preceding episode onset. 
It is not surprising that the LO group was found to report a greater frequency of health 
related changes prior to first lifetime onset of a GAD (hypothesis 10c), considering the 
significant difference in mean age at onset between LO and EO participants at this time 
(52.9 vs., 15.0 years). Given that a number of health-related problems commonly begin in 
middle- to late-adulthood (for example, cholesterol , high blood pressure, type II diabetes 
and problems with arthritis), and that these conditions are likely to be ongoing rather than 
to remit, the occurrence of these losses and/or changes in health may therefore be a 
precipitating or contributing factor to the development of LO anxiety. The present data, 
which are in support of hypothesis I Oc and I Od, are also consistent with previous findings 
of Raj et al. (1993), who found older adults with LO PD to cite medical events as well as 
financial and interpersonal problems as stressors occurring prior to episode onset. Ahhough 
the current sample predominantly had a principal diagnosis of GAD, LO participants were 
similarly found to report changes and/or difficulty with health and financial circumstances 
as stressors preceding first onset of a DSM-IV anxiety disorder at significantly higher rates 
than EO participants. 
Partial support for the current findings related to hypotheses I Oc and I Od can also be seen 
in those of De Beurs et al. (2000). In their study investigating factors effecting 
destabilisation to, and chronicity of anxiety in a two-wave longitudinal design, De Beurs 
and colleagues identified the deterioration of health and functioning as one of two types of 
stressors that had occurred between assessments that was associated with an increase in 
anxiety symptoms. These findings were replicated by De Beurs et al. (2001) in a further 
investigation in which major illness of a family member was found to be predictive of 
becoming anxious in late-life. While these latter investigations by De Beurs et al. (2000, 
2001) were not onset specific, they examined older adults without psychopathology who 
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then went on to develop psychopathology later in life, as is seen in those older adults in the 
present study with LO GAD. Further, although causality cannot be established for the 
present data, the findings of De Beurs et al. (2001) support the current findings and indicate 
that negative events involving health and finances may be more likely to contribute to the 
onset of a DSM-IV disorder in people having their first onset at 34 years of age or later. 
The hypothesis that LO participants would report a greater number of stressful events 
preceding the onset of both the presenting episode of GAD and first episode of GAD (l0e) 
was not supported by the current findings , in line with previous research (Sheikh, et al., 
2004). It is worth mentioning that there was a trend towards a greater mean number of 
negative life events preceding first onset of GAD amongst LO participants, raising the 
possibility that this finding may be significant with a greater sample size. Further research 
with a greater sample size is required to investigate this hypothesis before any concrete 
claims can be made about this relationship. 
Research question 5 (RQ5) aimed to investigate the relationship between the experience of 
negative life events across the lifespan and symptoms of psychopathology in late-l ife 
amongst older adults with early- and late-onset GAD. Due to a laclc of previous research 
regarding this relationship, six exploratory research questions (1 - 6) were put forward to 
examine this broader research question in further detail. In light of the absence of previous 
investigations with which to directly compare the current findings, where relevant, the 
current findings are discussed with reference to previous findings of Kraaij & De Wilde 
(2001), who investigated the relationship between negative life events and depression in a 
sample of older adults not distinguished by age of onset. 
The current investigation explored the prevalence of negative life events experienced by 
early-and late-onset participants in specific developmental periods and throughout life 
(Exploratory research question I). This exploratory analysis revealed that all older adults 
in the current sample reported at least one negative event during their life . For both EO and 
LO groups, these events predominantly concerned the death of significant others, severe 
illness of themselves and others, emotional abuse and neglect, relational stress, and 
problem behaviours of significant others. 
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The aim of exploratory research question 2 was to understand the relationship between the 
experience of specific negative life events during each developmental period and symptoms 
of anxiety, worry and depression in later life amongst older adults with EO and LO GAD. 
A number of negative events experienced in childhood and late adulthood were found to be 
significantly associated with symptoms of psychopathology in late life amongst EO 
participants, whilst significant associations between negative life events and symptoms of 
psychopathology were found across all four developmental periods for the LO group. 
Findings for the EO group were unusual in that significant relationships were 
predominantly negative, indicating that the experience of one or more negative life event 
was related to low scores on self-report measures of anxiety, worry and depression. On the 
other hand, significant relationships between the experience of negative life events per 
developmental period and self-reported symptoms of psychopathology in later life by those 
with LO GAD were all positive, indicating that the experience of one or more negative life 
events was associated with high scores on self-report measures of psychopathology. 
Catastrophic events experienced in early childhood and extreme experiences during WWII 
have previously been found to be related to depression in late life (Seekman, et al. , 1995). 
In contrast to these findings, the present data revealed a strong and significant negative 
relationship between CDW events in childhood and symptoms of worry and trait anxiety in 
older adults with EO GAD. These findings indicate that the experience of one or more of 
these events in childhood amongst the present sample of older adults with EO GAD is not 
associated with worry or the tendency to be anxious in later life. 
Negative life events involving the severe illness of a significant other in late adulthood was 
significantly associated with low scores on measures of depression and anxiety sensitivity 
in late life amongst older adults with EO GAD. These findings suggest that experiences of 
severe illness involving significant others in late-adulthood may not be considered to be as 
negative or as stressful as other events in this stage of life that may be more personally 
relevant for those with EO of GAD. 
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In contrast to findings for childhood, the experience of CDW events in late adulthood 
amongst EO participants was significantly associated with symptoms of trait anxiety. A 
significant relationship was also found between the experience of negative socio-economic 
circumstances in late adulthood and symptoms of trait-anxiety in the EO group. These 
findings highlight the negative impact of trauma experiences and difficult financial 
circumstances on psychological well-being in late-life, which may be maintaining factors or 
triggers to new episodes of anxiety amongst older adults with EO GAD. 
The current data revealed a significant relationship between events involving problem 
behaviours of significant others in childhood and high trait anxiety amongst those with LO 
GAD. In addition, sexual abuse in childhood was significantly associated with high scores 
on measures of trait anxiety and anxiety sensitivity in later life in the LO group. CDW 
events in adulthood were positively correlated with worry symptoms, whilst relational 
stress in adulthood was positively correlated with depressive symptoms in participants with 
LO GAD in late-life. Negative socio-economic circumstances in adulthood were 
significantly associated with both trait anxiety and anxiety sensitivity in late life amongst 
participants with LO GAD, as was the occurrence of sexual abuse in adulthood. Although 
there is no previous research with which to directly compare the· current findings , the 
finding of a relationship between the occurrence of sexual abuse events and both the 
tendency to be anxious and to fear anxiety symptoms in late-life are in line with previous 
findings (Kraaij & de Wilde, 2001). In their study, Kraaij & De Wilde found the occurrence 
of sexual abuse events in adulthood and late adulthood to be significantly associated w ith 
depressive symptoms in a sample of older adults with late-life depression not distinguished 
by age of on.set. 
Severe personal illness and negative socio-economic circumstances in late adulthood were 
both significantly associated with symptoms of trait anxiety in participants with LO GAD. 
Severe personal illness in the twelve months prior to assessment was significantly 
associated with symptoms of anxiety, trait anxiety, anxiety sensitivity and depress ion, in 
the LO group. Negative socio-economic circumstances in the year prior to interview was 
significantly associated with depressive symptoms in late-life, whilst CDW events in the 
year prior to interview were associated with anxiety sensitivity in late-life. Finally, problem 
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behaviour of significant others in the year prior to interview was significantly associated 
with high scores on a measure of anxiety in late-life. 
The current findings indicate that experiences of severe personal illness in later life have a 
significant impact on psychological wellbeing amongst older adults with LO GAD. Though 
not onset specific, these finding are consistent with previous findings of Kraaij & De Wilde 
(2001), who found the experience of severe personal illness in the twelve months prior to 
interview to be significantly associated with depressive symptoms in older persons. As with 
the current findings, this relationship was not found by Kraaij & De Wilde for either of the 
two earlier developmental periods. It is interesting to note that this relationship was not 
found for the EO group, and is keeping with the findings of research question 4 that 
negative health-related events are significantly more likely to precede the onset of LO GAD 
thanEOGAD. 
The finding that negative socio-economic circumstances was associated with high scores on 
one or more measure of psychopathology in late-life for LO participants in each of the three 
latter developmental periods also highlights the negative impact that such experiences have 
on the psychological well-being of older adults with LO GAD, aria is also in line with 
findings of Research Question 4 discussed in this chapter. Overall the finding of significant 
relationships between severe personal illness, negative socio-economic circumstances, 
CDW events and problem of behaviour of significant others in the latter developmental 
periods, during which time the majority of LO participants had their first onset of GAD, 
and symptoms of psychopathology _in late-life is in line with previous findings of Keller 
(2002) who found that the incidence of LO anxiety disorders was associated with more life 
stressors in the twelve months leading up to the onset of clinical anxiety. In addition, these 
findings support the model put forward by Boyd et al. (2000), proposing that LO anxiety is 
associated with greater levels of life than EO anxiety. 
The aim of exploratory research question 3 was to explore the relationship between the total 
number of negative life events experienced throughout life and symptoms of 
psychopathology in later life for early-and-late onset groups. Investigation of this 
relationship revealed a significant association between the experience of negative socio-
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economic circumstances throughout life and trait anxiety in late-life amongst EO 
participants. These findings indicate that financial circumstances throughout life may be a 
constant stressor and/or maintaining factor for anxiety amongst those with EO GAD. In 
contrast to findings for the EO group, severe personal illness, socio-economic 
circumstances, sexual abuse and relational stress experiences throughout life were all 
significantly correlated with high scores on one or more measure of psychopathology in 
late-life for the LO group. The current findings are in line with the diathesis-stress model 
put forward by Boyd et al. (2001; see Chapter Four) and adapted for the present study, 
according to which EO anxiety is associated with a greater cognitive or internal 
vulnerability to pathology and that fewer stressful and/or negative events are required to 
trigger the onset of psychopathology, whereas the experience and accumulation of stressful, 
negative events throughout life is associated with LO anxiety. 
To investigate the accumulation of negative life events per developmental period, 
exploratory research question 4 examined the relationship between the total quantity of 
negative life events per developmental period and symptoms of psychopathology in late life 
for older adults with EO and LO GAD. No significant relationships were found between the 
total quantity of negative life events experienced per developmentafjleriod and symptoms 
of psychopathology amongst participants with EO GAD. On the other hand, for those with 
LO GAD, a significant relationship was found between the total quantity of events 
experienced in childhood and trait anxiety in late-life. A significant relationship was also 
found between the total number of events experienced in adulthood and anxiety sensitivity 
in late-life. The total quantity of events in late adulthood and the year prior to interview 
were not correlated with symptoms of psychopathology in late-life. These findings further 
lend support to the diathesis-stress model proposed and the theory that LO GAD, which is 
the fust onset of GAD for the majority of LO participants, is associated with greater levels 
of life stress than for those with EO GAD. 
The goal of exploratory research question 5 was to examine whether there were differences 
between onset groups in the mean number of specific negative life events experienced per 
developmental period and throughout life. EO participants were found to have experienced 
a significantly greater number of events involving emotional abuse in childhood, relational 
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stress in adulthood, and problem behaviours of others in adulthood, the year prior to 
interview and throughout life, than LO participants. These findings are in line with 
previous research by Hoehn-Saric et al. (1993), who found EO patients to have greater 
developmental difficulties and interpersonal adjustment than those with EO GAD in a 
sample of adult patients. Specifically, Hoehn-Saric and colleagues found those with EO 
GAD to score significantly higher than the LO group on individual items of the Childhood 
History Questionnaire (CHQ), including being "unpopular with peers," being "withdrawn" 
and a trend for "feeling left out". Although items on the Negative Events Questionnaire 
used in the current investigation are worded differently to those of the CHQ, the current 
finding of a greater number of events of ' emotional abuse ' in childhood for the EO group at 
the .05 level, which included queries as to whether participants had been "teased, excluded 
or ignored by other children" in childhood is in line with the findings of Hoehn-Saric and 
colleagues. In addition, Hoehn-Saric et al. (1993) noted that high levels of distress during 
childhood including those caused by critical attitudes of parents towards their children have 
been associated with heightened anxiety. In the present study, criticism by others, including 
by parents and siblings was assessed as part of events described as ' emotional abuse ', 
which was found to occur at a greater rate in the EO group in childhood, further lending 
support to the cognitive model proposing greater emotional vulnerability to 
psychopathology in those with EO anxiety, as outlined in Chapter Four. 
In their investigation, Hoehn-Saric et al. (1993) further found the EO group to show 
significantly greater dysfunction or severity on the item "difficulties in marital or sexual 
relationships" as assessed by the Psychiatric History Rating Scale (PHRS), developed by 
the authors to obtain information about events in childhood, psychiatric history and marital 
adjustment problems. This is consistent with the current finding that the EO group reported 
a greater number of negative events involving relational stress in adulthood. These events 
included experiencing relationship problems with ones partner/s and having been divorced 
or separated. Hoehn-Saric and colleagues also found "a disturbed home environment in 
childhood" to distinguish onset groups, with the EO group being found to show greater 
dysfunction or severity on this variable. Although it is difficult to ascertain what ' disturbed 
home environment' entails, 'problem behaviours of others ' in the current study, which 
involved events such as addictions, suicide and convictions of criminality in participants, 
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their parents, siblings, partner/s and children, may encompass events that would be 
considered as a "disturbed home environment." Interestingly, the current study revealed a 
difference between onset groups in the number of such events in adulthood at the .01 level 
and in the year prior to the interview at the .05 level, perhaps reflecting a problem in these 
areas in the partner/s of participants or with their children, rather than experiencing these 
events in their own childhood. 
The aim of exploratory research question 6 was to examine whether there were differences 
between onset groups in the mean number of total life events experienced per 
developmental period and throughout life. The current data revealed a significant difference 
between onset groups in mean number of total life events experienced during adulthood, 
with EO participants experiencing a greater number of negative events in adulthood, on 
average, than those in the LO group at the .05 level. It is not surprising that EO participants 
experienced a greater number of negative events in adulthood, as this was the age range 
during which the majority of these participants had their first onset of a DSM-IV anxiety 
disorder (see Chapter Seven). This finding is also in line with the model put forward by 
Boyd et al. (2000) suggesting that the experience of stressful events early in life may not be 
more frequent or severe than those who go on to develop LO GAD, but in combination 
with a greater cognitive vulnerability to anxiety, contributes to the onset of anxiety amongst 
EO participants. Finally, onset groups were not found to differ in the mean number of total 
life events experienced in childhood, late-adulthood, the year prior to interview or 
throughout life. 
10.10 Conclusions 
In summary, the current findings indicate that LO GAD is distinguished from EO GAD by 
the frequency and severity of health-related events, the frequency and severity of events 
involving financial difficulty and the severity of events involving change in occupation 
and/or education as precipitating factors , with those in the LO group reporting greater 
frequency and severity for these events preceding first onset of GAD. These findings 
indicate that the role of precipitating events is significant for the LO group, and that 
environmental factors are perhaps less relevant in the development of EO GAD. These 
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findings are in line with the cognitive model put forward by Boyd and colleagues (2000), 
which is also considered relevant in accounting for and onset distinction in late-life anxiety. 
Symptoms of trait anxiety in late-life amongst older adults with EO GAD in the present 
study were related to the experience of CDW events and negative socio-economic 
circumstances in late adulthood. Notably, the experience of negative socio-economic 
circumstances throughout life was associated with trait anxiety in the EO group, 
highlighting the negative impact of such experiences in this sub-group of anxious, older 
adults. Symptoms of psychopathology in older adults with LO of GAD in the current study 
were related to problem behaviours of significant others and sexual abuse in childhood; 
CDW events, relational stress, sexual abuse and negative socio-economic circumstances in 
adulthood; severe personal illness and negative socio-economic circumstances in both late 
adulthood and twelve months prior to interview; and CDW events and problem behaviours 
of significant others in the twelve months prior to interview. Regarding the accumulation of 
each life event cluster throughout life, severe personal illness, socio-economic 
circumstances, sexual abuse and relational stress experiences throughout life were all 
significantly correlated with high scores on one or more measure of psychopathology in 
late-life for the LO group. Furthermore, the accumulation of events in childhood and 
adulthood were associated with symptoms of trait anxiety and anxiety sensitivity in late-life 
amongst LO participants. 
The findings for both EO and LO groups suggest that these negative events may have long-
term consequences for the well-being of adults in later-life, in particular for those with LO 
of GAD. The current findings suggest that the incidence of LO GAD is associated with 
more life stressors in the lead up to the onset of clinical anxiety, in particular health related 
events; and that the experience and accumulation of stressful , negative events throughout 
life is associated with LO GAD, in line with the diathesis-stress model put forward by 
Boyd et al. (2000). 
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SECTION III: 
AN INVESTIGATION OF THE IMPLICATIONS OF AN AGE 
OF ONSET DISTINCTION FOR THE TREATMENT OF 
LATE-LIFE GENERALISED ANXIETY DISORDER 
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CHAPTER ELEVEN 
An Investigation of the Relationship between Age of Onset and the 
Treatment of Late- life GAD 
11.1 Introduction 
A significant amount of outcome data from case studies suggests that CBT is useful for the 
reduction of anxiety in older adults (Stanley & Beck, 2000). The potential efficacy of a 
wide range of approaches including exposure and response prevention, relaxation train ing, 
and cognitive therapy (CT) in both individuals and group formats has been reported for 
older adults with GAD (Barrowclough et al., 2001; Gorenstein et al., 2005; King & 
Barrowclough, 1991; Moh Iman et al., 2003; Stanley, Beck, & Glassco, 1996; Stanley, 
Beck, et al. , 2003; Wetherell, Gatz, & Craske, 2003). At present, however, relatively little 
is known about the implications of an onset distinction for the treatment of late-life GAD. 
Gaining an understanding of potential treatment implications is increasingly important, so 
that those older adults diagnosed with GAD can receive the best possible psychosocial care. 
To this end, the current chapter sets out to summarise and review the exiting empirical 
literature relating to treatment implications of an onset distinction for late-life 
psychopathology. Although treatment implications of an onset distinction for late-life GAD 
have not previously been empirically examined, there is considerable empirical evidence 
relating to the implications for late-life depressive disorders. As previously mentioned, 
since anxiety and depression are closely related disorders (Barlow, 1988; Mineka, et al. , 
1998), particularly in late-life (Beekman, et al. , 2000; de Beurs, et al. , 2001 ; Flint, 1997), 
this literature will be considered in the current section of this chapter. In light of evidence 
ofa bimodal distribution in age at onset of GAD, both in the literature (Beck, et al. , 1996; 
Chou, 2009; Le Roux, et al., 2005) and as established in Section One of this thesis, the 
theoretical literature suggesting an age of onset difference in response to CBT for late-life 
GAD is then presented. Finally, the current chapter examines and presents the findings of a 
study investigating treatment outcomes for a sample of older adults with early-and late-
onset GAD. 
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I I. I. I Implications of an onset distinction for the treatment of late-life depression 
The implications of age at onset of illness for treatment response are not well understood. 
Some studies have suggested that EO of late-life depression is more difficult to treat 
(Brodaty, et al., 1991; Dew et al., 1997; Reynolds, et al., 1998), others have suggested LO 
late-life depression to be more difficult, (Alexopoulos et al., 1996), whilst other studies 
suggest neither one type to be more difficult than the other (Baldwin, Benbow, Marriott, & 
Tomenson, 1993; Barzega, et al. , 2001 ; Flint & Rifat, 1997a, 1997b ). In an early study of 
the prognosis of depression in older adults, Brodaty et al. (1993) found that older patients 
who experienced their first lifetime episode of major depression before age 60 were more 
likely to have a relapsing course. These findings led Brodaty and colleagues to conclude 
that "a history of recurrence and its corollary, early-onset depression, not surprisingly, 
predicted a poorer prognosis in the elderly" (p 594). Consistent with these findings, Dew et 
al. (1997) reported that patients who were older when they experienced their first episode 
of depression showed a more rapid, sustained response profile. 
In another study into the effects of age at onset of first lifetime episode of major depression 
on treatment response, Reynolds et al. (1998) found that age at onset in older patients did 
not affect absolute rates of remission, relapse, recovery or recurrence during the first year 
of maintenance therapy. They did, however, find that time to remission was significantly 
longer in the EO group, suggesting that EO is associated with a slower or diminished rate 
of response to treatment. In their study patients with EO depression did not differ from 
those with LO in treatment intensity or focus, either pharmacological or psychotherapeutic, 
leading Reynolds and colleagues· to conclude that the similarity of combined treatment 
received was the strongest determinant of similar outcomes found for both onset groups. In 
contrast to these findings , other studies have reported those with LO depression to have 
lower response rates to treatment and a greater tendency to relapse (Alexopoulos, et al., 
1996; Kalayam & Alexopoulos, 1999). On the other hand, some researchers report findings 
of no difference with regard to treatment outcome. For example, Barzega et al. (2001) 
report that of the differences noted amongst those with EO and LO dysthymia, no 
significant difference has been found in the response to treatment. 
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In light of these previous findings Driscoll et al. (2005) investigated the relationship 
between age of onset and treatment response in a sample of older adults with single and 
recurrent depressive episodes and found that patients with LO recurrent depression took 
longer to respond to treatment than those with LO single episode depression (12 weeks vs. 
8 weeks). Ultimately, the LO recurrent group was not found to differ from the other two 
groups in terms of categorical response, remission, or in relapse rates. In all , 70-80% of the 
study participants responded to treatment (with about half ultimately remitting) but differed 
in how long they took to respond. Patients with recurrent depression, regardless of age of 
. onset, were more likely to require at least one augmenting agent to achieve stabilisation, 
thus accounting for the longer response time. The results suggest that both recurrent illness 
course and late age of onset may affect depressive episode characteristics and treatment 
response variability. Specifically, the findings of Driscoll et al. (2005) indicate that 
recurrent depression did not lead to worse outcome, but rather, slower response, in 
association with increased cognitive and functional impairment. In summary, despite taking 
longer to respond, patients with LO recurrent depression ultimately demonstrate similar 
response rates, particularly if augmentation pharmacotherapy strategies are employed. In 
another study, Golian, Raffety, Gortner and Dobson (2005) found that patients with EO 
depression spent more time contending with elevated residual symptoms following 
recovery than adult-onset depressives, with EO depression continuing to exert negative 
effects in the form of residual depressive symptoms and shorter time-to-relapse despite 
successful response to CBT for depression. 
The literature reviewed indicate_s that treatment implications for early-and late-onset 
depression may differ, however, the findings are mixed. Overall there is evidence to 
suggest that older adults with EO of depression are more likely to have a relapsing course 
of illness (Brodaty, et al., 1993; Golian, et al., 2005) and to have a slower rate of response 
to treatment than those with LO depression (Reynolds, et al., 1998; Reynolds et al., 1996). 
There is some evidence to suggest that older adults with LO depression have a greater 
tendency to relapse (Alexopoulos, et al., 1996), whilst others report similar rates of 
response to treatment for both EO and LO depression (Barzega, et al. , 2001; Driscoll, et al., 
2005). Treatment implications of an onset distinction for late-life GAD are as yet unknown. 
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I I. I. 2 Implications of an onset distinction for the treatment of late-life GAD 
Given that anxiety is very stable over time (Wetherell, et al., 2001), with at least half of 
older adults with GAD reporting an onset in childhood or adolescence (Beck, et al. , 1996; 
Blazer, George, et al. , 1991; Le Roux, et al., 2005) it would seem that for these individuals, 
longstanding and deeply held negative core beliefs about the self, others and the world may 
underlie their chronic anxiety. According to Wetherell et al. (2005), these core beliefs about 
the self need to be identified, understood, challenged and replaced with more adaptive 
schema in order for the individual to recover, suggesting an important role for cognitive 
techniques in the treatment of anxiety in older adults with EO of symptoms. In line with 
this, in a review paper of anxiety disorders in older adults and the role of behaviour therapy, 
Beck and Stanley (1997) note that "in considering the available prevalence data, age of 
symptom onset appears relevant, particularly as this may impact the effectiveness of 
cognitive behavioural treatments with older adults. Specifically, if the majority of older 
adults with anxiety disorders have experienced anxiety problems since early or middle 
adulthood, the chronicity of these conditions could diminish the effectiveness of 
behavioural treatment".(p 87). This suggests that behavioural treatments such as exposure 
therapy may be less efficacious for older adults with EO anxiety. 
In light of these suggestions it appears that whilst CBT has been demonstrated to be 
efficacious in the treatment of anxiety in older adults (Stanley & Beck, 2000; Stanley & 
Novy, 2000), specific components of CBT may vary in the degree to which they bring 
about therapeutic change for those with early- versus late- age of onset. According to the 
cognitive model ofEO and LO depression put forward by Boyd et al. (2000; See Chapter 
Four, Section One) and adapted to account for an age of onset distinction in anxiety, 
individuals with EO of GAD are thought to have a higher cognitive vulnerability to GAD 
than those with LO GAD. As such, those with EO GAD are more likely to have firmly 
entrenched, negative cognitive beliefs underlying their anxiety. On the other hand, those 
with LO GAD are thought to be more cognitively robust and to have a lower cognitive 
vulnerability to anxiety, with anxiety onset being a result of the accumulation of highly 
stressful events. As the aim of psychotherapy is to try and ameliorate these diatheses 
(vulnerabilities), individuals with EO GAD might therefore be expected to respond to CT 
techniques better than to BT techniques. Conversely, those with LO GAD might be 
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expected to respond to BT techniques such as problem solving to manage these late-life 
stressors, better than those with EO GAD, as previously suggested (Beck & Stanley, 1997; 
Wetherell , Hopko, et al., 2005). 
The issue of whether certain elements of the cognitive- behavioural package are necessary 
for efficacious treatment of late-life GAD, or for example, whether behaviour therapy is 
less effective in treating those with EO versus LO GAD as suggested, is important 
considering that behaviour therapy (BT) is considered a simp ler and more economical 
treatment than CT (Butler, Fennell, Robson, & Gelder, 1991 ). Unlike behavioural therapy 
however, CT might have the flexibility and range of applications to help patients deal better 
with the more common consequences of GAD such as demoralisation, loss of confidence, 
social anxiety and depression. Elucidating the mechanism of action of CBT and whether 
this varies according to age at onset could therefore lead to the development of more 
effective treatments for anxiety in older adults. 
11.2 Conclusions 
Current research has effectively delineated the many implications of an age of onset 
distinction for the treatment of late-life depression; however, treatment implications for an 
onset distinction in late-life GAD are as yet unknown. It is also necessary to clarify the 
theorised relationship between the differential efficacy of specific treatment components of 
CBT and age of onset. Despite reference to such a relationship (Beck & Stanley, 1997; Le 
Roux, et al., 2005), no empirical investigations of this relationship have been conducted to 
date. As such, it remains unclear as to how much each component contributes to treatment 
outcome and whether certain elements of the cognitive behavioural package are necessary 
for efficacious treatment of both ear ly- and late- onset GAD. These issues highlight the 
need for furth er investigation regarding the relationship between age of onset and the 
treatment of GAD in older adults. As previously outlined, a better understanding of this 
relationship will assist in improving the psychosocial care that is provided to older adults 
with late-life GAD. Consequently, further research examining the mechanisms underlying 
successful psychotherapeutic treatment of early- and late- onset GAD is warranted. 
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11.3 Aims 
The research presented in this chapter aimed to explore and acquire an understanding of 
factors specific to CBT associated with a positive treatment response amongst older adults 
with early- and late-onset GAD. The purpose of this study was to investigate differences 
between onset groups in patterns of responding to components of treatment, with a view to 
better understanding the treatment implications of an age at onset distinction in late-life 
GAD. 
11.3.1 Research questions 
The primary aim of study two was to examine the research question : What are the 
implications of an age of onset distinction for the treatment of late-life GAD? Drawing on 
previous literature summarised earlier in this chapter, the intensive nature of the present 
study allowed for the exploration of a number of specific relationships stemming from this 
broader research question. The following relationships are specifically addressed in this 
chapter: 
I. The relationship between treatment components/time and levels of the dependent 
variables for the sample as a whole (EO and LO participants). It was predicted that 
there would be a significant improvement in levels of psychopathology from pre- to 
post-treatment for older adults with GAD. 
2. The relationship between age ·of onset and levels of the dependent variables. In light of 
mixed findings in the depression literature regarding differences in treatment outcome 
for 'those with EO and LO depression (Section 11.1.1) the current study explored 
whether early-and late-onset participants differed in response to treatment, including the 
maintenance of treatment gains at six-month follow-up . 
3. The interaction between age of onset and treatment components of CBT/time on levels 
of the dependent variables. Whilst this relationship has not been empirically examined 
before, a goal of this investigation was to clarify whether the efficacy of specific CBT 
components varies according to age at onset. Drawing on the cognitive model of early-
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and late-onset anxiety proposed in Chapter Four, and literature suggesting the 
differential efficacy of specific CBT components for the treatment of EO and LO GAD 
(Beck & Stanley, 1997; Wetherell, Hopko, et al. , 2005), it was predicted that onset 
groups would differ in response to specific treatment techniques. Specifically, it was 
predicted that: 
a. Cognitive therapy techniques would be more efficacious in the treatment of EO 
GAD and be associated with a greater change on outcome measures at 
completion of the cognitive skills module for those with EO GAD than for those 
in the LO group, and; 
b. Participants with LO GAD would have a better response to behavioural 
techniques than those with EO GAD, as reflected in significantly greater 
improvements on outcome measures at completion of the behavioural skills 
module for those with LO GAD than for those with EO of GAD. 
11.3.2 Clinical implications 
In terms of clinical implications, this study will delineate some of the factors that influence 
treatment outcomes for older adults with early- and late-onset GAD, the consequences of 
which are superior psychosocial care. Psychologists will be able to develop or tailor 
psychosocial interventions aimed at enhancing treatment response, therefore improving the 
psychological wellbeing of older adults with either a longstanding history or more recent 
onset of GAD. The interventions may aim to either reduce the use of treatment components 
or modules implicated in poorer outcomes, or enhance those implicated in superior 
outcomes. Examining the way in which older adults distinguished by age of onset respond 
to specific treatment modules of CBT will constitute a major advance in our understanding 
of the treatment of late-life GAD and lead to an improvement of psychosocial services for 
older adults. 
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11.4 Method 
I 1.4. I Participants 
Of the 76 treatment-seeking older adults who were included in investigations of aetiology, 
phenomenology and life events, presented in Section Two, 75 were eligible and invited to 
take part in the present investigation, with one participant being referred on for further 
assessment of potential cognitive decline. Full details as to the recruitment process, 
inclusion and exclusion criteria are described in Chapter Six, section 6.1. Classification of 
these participants into early-and late-onset subgroups is outlined in section 7.3. Of these 75 
participants, 43 elected to take part in the treatment study. Forty-one of these individuals 
completed all twelve sessions of cognitive behavioural therapy (CBT), whilst two dropped 
out in the early stages of the study. Both of these participants elected to drop out after four 
sessions, one due to ill health of their partner, and the other due to work commitments. Of 
the 32 participants who were eligible but declined participation, eleven wished to 
participate but were unable to due to factors such as caring for a terminally ill partner, 
moving interstate, and overseas travel, and a further three individuals had commenced 
therapy with another provider between the time of assessment and the present study. Five 
participants declined to take part as they felt it would be too confronting to bring up past 
experiences. The remaining thirteen who declined did not provide a reason. Of the 41 older 
adults who took part in this study, eighteen belonged to the EO group (43 .9%) and twenty-
three (56.1 %) to the LO group. The EO sample included six males (33.3%) and twelve 
females (66.6%), with a mean age of 63.0 for males (SD= 3.90) and 60.50 for females (SD 
= 6.16). The LO sample included seven males (30.4%) and sixteen females (69.6%), with a 
mean age of 65.0 for males (SD= 8.94) and 62.31 for females (SD= 5.13). A flowchart 
depicting participant inclusion in the current investigation is presented in Figure 1 I.I 
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Treatment- seeking 
participants 
N = 76 
(EO: n = 24; LO: n = 52) 
Study One 
Eligib le participants 
N = 75 
(EO: n = 24; LO = 51) 
Ineligible 
(LO: n = I ) 
Figure I l.l Flowchart of participants included in Study Two 
Participants who 
commenced Treatment 
N = 43 
(EO: n = 18; LO: n = 25) 
Participants who 
Declined treatment 
N = 32 
(EO: n = 6; LO: n = 26) 
Study Two 
Completed 
Treatment 
N = 41 
Non- completers 
(LO: n = 2) 
Earl y- onset 
N = 18 
Late- onset 
N =23 
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11.4.2 Design 
The study presented in this chapter was a quasi- experimental , prospective design. The 
study used a 5 x 2 factorial design (two-way mixed ANOV A). Time of 
assessment/measurement represented the within-subjects independent variable, with five 
levels; at initial assessment (TO), completion of the relaxation (Tl), cognitive (T2) and 
behavioural (T3) skills module, and at six-month follow-up (T4). Age at onset of anxiety 
defined the groups to be compared, thus belonging to the early onset vs. late onset group 
represented the between subjects independent variable. The dependent variables were 
outcome scores on measures of anxiety, worry, depression, trait anxiety, anxiety sensitivity, 
locus of control beliefs, self-efficacy and an index of GAD severity. Dependent variables 
also included participant-rated level of anxiety, perceived usefulness of CBT strategies (i.e. 
somatic control exercises, cognitive skills, and behavioural skills) and participant-rated 
ability to cope with worry. 
11.4.3 Materials 
11. 4. 3.1 Descriptive characteristics 
Information on the age of onset characteristics and psychiatric comorbidity were collected 
during the diagnostic assessment interview using the ADIS-IV-L (DiNardo, et al. , 1994), 
described in full detail in Section 6.3.2. Demographic and health characteristics of the 
sample were collected during participants ' initial assessment interview using a semi-
structured interview schedule constructed to obtain detailed information about the 
participants' personal history (see Appendix D for the full assessment schedule). For full 
details as to information collected on demographic characteristics and the categories these 
variables consist of see Section 6.3.4. For full details regarding medical conditions 
assessed ," description and categorization of medication use and information collected in 
participants psychiatric treatment history see Section 6.3.5 
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11.4.3.2 Primary outcome measures 
Anxiety 
The Geriatric Anxiety Inventory (GAI; Pachana et al. , 2007) was used to measure the 
clinical symptoms of anxiety disorders (Appendix E). Participants completed the GAI as 
part of a series of questionnaires provided before, during, and six-months following 
cognitive-behavioural therapy (CBT) treatment. For a full description of the GAI, its 
scoring and its norms, see Section 6.3.8. 
Worry 
The Penn State Worry Questionnaire (PSWQ; Meyer, et al. , 1990) was used to assess 
clinically significant pathological worry by measuring the tendency to engage in excessive 
worry, irrespective of the worry content, and associated ability to control worry (Appendix 
F). The PSWQ was completed as part of a series of questionnaires provided before, during, 
and six-months following completion of twelve sessions of CBT treatment. The PSWQ is 
described in full in Section 6.3.9. 
Depression 
The Geriatric Depression Scale (GDS-15 ; Sheikh & Yesavage, 1986a) was used to measure 
depressive symptoms in the current sample (Appendix G). The GDS-15 was completed as 
part of a battery of questionnaires completed before, during, and six-months post-
completion ofCBT treatment. For a full description of the GDS and its psychometric 
properties see Section 6.3 .10 
Participant-rated GAD symptom severity, experience of anxiety, coping with anxiety 
and usefulness of treatment components 
For the purposes of the present study, a self-report treatment evaluation form was created to 
assess participant-rated severity of GAD symptoms and record participant evaluations 
regarding their experience of anxiety, the usefulness of treatment strategies learnt and 
ability to cope with anxiety following the completion of each treatment module (Appendix 
N). The severity of GAD symptoms was measured using DSM-IV criteria. The GAD 
section of the ADIS-IV-L (Di Nardo, et al. , 1994), which asks questions about the severity 
of somatic GAD symptoms, was incorporated into the self-rated treatment sensitivity scale. 
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Using the same scale to elicit dimensional clinician ratings of the essential features of each 
disorder previously described in Section 6.3.7, participants were asked to rate the severity 
of symptoms on a scale of zero to eight where O = none, and 8 = very severe, which allows 
for judgment of the degree to which an individual experiences symptoms like restlessness 
or irritability. 
In addition to symptom severity, participants were asked to use a rating scale of O to 8 to 
answer questions regarding the impact of learning and implementing each of the relaxation, 
cognitive and behavioural strategies on their experience/level of anxiety and how useful 
participants find these skills in managing their anxiety. Ability to cope with anxiety was 
rated on a five-point scale from one to five , where 1 = "poor" and 5 = "excellent" (See 
Appendix N). This measure was completed by participants following completion of each 
treatment module and at six-month follow-up. 
11.4.3.3 Secondary outcome measures: Trait Anxiety, Anxiety Sensitivity, Self 
Efficacy and Perceptions of Anxiety Control 
Trait anxiety 
The Speilberger State-Trait Anxiety Inventory-Trait scale (STAI-T; Spielberger, et al. , 
1983) was used to assess participants ' general tendency to be anxious. The STAI-Twas 
completed prior to and six months following the CBT programme, respectively. Scale 
description, scoring and psychometric properties are outlined in Section 6.3.11. 
Anxiety sensitivity · 
The Anxiety Sensitivity Index (ASI; Peterson & Reiss, 1987) (ASI; Peterson & Reiss, 
1987) was used to measure fear of anxiety symptoms. Participants completed the ASI as 
part of the first and final set of questionnaires provided, prior to and six months following 
completion ofCBT treatment. Full details of this scale including scoring and scale norms 
can be found in Section 6.3.12. 
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Self Efficacy 
The Self Efficacy Scale (SES; Sherer, et al., 1982) was used to assess general and social 
self-efficacy (Appendix H). The SES was completed as part of the first and final battery of 
questionnaires, completed prior to and six months following CBT treatment respectively. 
The Self Efficacy Scale is previously described in Chapter Six, Section 6.3.13. 
Locus of control beliefs 
The Anxiety Control Questionnaire (ACQ; Rapee, et a l. , 1996) was used to assess 
perceived control over anxiety-related events, including the extent to which a person 
believes they have control over a variety of potentially threatening internal events and 
situations, such as mental or physical reactions, disasters, and control over other people 
(Appendix I). The ACQ was completed as part of a series of questionnaires provided at 
initial assessment, prior to the CBT treatment programme, and again as part of the final 
battery of questionnaires completed six months following completion of CBT treatment. 
For full details of this scale and its psychometric properties see section 6.3.14 
11.4.3.4 CBT Manual for Anxiety (GAD and Panic) in Laler•Lije: 12- Session 
Modular Format 
CBT was conducted according to a detailed manual designed specifically for the treatment 
of anxiety disorders in older adults, based on existing, empirically validated treatment 
protocols for anxiety (Craske, Barlow, & O'Leary, 1992; Gorenstein , Papp, Kleber, & 
Marc, 1999; Greenberger & Padesky, 1995; Stanley, Diefenbach, & Hopko, 2004). A 
summary of the treatment modules and outline of principles underlying the treatment 
contained in this manual can be found in Appendix 0. Throughout treatment, participants 
were given handouts and homework sheets corresponding to each session. The handouts 
provided participants with a summary of the essential points covered during the session, as 
well as further reading and instruction on the participant' s specific assignments for that 
week. 
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11.4.4 Procedure 
Treatment seeking participants who took part in Study One (see Chapter Six for full details 
as to methodology for Study One) were contacted once the battery of questionnaires 
provided at initial interview (refer to section 6.4) had been completed and returned to the 
investigator to discuss eligibility and commencement of participation in the second phase of 
the study. Eligible participants meeting diagnostic criteria for GAD were invited to 
participate in a twelve-week CBT program for the treatment of GAD. Participants were 
offered treatment on an individual basis, according to a manualised protocol. Individual 
therapy sessions took place at the Australian National University (ANU) psychology 
Clinic. Sessions ran for 75 minutes on a weekly basis. The treatment program consisted of a 
(i) Psychoeducation and awareness module, (ii) relaxation skills module; (iii) cognitive 
skills module; and (iv) behavioural skills and skills application. 
ln the psychoeducation and awareness module, participants were given an overview of the 
treatment program and were provided with psychoeducation to convey the nature, processes 
and consequences of anxiety and worry, as well as to correct any ·misconceptions held by 
the client about anxiety. Participants were also presented with the tripartite model of 
anxiety, explaining the client's own presenting problems in terms of the physiological, 
cognitive, and behavioural facets of anxiety, to increase the participant's awareness of their 
own daily worries. The relaxation skills module consisted of somatic control exercises in 
the form of progressive muscle relaxation (PMR) training and included training in 
controlled, diaphragmatic breathing. Participants were also taught about relaxation by recall 
and cued relaxation. These methods focus on both physical and mental relaxation, and were 
included to directly target the physiological arousal and tension that are core components of 
anxiety, particularly GAD and panic disorders. Relaxation exercises were conducted in 
session, and participants were then given an audiotape with progress ive muscle relaxation 
instructions and its variants read by their therapist to continue practice at home. The script 
for the taped exercise was provided to therapists in the treatment manual. 
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The cognitive sk ills module was des igned to foster the recognition and replacement of 
anxious, negatively skewed styles of thought. This consisted of explaining the ro le of 
thinking and common logical errors in thinking, designed to impart on the client a sense 
that their way of thinking, and thus their exper ience of anxiety is modifiab le. In these 
sessions participants were given instruction on se lf-monitoring of symptoms according to 
the cognitive-behavioural format, and taught to identify cognitive distortions such as 
overestimating and catastrophising. In addition, c lients were taught about risk estimation, to 
look for evidence for and aga inst the ir negative beliefs, and to apply alternative 
explanations. Participants were also provided w ith one sess ion on sleep hygiene, between 
the cognitive and behavioural skills modules. 
In the behavioural skills module, skills such as establishment of daily structure/activity 
scheduling and worry behaviour prevention were taught to participants in order to increase 
the client' s activity, thus imparting a sense of control and mastery over ones activities and 
daily life. Problem solving was delivered to instil a sense of manageability in regards to 
problems that have arisen or may do so. Worry exposure for those with GAD was used to 
evoke the worries most salient to the individual. Repeated exposures and increas ing control 
over the worry process focused on gradually replac ing cognitive avoidance tendencies with 
acceptance and eventual habituation to certain emotional responses. In addition, exposure 
to avo ided or anxiety-provoking situations and response prevention of safety behaviours 
was included. 
The last session was devoted to relapse prevention. The latter half of the second last session 
was used to summarise all the interventions introduced to the clients during treatment. 
Participants were asked to identify worries that might still be excessive and/or vu lnerable 
situations in which worries are li kely or may be exacerbated in the future, and to generate a 
li st of strategies or appropriate interventions to be applied in such instances. The distinction 
between a lapse and relapse was highlighted to participants, and they were further reminded 
that worrying is a norrnal phenomenon. Participants were also encouraged to read the 
handouts and readings given to them throughout treatment on a regular basis as a 
prevention technique, to refresh their understanding of anxiety and the strategies learnt to 
manage this. 
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Participants were asked to complete the GAI, PSWQ and GDS-15 (Appendices D through 
F) as well as treatment evaluation fonns (Appendix N) as homework following the 
relaxation skills component of treatment (session four) , and to return these to their clinician 
at the subsequent session. If questionnaires were not completed prior to the subsequent 
session, participants were asked to complete the questionnaires prior to the commencement 
of that session. This process was repeated following completion of the cognitive ski ll s 
module (session eight). At completion of the behavioural skills components of treatment 
(session twelve) , participants were provided with the questionnaires to be completed and a 
replied paid envelope in which to return completed measures. Participants were instructed 
to complete the questionnaires in the week following the last session (one week ~allowing 
the last session) before returning it to the investigator. When the questionnaires were not 
received within two weeks following the final treatment session, participants were given a 
phone call requesting them to complete the questionnaires as soon as possible, with 
questionnaires and a reply-paid envelope being resent if they had been misplaced or lost. 
At the completion of these twelve sessions, participants were invited to attend a booster 
sess ion one month after completion of the program to follow-up on participants, to help 
with independent management of their anxiety, and to reinforce the use of techniques learnt 
in weekly sessions. 
Six months following the completion of treatment, participants were sent the battery ofself-
report psychometric scales given to participants at the end of the initial interview, in 
addition to a follow-up questionnaire constructed by the investigator (Appendix N), with a 
reply paid envelope to complete and return to the investigator. Again, when the 
questionnaires were not received within two weeks following the final treatment session, a 
second set of questionnaires and a replied paid envelope were sent to participants with a 
letter reminding them to complete and return the questionnaire. A timeline of the 
assessment points and questionnaires completed at these times is illustrated in Figure 11.2. 
Therapists in the study were nine Master ' s and doctoral students in clinical psychology who 
had specialised training in CBT, and the primary investigator, who also had specialised 
training in therapy with older adults. Three of the therapists were male and six were female. 
In addition to standard training received as part of the clinical program, which included 
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CBT, the principal investigator trained for the study by treating an older adult with GAD 
under the supervision of a senior psychologist, and another adult with panic disorder in late 
life under the supervision of an expert in therapy with older adults. Six of the other 
therapists worked under the supervision of the senior psychologist and clinic manager at the 
ANU psychology clinic, and two were supervised by a second senior clinician, also a 
registered clinical psychologist in the psychology department at the ANU. The other 
therapists were further trained by attending a workshop run by the primary investigator on 
working with older adults in a clinical setting, which included training on the treatment 
manual to be used by therapists, and briefing on the research protocol and ap propriate 
procedures with reference to the research project. Therapists were supervised weekly on an 
individual basis by their primary supervisor, and in a group format with the primary 
investigator. Supervision sessions typically consisted of discussing sessions, problem-
solving difficult issues, and preparing for the following week 's sessions. 
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11.5 Results 
11.5. 1 Data Analysis 
Jl.5.1.1 Analysis plan 
Comparison of participants who were treated versus those who did not take part in the 
treatment study on age at onset, demographic and clinical characteristics as measured by 
self-report psychometric inventories was conducted using independent-samples !-tests and 
x2 analyses. The effect of treatment and age at onset on the primary and secondary outcome 
measures was assessed using mixed between-within subjects ANOV As. The test of the 
main effect for the within-subject factor examined whether participants exhibited any 
change on primary and secondary outcome measures over time. The test of the main effect 
for the between-subjects grouping factor examined whether scores on the primary and 
secondary outcome measures differed for early-and late-onset groups. The test of the 
interaction between the within-subjects and between-subjects factors examined whether 
scores for the two groups exhibited different patterns of change over time. In addition, 
Bonferroni-corrected post-hoc tests were conducted as part of these mixed-between 
subjects ANOVAs to examine where differences occurred between groups and/or across 
time. Paired-samples !-tests were performed to examine the significance of these. 
Independent-samples !-tests were conducted to determine whether onset groups differed in 
evaluations of the ' usefulness' of each treatment module in helping to manage their anxiety. 
11.5.1.2 Data preparation and screening 
All data collected were entered and analysed using the Statistical Package for the Social 
Sciences version 14 (SPSS 14: SPSS lnc, 2005), and version 16 (SPSS 16: SPSS lnc, 2008) 
when it became available. Two participants belonging to the LO group did not complete the 
treatment program, and were therefore omitted from analyses of psychometric data. All of 
the remaining 41 participants who completed the treatment program completed pre-
treatment measures at initial assessment, as well as questionnaires given throughout 
treatment, and returned the battery of measures at six-month follow-up. Items on all 
measures returned were complete. 
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Scores on the relevant items of the Geriatric Depression Scale (GDS-15: Sheikh & 
Yesavage, 1986b), the Penn State Worry Questionnaire (PWSQ: Meyer, et al. , 1990), the 
Spiel berger State-Trait Anxiety Inventory- Trait scale (ST AI-T: Spielberger, et al. , 1983) 
and relevant subscale items of the Self Efficacy Scale (SES: Sherer, et al. , 1982), and 
Anxiety Control Questionnaire (ACQ: Rapee, et al. , 1996) were reversed. Item scores were 
summed to calculate the relevant overall and/or subscale scores on the Geriatric Anxiety 
Inventory (GAi: Pachana, et al. , 2007), the PWSQ, the GDS-15, the STAI-T, the Anxiety 
Sensitivity Inventory (ASI: Peterson & Heilbronner, 1987; Peterson & Reiss, 1987), the 
SES, and the ACQ. Internal reliabilities were calculated for all of the scales at each time-
point measured. Reliabilities are presented in Table I I. I and range from good to excellent 
for each of the scales and subscales. Of concern are the lower reliabilities reported for the 
GDS-15 and the SSE subscale. The low reliabilities were reported at Time 3, following the 
behavioural component of CBT for the GDS-15 and at follow-up for SSE subscale. Item 
deletion did not improve the reliabilities of any of the subscales. 
Table 11.1 
internal Reliabilities of Psychometric Scale Scores across TO to T4 
Scale Cronbach ' s a 
The Geriatric Anxiety Inventory (GAi) 
The Penn State Worry Questionnaire (PSWQ) 
The Geriatric Depression Scale -15 (GDS-15) 
The State-Trait Anxiety Inventory - Trait scale (STAI-T) 
The Anxiety Sensitivity Index (ASI) 
The Self Efficacy Scale (SES) 
General Self Efficacy (GSE) 
Social Set f Efficacy (SSE) 
The Anxiety Control Questionnaire (ACQ) 
.62 - .85 
.82 - .87 
.55 - .81 
.89 - .90 
.92 
.87 - .88 
.59 - .67 
.82 - .86 
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Prior to data analysis, data were screened for accuracy of data entry, missing values, 
univariate outliers, and fit between their distributions and the assumptions of analysis 
(normality, linearity, homoscedasity). With the exception of the GDS-15 (Sheikh & 
Y esavage, I 986b ), inspection of the scale distributions revealed that all scales and 
subscales were normally distributed. The distribution for the GDS-15 illustrated a slight 
positive skew and kurtosis at all five assessment points, indicating that most participants 
reported lower levels of depression as measured by the GDS-15. This was significant at 
baseline and at six-month follow-up. This is not surprising given that the majority of 
participants had a principal or co-principal (i.e., most severe) diagnosis of GAD according 
to DSM-IV-TR criteria and reported symptoms of anxiety rather than depression to be their 
primary problem of concern. For this reason, a decision was made not to transform this 
variable. 
The distributions for all remaining measures of psychopathology illustrated a sl ightly 
negative skew at baseline (TO) and were positively skewed at 6-month follow up (T4). This 
was as expected, with high scores on outcome measures at baseline being consistent w ith 
participants having a diagnosis of clinically significant GAD for which they were seeking 
treatment and low scores following treatment reflecting a positive response to treatment on 
outcome measures. Similarly, distributions for the SES and the ACQ, on which high scores 
reflect better locus of control and self efficacy, illustrated a slight negative skew at TO. A 
single case with a high z score on the GDS-15 and GAi (z > 3.29, p < .001 , two-tailed test), 
and a high but non-significant z-scores using p < .001 criterion on the STAI-T and ASI at 
six-month follow-up was identifie_d as a univariate outlier. Inspection of the ind ividual z-
scores revealed that this outlier was the same case on each of these variables and appears to 
be an individual who had a relapse in their psychiatric condition at follow -up, six months 
post-treatment. This outlier was included in the analyses as it was necessary to maintain the 
moderate'size of the sample thus ensuring adequate power of analyses (Tabachnik & Fidell , 
2001). In addition, given the clinical nature of the study and the fact that relapse and 
consequent extreme scores at follow-up is a plausible result, it was determined that this 
case was from the intended population. 
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11.5.2 Descriptive Analysis 
11.5.2.1 Analysis of EO and LO participants 
Participants taking part in the present investigation were a subsample of those participants 
included in previous empirical investigations set out in this thesis (see Methods section 
11.4). Therefore, as with investigations for the overall sample (see Chapter Eight and 
Nine), the demographic, health, psychiatric comorbidity, genetic and psychological 
characteristics of the current sample were investigated to provide an overall description of 
the sample recruited. These analyses are presented and discussed in Appendix P. The 
significant differences found in the analyses presented in Appendix P are summarised as 
follows: (i) LO participants were significantly older at first onset of any DSM-IV disorder 
than EO participants; (ii) LO participants were significantly older at first onset of an 
anxiety disorder of any kind than EO participants; (iii) EO participants were found to have 
a higher mean number of episodes of psychiatric illness than LO participants; and (iv) EO 
participants were found to have a greater history of anxiety with respect to time since first 
onset of both a DSM-IV anxiety disorder and a DSM-IV disorder of any kind than LO 
participants. 
11.5.2.2 Analysis of treated versus untreated participants 
Analyses were conducted to determine whether there was a difference in age at onset, 
demographic, and clinical characteristics of those participants who took part in the 
treatment programme and those who were seeking treatment but declined to take part for 
various reasons. Treated and untreated participants were not further differentiated by onset 
group in analyses due to Small sample sizes. Where significant differences were found 
between treated and untreated groups, groups were further differentiated by onset and 
analysed ·where cell size permitted, to investigate whether such differences varied by onset. 
The findings of these analyses are presented in Appendix Q. Significant differences that 
were found in the analyses presented in Appendix Qare summarised as follows : (i) There 
were significantly more single participants in the untreated group than expected and more 
married participants in the treated group. Of those, there were significantly more LO 
participants who were single and/or never married in the untreated group than expected; 
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and (ii) Participants taking part in the treatment study were found to have significantly 
higher scores on measures of anxiety and anxiety sensitivity than those who went untreated. 
11.5.3 Primary Treatment Outcomes 
Measures of anxiety (GAI: Pachana, et al. , 2007) , worry (PSWQ: Meyer et al., 1990) and 
depression (GDS-15: Sheikh & Yesavage, 1986) were completed by participants at each of 
the five assessment points (see Figure I I.I in section 1_1.3.4) in order to investigate the 
impact of age at onset on participants' scores on these primary outcome measures from pre-
treatment (TO) to six-months following completion of treatment (T4). Participant-rated 
severity of GAD symptoms, level of anxiety and ability to cope with anxiety were 
evaluated by participants at the conclusion of each treatment module and at six-month 
follow-up (Tl through to T4). 
A series of mixed between-within subjects Analysis of Variance (ANOV A) were conducted 
to assess the impact of age at onset on levels of these primary outcome measures. The 
ANOV A test assumption of homogeneity of variance (sphericity) was not met for the ma in 
effect of time and interactions between time and onset. Accordingly, for outcome measures 
where E > .75 (GAI, ODS, participant-rated GAD symptom severity, overall level of 
anxiety and coping), degrees of freedom were corrected using Huynh-Feldt estimates of 
sphericity. For outcome measures where E < . 75, (PSWQ), degrees of freedom were 
corrected using Greenhouse-Geisser estimates of sphericity. Where relevant, Bonferroni 
corrected post-hoc tests based on estimated marginal means were examined to identify 
where differences across time occurred. Paired-samples !-tests were performed to examine 
the significance of these differences. Descriptive data for primary outcome measures by 
group and the results of measures analysed using mixed between-within subjects ANOV As 
are presented in Table 11.2 
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Table 11.2 
Means (SD) for Primary Outcome Measures by Group at TO and T4 and F-va/ues as a Function of Time and Age of Onset 
Early-Onset Lale-Onset Onset Time (n = 18) (n = 23) 
M(SD) M(SD) F[df] 2 F[df] 1/p 
GAi 68 .1 [3.26, 127.15]*** .64 .05[1,39] 
TO 13.11(4.13) I 3.95 (5.08) 
Tl 11.83 (4.55) 12.35 ( 4.20) 
T2 6.56 (3.33) 6.57(3.09) 
T3 5.61 (3.48) 4.91(3.06) 
T4 5.17 (3.01) 4.65 (4.43) 
PSWQ 72.47[2.45, 95.41]*** .65 1.93[1 ,39] 
TO 64.00 (9 .6 I) 60.52 (9.39) 
Tl 60.56 (10.19) 57.39 (847) 
T2 50.00 (8.88) 46.74 (6.47) 
T3 45.44 (9.09) 44.61 (5.26) 
T4 44.94 (9.57) 41.70(8.29) 
GDS-15 15 .3 7[J 25,126.87]*** .28 .l2[1,39J 
TO 5.17 (3.65) 4.74 (2.47) 
Tl 5.11 (3.83) 5.83 (3.54) 
T2 3.11 (2.37) 3.52 (2.69) 
T3 2.22 (1.66) 2.74 (2.00) 
T4 3.06 (2.92) 3.00 (2.68) 
GAi , Geriatric Anxiety Inventory; PSWQ, Penn State Worry Questionnaire; GDS- 15, Geriatric Depression Scale 
• p :S 0.05; **p :S 0.0 I; •••p :S 0.00 I (two-tailed) 
Timex Onset 
1/p 
2 F[df] 
.000 
.45 [3.26, 127.15] .01 
.05 
.3 0[245, 95.4 I ] .0 1 
.003 .50 [3 .25, 126.87] .01 
1/p 
2 
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Table 11.2 continued 
Means (SD) for Primary Outcome Measures by Group at TO and T4 and F-values as a Function of Time and Age of Onset 
Early-Onset Late-Onset 
Time Onset Timex Onset (n = 18) (n = 23) 
M(SD) M(SD) 2 2 2 F[dj] /Jp F[dj] /Jp F[dj] /Jp 
Symptom Severity 34.31[3.25, 126.87]*** .47 1.65[1 ,39] ,04 4.43[233,9075] * .10 
Tl 3.21 (1.29) 4.21 (.80) 
T2 2.70(1.11) 2.71 (.91) 
T3 2.25 (1.15) 2.41 (.71) 
T4 2.42 (1.13) 2 .70 (1.34) 
Experience of Anxiety 31.90[234, 9818]*** .45 .00[1,39] .00 .70[234, 98 18] .02 
Tl 4.61 (1.24) 4.96 (1.36) 
T2 3 .28 (1.18) 3.30 (1.22) 
T3 3.11 (1.28) 3 .00 (1.09) 
T4 3.00 (1.28) 2.74 (1.39) 
Coping Ability 28.74[2 76, 107.60]*** .42 2.01[1,39] .05 .31[276, 107 60] .01 
Tl 2.67 (.77) 2.30 (.70) 
T2 3.39 (.61) 3.22 (.67) 
T3 3.67 (.69) 3.48 (.51) 
T4 3.44 (.62) 3.30 (.88) 
* p :S 0.05; **p :S 0.01; ***p :S 0.001 (two-tailed) 
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11.5.3.1 Anxiety 
Figure 11.3 presents the mean anxiety scores for EO and LO groups across TO to T4. 
The results revealed a large, significant main effect for time. On average, participants 
had an eight-point reduction in anxiety from pre-treatment to six-month post-treatment, 
as illustrated in Figure 11.3. The main effect of onset was non-significant, indicating that 
onset did not have a significant effect on overall mean anxiety scores. The interaction 
effect between time and onset was not statistically significant. 
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Figure 11.3. Mean Anxiety scores across TO to T4 for EO and LO participants 
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Table 11.3 presents descriptive data for the mean difference in participants' anxiety 
scores between each time point and the significance of these differences. The results 
revealed a significant reduction in mean anxiety score from TO to T2, TO to T3 and TO to 
T4. Similarly, there was a significant reduction in mean anxiety score from Tl to T2, Tl 
to T3 and Tl to T4. A significant reduction in mean level of anxiety was also found 
from T2 to T3 and T2 to T4. Anxiety scores were not found to significantly differ from 
.TO and, or from T3 to T4. 
Table 11.3 
Mean Difference (SD) in Anxiety Scores between each Time-point and Significance of 
Differences/or EO and LO Participants (N = 41) 
Mean Difference 95%CJ 
Significance 
Test 
Anxiety M(SD) Lower limit Upper limit t{d/J 
TO - Tl 1.46 (4.70) - .02 2.94 l .99140J 
TO-T2 7.02 (4.92) 5.47 8.60 9.15[40J*** 
TO - T3 8.37 (4.86) 6.83 9.90 11.03[40]*** 
TO-T4 8.71 (5.82) 6.87 10.54 9.58[40]··· 
Tl - T2 5.56 (3.98) 4.30 6.82 8.93[40]··· 
Tl - T3 6.90 (4.22) 5.57 8.23 10.46[40]*** 
Tl - T4 7.24 (4.67) 5.77 8.72 9.94[40J *** 
T2 - T3 1.34 (2.40) .59 2.10 3.56[40J *** 
T2-T4 1.68 (3.47) .60 2.77 3.11 [40]** 
T3 - T4 .34 (3.76) - .85 1.53 .58[40] 
* p :5 0.05 ; **p :5 0.01; ***p :5 0.001 (two-tailed) 
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11.5.3.2 Worry 
The results revealed a substantial main effect for time, with both onset groups showing a 
significant reduction in worry scores across the five time periods (See Figure 11.4). On 
average, participants had a nineteen-point reduction in worry from TO to T4. The main 
effect of onset was non-significant, indicating that onset did not have a statistically 
significant effect on overall mean worry scores. The change in worry scores at each time 
point did not differ between early-and late-onset groups, as confirmed by a non-
significant interaction effect of time by onset. 
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Figure 11.4. Mean Worry scores across TO to T4 for EO and LO participants 
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Table 11.4 presents descriptive data for the mean difference in participants' worry scores 
between each time point and the significance of these differences. The results revealed a 
significant reduction in worry scores from TO to T2, TO to T3, and TO to T4. In addition, 
there was a significant reduction in mean worry scores from Tl to T2, Tl to T3 , and 
from Tl to T4. A significant reduction in worry score was also found from T2 to T3 and 
T2 to T4. Worry scores were not found differ from TO to Tl or from T3 to T4. 
Table 11.4 
Mean Difference (SD) in Worry Scores between each Time-point and Significance of 
Differences for EO and LO Participants (N ~ 41) 
Mean Significance 
95%CI 
Difference Test 
Worry M(SD) Lower limit Upper limit t[dj] 
TO-Tl 3.27 (7.50) .90 5.63 2.79[40J** 
TO-T2 13.88 (I 0.25) 10.64 17.11 8.67[40J*** 
TO-T3 17.07 (10.90) 13.63 20.51 10.02[40]*** 
TO-T4 18.93 (10.32) 15.67 22.18 1 l.75[4oJ*** 
Tl-T2 10.61 (9.22) 7.70 13.52 7.36[40]*** 
Tl-T3 1380 (10.10) 10.62 17.00 8.75[40J*** 
Tl - T4 15.66 (9.93) 12.52 18.79 10.10[40J*** 
T2-T3 3.19 (4.00) 1.93 4.46 5.ll [4oJ*** 
T2-T4 5.05(7.13) 2.80 7.30 4.53[40]** 
T3-T4 1.86 (7.45) - .50 4.21 1.59[40] 
* p :S 0.05'; **p :S 0.01; ***p :S 0.001 (two-tailed) 
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11.5.3.3 Depression 
There was a significant main effect for time. The effect size for this main effect was 
quite large (see Table 11.2), with a significant reduction in depression scores from TO to 
T4 for both onset groups, illustrated in Figure 11.5. On average, participants had a two-
point reduction in depress ion from pre- treatment to six-months post- treatment. This 
effect was not due to age of onset. The interaction between time and onset was also non-
significant, indicating that the difference in depression scores for EO and LO groups was 
the same at each time point. 
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Figure 11.5. Mean Depression scores for EO and LO participants across TO to T4 
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Table 11.5 presents descriptive data for the mean difference in participants ' depression 
scores between each time point and the significance of these differences. Depression 
scores were not found to significantly differ from TO to Tl , T2 to T4, or T3 to T4. There 
was a significant reduction in mean depression scores from TO to T2, TO to T3 and TO to 
T4. There was also a significant decrease in depress ion scores from Tl to T2, Tl to T3 
and to Tl to T4. In addition, there was a significant reduction in mean depression score 
from T2 to T3. 
Table 11.5 
Mean Difference (SD) in Depression Scores between each Time-point and Significance 
of Differences/or EO and LO Participants (N = 41) 
Mean Significance 
9j% CI 
Difference Test 
Depression M(SD) Lower limit Upper limit t{df] 
TO-Tl - .58 (3.40) - 1.66 .49 - 1.01[40] 
TO-T2 1.58(3.11) .60 2.57 3.26[40J** 
TO-T3 2.4 1 (2.88) 1.50 3.23 5.37[40] *** 
TO-T4 1.90 (3.32) .85 2.95 3.66[40]*** 
Tl -T2 2.17 (3.40) 1.09 3.24 4.09[40]*** 
Tl -T3 3.00 (3.24) 1.95 4.05 5.78[40]*** 
Tl-T4 2.48 (2.53) .39 1.69 6.29[40J*** 
T2-T3 .83 (1.50) .35 1.30 3.54[40J*** 
T2-T4 .32 (2.80) .56 1.20 .73[40] 
T3-T4 -5.1 (2.62) - 1.34 .31 -1.25[40] 
* p :S 0.05; **p :S 0.01; ***p :S 0.001 (two-tai led) 
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11.5.3.4 Participant-rated mean GAD symptom severity 
The severity of DSM-IV symptoms of GAD experienced by participants was rated 
following the completion of each treatment component on a scale from zero to eight 
where O = "none" and 8 = "very severe". Participant-rated symptom severity scores 
were calculated by summing the scores for each of the six DSM-IV GAD symptoms 
rated, and dividing the summed score by the number of symptoms (6). Mean symptom 
severity across TI to T4 was explored in order to investigate how symptom severity 
varied throughout and following treatment. There was a substantial main effect for time, 
with participants showing a significant reduction in mean symptom severity from Tl to 
six-month fol low-up, illustrated in Figure 11.6. Onset was not found to have a 
significant effect on overall mean symptom severity, as confirmed by a non-significant 
main effect of onset 
There was however a moderately large, significant interaction effect between age of 
onset and time, indicating that the rate of reduction in mean GAD symptom severity 
scores for EO and LO participants differed across time. Consideration of the mean GAD 
symptom severity scores presented in Figure 11.6 illustrates that LO participants had a 
significantly greater reduction in mean symptom severity score from T l to T2 (M = -
1.50, SD = .74) than EO participants (M = -.51 , SD = 1.08), confinned by an 
independent-samples t-test, t (39) = 3.48, p <: .01. The change in mean severity scores 
did not significantly differ between EO and LO groups from T2 to T3 (EO: M = -.45, SD 
= .49; LO: M = -.30, SD= .42), t (35.42) = 1.10 p > .05, equal variances not assumed (F 
= 8.55, p < .05), or from T3 to T4 (EO: M = .17, SD = .70; LO: M = .29, SD= 1.27), t 
(39) =. 39, p > .05. 
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Table 11.6 presents descriptive data for the mean difference in participant-rated GAD 
symptom severity between each time point and the significance of these differences. The 
results revealed a significant reduction in mean symptom severity scores from Tl to T2, 
Tl to T3 and Tl to T4. There was also a significant reduction in mean symptom severity 
from T2 to T3. No significant difference was found in mean symptom severity from T2 
to T4 or from T3 to T4. 
Table 11.6 
Mean Difference (SD) in GAD Symptom Severity Ratings between each Time-point and 
Significance of Differences for EO and LO Participants (N = 41) 
GAD symptom 
severity 
Tl - T2 
TI - T3 
Tl -T4 
T2-T3 
T2 - T4 
T3-T4 
Mean 
Difference 
M (SD) 
1.06 ( 1.02) 
1.43 (.88) 
1.19 (1.19) 
.37 (.45) 
.13(1.08) 
-.24 ( 1.05) 
95%CI 
Lower limit Upper limit 
.74 1.39 
1.15 1.71 
.82 1.57 
.22 .5 1 
-.2 1 .47 
-.57 .09 
* p :S 0.05; **p :S 0.01; ***p :S 0.00l(two-tailed) 
Significance 
Test 
t[df] 
6.67(40]*** 
l0.45(40]*** 
6.45[40J*** 
5.20[40] *** 
,77[40] 
-1 .44[40] 
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11.5.3.5 Participants-rated level of anxiety 
Overall level/experience of anxiety was also evaluated by participants at the completion 
of each CBT treatment module using a rating scale of zero to eight where O = "no 
anxiety" and 8 = "very severe anxiety" . The results revealed a large and significant 
main effect for time (see Table 11.2). On average, participant-rated levels of anxiety 
decreased by an average of two points from pre- to post treatment, illustrated in Figure 
11.7. 
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Figure 11. 7. Participant-rated level of mean anxiety severity across Tl to T4 for EO and 
LO participants 
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Table 11.7 presents descriptive data for the mean difference in participant-rated leve ls of 
anxiety between each time point and the significance of these differences. There was a 
significant reduction in mean participant-rated anxiety levels from Tl to T2, T l to T3, 
Tl to T4 and T2 to T3. No significant difference was found in mean anxiety ratings 
from , T2 to T4 or T3 to T4. 
Table 11.7 
Mean Difference (SD) in Participant-rated Levels of Anxiety between each Time-point 
and Significance of Differences for EO and LO Participants (N = 41) 
Participant-rated Mean Significance 
Level of Anxiety Difference 
95% CI 
Test 
M(SD) Lower limit Upper limit ![ctn 
Tl -T2 1.51(1.34) I. I 1.94 7.21 [40J*** 
Tl -TI 1.76 (1.22) 1.37 2.14 9.22[40J*** 
Tl-T4 1.95 ( 1.63) 1.44 2.47 7.68[40]*** 
T2-T3 .24 (.66) .03 .45 2.36[40]* 
T2-T4 .44 (I .67) -.09 .97 1.68[40] 
T3 - T4 .19 (1.52) -.28 .67 .82[40] 
*p '.cc O.OS ;**p '.cc 0.0l;***p'.cc0.00l(two-tailed) 
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11.5.3.6 Participant-rated ability to cope with anxiety and/or worry 
Ability to cope with anxiety was rated by participants across the three treatment periods 
and at six-month follow-up (Tl to T4), on a five-point scale from one to five , where 1 = 
"poor" and 5 = "excellent." The results revealed that there was a significant main effect 
of time. This effect was quite large (see Table 11.2), with participants ' ability to cope 
improving by an average of one point over time (see Figure 11.8). 
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Figure 11.8. Mean participant-rated ability to cope with anxiety symptoms 
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Table 11.8 presents descriptive data for the mean difference in participant-rated ability 
to cope with anxiety between each time point and the significance of these differences. 
There was a significant increase in participant ratings of coping ability from Tl to T2, 
Tl to T3 and Tl to T4. There was also a significant increase in mean ratings of ab ility 
to cope from T2 to T3 . Mean ratings of ability to cope were not found to differ from T2 
to T4, or from and T3 to T4. 
Table 11.8 
Mean Difference (SD) in Participant-rated Evaluations of Ability to Cope with Anxiety 
between each Time-point and Significance of Differences for EO and LO Participants 
(N = 41) 
Participant-rated Mean Significance 
95% CJ 
Ability to Cope Difference Test 
M(SD) Lower limit Upper limit t[df] 
TJ- T2 -.83 (.80) -1.08 -.57 ·- -6.61 [40J*** 
Tl - T3 -1.10(.77) -1.34 .85 -9.15[40J*** 
Tl - T4 -.90 (.92) -1.19 -.61 -6.30[40J*** 
T2-T3 -.27 (.50) -.43 -.11 -3.40[40J ** 
T2-T4 -.07 (.87) -.35 .20 -.53[40] 
T3 - T4 .19 (.84) -.07 .46 1.48[40] 
* p <:; 0.05; ·••p <:; 0.01 ; ***p S 0.00l(two-tailed) 
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11. 5. 3. 7 Participant-rated evaluations of the 'usefulness ' of CBT techniques learnt in 
managing anxiety 
Participant-rated perceptions of the ' usefulness ' of the skills learnt in each treatment 
module in helping to manage anxiety were evaluated by participants at the conclusion of 
each treatment module and at six-month follow-up (Tl through to T4). 'Usefulness ' of 
each treatment module and of the overall treatment program were rated on a scale from 0 
= ' not at all helpful' to 8 = 'very helpful. ' Independent-samples t-tests were performed 
to determine whether onset groups differed in evaluations of the perceived usefulness of 
specific CBT treatment techniques in managing anxiety. Descriptive statistics for mean 
rati ngs of each of these treatment components and the results of these analyses are 
presented in Table 11.9. Comparison of means using independent-samples t-tests 
revealed that onset groups did not significantly differ in mean ratings of the usefulness 
of somatic control exercises, cognitive skills, behavioural skills and the treatment 
program overall, in managing their anxiety. 
Table 11 .9 
Descriptive Statistics for Participant-rated Evaluations of the Usefulness of CBT 
Techniques from TO to T4 
Early onset Late onset Significance 
(N=l8) (N = 23) test 
Time Point M SD M SD t[df] 
Tl - Somatic contro l techniques 4.83 1.47 3.96 1.55 1.84[39] 
T2 - Cognitive techniques 6.17 1.04 5.83 1.40 0.86[39] 
T3 - Behavioural techniques 5.17 1.34 5.17 1.30 - 0.02[39] 
T4 - CBT .programme overall 6.28 1.60 5.91 1.47 0.76[39] 
* p :S 0.05; **p :S 0.01; ***p :S 0.00 1 
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11.5.4 Secondary Treatment Outcomes 
Measures of trait-anxiety (STAI-T), anxiety sensitivity (ASI) , self-efficacy (SES) and 
perceptions of anxiety control (ACQ) were completed by participants at initial 
assessment and again at six-month follow-up (see Figure 11.10). M ixed between-within 
subjects ANOVAs were performed to investigate the main effect of time, of age at onset 
and the interaction between time and onset for these outcome measures. The ANOV A 
test assumption of homogeneity of variance (sphericity) was met for all main effects and 
interactions. Levene ' s test for equality of variance was significant for scores on the 
general subscale of the SES at TO, indicating non-equal variances for onset groups on 
this variable (F (I, 39) = 4.94, p < .05). Inspection of the group statistics revealed a 
greater variance in scores for the EO group than the LO group at TO, also reflected in a 
greater range of scores on the scale for the EO group at TO. As the scores on these scales 
for both groups were otherwise normally distributed, and Levene' s test was significant 
only at this point, a decision was made not to transform the data. Descriptive data for 
these secondary outcome measures by group and the results of these analyses are 
presented in Table 11.10 
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Table 11.10 
Means (SD) for Secondary Outcome Measures by Group at TO and T4 and F-values as a Function of Time and Age of Onset 
Early onset Late onset 
Time Onset Timex Onset (N=l8) (N = 23) 
M(SD) M(SD) F[dj] 1/p 2 F[dj] 2 1/p F[dj] 2 1/p 
STAl-T 54 .68(1,39]*** .58 .08[1,39] .002 .01 [1 ,39] .00 
TO 50.28 (10.70) 50.87 (9.59) 
T4 40.44 (8.17) 41.35 (8.54) 
ASl 36.41[! ,391*** .48 .05r1 ,39J .00 .03[1,39] .001 
TO 33.78 (12.06) 33.65 (14.62) 
T4 20.80 (9.04) 21.48 (13.70) 
SES - General 13.30(1,39]*** .25 .84[1 ,39] .02 .01[1 ,39] .01 
TO 53.83 (14.79) 51.13 (9.68) 
T4 60.56 ( 11.45) 57.52 (10.07) 
SES-Social 11.05[1,39]* .22 .Olr1 ,39J .00 .01 [1,39] .01 
TO 17.78 (4.92) 17.91 (4.21) 
T4 19.94 (14.96) 19.52 (3.40) 
ACQ 53.62(1 ,39] *** .58 .37[1 ,39] .01 1.98[! ,39] .05 
TO 69.22 (17.85) 69.96 (17.88) 
T4 92.50 (15 .37) 85.74 (19.56) 
STAI-T, Trait Anxiety; ASI, Anxiety Sensitivity Index; SES, Self Efficacy Scale; ACQ, Anxiety Control Questionnaire 
* p S 0.05; **p S 0.01; ***p S 0.001 
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The results revealed a statistically s ignificant main effect of time for all fo ur secondary 
outcome measures, with participants reporting significant reductions in trait anxiety 
(STAI-T) and anxiety sensitivity (AS!) and sign ificant improvements in general (GSE) 
and social (SSE) self efficacy, and perceptions of anxiety control (ACQ). The effect size 
for these findings were considerably large (see Table 11.10). On average, participants 
had a ten-point reduction in trait anxiety, a twelve-point reduction in anxiety sensitiv ity, 
a six-point improvement in general self-efficacy and a 20-point improvement in 
perceptions of anxiety control from pre- treatment to six- months post- treatment. These 
effects were not related to age of onset and nor was there a difference between onset 
groups in the rate of improvement in these outcomes, as reflected in a non-significant 
effect between time and age of onset fo r these four outcome measures. 
11.6 Discussion 
The experience of anxiety, worry and depress ion, in addition to level s of participant-
rated GAD symptom severity, anxiety, coping with anxiety and ratings of the usefulness 
of treatment techniques were investigated in the present study to determine whether i) 
treatment/time had an effect on levels of these variables; ii) age of onset had an effect 
levels of these dependent variables, and; iii) whether the influence of onset on levels of 
the dependent variable depends on treatment component/time. An additional aim of the 
study was to determine whether improvements made on outcome measures fo llowing 
treatment were maintained at six-month follow-up. 
The hypothesis that CBT for late-life GAD would result in a significant improvement in 
levels of the primary and secondary outcome measures over the course of treatment was 
supported by the current data. Treatment was found to be effective in significantly 
reducing levels of anxiety, worry and depression as well as the severity of GAD 
symptoms in the current sample of older adults from pre- to post-treatment, and resulted 
in significant improvements in participant-rated levels of anxiety and abili ty to cope. 
The current findings are in line with previous research reporting significant 
improvements on self-rated measures of an~iety, worry and depression in studies of 
CBT for older adults aged 55 and over with GAD (Barrowclough, et al., 200 I ; 
Gorenstein, et a l. , 1999; King & Barrowclough, 1991; Mahlman, et al., 2003; Stanley, 
Beck, & Glassco, 1996; Stanley, Beck, et al. , 2003 ; Wetherell, Gatz, et al. , 2003; 
Wetherell , Sorrell, et al. , 2005). 
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Regarding this finding of a significant main effect of time for all outcome measures, 
Bonferroni corrected post-hoc tests were examined to determine at what time points 
differences occurred. Paired-samples t-tests revealed that anxiety, worry and depress ion 
scores did not differ between initial assessment and completion of the relaxation skills 
component (from TO to Tl), nor between completion of treatment and six-month 
follow-up (from T3 to T4). Additionally, depression scores were not found to differ 
from T2, following completion of the cognitive skills module, to T4, at six-month 
follow-up. All remaining tests were significant, with a reduction in anxiety, worry and 
depression scores from TO to T2, T3 and T4, from Tl to T2, T3, and T4, from T2 to T3 
and from T2 to T4. Participant-rated GAD symptom severity, experience of anxiety and 
coping with anxiety were all found to significantly improve from Tl to T2, Tl to T3 
and Tl to T4. GAD symptom severity and ability to cope with anxiety were also found 
to improve from T2 to T3, whilst participant-rated anxiety did not differ from T2 to T3. 
Symptom severity, experience of anxiety and coping ratings were not found to differ 
from T2 to T4 or from T3 to T4. 
The finding that participants' scores on measures of anxiety, worry and depress ion did 
not significantly differ from TO to Tl but did so from Tl to T2, in addition to TO to T2, 
suggests that the reduction in these scores may be attributable to the cognitive skill s 
component of treatment, rather than a combination of these two components of 
treatment. Although data for participant-rated symptom severity, levels of anxiety and 
ability to cope with anxiety were not available for TO, findings of a significant 
improvement in these outcome measures between Tl and T2 further supports the 
contribution of cognitive therapy techniques to positive treatment outcome . The 
improvement on primary outcome measures from Tl to T3 and from Tl to T4 indicate 
that both the cognitive and behavioural components combined had a positive effect on 
outcome at the end of treatment and at 6-month follow-up. The improvement on 
outcome measures from T2 to T3 and T2 to T4 indicates that the behavioural skill s 
component had a further positive impact on outcome measures at the end of treatment, 
which was maintained at follow-up. It is important to note that components of CBT 
were not administered in a counterbalanced order. Therefore, it may be that the current 
findings were due to the additive effects of CBT, rather than due to the cognitive skills 
component alone. 
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Investigation of the relationship between age of onset and levels of the primary and 
secondary outcome measures revealed that age at onset did not have a significant effect 
on overall mean psychopathology scores, symptom severity, self-rated levels of anxiety, 
or ability to cope with anxiety symptoms. Investigation of between-group differences 
also showed that onset groups did not significantly differ in their evaluations of the 
usefulness of each CBT treatment module, or the treatment programme overall, in 
managing their symptoms of GAD. The finding of a non-significant main effect of 
onset is in contrast to previous findings in the depression literature suggesting that EO 
late-life depression is more difficult to treat than LO of depression (Brodaty, et al. , 
200 l ; Dew, et al. , 1997; Reynolds, et al. , 1998). The findings of Driscoll et al. (2005) 
that LO depression does not lead to worse treatment outcome, but rather, that more 
sessions are required to achieve the same outcome as those in the EO group were also 
not supported by the current findings. Although time to respond was not specifically 
investigated in the current investigation, a ll participants took part in the same number of 
sessions and were found to demonstrate similar improvements on se lf-report measures 
of psychopathology and participant-rated evaluations of symptom severity, anxiety and 
coping. As such, the conclusion that late age of onset may be associated with longer 
time to respond is not supported by the current findings. The current findings are 
however in line with findings ofBarzega et al. (2001), who found ho significant 
difference in response to treatment between older adults with EO and LO dysthymia. 
The hypotheses that EO participants would respond better to CT techniques than those 
with LO GAD (Hypothesis 2a) and that LO participants would respond to BT 
techniques better than those with EO GAD (Hypothesis 26) were not supported by the 
current data. With the exception of a significant interaction effect for mean participant-
rated GAD symptom severity, ear ly-and late-onset participants were not found to differ 
in levels of the dependent variables measured over time. On average, LO participants 
reported significantly greater symptom severity at Tl than EO participants. There was 
also a significantly greater reduction in mean symptom severity from Tl to T2 for LO 
participants than for those with EO GAD. The difference in mean symptom severity 
ratings for onset groups was similar at the remaining time points (T2 through to T4). It 
may be that as many of the participants in the LO group had a relatively recent onset of 
GAD with a shorter illness duration, participants in the LO group perceived their 
symptoms as more severe at initial assessment. On the other hand, due to the long and 
chronic illness course experienced by those with EO of GAD, it may be that participants 
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in the EO group may be accustomed to the experience of these symptoms, which may 
account for the difference in symptom severity found between groups at Tl . 
The current findings indicate that cognitive techniques have an important role in the 
treatment of anxiety in older adults regardless of age at onset. These findings do not 
support the proposal that cognitive techniques may have a more important role in the 
treatment of those with EO of anxiety than those with LO anxiety (Wetherell , Hopko, et 
al., 2005). Although participants with LO GAD were found to have a shorter duration of 
illness (see Chapter Eight) it would seem that once developed, the faulty cognitions that 
are characteristic of GAD are equally as entrenched for those with LO GAD as for those 
with EO of GAD. Consequently, CT techniques appear to be equally as important in the 
treatment of LO GAD as for EO GAD. Furthermore, despite a significant difference 
between onset groups in chronicity, with those in the EO group previously being found 
to have a greater number of episodes of psychiatric illness and greater duration of 
illness since initial onset (see Study One, Chapter Eight), the current findings indicate 
that behavioural techniques are no less important for the treatment of those with EO 
GAD than LO GAD. These findings do not support the suggestion put forward by Beck 
and Stanley (1997) that behavioural treatment may be less efficacious for those with EO 
of anxiety. 
The finding that onset groups did not differ in their evaluations of the usefulness of each 
treatment module is also in contrast to the hypothesised relationship between treatment 
and age of onset. The current findings are in line with earlier findings presented in 
Section One of this thesis (see Chapter Nine) , showing that onset groups did not differ 
in the frequency or severity of GAD- related worries, the frequency or severity of GAD 
symptoms, or on self-rated measures of anxiety, worry and depression at initial 
assessment. As such, it may be that similarity in certain phenomenological aspects of 
GAD between EO and LO participants at pre-treatment may also be indicative of 
treatment outcome. Given that treatment components were not directly compared to one 
another, it would be informative to analyse components of CBT separately in future 
research to further investigate the hypotheses of differential efficacy of CBT 
components for older adults with EO and LO GAD in future research. 
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The current data revealed that improvements in anxiety, worry and depression scores 
and participant-rated symptom severity, levels of anxiety and ability to cope with 
anxiety at the completion of treatment were maintained at six-month follow-up. These 
improvements and maintenance of treatment gains was similar for both EO and LO 
groups of older adults with either a principal or co-principal diagnosis of GAD. There 
was a small but non-significant further reduction in anxiety and worry levels and in 
participant-rated experience of anxiety from T3 to T4. This further improvement may 
have reached significance for the LO group however mean anxiety and worry scores at 
T4 were influenced by two individuals in the LO group who had a relapse in their 
anxiety condition/GAD, as reflected in increased anxiety and worry symptoms at T4. 
On the other hand, there was a small but non-significant increase in mean symptom 
severity from T3 to T4 and a reduction in ability to cope with anxiety following 
improvements from Tl to T3. This was slightly greater for EO group. Inspection of the 
distributions of these variables indicates that this was because two individuals in the EO 
group and one in the LO group relapsed at T4. 
The finding that, on average, both onset groups maintained treatment gains at six-month 
follow-up is in contrast to previous findings indicating that older aoults with EO 
depression have a shorter time to relapse (Golian, et al. , 2005) and have higher rates of 
relapse than those with LO depression (Brodaty, et al., 200 I) . As previously noted by 
Reynolds et al. (1998) who did not find age at onset of first lifetime episode of recurrent 
major depression to affect absolute rates of relapse or recurrence during the first year of 
maintenance therapy, older patients with EO depression did not differ from those with 
LO in treatment intensity or focus , either pharmacological or psychotherapeutic. 
Reynolds and colleagues suggest that the similarity of combined treatment received was 
the strongest determinant of similar outcomes found for onset groups. As with the 
present investigation, older adults with early-and late-onset GAD took part in the same 
treatment program with the same treatment components for the same duration, which 
may have contributed to the similarity in outcomes for both onset groups. Further 
longitudinal follow-up is required to examine this further. 
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11.7 Conclusions 
In summary, participants w ith early-and late-onset GAD in late-li fe showed sign ificant 
improvement in levels of anxiety, worry, depression, participant-rated GAD severity, 
anxiety and ability to cope with anxiety over time/treatment. In addition, participants ' 
levels of trait-anxiety, anxiety sensitivity, self-efficacy and perceptions of control over 
anxiety-related symptoms significantly improved from pre- to post-treatment. The 
findings of the current investigation revealed that a di sti nction in age at onset oflate-life 
GAD did not have any significant treatment implications. Participants with early- and 
late-onset of GAD were found to be simi lar with regard to treatment outcome and 
response on all outcome measures, with treatment gains being maintained by 
participants at six-month follow-up. The hypotheses that cognitive therapy techniques 
would be more efficacious in the treatment ofEO GAD and be associated w ith a greater 
change on outcome measures for those with EO GAD, and; that participants with LO 
GAD would have a better response to behavioural techniques than those with EO GAD 
were not supported by the current data. Both early- and late-onset participants 
demonstrated similar improvements on outcome measures following somatic, cognitive 
and behavioural treatment modules. Overall these findings suggest that age of onset is 
not a significant factor as to treatment outcome. Furthermore, the current findings 
indicate that older adults with EO and LO of GAD can expect similar treatment 
outcomes in response to a full package of CBT including all three of these treatment 
components, regardless of this differentiating factor. 
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CHAPTER TWELVE 
General Discussion 
The present study is one of the first and most comprehensive attempts to outline and 
apply a statistical methodology for identifying whether there exists two subgroups of 
older adults with early-and late-onset anxiety and to determine a cut-off point for best 
deciding to which subpopulation a given age of onset belongs. Aetiological and 
phenomenological factors associated with early- and late-onset GAD in a sample of 
older adults were also examined. In addition, the relationship between the experience of 
negative life events and age at onset of GAD was investigated. Finally, psychological 
wellbeing before, during and six months following CBT treatment was intensively 
examined. The results highlighted the importance of understanding the role of age at 
onset in the experience and treatment of late-life GAD and as such, offer numerous 
significant theoretical and clinical implications. 
12.1 Study One 
12.1. J Research Question I: Is there an Empirically Jdent_ifiable Cut-off Age 
that Differentiates EO GAD from LO GAD? 
In terms of the theoretical imp! ications, the present study is the first of its kind to 
investigate the theoretical conceptualization and empirical measurement of a bimodal 
distribution of age at onset of GAD. The onset of current and lifetime episodes of DSM-
IV anxiety disorders was assessed in the present study in order to investigate whether 
there exists two sub-populations of older adults representing a group with "earl y onset," 
(EO) and a group with " late onset" (LO) of anxiety. Descriptive analyses of the sample 
revealed that the majority of participants had a primary diagnosis of GAD at evaluation 
and for GAD to be the most commonly diagnosed anxiety disorder at first onset of a 
DSM-IV anxiety disorder and DSM-TV disorder of any kind. A maximum-likelihood 
estimation procedure used to apply gamma probability density function (pdf) 
distributions to the data revealed a bimodal distribution for first lifetime onset of a 
DSM-IV anxiety disorder. A cut-offof34.4 yea rs was identified as the point at which 
the probability that a given age of onset belonged to either subpopulation would be 
identical. Accordingly, participants identified as having an onset of GAD prior to and 
including 34 years of age in the present study were classified as having an EO disorder. 
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Participants with an onset of GAD at 35 years or later were identified as belonging to 
the LO group. 
The statistical procedure used to determine modality of the attained distribution of onset 
represents a significant advancement on previous research. Past research has tended to 
se lect an arbitrary cut-off age for the determination of age of onset, with cut-off points 
ranging from fifteen years (Beck et al. , 1996) to fifty years (Chou, 2009; Le Roux et a l. , 
2005) in studies of late-life GAD . Previous research has also varied in the methodology 
used in eliciting age of onset, with a number of investigations assess ing onset of the 
current episode rather than lifetime episodes of illness onset. This has led to a lack of 
clarity as to whether ' late-onset ' refers to the onset of a disorder for the first time in late 
life without a prior history of illness, or merely the first onset to occur in late life after a 
threshold selected by the researcher. lt is therefo re likely that the results of past research 
may be misleading due to the failure to assess lifetime episodes of psychiatric illness, 
lack of clarity about definitions of ' age at onset' and inconsistency in the cut-off 
selected to determine onset groups across the research literature . The methodology used 
in the present study presents a means of identifying a cut-off specific to the sample 
which is highly accurate and minimi ses the probabili ty of misclassification that may 
result when an arbitrary cut-off is se lected by the researcher. The -results indicate that a 
more accurate conceptualization and measurement of age at onset is a priority for future 
research, and that future research considers the use of a standard methodology such as 
the statistical method used here to examine age of onset in a given population. 
12.1.2 Research Question 2: What are the Aetiological Differences between 
Older Adults with EO and LO GAD? 
The present study has significantly extended the ex ist ing knowledge regarding the 
re lationsh1p between age at onset and the aetiology of late-life GAD. Investigating 
aetio logical differences between earl y-and late-onset GAD is important not only in 
clarifying the dimensions by which EO and LO GAD may be differentiated, but m 
helping to identify factors to be addressed in education, early-intervention and 
prevention programs for GAD. The sample of early- and late-onset participants was 
similar in terms of demographic characteristics, consistent with previous research (Beck 
et al. , 1996; Chou, 2009; Le Roux et al. , 2005). Participants were also found to be 
homogeneous with regard to health characteristics including the number and types of 
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health conditions reported, in line with previous findings (Chou, 2009; Le Roux et al. , 
2005). With the exception of a small but significant finding for greater use of 
benzodiazepines and health supplements amongst EO participants, prescription and 
non-prescription medication use was also found to be similar between onset groups. 
Onset groups were not found to differ with regards to age at which they first sought 
treatment for a psychiatric problem, nor in terms of a history of psychotherapeutic 
and/or psychotropic treatment sought prior to the present investigation, consistent with 
previous findings (Le Roux et al., 2005). EO GAD was, however, found to be 
characterised by greater chronicity, as reflected in a significantly longer course of 
illness since initial onset and a greater number of episodes of psychiatric illness (i.e. 
di screte episodes of anxiety and/or depress ion). These findings are as expected given 
the much younger mean age at onset of first anxiety episode for EO participants, and are 
consistent with previous findings of late-life GAD (Beck et al., 1996; Le Roux et al., 
2005). 
Investigation of genetic factors also revealed a sign ificant difference between onset 
groups for a positive family history of psychiatric illness, with a significantly greater 
proportion of EO participants reporting their mothers to have a history of psychiatric 
illness than LO participants. These findings suggest that EO GAD·may be related to a 
psychobiological (genetic) vulnerability. Although the relationship between a famil y 
history of psychiatric illness and age at onset of GAD has not previously been 
investigated, the current findings are supported by previous investigations in the 
depress ion (Brodaty et al., 2001 ; Devanand et al., 2004) and panic disorder (Sheikh et 
al. , 2004) literature. These findings suggest the need for early intervention, including 
more education and support, for individuals identified with a family history of 
psychiatric illness . 
The finding of significantly greater benzodiazepine use amongst EO participants 
compared to those with LO GAD suggests that older adults with a longer hi story of 
anxiety may be receiving less effective treatment than those with a more recent onset of 
anxiety and that over the long-term, EO GAD is poorly managed. The longer history of 
anxiety characterised by multiple episodes of psychiatric illness found to be associated 
with EO GAD may contribute to increased hopelessness about improvement amongst 
these individuals, which may further perpetuate the use of benzodiazepines amongst EO 
participants. The implications of ongoing benzpdiazepine use over a number of years 
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may include dependence, which is common with this class of drugs. Amongst aging 
individuals ongoing use may have further adverse consequences. For example, as 
previously noted, benzodiazepine use in older adults has been associated with increased 
risk of hip fracture (Ray, et al., 1989), sedation, falls , confusion and memory 
impairment, even at low doses (Schneider, 1996; Wengel , et al., 1993). Despite their 
disadvantages and limitations in safe use among older adults , benzodiazepines have 
remained the treatments of choice for acute or sub-acute anxiety amongst medical 
practitioners (Schneider, 1996). Accordingly, the current findings suggest the need for 
education amongst the medical community regarding the first line management of 
anxious presentations that doctors and G.P's may come across in their areas of practice. 
Overall, the current findings suggest that benzodiazepine use, the use of health 
supplements, illness duration, number of episodes of psychiatric illness and a positive 
family history of anxiety are the distinguishing aetiological factors between early- and 
late- onset GAD. Accordingly, these factors highlight areas of need with regard to early 
intervention and therefore the management ofEO GAD. 
12.1.3 Research Question 3: What are the phenomenological differences 
between older adults with EO and LO GAD? 
Phenomenological differences between older adults with EO and LO GAD have not 
been well_ examined in past research, with previous investigations focusing on 
differences in scores on psychological inventories as a measure of difference (Beck et 
al., 1996; Hoehn-Saric et al., 1993; Le Roux et al. , 2005). Furthermore, previous 
findings in both the depression (Brodaty et al., 2001) and panic (Battaglia, et al., 1995; 
Sheikh, et al., 1991; Sheikh, et al., 2004) literature have been inconsistent. Investigating 
phenomenological differences between EO and LO GAD is therefore important, not 
only in el<tending the current knowledge regarding such differences but also because of 
potential implications for the clinical treatment of early-and late-onset GAD. 
Participants in both onset groups met criteria for a wide range of comorbid psychiatric 
conditions at all assessment points. Onset groups were not, however, found to differ in 
rates of psychiatric comorbidity at presentation, at first onset of a DSM-IV disorder of 
any kind, nor at first onset of a DSM-IV anxiety disorder. Findings of non-significance 
between onset groups in psychiatric comorbidity using a cut-off of 34 are in line with 
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previous findings in the panic disorder literature (Sheikh et al , 2004). On the other hand, 
findings of significance using a cut-off of 50 are supported by previous findings using a 
similar age-cut-off (Chou, 2009; Le Roux et al., 2005), with both Chou and Le Roux 
and colleagues finding that EO GAD patients were significantly more likely to report 
psychiatric comorbidity than those with LO GAD. 
Overall, participants were similar with regard to the frequency and severity of GAD-
related worries, in line with previous findings (Beck et al., 1996). With exception of the 
symptom "feelings ofrestlessness, keyed up and/or being on edge", which was rated as 
significantly more severe by participants wi th EO GAD than those with LO GAD, onset 
groups did not significantly differ with regard to the frequency and severity of GAD-
related symptoms experienced. In line with this, onset groups were not found to 
significantly differ in scores on self-reported measures of anxiety, worry, or depression . 
Although differences in the frequency and severity of GAD-related symptoms in EO 
and LO groups of older adults have not been previously examined, the current findings 
are supported by previous investigations of an onset distinction in the PD (Raj et al., 
1993; Sheikh et al., 2004) and depression (Brodaty et al., 2001) literature. These 
previous findings suggest that there are few differences between EO and LO panic and 
depression in terms of phenomenology. In line with the conclusiort of Brodaty et al. 
(2001) that "once expressed, the phenomenology [ of a disorder] is stereotyped" 
(pp.234), the current findings suggest that once GAD has developed, the symptoms 
experienced by older adults are similar, regardless of age of onset. Furthermore, in line 
with these conclusions, given that participants in both the early-and late-onset 
subgroups have had GAD symptomatology for a number of years, it is unlikely that age 
at onset is central to symptom severity in older adults with clinical levels of anxiety. 
The findings that onset groups were broadly similar with regard to symptom frequency 
and severity indicate that the impact. of LO GAD is as serious as that ofEO GAD and 
should not be considered a ' normal part of aging' . 
Participants with EO GAD spent a significantly greater percentage of time worrying 
each day, were rated as being significantly more distressed due to symptoms of GAD 
and had greater interviewer-rated severity of GAD than LO participants. Participants 
did not, however, differ with regard to level of interference in daily life due to 
symptoms of GAD. The current findings suggest that whilst participants do not differ 
regarding GAD symptom severity, they do with overall syndrome severity. As such, 
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although percentage of time worrying, di stress and interference have not previously 
been investigated in studies of an onset distinction, the current findings indicate that the 
greater chronicty of EO GAD, as reflected in a significantly greater number of discrete 
episodes of anxiety and greater duration of illness since initial onset (See Research 
Question 2, Chapter Eight) , may contribute to the findings of greater distress, time spent 
worrying, and overall severity of GAD observed in these individuals. Further 
investigation is required to examine the role of these variables in the phenomenology of 
late-life GAD. 
Participants with LO GAD were found to have poorer se lf-perceived health and report 
greate r functional limitations than those with EO GAD. These findings may have 
important implications for the identification and treatment of GAD. Previous findings of 
greater functional limitations amongst those with LO GAD (Chou, 2009; Le Roux et al. , 
2005) have led Le Roux and colleagues to suggest that disability may be a risk factor 
for the deve lopment of GAD in later life. Accordingly, functional impai rment and self-
perceived health , which have also been found to be worse amongst those with LO GAD 
(Chou, 2009), may be markers for LO GAD . The assessment of functi onal limitations 
and perce ived health by GP' s may help to identi fy those with, or those at ri sk of 
developing LO GAD. This would therefore facilitate early intervention and contribute 
to reducing the burden of disease and di sab ility currently associated with anxiety 
amongst o lder adults. 
12.1. 4 Research Question 4: What are the Differences between Older Adults 
with EO and LO GAD in the Frequency and Severity of Stressful Life Events 
Preceding the Onset of Anxiety? 
The present study is one of the first of its kind to investigate the theoretical 
conceptualization and empirical measurement of a diathes is-stress model to account for 
a di stinction in age at onset of late-li fe GAD. Despite previous research indicating that 
stressful life events precede episodes of anxiety di sorders (Faravelli , 1985 ; Finlay-Jones 
& Brown, 1981 ), relatively little is known about the relationship between stressful life 
events and anxiety in older adults (Kendler et al. , 2003). Given the role of negative 
events in the onset of psychopathology, it is therefore important to investigate the ro le 
of the stress-diathesis interaction in the onset of GAD. A greater understanding of the 
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environmental precipitants to the onset of GAD will further help to inform early-
intervention and the treatment of late-life GAD. 
The current investigation revealed that EO and LO participants with a principal or co-
principal diagnosis of GAD were similar with respect to the frequency and severity of 
stressful life events reported to precede the onset of the presenting episode of GAD. On 
the other hand, participants with LO GAD reported a greater frequency and severity of 
both health-related stressful events and difficult financial circumstances preceding first 
onset of GAD, in addition to greater severity of events involving change in education 
and/or occupation prior to first onset of GAD than those with EO GAD. These findings 
are in line with the cognitive model put forth by Boyd et al. (200 l ), proposing that LO 
of psychopathology is associated with the experience of more environmental stressors 
preceding episode onset. The present data are supported by previous findings in the 
panic literature, in which older adults with LO PD have been found to cite medical 
events as well as financial and interpersonal problems as stressors occurring prior to 
episode onset (Raj et al., 1993). 
The finding that negative health-related events preceded the first onset of GAD for LO 
participants' has significant clinical implications. The knowledge that the experience of 
negative health-related events in later life affects psychological wellbeing means that 
medical professionals and psychologists may offer appropriate support to prevent 
declines in psychological wellbeing related to these changes. This might involve 
providing adequate education to individuals in the lead up to an upcoming surgery, for 
example knee replacement surgery or heart surgery, or following an unexpected health 
event, including a realistic timeframe for rehabilitation and what this would involve. 
This might also involve short-term therapy to monitor patients ' levels of distress and to 
provide support to reduce this distress in the lead up to a health event if it is known, 
and/or after the incidence of a significant health-related event. This may serve to 
improve coping with stressful health-related events and to prevent the likelihood of 
either developing or continued experience of poor psychological wellbeing after such an 
event. 
In line with this finding is the previous finding that participants with LO GAD report 
significantly greater functional limitations and poorer perceptions of their health than 
those with EO GAD (Research Question 3, Chf!pter Nine and discussed above), which 
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may be a result of the experience of negative health-related events. As such, appropriate 
education and early intervention may better prepare older adults for these limitations 
and how to manage them, and may serve to minimise or reduce the likelihood of some 
older adults going on to develop LO GAD. 
12.1.5 Research Question 5: What is the Relationship between the Experience of 
Negative Life Events across the Lifespan and Symptoms of Anxiety, Worry and 
Depression in older adults with GAD? 
The inclusion of a measure of negative life events in the present study allowed for the 
exploration of a number of relationships between the age at onset of GAD and the 
experience of negative life events across the lifespan that have not previously been 
addressed. The experience of negative life events at different developmental periods 
throughout life was explored so as to get a picture of the prevalence of negative life 
events experienced by the current sample of older adults with EO and LO GAD 
(Exploratory Research Question 1). All EO and LO participants reported the experience 
of at least one negative event during their life. Events involving the death of significant 
others, severe illness of oneself and others, emotional abuse and neglect, relational 
stress, and problem behaviours of significant others were all foung _to occur at high rates 
throughout life for the current sample ofEO and LO participants . 
Exploratory research question 2 aimed to understand the relationship between the 
experience of specific negative life events during each developmental period and 
symptoms of depression, anxiety and worry in later life amongst older adults with EO 
and LO GAD. The results revealed crime, disaster and/or war (CDW) events in 
childhood and severe illness of others in late-adulthood to be associated with low scores 
on self-report measures of pathology in late-life amongst EO participants. On the other 
hand, events involving negative socioeconomic circumstances and CDW events in late-
adulthood were significantly associated with symptoms of trait anxiety in late-life. The 
current findings indicate that financial problems and/or instability and trauma-related 
events in late-adulthood are associated with the tendency to be anxious in late-life 
amongst those with EO GAD. 
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In contrast to findings for EO participants, significant associations between negative life 
events and symptoms of psychopathology were found across all four developmental 
periods for the LO group. These re lationships were all positive, indicating that the 
experience of one or more negative li fe events was associated with high scores on self-
report measures of psychopathology. Specifically, sexual abuse in childhood was 
associated with high scores on measures of trait anxiety and anxiety sensitivity in later 
li fe, whilst problem behaviours of significant others in childhood was also associated 
with high trait anxiety in later-life. A significant relationship between relational stress in 
adulthood and symptoms of depression in late-life was found for participants with LO 
GAD. CDW events experienced in adu lthood were associated with high scores on a 
measure of pathological worry in late-life, whilst sexual abuse in adulthood was 
associated with poor emotional well-being in late- life, as reflected in high scores on 
measures of trait anxiety and anxiety sensitivity in later life. 
Experiences of severe personal illness in late-adulthood and in the year prior to 
interview were significantly associated with symptoms of anxiety and depression. These 
findings suggest that events involving severe personal illness in late li fe , particularly in 
the twelve months prior to time of interview are significantly associated with poor 
psychological health in late-l ife amongst those with LO GAD. The experience of 
negative socio-economic circumstances in the three latter developmental periods was 
associated with high scores on one or more measure of psychopathology in late-life, 
also highlighting the negative impact of such experiences throughout li fe on the 
psychological well-being of participants with LO GAD. CDW events experienced in the 
year prior to interview were associated with high scores on a measure of anxiety 
sensitivity, whilst problem behaviours of significant others in the year prior to interview 
was associated with high scores on a measure of anxiety. 
Overa ll , the findings of multiple significant relationsh ips between negative life events in 
the latter developmental periods, during which time the majority of LO participants had 
their first onset of GAD, and symptoms of psychopathology in late-life amongst the LO 
group are in keeping with the findings of research question 4, that negative health-
related events and negative financial circumstances are significantly more likely to 
precede the onset of LO GAD than EO GAD. These findings are also in line with the 
model put fo rward by Boyd et al. (2000) suggesting LO GAD is associated with greater 
levels of life stress than EO GAD. 
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Exploratory Research Question 3 aimed to explore the relationship between the tota l 
number of specific negative life events experienced throughout life and symptoms of 
psychopathology in late-life. Amongst EO participants, only the experience of negative 
socio-economic circumstances throughout life was found to be associated with high trait 
anxiety in late life. On the other hand, experiences of severe personal illness, negative 
socio-economic circumstances, sexual abuse, relational stress and the total number of 
negative life events experienced from all event clusters throughout life were all 
correlated with high scores one or more se lf-report measure of anxiety, worry and/o r 
depress ion. In line with the findings of exploratory Research Question 2, investigation 
of the accumulation of specific life events throughout life also support the diathes is-
stress model put forward to account for an age of onset distinction in late-life GAD, 
according to which the incidence of LO anxiety is associated with the accumulation of, 
and greater levels of life stress than EO anxiety. 
Exploratory Research Question 4 examined the relationship between the total number of 
negative events occurring in each deve lopmental period and symptoms of 
psychopathology in late-life. Amongst EO participants, no significant relationships 
were found between the total number of negati ve life events experienced in each of the 
four developmental periods and symptoms of psychopathology in-late-life. For 
participants with LO of GAD, a significant relationship was found between the total 
number of negative life events experienced in childhood and trait anx iety in late-life, 
and with the total number of events experienced in adulthood and anxiety sensitiv ity in 
late-life. The findings of Research Questions 2-4 indicate that LO GAD is associated 
with greater levels of life stress than EO GAD, as proposed by the diathesis-stress 
model of early- and late- onset anxiety. It is important to note, however, that although 
both EO and LO participants experienced multiple negative events across the li fespan, 
the incidence of these events in specific developmental periods and throughout li fe was 
only associated with significant anxiety symptoms as per self-report measures amongst 
those with LO GAD. As such, whilst both groups experience numerous stressors 
throughout life, this stress may not be as significant to the onset of GAD in late- life for 
those with a greater emotional vulnerability to anxiety (EO) than those who are more 
psychologically resilient (LO), as suggested by the cognitive model put forward by 
Boyd et al. (2000). 
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Finally, the research reported in Chapter Ten examined whether older adults with EO 
and LO GAD differed with regard to the total number of specific negative life events 
experienced in each developmental period and throughout life (Exploratory Research 
Question 5), as well the total number of all events experienced in each developmental 
period and throughout life (Exploratory Research Question 6) . The findings that EO 
participants experienced a significantly greater number of events involving emotional 
abuse in childhood, relational stress in adulthood, and problem behaviours of others in 
adulthood, the year prior to interview and throughout life, as well as a significantly 
greater number of total negative events in adulthood than those in the LO group 
(Research Question 5) are in line with previous research (Hoehn-Saric et al. , 1993) 
reporting greater developmental difficulties and interpersonal adjustment for the EO 
group. These findings further lend support to the cognitive model proposing greater 
emotional vulnerability to psychopathology in those with EO GAD, as outlined in 
Chapter Four. 
12.2 Study Two 
12. 2. 1 What are the Implications of an Age at Onset Disti~ction for the 
treatment of Late-life GAD? 
The present study is one of a few to examine the implications of an age at onset 
distinction in the treatment of GAD in late-life. The research provided considerable 
information regarding the nature of the relationship between age at onset of GAD and 
psychological wellbeing before, dµring and after a twelve-week CBI treatment program 
for older adults . In addition, the study provided valuable information regarding the 
contribution of the specific components of CBI to treatment outcome in late-life. 
Levels of the primary outcome measures including anxiety, worry, depression, 
participant-rated GAD symptom severity, anxiety, coping and evaluations of the 
usefulness of treatment, as well as secondary outcome measures including trait anxiety, 
anxiety sensitivity, self efficacy and perceptions of anxiety control were examined over 
time to investigate i) the effect of time/ treatment on levels of the dependent variables; 
ii) the effect of age at onset on levels of the dependent variables; and iii) the interaction 
effect between treatment and age at onset on levels of the dependent variables. In 
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addition, the study aimed to investigate the maintenance of treatment gains at six-month 
follow-up. 
Given the paucity of research into age at onset of late-life GAD and the variability in 
measures used across the research literature, it was not possible to compare baseline 
levels of anxiety and depression with other samples. The mean levels of worry and trait 
anxiety reported were however equivalent to those reported in other samples of early-
and late-onset older adults undergoing treatment for GAD (Beck et al. , 1996; Le Roux 
et al., 2005). The hypothesis that treatment would result in significant improvements in 
scores on primary and secondary outcome measures from pre- to post-treatment was 
supported by the current data, in line with previous research reporting the efficacy of 
CBT for GAD in older adults (Barrowclough, et al. , 2001; Gorenstein, et al. , 1999; King 
& Barrowclough, 1991 ; Mahlman, et al., 2003; Stanley, Beck, & Glassco, 1996; 
Stanley, Beck, et al., 2003 ; Wetherell , Gatz, et al., 2003). 
Age of onset was not found to have a statistically significant effect on any of the 
primary or secondary outcome measures . These findings suggest that there is no 
difference in response to treatment between older adults with EO and LO GAD, in line 
with previous findings in the dysthymia literature (Barzega et al. , 2001 ). These findings 
are promising in that participants with a lifetime history of GAD and those with a 
relatively shorter duration since illness onset both demonstrated a positive treatment 
outcome to a 12-week CBT program for GAD, which was maintained at six-month 
follow-up . The current findings have important clinical implications as they indicate 
that participants with EO and LO GAD both respond well to a manualised CBT 
program for GAD. These findings further suggest that the similarity of treatment 
received by both onset groups with respect to treatment focus and duration, rather than 
age of onset, may be the determinant of similar outcomes found for both onset groups, 
as previously suggested by Reynolds et al. (1998). Despite this outcome, participants 
who have experienced the disorder for many decades may feel understandably sceptical 
about their ability to benefit from the treatment, which may also contribute to the higher 
rates ofbenzodiazepine use found amongst those with EO GAD. Accordingly, both 
participants with EO and LO GAD may need ongoing education and encouragement 
about the treatment process and the benefits of CBT. 
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The current findings did not support the hypotheses that EO participants would respond 
better to CT techniques than those with LO GAD; and that LO participants would 
respond to BT techniques better than those with EO GAD. With the exception of a 
significant interaction effect for mean participant-rated GAD symptom severity, early-
and late-onset participants were not found to differ in the rate of change on primary or 
secondary outcome measures over time. On average, LO participants reported 
significantly greater symptom severity at Tl than EO participants. Mean symptom 
severity was, however, similar for both onset groups from T2 onwards. Overall, the 
findings of the present study demonstrated that older adults with an onset of GAD early 
in life and those with a more recent hi story responded equally as favourably to all 
components of treatment. Although the biggest change on outcome measures fo llowed 
completion of the cognitive skills component, relaxation and behavioural ski ll s were 
nonetheless also rated as useful , suggesting that cognitive and behavioural therapy 
techniques are both necessary components in the treatment of GAD in late-life 
regardless of age at onset . The current findings highlight the fact that older adults with 
EO and LO GAD both respond well to an integrated CBT program and would suggest 
that a full package ofCBT including all three components ofCBT to target the core 
symptoms of GAD would be superior to specific treatment components delivered in 
isolation. 
The current data revealed that improvements on primary and secondary outcome 
measures at the completion of treatment were maintained at six-month follow-up by 
both early- and late-onset participants. The present findings suggest that at least in the 
short-term, older adults with EO and LO GAD do not differ with regard to time to 
relapse and/or maintenance of treatment ga ins. Further longitudinal follow-up is 
required to examine this further. 
The current findings point to fact that older adults are capable of engaging in , learning 
and benefitting from therapy, as reflected in the statement of one participant: "if only I 
had done this twenty years earlier." As such, these findings also indicate that there is a 
need for education about this amongst GPs and other service providers who may be 
reluctant to refer older adults, especially those with a long history of anxiety, for 
psychological services due to the belief that they may not respond well to this treatment. 
Regarding the role of psychologists then, there is a need for psychologists to have the 
appropriate training necessary to work with older adults and also a willingness to offer 
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services to older adults. The provision of psychological services to older adults may 
require greater flexibility in the implementation of the various components ofCBT in 
terms of the order in which they are delivered and the amount of time and/or number of 
sessions spent on each component. Although the number of sessions in each treatment 
module delivered as part of CBT was limited according to the treatment manual , it may 
be that some participants would have benefitted from additional sessions focusing on 
cognitive therapy skills and some participants also expressed this. As such, an 
integrated CBT programme with the inclusion of aspects such as relaxation training that 
give the sense of immediate mastery in addition to an emphasis on or a greater number 
of sessions on cognitive strategies such as reformulation of inaccurate or maladaptive 
beliefs may be implemented in future treatment of GAD in late-life. 
12.3 Limitations 
Although the current study improved upon previous investigations by measuring 
lifetime rather than current psychiatric comorbidity, and examining differences in age at 
onset in a sample of adults with late-life anxiety using an empirically supported 
threshold to distinguish early and late-onset groups, there are several limitations that 
may affect the generalisabilty of the current findings. First, the stucly relates to a self-
selected sample, whereby participants were individuals responding to an invitation to 
participate in research. As such, sampling bias inherent in self-referral studies such as 
this are possible, as individuals volunteering for such studies may differ from other 
psychiatric patients. Indeed, the current sample consisted of older adults with relatively 
good physical health , and it is possible that older adults with relatively good 
physical/medical health are more likely to self-refer to a treatment study, which may 
have further influenced the current findings . To this end, it would be beneficial for 
future investigations to consider non-treatment seeking individuals, including referrals 
made by general practitioners, psychiatrists, and other specialist services. 
The fact that there appear to be a greater number of LO participants in studies one and 
two may be also be a product of sampling bias in that those with a more recent onset 
were more likely to be seeking treatment, whereas those with a long history or course of 
illness do not seek treatment. However, as seen in the descriptive analysis of treatment 
history, 75% of the EO sample had previously sought treatment of some kind, be it 
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medication or psychotherapy, versus 66.7% of the LO sample, and therefore does not 
account for the larger proportion of older adults with a LO disorder in the present study. 
One potential limitation as highlighted by Van den Berg et al. (2001) is that in studies 
where psychiatric history (i.e., age of onset) is assessed retrospectively, recall bias may 
be an important confounding factor. According to Van den Berg and colleagues, errors 
in recall may lead to a significant underestimation of the true lifetime prevalence of 
psychiatric disorders, and that subjects have been found to be more likely to forget 
episodes than to 'gain ' them. As such, it is possible that the group of participants with 
LO GAD may include participants that should be classified as EO cases. The lifetime 
version of the ADIS-IV has prompts for other events occurring at the time of the 
recalled episode (family, work and education, health and other events) which are more 
easily associated with dates than time of illness occurrence, and was therefore used in 
order to minimise this bias. 
One consideration with regard to investigation of negative life events across the lifespan 
is that of the validity of retrospective recollections of life events by older subjects. 
According to Brown (1972) and Teasdale (1983) (cited in: Kraaij & de Wilde, 2001), 
there is evidence to suggest that depressed persons may report more negative life events 
than non-depressed persons in order to account for their current emotional state. It has 
also been suggested that older people may not remember early experiences accurately 
(Kraaij & de Wilde, 200 I). However, in their review ofretrospective reports Brewin, 
Andrews, & Gotlib (1993) concluded that there is little reason to link psychiatric status 
with reduced reliability or validity for recall of early experiences, and that much of our 
autobiographical recollection of the past is reasonably free from error, so long as we 
stick to remembering the broad outline of events and not detailed information. The 
present study focused on the broad outline of events only, and did not include questions 
regarding the details of an event. Another issue addressed by Kraaij and de Wilde 
(2001) is that memory for dates and the temporal order of events may be subject to 
error, and therefore the negative life events questionnaire did not date events precisely, 
but rather used four time periods within which to identify the occurrence of events. 
Another limitation of the current investigation is the fact that participants were 
relatively homogeneous. Participants were mostly Caucasian, female, physically healthy 
and relatively well educated. Thus, the current findings may not generalise to older 
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GAD patients who are male, frail, have low education or socio-economic status, or are 
from other ethnic backgrounds. Moreover, the current sample consisted of community-
dwelling older adults who were cognitively intact, further limiting the generalisabilty of 
the current finding to other populations. Previous investigations of an onset distinction 
in the depression literature indicate that there is some evidence for greater cognitive 
impairment in individuals with LO depression, though findings are inconsistent 
(Brodaty et al., 2001), and it is possible that cognitive functioning may further 
differentiate anxious older adults with EO of anxiety from those with first onset later in 
life. Future investigations should therefore consider older adults from varying socio-
economic backgrounds, levels of cognitive functioning as well as those from in-patient 
settings. 
One limitation of the treatment study (Study Two) was the smaller sample size of 
participants who took part (EO group= 18; LO group= 23). As such, whilst the main 
effect of treatment was strong enough to be significant, even with a small sample size, it 
is possible that differences between age of onset groups exist, but that the sample size 
did not allow the study to have enough power to detect age of onset differences or an 
interaction effect. Further research should involve a larger sample size as this will 
allow for the use of more sophisticated statistical analyses and inc tease the power to 
detect significant differences 
As GAD symptom severity was clinician-rated at TO and participant-rated from Tl 
through to T4, another limitation of the treatment study was the exclusion of ratings at 
TO from the analysis of GAD symptom severity over time. It is therefore difficult to 
make conciusions about changes in symptom severity following the somatic control 
component of treatment, without a baseline measure. Future investigations should 
include both participant and clinician-rated symptom severity across all time-points to 
further understand the contribution of relaxation skills in the management of GAD and 
whether this differs according to subjective and objective ratings of symptom severity. 
A further limitation of the investigation in Section Two was the variability associated 
with different group leaders. Whilst this did not appear to affect the attrition rate of 
participants it is unknown as to whether this affected treatment outcome. Therapist 
variables have previously been suggested to be important in predicting treatment 
outcome (Wetherell, 2000). Therapist competence was not assessed in the current study 
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and therefore it is not possible to make conclusions as to whether this contributed to any 
differences in treatment outcome amongst individuals. 
Another weakness of this study was the fact that the order in which components ofCBT 
was delivered was not counterbalanced across partic ipants. As such, the improvements 
seen after the cognitive skills module and after treatment may have been due to the 
cumulative effects of CBT, rather than the cognitive ski lls component alone. 
Furthermore, the fact that treatment components were administered to participants in a 
standard format rather than being direct ly compared to one another may limit the 
conclusions made regarding the differential efficacy of specific CBT components for 
early- and late- onset groups . Although this was addressed in part by having participants 
rate the usefu lness of each component at the end of each treatment module, it would be 
informative to analyse components of CBT separately in future research to further 
investigate hypotheses of differential efficacy of CBT in older adults distinguished by 
age at onset. 
Fi nally, GAD was the most severe or disabling condition for the majority of participants 
in the present sample. As a result, despite the high rates of comorbidity between GAD 
and other disorders such as major depression or panic disorder, the ·genera li sabi li ty of 
these results to individuals with princ ipal diagnoses of disorders other than GAD may 
be limited. In addition, because the study was a cross-sectional design in which data 
were gathered at one time point, it is not possible to draw conclus ions regarding the 
causal direction of associations. 
Despite such limitations the results of the present study has several advantages 
compared to those previously conducted. These include the use of a semi-structured 
clinical interview administered by the invest igator to assess lifetime episodes of 
psychiatric illness in addition to the current episode. In addition, the present study 
included the use of an independent rater to confirm diagnoses and age of onset with 
good reliab ility. The psychometric measures used also had good reliability and validity 
and the present study also made use of a manualised treatment protocol. 
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12.4 Conclusions and Recommendations for Future Research 
Although anxiety symptoms in patients who develop GAD typically start at an early 
age, the current study confirms the clinical observation that anxiety symptoms can 
develop fo r the first time in later life and presents important information about the 
relationship between age at onset and late-life GAD. Overall, EO participants were 
found to differ from those with LO GAD with regard to benzodiazepine and health 
supplement use; history of anxiety since initial onset; number of discrete episodes of 
illness; family history suggesting a longstanding genetic vulnerability; psychiatric 
comorbidity (using cut-off of 50); percentage of time spent worrying, distress; and 
interv iewer rated severity of GAD .On the other hand, LO GAD was found to be 
associated with- poorer perceived health, greater functional limitations, greater 
frequency and severity of both health-related stressful events and difficu lt financial 
circumstances, and with greater severity of events involving change in education and/or 
occupation prior to first onset of a DSM-IV anxiety disorder of any kind. 
The current findings suggest that over the long term, EO GAD is poorly managed . 
These findings highlight the need for education amongst the medical community 
regarding the first line management of anxious presentations and inaicate a ro le for 
psychologists in providing early intervention, including more education and support, for 
individuals identified with a family history of psychiatric illness and those presenting 
with functional limitations and poor perceptions of their health . Appropriate education 
and early intervention from medical professionals and psychologists may a lso better 
prepare o lder adults for limitations associated with negative health-related changes in 
later life and how to manage them, therefore minimi sing the likelihood of some older 
adults going on to develop LO GAD. 
The current findings indicate that age at onset is not a factor as to treatment response 
and that both onset groups respond equally as well to manualised, individual CBT fo r 
GAD. Accordingly, it is important for both the medical profession and psychologi sts to 
recognize that anxiety causing impairment and/or interference to daily li fe should not be 
considered as part of ' normal ' ageing and that older adults are able to benefit from 
CBT. This is significant considering the side effects that some older adults may 
experience with psychotropic medications, issues of poly-pharmacy and the reluctance 
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of many older adu lts to add yet another medication to often complicated medication 
regimes. 
As outlined in the above section, it is recommended that future investigations of age at 
onset research use the statistical method outlined in this investigation for identifying a 
cut-off age that is specific to the samp le in order to distinguish between an EO and LO 
sample. The present findings further suggest that future investigations of late-life GAD 
should examine the possibility of a tri-modal distribution of age at onset in a larger, 
more heterogenous sample of older adults. A considered, long-term investigation of age 
at onset in which individuals are fo llowed from an early age would allow for a more in-
depth examination of the model put forward by Boyd et al (2001), including an 
investigation of the role of vulnerabi lity factors in EO GAD. With regard to the 
psychological treatment of GAD in late-life, both cognitive and behavioural 
interventions appear to be significant in bringing about therapeutic change and should 
be included in an integrated CBT programme for the treatment of late-life GAD for 
those older adults who are cognitively intact. It is recommended that future research 
compare cognitive and behavioural components of CBT with one another to determine 
whether the efficacy of CT and BT varies according to age of onset. Furthermore, 
future studies should conduct follow-up over a longer period oftirfre, (i.e. at 12 months, 
2 years) to investigate the long-term maintenance of treatment gains and course of 
recovery further. 
Age at onset of GAD appears to be a factor in the long-term management of GAD . With 
the assistance of further research, a greater understanding of the nature and influence of 
age at onset on the presentation and treatment of late-life GAD may inform the 
possibilities for improving the psychological well being of individuals, particularly in 
late-life. The ability to intervene and improve the psychological well-being of older 
adults, in particular given the complex medical comorbidities that many older adults 
often face with advancing age could have significant social , economic and health-
related benefits for Australia's aging population. 
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ADDENBROOKE'S COGNITIVE EXAMINATION 
~ ~ 
-
Name Years of education 
Date of birth : Date of testing 
Reference no. Tester's name 
--
All instructions to the tester are in italics. All instructions to be said aloud to the patient are in bold 
non-italic print. 
-~=---=--------------m li&RW ORIENTATION 
Ask the subject the following questions and score a point for each correct answer. Record all errors. 
Qla) What is the Year 
Season 
Date* 
Day 
Month 
QI b) Where are we Country 
*A/low an error of± 2 
County/ State 
Town 
Hospital/building 
Floor/Level* 
Total score for orientation [SGOre O - I OJ Do 
ATTENTION/CONCENTRATION 
Q2) Tell the subject I am going to ask you to recall the names of three things. 
Say aloud: lemon, key, ball. Then ask the subject to repeat them. Give one point for each correct 
answer at first attempt only. 
If score<] repeat all three items until the subject learns them all 
[O - 3] 
Maximum trials allowed = 5. 
Q3) Ask the subject to take away 7 from 100. 
I. Give one point only for the right answer (93). 
2. If the subject's answer is wrong then tell the correct answer. 
3. Ask the subject to now take away 7 from the correct answer (93). 
Repeat steps 1 to 3 for a total of 5 substractions (93, 86, 79, 72, 65). Score the total number of 
correct subtractions. 
If score<5 then ask the subject to Spell 'WORLD' backwards. Score the number of letters in 
the correct order, eg dlorw = 4. 
Take score of better of the two tasks. Record errors: 
[O - 5] 
D 
D 
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MEMORY 
Q4) Ask the subject to recall the names of the 3 things learned earlier in question 2. 
Score one point/or each correct answer. [0 - 3] 
Q5) Anterograde Memory: Tell the subject I will read a name and address and ask you to repeat it 
when I have finished. Now read aloud the following name and address. Score one point for 
each element recalled correctly. Regardless of the score after the first trial, repeat the instruction 
and the task twice in exactly the same way. Record scores for each of the three trials. 
Peter Marshall 
42 Market Street 
Chelmsford 
Essex 
1st trial 2nd 3rd 5 min delay 
/7 /7 /7 /7 
Trial 1-3 [0-21] D 
5 min delay [0 - 7] LJ M 
Q6) Retrograde MemoryScore one point/or each correct answer and record errors. Tell me the full 
name of the prime minister 
The last prime minister 
The Leaderof the Opposition 
The United States of America ____ __ [0 - 4] 
VERBAL FLUENCY 
Q7) Letter: Ask the subject to: tell me all the words you can think of, but not people and places, 
beginning with the letter P. Time the subject for 1 minute and record all answers in the space 
provided below. Error types: perseverations and intrusions. 
Q8) Category: Say: Now tell me the names of as many animals as you can, beginning with any 
letter of the alphabet. Time the subject for 1 minute and record all responses in the space 
provided below. Error types: perseverations and intrusions. 
P Animals 
(Start here) (Continue) (Start here) (Continue) 
Raw Score Scaled 
p Animal 
> 17 >21 
14-17 17-21 
11-13 14-16 
8-10 11-13 
6-7 9-10 
4-5 7-8 
<4 <7 
Record the total number of responses. To calculate the raw score give one point/or each correct 
response and exclude all repetitions. Enter the scaled scores using the table shown above. 
P: Total response~- Raw score _ __ Scaled Score [0 - 7] = 
Score 
7 
6 
5 
4 
3 
2 
1 
□ . 
Animals: Total response Raw score Scaled Score [0 - 7] = 
~- Total Scaled Score [0- 14] D V 
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LANGUAGE 
Q9) Naming: Show the subject the following two line-drawings and ask him/her to name each of them. 
Record responses and errors. Give one point for each correct response. 
[0-21 D 
Q I 0) Naming: Show the subject the following ten line-drawings and ask him/her to name each of them. 
Record responses and errors. Give one point for each correct response. Allow close synonyms (e.g. tub 
@1 I 
for barrel; coronet for crown; dromedary for camel etc) 
[0-10] 
'Jfl~~~I 
[O - 10) 11 =:J 
QI I) Comprehension (one-stage) .· Ask/ the subject to please obey the following simple commands. 
• point to the door 
• point to the ceiling [O - 2] D 
Show the subject the following instruction and ask him/her to read this aloud and obey it. 
CLOSE YOUR EYES 
Score one point if pe1formed correctly. [O - 1] D 
Q 12) Comprehension (3 -stages): Give the subject a piece of paper and tell him to take this paper in 
your hands. Fold it in half. Then put the paper on the floor. 
Score one point/or each correctly performed step. [O - 3] D 
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Q 13) Comprehension (complex grammw) : Ask the subject to please obey the following commands. 
• point to the ceiling then the door 
• point to the door after touching the bed/desk 
Score one point for each correctly performed command. [O - 2] D 
Q14) Repetition (single words): Ask the subject to repeat each of these words after me. Score one 
point for each correct repetition Allow only one repetition. 
• brown 
• conversation 
• articulate [O - 3] CJ 
Q15) Repetition (phrases): Ask the subject to repeat each of these phrases after me. Allow only one 
repetition. 
• No ifs, ands, or buts [O - I] D.____ 
• The orchestra played and the audience applauded [O - I] · D 
QI 6) Reading (regular): Ask the subject to read each of these words aloud and show him/her the 
followingfive words. 
•shed 
•Wipe 
• board 
• flame 
• bridge 
Score one point only if all five words are read correct. [O - 1] 
QI 7) Reading (irregular). Ask the subject to read each of these words aloud and show him/her the 
following five words. 
•sew 
• pint 
• soot 
• dough 
• height 
Score one point only if all five words are read correct. [O - I] 
QI 8) Writing: Ask the subject to make up a sentence and write it down in the space below. If stuck 
suggest a topic e.g. weather, journey. Score one point if the sentence has a correct subject and 
verb and is meaningful. 
[O - I] 
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D 
D 
D 
Q 19) Now to check delayed recall ask the subject Can you tell me the name and address that I told 
you and that you practised at the beginning of the test. Record points, scores and errors as for 
question 5 in the space provided in question 5 on page 1. 
VISUOSPATIAL ABILITIES 
Q20) Overlapping pentagons. Show the subject the following figure and ask him/her to copy this 
diagram in the space provided next to it. 
Score one point if copied correct. [O -1] 
Q21) Wire cube: Show the subject the following figure and ask him/her to copy this diagram in the 
space provided next to it. 
Score one point if copied correct. [O -I] 
Q22) Clock: Ask the subject to draw a clock-face with numbers and the bands at ten past five. 
Score one point each, for correct circle, numbering of the clock-face and position of the hands. 
[O - 3] 
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D 
D 
CHECK: Have you tested and recorded the delayed recall for name and address in Q 5 011 page I? 
OVERALL SCORES 
VLOM-RATIO: 
lf < 2.2: FTD 
If > 3.2: AD 
F7 +[ SL* I 
~+[M I 
MMSE*** = 
ACE** El 
***Sum of scores entered in the shaded boxes. ** Sum of scores entered in all boxes. *Sum of scores 
entered in all boxes form Q9 to Ql 8 = SL 
MMSE - Scored out of 30 
ACE scored out of 100 
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MEDIA 
THE AUSTRALIAN NATIONAL UNIVERSITY RELEASE 
TUESDAY 5 JULY 2005 
ANXIETYINOVER55's-NEW ANUSTUDY 
New ANU research aims to gain an understanding of first-onset anxiety in late life, 
and investigate the causes and treatments of anxiety in older people, which 
potentially effects up to 10 per cent of people over 55 years of age. 
Researchers are seeking residents over 55 years in Canberra, Queanbeyan and 
Goulburn to participate in a new study of anxiety problems, in which they will be 
provided with a free, effective non-drug treatment for the management of anxiety 
problems. 
"Whilst depression is becoming increasingly recognised in older people, anxiety in 
late-life is an under-studied area, and can often be misidentified as depression," 
according to psychology PhD student Ms Maaria Haque. "This is partly because 
depression is also usually present in those experiencing anxiety problems. There is 
increasing evidence that like depression, anxiety can occur for the first time later in 
life, without the individual having to have suffered it previously." 
"Examples of anxiety problems include excessive concern or worry about a range of 
issues, fear and/or avoidance of certain situations, events and activities, sudden and 
intense fear or apprehension (panic), and concern about presenting in socia l 
situations," Ms Haque said. 'These problems can cause a great deal of distress in 
anxious individuals, however, there are good treatments not involving medication that 
are available." 
"Anxiety problems and responses to treatment in late life may be different for people 
who have had these problems since early adulthood than for those who experience 
such problems for the first time later in life. So this study will look at previous history 
of anxiety problems, and life factors that may contribute specifically to the first onset 
of anxiety - for example job or financial insecurity, or health related factors." 
Local participants in the study would be required to complete an initial assessment 
involving an interview and some questionnaires, and would then complete a 12-week 
treatment program of cognitive behaviour therapy - a non-drug therapy found to be 
effective for the management of anxiety problems - on an individual basis. 
The information from this study would be invaluable, according to Dr Jeff Looi, 
Director of the Research Centre for the Neurosciences of Ageing, at the older persons 
mental health service. 
285 
"We are just beginning to realise the extent and complexity of mood disorders, such 
as depression and anxiety, as people age," Dr Looi, also a senior lecturer at the ANU 
Medical School, said. "There is an increasing amount of research particularly in the 
area of depression. This study of anxiety would complement these studies and provide 
significant new data for researchers and clinicians on the onset and treatment of 
people with anxiety problems in late life." 
People over 55 years of age who believe they might be suitable for the study or are 
interested in participating as a control subject and would like more information can 
contact Ms Haque on 02 6125 3972 during business hours. 
ANU MEDIA OFFICE CONTACT: Amanda Morgan (02) 6125 5575 / 0416 249 245 
Website: www.anu.edu.au/mac/media/index.html 
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DO YOU SUFFER FROM ANXIETY? 
ARE YOU OVER 55? 
A NEW RESEARCH PROJECT AT THE ANU 
The purpose of this project is to gain a better understanding of anxiety and worry in 
older people's lives, and any links there may be wi th difficult life events depending 
on when these events occurred. The project wi ll also exam ine which types of 
treatment are more effective in managing anxiety, and whether a person ' s response to 
treatment depends on when the anxiety problem began. 
The study wi ll be conducted in two stages. If you choose to participate in this study, 
the first stage will involve attending an interview and answering some questions 
about yourself, your family and medical history, and two simple phys ical 
measurements including a measure of your blood pressure. You wi ll also be asked to 
complete some questionnaires that wi ll ask you how you've been feeling lately. 
These wi ll take approximately 45 minutes. Should you be consid_ered su itab le, in the 
second stage of the study you will be invited to participate in a 12-week treatment 
programme which will offer personalised attention for your anxiety and worry 
problems. 
Who can participate in the study? 
• Individuals aged 55 years and over 
• Individuals experiencing symptoms of anxiety such as worry, muscle tension, 
panic, and sleep disturbance 
How can I Participate? 
If you are interested in participating or wou ld like more information about the study, 
please contact Maaria Haque at the ANU (Tel: 6 125 3972) to arrange an interview. 
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Date: 
Client ID number: 
Initial Assessment Interview Schedule 
Hi, My name is Maaria Haque, and lam an intern psychologist. Part of being an 
intern is that I have a supervisor who monitors my work. This is done by video or 
audio-taping the sessions. The only people who will see and/or hear the tape are my 
supervisor and myself. So do you mind if we tape these sessions? 
Have you had a chance to read through the information I sent you? Is there anything 
that you don't understand, or you would like for me to go through with you? (Ensure 
that the participant has read the information and consent form, and go through the 
information outlined in both) 
Before we start, I'd just like to go over some of the information provided in the 
information sheet, and answer any questions you might have. As outlined in the 
information sheet, as part of the interview, I' II be asking you some questions about 
you medical history. With your permission, I would like to contact your G.P. This is 
primarily done so that all health professionals involved in your care are informed of 
your medication and your health status, so we can better manage your treatment. I 
will only contact him/her with your permission, and we will only discuss information 
regarding your medication and your physical/medical health . If you do not want me 
to contact your G.P, this will not affect your ability to take part in this study or 
receive treatment from any other service provider. Do you have_any questions about 
ili~ -
Is it ok if I contact your G.P after ou~ interview? y N 
As part of the interview, I will also be recording some data on your heart rate and 
skin conductance. In order to get accurate measures, I will need you to answer some 
questions about your activities this morning, and to record your height at the end of 
the interview. 
Confidentiality between you, me, and my supervisor is preserved as much as 
possible, however, in the case that I feel there is a risk of harm to yourself or others, 
then I am obliged to involve other relevant agencies or professionals. 
Do you"have any questions? 
(Ensure that participants have understood both the information and consent form, 
and that the consent form has been signed by the participant) 
My aim today is to get an understanding of who you are and your experiences, and 
whether there is a link between various ev~nts in life, and how people feel. In order 
to do so, I' II be asking you some questions about what brought you here today, and 
some questions about yourself, your family, and your health. Does that sound ok? Do 
you have any questions? 
290 
I. I'm going to begin by asking you some general questions, which involve 
memory and recall, followed by some questions about your general attitude 
towards life at the moment. 
Start with Administration of the Addenbrookes Cognitive examination and the GDS 
2. In this next part of the interview, I'll be asking you a number of questions 
about different experiences in your life, and your thoughts and feelings 
regarding these. This part of the interview is expected to go for about __ _ 
Please let me know if you need a break or need to stop at any point during the 
interview. 
Do you have any questions? 
Begin administration of the ADIS-IV-L 
Following ADIS-!V-L, check if participant is tired, or needs a break. If they are 
happy to continue with a break, do so, continuing with the assessment of their family 
and personal history, followed by the negative events questionnaire. If not, 
reschedule a second interview for the remainder of the assessment. 
3. In this next pa1t of the inte rview, I want to ask you some __ questions about you, 
your fami ly, and your medical history in more detail. I'm going to stait by 
asking you some questions about what it was like growing up. 
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Personal History 
Developmental history 
(Attach additional notes where necessary) 
I. What was your upbringing/childhood like? 
2. What were your parents like? (Inquire as to who they are and what they do/did) 
3. What was/is your relationship with your parent/s (carer/s) like? 
4. Are they a part of your life today? If so , In what way are they involved? 
5a. Do you have brothers and/or sisters? YES NO 
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b. If yes, Inquire as to how many, who they are, age differences) 
6. What was/is (name of sibling) like? (Inquire for all siblings) 
7. What was/is your relationship with (name of sibling) like? (Inquire for all 
siblings, i.e., are they still close, amount of contact) 
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Education and employment 
1. What was your school life like?/ How did you fit into school? (Inquire as to 
where they went to school for primary, secondary and tertiary education, where 
relevant) 
2a. Do you work/ have you worked in the past? YES NO 
If yes, 
b. What do you do/ have you done (enquire about all occupational experiences) 
c. Do you enjoy your work? YES NO 
Comments 
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Relationships/Marital history 
la. Are you/ have you been in a long-term relationship? YES NO 
If yes, 
b. How long have you and your partner been together? ____ ___ _ _ 
c. How would you describe your partner and your relationship? (Inquire as to how 
they feel about their relationship, current state of the relationship) 
d. Is your partner supportive of you /Do you find your partner a source of support? 
YES NO 
2. If current partner is not the first partner, What was your previous relationship 
like? (Inquire about partner, type of relationship, supportive nature, similarity/ 
dissimilarity to current relationship) 
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Family constellation 
la. Do you have children? (Inquire about own family life) YES NO 
Comments 
If Yes, 
b. How many? (Inquire as to who they are, age differences, what they do) 
2a. What is your relationship with _ _ like? (Inquire for all children, e.g. , Are you 
still close) 
b. Are they a part of your life today? (e.g., Amount of contact) 
3a. Would you say that you get the emotional help and support you need from your 
family? 
YES NO 
b. Do you feel that you can confide in/talk about your problems with your family? 
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c. Does your family help you to make important decisions? 
YES NO 
Comments 
4a. Do you have grandchildren? YES NO 
b. If yes, How many? (Inquire as to nature of relationship) 
5a. Are there other family members such as aunts/uncles, nieces/nephews that you 
consider an important part of your life or are close to? 
YES NO 
b. If yes, Whom? 
c. What is your relationship with them like? (Inquire as to nat~re of relationship, 
amount of contact, level of support) 
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6. 
Family History (Genogram) 
0 Female f. Divorced/ separated 
■ Male x - Deceased 
• Affected 
Paternal Family Maternal Family 
\ 
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Friendships and social groups 
1. What is your social network like? (Inquire as to who makes up this social 
network, frequency of contact) 
2. How would you describe your friends and your relationship? (i.e., are you able to 
confide in your friends and/or are you able to talk to friends about any of your 
problems?) 
3. Do you find your friends to be a source of support? 
Comments 
YES NO 
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Is there anything about your friends, family or relationship that you would like to 
add, or that we have not covered? 
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Health and Medical History 
Now I am going to ask you some questions about your current health status and 
your views about your health, as well as your medical history, and medication 
use. 
If the client has given consent to contact and exchange information with their G.P, 
then, 
I. Who is your general practitioner? 
2. How often do you see your G.P? ___________ _ 
3. Are you involved with and/or receiving treatment from any other services? 
y N 
If yes, other services currently involved in clients care: ( can tick more than one) 
□ Department of Community Services □ Mental Health ACT 
□ Family Support Agency □ Older Persons Mental Health ACT 
□ Aged Care Service □ Other 
(Aged and community care) 
Contact Details: 
Health status 
4. Do you experience any physical problems on a regular basis? (e.g., 
headaches, extreme tiredness, stomach aches?) Y N 
a. If yes, specify (type of problem, since when) 
b. How often do you experience (type of problem)? 
0----------1----------2----------3----------4----------5----------6----------7----------8 
Never Rarely Occasionally Frequently Constantly 
None 
c. When you experience this problem, how severe is/are the (name 
problem)? 
O---------- l ----------2----------3----------4----------5----------6----------7----------8 
Mild Moderate Severe Very severe 
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a. 
b. 
C. 
d. 
e. 
f. 
g. 
5. Do you or have you had a chronic medical/physical illness? 
a. If yes, specify (type of illness, when this illness began) 
y N 
b. What is the current status of (illness)? (i.e is it ongoing, are you receiving 
treatment and if so, what kind, has this been treated or subsided) 
6. Do you experience any physical pain? y N 
If yes, what kind of pain (where)? _______________ _ 
When did this begin? 
7. The following questions are about activities that you might do in a typical 
day. Does your health now your limit your ability to do any of these 
activities? If so, how much? (Write the number on the corresponding line 
according to the following scale) 
'Y Not at all Limited Limited Activities limited a little a Lot 
Vigorous activities, such as jogging or running, I 2 3 
lifting heavy objects, or participating in sports 
Moderate activities, such as pushing a vacuum I 2 3 
cleaner, moving furniture, bowling, or playing golf. 
Light .activities, such as walking 1 2 3 
Climbing stairs 1 2 3 
Bending, kneeling, or stooping 1 2 3 
Bathing and dressing yourself 1 2 3 
Other? 1 2 3 
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Medical conditions 
8. Do you have any problems with your hearing and/or vision (e.g., do you wear 
glasses, have cataracts, wear a hearing aid)? Y N 
a. If yes, specify 
Some medical conditions can mimic or influence the symptoms of anxiety. 
9. Do you have a history of any of the following medical conditions: 
Cardiovascular conditions 
a. Congestive heart failure y N 
b. Pulmonary embolism y N 
C. Angina y N 
d. Arrhythmias y N 
e. High/low blood pressure y N 
Endocrine conditions 
f. Hyperthyroidism y N 
g. Hypothyroidism y N 
h. Systemic lupus erythematosus y N 
I. Anemia y N 
Respiratory conditions 
j. Asthma Y N 
k. Chronic obstructive pulmonary disease Y N 
I. Pneumonia y N 
Do you suffer from: 
m. Arthritis y N 
n: Rheumatism y N 
0. Diabetes y N 
p. Other? y N 
~pecify, 
10.Is there a family history of any of these problems? y N 
If yes, specify: _ ___________________ __ _ 
303 
Current Medication 
Some medications can mimic or influence the symptoms of anxiety, and measures of 
physiological reactivity. 
11. Are you currently taking any of the following medications: 
a. Psychiatric medication y N 
b. Prednisolone (Prelone syrup, Blephamide eyedrops, 
Hydeltra/Hydeltrasol) y N 
C. Metatyrapone y N 
d. Phenytoin (Dilantin) y N 
e. Thyroid hormones y N 
f. Estrogen y N 
g. Diuretics y N 
12. Are you currently taking any other medications, prescribed and non-
prescribed, that have not been mentioned above? When did you start taking 
this? 
Prescriber: Medication/Dosage: Comments 
Adverse drug effects 
13. Have you ever experienced any problems with any medications (prescribed 
and non-prescribed), such as side effects or withdrawal problems? 
a. If yes, specify 
14. Do you have any allergies? 
a. If yes, specify 
y 
y N 
N 
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Substance use 
15. Use of various substances can also mimic symptoms of anxiety, as well as 
effect measures of physiological reactivity. In the next section, I'm going to 
ask you some questions about the use, including the amount and frequency of 
use of the following substances. 
Pattern of use Recent and past use 
Ever Used Last Drug Typical Frequency Comments 
Drug Category used in date Name amount of use 
past used used/day 
month 
Nicotine No □ No D 
Yes □ Yes □ Cigs /week 
Caffeine Not No il (e.g. coffee, tea, cola, 
required choco late) Yes □ /week 
Alcohol No □ No □ 
Yes □ Yes □ Drinks /week 
Cannabis No □ No □ 
Yes □ Yes □ /week 
Stimulants No □ No □ 
Yes □ Yes □ /week 
Opiates No □ No □ (Codeine, Peth id ine, 
Morphine, Methadone, Yes □ Yes □ /week Palfium, Endo□e) 
Benzodiazepines No □ No □ (Valium, Mogadon, 
Serepax, Librium, Yes □ Yes □ 
Euhypnos, Xanax, 
Tablets /week Normison, Rohv□nol) 
Hallucinogens No □ No □ 
Yes □ Yes D Tablets /week 
Inhalants No· □ No D 
Yes □ Yes □ /week 
Other No □ No □ (Please specify) 
Yes □ Yes □ /week 
Perceived Health (reverse score fo llowing items) 
16. For your age, in general, would you say your health is: 
I ---------------2---------------3---------------4---------------5 
Excellent Very good Good Fair Poor 
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17. Compared to one year ago, in general , how would you rate your health now? 
Much better than one year ago 
Somewhat better than one year ago 
About the same as one year ago 
Somewhat worse than one year ago 
Much worse than one year ago 
2 
3 
4 
5 
Following completion of assessment of history, check if participant is tired, or needs 
a break. If they are happy to continue with a break, do so, continuing with the 
administration of the negative events questionnaire. 
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Date: 
ID: 
GAi: Please answer the items according to how you've felt in the last week. 
Tick the circle under AGREE if you mostly agree that the item describes you; 
tick the circle under DISAGREE if you mostly disagree that the item describes 
you. 
AGREE DISAGREE 
1 I worry a lot of the time. 0 0 
2 I find it difficult to make a decision. 0 0 
3 I often feel jumpy. 0 0 
4 I find it hard to relax. 0 0 
5 I often cannot enjoy things because of my 0 0 
worries. 
6 Little things bother me a lot. 0 0 
7 I often feel like I have butterflies in my 0 0 
-- L 
8 I think of myself as a worrier. 0 0 
9 I can't help worrying about even trivial .. o 0 
•h;~~~ 
10 I often feel nervous. 0 0 
11 My own thoughts often make me anxious. 0 0 
12 I get an upset stomach due to my 0 0 
··--- ~--
13 I think of myself as a nervous person. 0 0 
14 I always anticipate the worst will happen. 0 0 
15 I often feel shaky inside. 0 0 
16 I think that my worries interfere with my 0 0 
1;~~ 
17 My worries often overwhelm me. 0 0 
18 I sometimes feel a great knot in my 0 0 
~•~.._,,,.h 
19 I miss out on things because I ,worry too 0 0 
ml'~h 
20 I often feel upset. 0 0 
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Date: _ __ _ 
Client ID: _ _ _ _ 
The Penn State Worry Questionnaire 
Enter the number that best describes how typical or characteristic each item is of 
you, putting the number next to the item. 
1--------------- 2--------------- 3--------------- 4----------------5 
Not at all 
Typical 
Somewhat 
Typical 
Very 
Typical 
1. If I don't have enough time to do everything I don't worry about it. 
2. My worries overwhelm me. 
3. I don't tend to worry about things. 
4. Many situations make me worry. 
5. I know I shouldn't worry about things, but I just can't help it. 
6. When I am under pressure I worry a lot. 
7. I am always worrying about something. 
8. I find it easy to dismiss worrisome thoughts. 
9. As soon as I finish one task, I start to worry about everything 
else I have to do. 
10. I never worry about anything. 
11. When there is noth\ng more I can do about a concern, I don't worry 
about it anymore. 
12. I've been a worrier all my life. 
13. I notice that I have been worrying about things. 
14. Once I start worrying, I can't stop. 
15. I worry all the time. 
16. I worry about projects until they are all done. 
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Date: 
ID: 
(GDS- Short Form) 
Circle the response that best describes how you feel in response to 
each of the following statements 
1. Are you basically satisfied with your life? 
2 Have you dropped many of your activities and interests? 
3 D o you feel that your life is empty? 
4 Do you often get bored? 
5 Are you in good spirits most of the time? 
6 Are you afraid that something bad is going to happen to you? 
7 D o you feel happy most of the time? 
8 Do you often feel helpless? 
9 D o you prefer to stay at home, rather than going out and doing 
new things? 
10 Do you feel you have more problems with memory than most? 
11 D o you think it is wonderful to be alive now? 
12 Do you feel pretty worthless the way you are now? 
13 D o you feel full of energy? 
14 D o you feel that your situation is hopeless? 
15 D o you think that most people are better off than you are? 
Yes / No 
Yes / No 
Yes/ No 
Yes/ No 
Yes/ No 
Yes/ No 
Yes / No 
Yes / No 
Yes/ No 
Yes/ No 
Yes/ No 
Yes / No 
Yes / No 
Yes / No 
Yes/ No 
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Date: ___ _ 
Client ID:. ___ _ 
The Self-Efficacy Scale (SES) 
Instructions: This questionnaire is a series of statements about your personal 
attitudes and traits. Each statement represents a commonly held belief. Read each 
statement and decide to what extent it describes you. There are no right or wrong 
answers. You will probably agree with some of the statements and disagree with 
others. Please indicate your own personal feelings about each statement below by 
marking the letter that best describes your attitude or feeling. Please be very 
truthful and describe yourself as you really are, not as you would like to be. 
Mark: A If you Disagree Strongly with the statement 
B If you Disagree Moderately with the statement 
C If you Neither Agree nor Disagree with the statement 
D If you Agree Moderately with the statement 
E If you Agree Strongly with the statement 
A------------------B------------------C-----------------D-----------------E 
Strongly 
Disagree 
Moderately 
Disagree 
1. I like to grow houseplants. 
Neither Agree 
nor Disagree 
Moderately 
Agree 
2. When I make plans, I am certain I can make them work. 
3. One of my problems is that I cannot get down to work when I 
should. 
4. If! can't do a job the first time, I keep trying until I can. 
5. Heredity plays the major role in determining one's personality. 
6. It is difficult for me to make new friends . 
7. When I set important goals for myself, I rarely achieve them. 
8. I give up on things before completing them. 
9. I like to cook. 
10. If I see someone I would like to meet, I go to that person instead of 
waiting for him or her to come to me. 
11. I avoid facing difficulties. 
12. If something looks too complicated, I will not even bother to try it. 
13. There is some good in everybody. 
Please Turn Over 
Strongly 
Agree 
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A------------------B------------------C----------------D--------------E 
Strongly 
Disagree 
Moderately 
Disagree 
Neither Agree 
nor Disagree 
Moderately 
Agree 
14.Ifl meet someone interesting who is hard to make friends with, 
I'll soon stop trying to makes friends with that person. 
Strongly 
Agree 
15. When I have something unpleasant to do, I stick with it until I finish it. 
16. When I decide to do something, I go right to work on it. 
17. I like science. 
18. When trying to learn something new, I soon give up ifl am not 
initially successful. 
19. When I'm trying to become friends with someone who seems 
uninterested at first, I don't give up easily. 
20. When unexpected problems occur, I don' t handle them well. 
21. Ifl were an artist, I would like to draw children. 
22. I avoid trying to learn new things when they look too difficult to me. 
23. Failure just makes me try harder. 
24. I do not handle myself well in social gatherings. 
25. I very much like to ride horses. · 
26. I feel insecure about my ability to do things. 
27. I am a self-reliant person. 
28. I have acquired my friends through my personal abilities at 
making friends. 
29. I give up easily. 
30. I do not seem capable of dealing with most problems that come 
up in· my life. 
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Date: 
- - ---
Client ID: 
----
The Anxiety Control Questionnaire (ACQ) 
Listed below are a number of statements describing a set of beliefs. Please 
read each statement carefully and, on the 0-5 scale given, indicate how much 
you think each statement is typical of you. 
0--------------- 1 --- --- ---------2------------- --3--------- ------4---------------5 
Strongly Moderately Slightly Slightly Moderately Strongly 
Disagree Disagree Disagree Agree Agree Agree 
1. I am usually able to avoid threat quite easily. 
2. How well I cope with difficult situations depends on whether 
I have outside help. 
3. When I am put under stress, I am likely to lose control. 
4. I can usually stop my anxiety from showing. 
5. When I am frightened by something, there is generally nothing 
I can do. 
6. My emotions seem to have a life of their own. 
7. There is little I can do to influence people's judgements of me. 
8. Whether I can successfully escape a frightening situation is 
always a matter of chance with me. 
9. I often shake uncontrollably. 
10. I can usually put worrisome· thoughts out of my mind easily. 
11. When I am in a stressful situation, I am unable to stop myself. 
from breathing too hard. 
12. I can·usually influence the degree to which a situation is 
potentially threatening to me. 
13. I am able to control my level of anxiety. 
14. There is little I can do to change frightening events. 
Please Turn Over 
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0---------------1---------------2---------------3---------------4---------------5 
Strongly Moderately Slightly Slightly Moderately Strongly 
Disagree Disagree Disagree Agree Agree Agree 
15. The extent to which a difficult situation resolves itself has 
nothing to do with my actions. 
16. If something is going to hurt me, it will happen no matter 
what I do. 
17. I can usually relax when I want. 
18. When I am under stress, I am not always sure how I will react. 
19. I can usually make sure people like me ifl work at it. 
20. Most events that make me anxious are outside my control. 
21. I always know exactly how I will react to difficult situations. 
22. I am unconcerned ifl become anxious in a difficult situation, 
because I am confident in my ability to cope with my symptoms. 
23. What people think of me is largely outside my control. 
24. I usually find it hard to deal with difficult problems. 
25. When I hear that someone has a serious illness, I worry that I 
am next. 
26. When I am anxious, I find it difficult to focus on anything other 
than my anxiety. 
27. I am able to cope as effectively with unexpected anxiety as I am 
with anxiety that I expect to occur. 
28. I sometime think, " Why even bother to try cope with my anxiety 
when nothing I do seems to affect how frequently or intensely I 
experience it?" 
29. I often have the ability to get along with "difficult" people. 
30. I will avoid conflict due to my inability to successfully resolve it. 
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General interview information 
The following details need to be filled in by the interviewer. 
1. Date and duration of interview 
First session: 
Date Commencement time Finishing Time __ _ 
Second session: 
Date Commencement time Finishing time __ 
2. Special observations and remarks ( e.g reason why the interview was not 
completed): 
The interview booklet needs to be filled in by the interviewer. Each question is 
preceded by brief instructions. 
There are two types of text in the booklet: 
I. cursive text: this text contains information for the interviewer and should NOT 
be read out; 
2. normal text: this text contains the information for the respondent and needs to 
be read out by the interviewer. 
Answer options: 
The interviewer is required to enter the answers of the respondent into the 
booklet. This needs to be done in the following manner: 
• When there are dotted lines after a question which do not lead to answer 
categories, the answer of the respondent is to be filled in on the dotted 
line. 
• When there are answer categories with numbers: circle the relevant 
number. 
• When there are answer categories with a square or circle before it, place a 
tick in the relevant square or circle. 
• When there are answer categories without numbers, squares or circles, 
circle the relevant word. 
• For some questions, the respondent is required to choose from a number 
of answer categories. These are printed in the questionnaire booklet. Place 
the options in front of the respondent. If possible and preferable, let the 
respondent read or look into the interview booklet, and complete the 
questions together. 
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Check with the respondent if they are getting tired or need a break. If so, have a 
short break, or schedule another appointment in which to complete the 
interview. Allow for emotional reactions. 
Life experiences 
The following questions are about events which you may have experienced in life. 
The questions have been sub-divided into the following categories: parents, brothers 
and sisters, partners, children, other important people in your life, about yourself, 
other events, and war-experiences. 
For each question, you are also asked to indicate the period in your life 
during which particular events were experienced. 
These periods can be classified as follows: 
• Childhood (from Oto age 15) 
• Early and middle adulthood (from age 16 to age 49) 
• Late life (from age 50 onwards) 
• In the last 12 months (the year prior to treatment) 
They appear on the chart. Place the chart with the age-categories in front of the 
responder.? 
Questions may be answered yes or no. Some questions have multi-lpe choice answers. 
When scoring from the list make a choice for EACH category and circle it. 
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Category 1: PARENTS 
1. Who were you brought up by (you may tick more than one) 
0 Biological mother 
O Biological father 
O Biological parents 
0 Others, e.g. 0 Family members 
0 Step-parents 
0 Adoptive-parents 
0 Acquaintances 
0 Foster home 
0 Other 
*Instructions for >1 'situation' 
entire youth 
0 
0 
0 
0 
0 
0 
> 1 situation* 
0 
0 
0 
0 
0 
0 
Check whether the respondent was brought up for his/her whole youth by the same 
person(s), or whether there were more situations in the same category. For example: was 
the respondent brought up for his/her whole youth by adoptive-parent(s), or did the 
respondent live in various adoption families when growing up; was the respondent brought 
up in I foster home, or were they placed in more than one home? 
If the respondent was NOT brought up by the biological parents, then read 'carers' instead 
of 'parents 'for the following questions. 
Early and Late - life 
Childhood middle (age 50 In the last 
(0-15) adulthood and 12 months 
(a1:1es 16-49) onwards) 
2. Is your biological father 
deceased? Yes No Yes No Yes No Yes No 
If yes, what was the cause? N/A N/A N/A N/A 0 _suicide 
0 murder 
0 accident 
0 natural causes 
0 unknown 
0 other, 
namely ............. 
3. Is your biological mother 
deceased? Yes No Yes No Yes No Yes No 
If yes: what was the cause? N/A N/A N/A N/A 0 suicide 
0 murder 
0 accident 
0 natural causes 
0 unknown 
0 other, namely ............. 
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Childhood Early and Late - life In the last 
(0-15) middle (age 50 12 months 
adulthood and 
(ages 16-49) onwards) 
*3a This question is to be 
answered only if not (solely) 
Yes No Yes brought up by biological No Yes No Yes No 
parent(s): 
N/A N/A N/A N/A 
Are any of the people who 
brought you up deceased? 
Whom Whom Whom Whom 
If yes: what was the cause? 
(can tick more than one) 
0 suicide 
0 murder 
0 accident 
0 natural causes 
0 unknown 
O other, namely ....... .. ... 
4. Have either of your parents Yes No Yes No Yes No Yes No 
been away from home for a 
year or more when you N/A N/A N/A N/A 
were a child? 
5. Did your parents ever have Yes No Yes No Yes No Yes No 
serious financial problems? N/A N/A N/A N/A 
6. Did your parents ever have Yes No Yes No Yes No Yes No 
serious relationship N/A N/A N/A N/A problems? 
7. Have your parents been Yes No Yes No Yes No Yes No 
divorced OR separated ? N/A N/A N/A N/A 
8. Have either of your parents Yes No Yes No Yes No Yes No 
ever suffered from a 
chronic or life-threatening N/A N/A N/A N/A 
physical illness? 
9. Have either of your parents Yes No Yes No Yes No Yes No 
been addicted to alcohol , 
drugs, medications, or N/A N/A N/A N/A 
gan:,bling , for a year or 
more? 
10. Have either of your parents Yes No Yes No Yes No Yes No 
ever been admitted to a N/A N/A N/A N/A 
osvchiatric clinic? 
11. Have either of your parents Yes No Yes No Yes No Yes No 
ever attempted to commit 
suicide, without fatal N/A N/A N/A N/A 
consequences? 
323 
Childhood Early and Late - life In the last 
(0-15) middle (age 50 12 months 
adulthood and 
(ages 16-49) onwards) 
12. Have either of your parents Yes No Yes No Yes No Yes No 
ever been convicted of a 
criminal offence or N/A N/A N/A N/A 
sentenced to prison? 
13. Have you ever had to bring Yes No Yes No 
up your (half/step) brothers N/A N/A 
and sisters whilst you were 
i:irowing up? 
14. Were you often left to your Yes No Yes No 
own devices by your 
parenVs, and thus feel that N/A N/A 
you did not receive enough 
care and attention when 
growinq uo? 
15. Have you ever been Yes No Yes No Yes No Yes No 
humiliated or tormented by N/A N/A N/A NIA ( one of) your oarenVs? 
16. Were you ever seriously Yes No Yes No Yes No Yes No 
disciplined by either of your 
parents? NIA N/A N/A N/A 
17. Have you ever had sexual Yes No Yes No Yes No Yes No 
intercourse with (one of) N/A N/A N/A N/A 
vour parent(s)? 
18. Have you ever had sexual Yes No Yes No Yes No Yes No 
contact with ( one of) your 
parents, such as touching N/A N/A N/A NIA 
or showing of sexual body 
parts ( other than sexual 
intercourse)? 
19. Have you ever had such a Yes No Yes No Yes No Yes No 
bad relationship with either N/A N/A N/A N/A 
of your parents that you felt 
a great deal of ill will 
towards him or her? 
20. Have there been other 
negative events in 
connection with your 
parents (or upbringers) 
which have not yet been 
mentioned here? Yes No Yes No Yes No Yes No 
1. NIA N/A NIA NIA 
Yes No Yes No Yes No Yes No 2. 
N/A NIA N/A NIA 
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Category 2: BROTHERS and SISTERS 
Do you have (half/step) brothers or sisters, or have you had them? Yes No 
If No: would you have liked to have them? Yes No 
(If the client does not have brothers or sisters, Go to the PARTNERS category) 
In the questions below, the wording brothers and sisters also includes half and/or 
step brothers and sisters 
How many brothers and sisters do you have (have you had)? 
Childhood Early and Late - life In the last 
(0-15) middle (age 50 and 12 months 
adulthood onwards) 
(ages 16-49) 
21. Are any of your brotherls Yes No Yes No Yes No Yes No 
or sisterls deceased? NIA N/A N/A N/A 
If yes: what was the cause? 
(complete for all siblings) Whom Whom Whom Whom 
0 suicide 
0 murder 
0 accident 
0 natural causes 
0 unknown 
0 other, namely ............ 
22. Have any of your brothers Yes No Yes No Yes No Yes No 
or sisters ever suffered from N/A N/A NIA NIA 
a chronic or life-threatening 
physical illness? 
23. Have any of your brother/s Yes No Yes No Yes No Yes No 
or sister/s been addicted to 
alcohol, drugs, medicines, N/A N/A N/A N/A 
or gambling for a year or 
more? 
24. Have any of your brother/s Yes No Yes No Yes No Yes No 
or sister/s ever been NIA N/A N/A N/A 
admitted to a psychiatric 
clinic? 
25. Have any of your brothers Yes No Yes No Yes No Yes No 
or sisters ever made an 
attempt to commit suicide, N/A NIA NIA N/A 
without fatal 
consequences? 
26. Have you ever been No Yes No Yes No Yes No Yes 
humiliated or tormented by N/A N/A N/A N/A ( one of) your bother/s or 
sister/s over a lonq period? 
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Childhood Early and Late - life In the last 
(0-15) middle (age 50 and 12 months 
adulthood onwards) 
(ages 16-49) 
27. Have you ever been Yes No Yes No Yes No Yes No 
seriously wounded or 
disciplined by any of your NIA NIA NIA NIA 
brothers or sisters? 
28. Have you ever had sexual Yes No Yes No Yes No Yes No 
intercourse with ( one of) NIA NIA NIA your brotherls or sisterls NIA 
aaainst vour wi ll? 
29. Have you ever had sexual Yes No Yes No Yes No Yes No 
contact with ( one of) your 
brotherls or sisterls such as NIA NIA NIA NIA 
touching or showing of 
sexual parts of the body, 
aaainst vour wi ll? 
30. Have you ever had such a Yes No Yes No Yes No Yes No 
bad relationship with any of NIA your brothers or sisters that NIA NIA NIA 
you fe lt ill wi ll toward him or 
her? 
31. Have there been other 
negative events in 
connection with your 
brotherls or sisterls which 
have not been mentioned 
as yet? (detai ls below) 
Yes No Yes No Yes No Yes No 1 .............. ... ...... 
NIA NIA NIA NIA 
........ ... .. .. . ..... .... ....... 
2. .... . ... , ... . ... ...... .... . .. .... .. Yes No Yes No Yes No Yes No 
. . . . · ·· ·· · · · ··· · ··· · · · · · · ••,0 •• ···· · ···· NIA NIA NIA NIA 
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category 3: PARTNERS 
Are you, or have you been in a long-term relationship, i.e. are you married, have you 
lived with someone for a minimum of 3 months, or have you had a long-term 
relationship in the past? 
Yes No 
If no: would you like to have a partner? Yes No 
If you have not been in a long term relationship, go to the CHILDREN category 
How many long-term relationships have yon had? ... ........... ........ . 
Childhood Early and Late - life In the last 
(0-15) middle (age 50 12 months 
adulthood and 
(ages 16-49) onwards) 
32. Has your partner (or a Yes No Yes No Yes No 
previous partner) passed NIA 
away during your 
NIA NIA 
relationship? 
If so: what was the cause? 
Whom Whom Whom 
(can give more than one 
reason) 
0 suicide 
0 murder 
0 accident 
0 natural causes 
0 unknown 
0 other, namelv ...... 
33. Have .either yourself and Yes No Yes No Yes No 
( one of) your partnerls NIA NIA NIA 
ever had serious financial 
problems? 
34. Have you and (one of) Yes No Yes No Yes No 
your partnerls ever had NIA NIA NIA 
serious relationship 
problems? 
35. Have you been or are you Yes No Yes No Yes No 
divorc.ed or separated from NIA NIA NIA (one of) your partnerls? 
36. Does or did (one of) your Yes No Yes No Yes No 
partnerls suffer from a NIA NIA NIA form of dementia? 
37. Does or did (one of) your Yes No Yes No Yes No partnerls suffer from a 
NIA NIA NIA chronic or life-threatening 
physical illness (excluding 
dementia)? 
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Childhood Early and Late - life In the last 
(0-15) middle (age 50 12 months 
adulthood and 
(ages 16-49) onwards) 
38. Has (one of) your partnerls Yes No Yes No Yes No 
been addicted to alcohol, NIA NIA NIA drugs, medications, or 
gambling for a year or 
more? 
39. Has (one of) your partnerls Yes No Yes No Yes No 
ever been admitted to a NIA NIA NIA psych iatric clinic (during 
vour relationship)? 
40. Has (one of) your Yes No Yes No Yes No 
partnerls ever tried to NIA NIA NIA commit suicide, without 
fatal results? 
41 . Has ( one of) your partnerls Yes No Yes No Yes No 
over been convicted of a 
crime or sentenced to a NIA NIA NIA 
prison term (during your 
relationship)? 
42. Has (one of) your partnerls Yes No Yes No Yes No 
ever worked against you in NIA NIA NIA reach ina vour aoals? 
43. Have you and (one of) Yes No Yes No Yes No 
your partnerl s had NIA NIA NIA problems in having your 
own chi ldren? 
44. Have you ever had sexual 
problems with (one of) Yes No Yes No Yes No 
your partnerls, such as not NIA NIA NIA 
enjoying sex or problems 
with oettinq? 
45. Has (one of) your partnerls Yes No Yes No Yes No 
ever cheated one you with NIA NIA NIA 
someone else? 
46. Have you ever been 
humiliated or tormented Yes No Yes No Yes No 
by ( one of) your partnerls NIA NIA 
over a long period of time? NIA 
47. Have you ever been 
deliberately wounded or Yes No Yes No Yes No 
diciplined by ( one of) your NIA NIA NIA 
oartnerl s? 
48. *Have you ever had sexual 
intercourse with ( one of) Yes No Yes No Yes No 
your partnerls against your NIA NIA NIA 
will? 
49. *Have you ever had sexual 
contact against your will Yes No Yes No Yes No 
with (one of) your NIA NIA NIA 
partnerls ( different from 
sexual intercourse)? 
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Childhood Early and Late- life In the last 
(0-15) middle (age 50 12 months 
adulthood and 
(ages 16-49) onwards) 
50. Has (one of) your partnerls 
ever forced you into Yes No Yes No Yes No 
prostitution? NIA NIA NIA 
51. Have there been any other 
negative events in relation 
to your partnerls which 
have not as yet been 
mentioned? 
Yes No Yes No Yes No 1 . ............... .... ..... .. . ... .. . NIA NIA NIA 
........ .. .. .. . .. . .. . .. . 
2. ... . ..... . ....... ... .. . .. . .. . Yes No Yes No Yes No 
.... .. .... .. .... .. ... ... ... .. .... 
NIA NIA NIA 
• Rather, say, " Have you ever engaged in any activities at the request of your 
partner against your will" in place of questions 48 and 49 
category 4: CHILDREN 
Have you had chi ldren? YES NO 
If no , Go to category OTHER PERSONS WHO ARE IMPORTANT FOR YOU 
How many children do you have or have you had? ........ . 
Childhood Early and Late - life In the 
(0-15) middle (age 50 last 12 
adulthood and months 
(aqes 16-49) onwards) 
52. Have any of your children Yes No Yes No Yes No Yes No 
passed away? NIA NIA NIA NIA 
If yes: what was the 
cause/s Whom Whom Whom Whom 
O Suicide 
0 Murder 
0 accident 
0 Natural causes 
0 unknown 
O Other, namely 
...... ... .. 
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Childhood Early and Late - life In the 
(0-15) middle (age 50 last 12 
adulthood and months 
(ages 16-49) onwards) 
53 . Have you ever had serious Yes No Yes No Yes No Yes No problems with bring ing up 
your child(ren)? N/A N/A N/A N/A 
54. Has someone else ever Yes No Yes No Yes No Yes No 
taken over the upbringing of 
vour children? N/A N/A N/A N/A 
55. Has the relationship with Yes No Yes No Yes No Yes No 
(one of) your chi ld(ren) been 
N/A N/A N/A N/A broken? 
56. Is (one of) your chi ld(ren) Yes No Yes No Yes No 
divorced or separated? NIA N/A N/A 
57. Did (one of) your ch ild(ren) Yes No Yes No Yes No Yes No 
suffer from a chronic or life-
th reatening physical illness? N/A N/A N/A N/A 
58. Has (one of) you r child(ren) 
Yes No Yes No Yes No been addicted to alcohol, 
drugs, medication, or 
N/A N/A N/A gambling for a year or 
more? 
59 . Has (one of) your ch ild(ren) 
Yes No Yes No Yes No ever been admitted to a 
psychiatric clinic? N/A N/A N/A 
60. Has (one of) your child(ren) 
Yes No Yes No Yes No ever tried to commit su icide, 
without fatal results? N/A N/A N/A 
61. Has (one of) your child(ren) 
Yes No Yes No Yes No ever been convicted of a 
crimina l offence or N/A N/A N/A 
sentenced to a prison term? 
62. Have there been any other 
negative events with relation 
to your child(ren) which 
have not been mentioned as 
yet? Yes No Yes No Yes No Yes No 
1. ········ · ... . .. . .. ... ..... .. . N/A N/A N/A N/A 
. . . . . . . . . . . . . . . . . . . ' .. . ' .. .. 
Yes No Yes No Yes No Yes No 
2. . . . . . . . . . . . . . . . . . . . . . . . . . . N/A N/A N/A N/A 
... , ..... ······ ···· ··· ········ 
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Category 5: OTHER PEOPLE WHO ARE IMPORTANT TO YOU 
The questions below are about other people who are important to you. This can 
include people such as friends, grand-children, family-in-law, confidants, a 
mentor or exemplar (e.g a priest, or pastor) or anyone who is or was important 
to you. 
Childhood Early and Late - life In the last 
(0-15) middle (age 50 12 months 
adulthood and 
(ages 16- onwards) 
49) 
63. Have you ever had a bad Yes No Yes No Yes No Yes No 
relationship with someone 
who was important to you , N/A N/A N/A NIA 
over an extended period of 
time? 
64. Is someone who was 
important to you now 
deceased? Yes/No 
If yes, whom? 
(can tick more than one). 
0 grand-child Yes No Yes No Yes No Yes No 
What was the cause? N/A N/A N/A N/A 
O suicide 
0 murder 
0 accident 
0 natural causes 
0 unknown 
0 other, namely ............. 
0 family (in-law) Yes No Yes No Yes No Yes No 
What was the cause? N/A N/A N/A N/A 
0 suicide 
0 murder 
0 accident 
0 natural causes 
0 unknown 
0 other, namely ..... .. .. .. ... 
Yes No Yes No Yes No Yes No 
0 friend/acquaintance N/A N/A N/A NIA 
What was the cause? 
0 suicide 
0 murder 
0 accident 
0 natural causes 
0 unknown 
0 other, namelv ... ...... ..... 
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0 confidant Yes No Yes No Yes No Yes No 
What was the cause? N/A N/A N/A N/A 
0 suicide 
0 murder 
0 accident 
0 natural causes 
0 unknown 
0 other, namely .......... .... 
O mentorlexamplar Yes No Yes No Yes No Yes No 
N/A N/A N/A N/A 
What was the cause? 
0 suicide 
0 murder 
0 accident 
O natural causes 
0 unknown 
0 other, namely ............. 
Yes No Yes No Yes No Yes No 
Others, namely. . .......... N/A N/A N/A N/A 
What was the cause? 
O suicide 
0 murder 
O accident 
0 natural causes 
0 unknown 
0 other, namely .. . ........... 
65. Have you ever been 
humiliated or tormented for Yes No Yes No Yes No Yes No 
a considerable period by N/A N/A N/A N/A 
someone who was 
important to you? 
66. Have you ever been 
Yes No Yes No Yes No Yes No deliberately wounded or 
disciplined by someone N/A N/A N/A N/A 
who was important to vou? 
67. Have there been other 
negative events with 
relc1tions to important 
people which have not 
been mentioned as yet? 
(List below) 
Yes No Yes No Yes No Yes No 
1 . ... .......... .... .... ..... .... ...... 
N/A N/A N/A N/A 
..... ...... ... ...... .... .. .. .... ... 
2 . .... ........ ..... ........... ... .... . Yes No Yes No Yes No Yes No 
.... ......... ..................... N/A N/A N/A N/A 
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Category 6: YOURSELF 
Childhood Early and Late life In the last 
(0-15) middle (age 50 and 12 months 
adulthood onwards) 
(ages 16-
49) 
68. During your childhood Yes No 
were you ever teased, 
excluded or ignored by NIA 
other children? 
69. Did you go to boarding Yes No Yes No 
school and board NIA NIA 
70. Do you have a chronic Yes No Yes No Yes No Yes No 
or life-threatening 
physical illness? NIA NIA NIA NIA 
71 . Have you ever had to Yes No Yes No Yes No Yes No 
remain in hospital or at 
home for a long time, 
NIA NIA NIA NIA (i .e. 3 months or 
longer) , due to a 
physical illness? 
72. Have you ever been Yes No Yes No Yes No Yes No 
addicted to alcohol, 
drugs, medications, or 
NIA NIA NIA NIA gamblinJJ.? 
73. Have you ever been Yes No Yes No Yes No Yes No 
admitted to a 
psychiatric clinic? NIA NIA NIA NIA 
74. Have you ever been Yes No Yes No Yes No Yes No 
convicted of a crime or 
sentenced to a prison 
NIA NIA NIA NIA term? 
75. Have you ever been Yes No Yes No Yes No Yes No discriminated against? 
If yes: what was the NIA NIA NIA NIA 
reason? 
O race 
O belief 
O sex/gender 
O sexual preference 
O age 
O other, 
namely .......... 
76. Have you ever had Yes No Yes No Yes No Yes No 
concerns about your 
sexual orientation? NIA NIA NIA NIA 
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77. Have you ever had Yes No Yes No Yes No Yes No concerns about your 
religious beliefs? NIA NIA NIA NIA 
If yes: in what way? 
78. Have you ever had Yes No Yes No Yes No serious financial 
problems? NIA NIA NIA 
79. Have you ever been Yes No Yes No Yes No 
unemployed against 
your will for an 
NIA extended period of NIA NIA 
time, e.g. 6 months or 
longer? 
80. Have you ever Yes No Yes No Yes No Yes No 
experienced a loss of 
people, a nice place to 
NIA NIA NIA NIA live, or of customs, due 
to moving to a new 
place of abode? 
81 . Have you ever Yes No Yes No Yes No Yes No 
experienced a violent 
crime? NIA NIA NIA NIA 
82 . Have you ever nursed Yes No Yes No Yes No Yes No 
someone for a longer 
period , e.g. 3 months or 
NIA NIA NIA NIA more (not 
professionally)? 
83. Have you or your Yes No Yes No Yes No Yes No partner ever had a 
miscarriage or still-born 
NIA NIA NIA NIA child? 
84. Have you or your Yes No Yes No Yes No Yes No partner ever had an 
abortion? NIA NIA NIA NIA 
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Category 7: OTHER EVENTS 
Childhood Early and Late - life In the last 
(0-15) middle (age 50 and 12 months 
adulthood onwards) 
(ages 16-
49) 
85. Have you ever experienced 
a crisis, such as: 
0 direct involvement with a 
fire. 
0 major flood Yes No Yes No Yes No Yes No 
0 storm/tempest 
Yes No Yes No Yes No Yes No 0 other natural disaster 
(earthquake, vulcanic Yes No Yes No Yes No Yes No 
eruption) 
0 car or train accident Yes No Yes No Yes No Yes No 
0 bomb attack (NOT during Yes No Yes No Yes No Yes No war) 
0 other, namelv ................ Yes No Yes No Yes No Yes No 
86. Has anyone ever made Yes No Yes No Yes No Yes No threatening sexual remarks 
to you? 
NIA N/A N/A N/A 
If yes: who? 
0 Upbringer(s) 
0 brother(s)/sister(s) 
0 other family members 
0 acquaintance(s) 
0 others, namelv ........... .... 
87. Have you ever engaged in Yes No Yes No Yes No Yes No 
any activity or been asked to 
do something by someone 
N/A N/A N/A N/A known to you (who has not 
yet been mentioned) , 
anainst vour will? 
88. Have you ever, against your Yes No Yes No Yes No Yes No 
will, had sexual contact with 
·a stranger, such as touching 
N/A N/A N/A N/A or showing of sexual parts 
of the body ( other than 
sexual intercourse)? 
89. Are there any other negative 
experiences which have not 
yet been mentioned? 
Yes No Yes No Yes No Yes No 1 . ...... ...................... .. .. .. . 
NIA N/A N/A N/A 
...... ..... .... ......... ....... .... .. 
Yes No Yes No Yes No Yes No 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
N/A N/A N/A N/A 
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Category 8 : WAR EXPERIENCES 
Have you ever personally experienced war? 
If no: This is the end of this section . 
If yes: which one? (Can fill in more than one) 
0 WVl/1 (1914-1918) 
0 WVl/2 (1940-1945) 
0 Indonesian war of independence (1945-1950) 
0 Vietnam War 
0 Others, namely .... .... .... .... ............... .. . 
Did you experience the following events personally during a war (in war-or battle 
situations?) 
Childhood Early and Late life In the 
(0-15) middle (age 50 last 12 
adulthood and months 
(ages 16- onwards) 
49) 
90. Served as a military Yes No Yes No Yes No Yes No 
volunteer, in a military 
service call up, or as a N/A N/A N/A N/A 
military _JJ_rofessional 
91 . Violent activities experienced Yes No Yes No · -Yes No Yes No in immediate surroundings 
NIA N/A N/A N/A 
92. Loss of friends or family Yes No Yes No Yes No Yes No 
members 
N/A N/A N/A N/A 
93. Seriously wounded, Yes No Yes permanently disabled or No Yes 
No Yes No 
contracted illness N/A N/A N/A N/A 
94. Personally being tortured Yes No Yes No Yes No Yes No 
N/A N/A N/A N/A 
95. Your life was in danger Yes No Yes No Yes No Yes No 
N/A N/A N/A N/A 
96. Serious hunger problems Yes No Yes No Yes No Yes No 
N/A N/A N/A N/A 
97. Experienced bombardments Yes No Yes No Yes No Yes No 
N/A N/A N/A N/A 
98. You personally needed to Yes go underground 
No Yes No Yes No Yes No 
N/A N/A N/A N/A 
if yes: what was the reason 
for that? 
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O escape from forced 
labour 
O Jewish underground 
O resistance activities 
0 other, namely ...... ...... 
99. Experienced forced Yes No Yes No Yes No Yes No 
evacuation 
NIA NIA NIA NIA 
100. Home or living Yes No Yes No Yes No Yes No 
environment destroyed 
NIA NIA NIA NIA 
101 . Interned or imprisoned Yes No Yes No Yes No Yes No 
NIA NIA NIA NIA 
102. Placed on transport Yes No Yes No Yes No Yes No (note: to concentration 
camps) NIA NIA NIA NIA 
103. Forced labour Yes No Yes No Yes No Yes No 
NIA NIA NIA NIA 
104. Worked for the Yes No Yes No Yes No Yes No 
resistance movement 
NIA NIA NIA NIA 
105. Accused of collaboration. Yes No Yes No Yes No Yes No 
If yes: this was: 
NIA NIA NIA NIA 0 true 
0 untrue 
106. Personally killed Yes No Yes No --Yes No Yes No 
someone 
NIA NIA NIA NIA 
107. Are there any other 
negative experiences 
relating to the war which 
have not been mentioned 
before? 
1. ............ ... ... ..... ... · · ··· · · Yes No Yes No Yes No Yes No 
NIA NIA NIA NIA 
... ......... . ... .. .. ............ . 
2 . .... .. .. ... . .. .. .. . .. . ......... Yes No Yes No Yes No Yes No 
NIA NIA NIA NIA 
... .... .... .. .. . ... . .. , •. . ••.. • .. 
This is the end of this section. 
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Early and late-onset anxiety in older adults: Implications for the clinical presentation 
and management of anxiety in late-life. 
CLIENT INFORMATION SHEET 
The purpose of this study is to gain a better understanding of anxiety and worry in adults 
over 55 and the life events that may contribute to the development of these concerns. The 
study also aims to look at whether the impact of various life events and the concerns of 
people over 55 differ between individuals who feel anxious, and those who do not. Finally, 
the study aims to determine whether particular components of treatment are more effective 
in managing anxiety, and whether a person's response to treatment depends on when the 
anxiety problem began. 
The study will be conducted in two stages. If you choose to participate in this study, the 
first stage will involve attending an inte.rview and answering some questions about 
yourself, your family, your medical history, and your experiences of anxiety and 
depression. With your permission, the investigator will also communicate with your general 
practitioner with regards to your physical health and medication use. This interview will 
also include the measurement of your blood pressure and skin conductance, and the 
measurement of your height and weight. You will also be required to fill out some 
questionnaires asking you to consider various statements about how you 've been feeling 
lately, and how you feel in response to various situations. These may be completed in your 
own time and returned to the researcher in a stamped, self-addressed envelope provided . 
Alternatively, we can assist with the .completion of the questionnaire if this is preferable. 
The package of questionnaires will take about 45 minutes to complete, and the interview is 
expected to take up to three hours with breaks as required. 
Should you be considered suitable, in the second stage of the study you will be invited to 
participfite in a 12-week cognitive-behavioural (CBT) treatment programme, which will 
offer, personalised attention for your anxiety and worry problems. Throughout the 
treatment programme, as in the first study, you will be required to complete questionnaires 
asking you to consider your symptoms of anxiety and depression, and to provide ratings of 
various components of treatment. For supervision purposes, interviews and treatment 
sessions may be audio and/or videotaped. Taping of these sessions will only be undertaken 
after consultation with you. 
Your participation in this study is voluntary and greatly appreciated. You are free to 
withdraw from this study at any time and for any reason without explanation, and your 
withdrawal will not affect treatment provided by the ANU psychology clinic or any other 
treatment provider. Your participation is also confidential. All questionnaires and 
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information we collect will be kept in a locked cabinet, which can only be accessed by the 
researcher. Moreover, the questionnaires and information will be coded so that you cannot 
be identified. The research will contribute to a PhD thesis and potentially a journal art icle. 
Info rmation about the project will not be made public in any way that identifies individual 
participants. 
If you choose to participate, you are required to complete an infonned consent form 
indicating that you do wish to participate in this research and are doing so voluntarily. If, 
after reading thi s information you wish to participate in this research please sign the 
informed consent form. 
lf you have any questions regarding any of the information in this sheet or about the 
research in general , please do not hesitate to contact either of the following researchers 
Ms. Maaria Haque 
School of Psychology 
Building 39 
The Australian National University 
Canberra ACT 0200 
Ph: (02) 6 I 25 3972 
Fax: (02) 6125 0499 
Email: Maaria.Hague@anu.edu.au 
Dr. Mike Bird 
Southern Area Mental Health 
Queanbeyan NSW 2620 
Ph (02) 6124 9874 
Email: Mike.Birdralsahs .nsw.gov.au 
Dr. Richard O'Kearney 
School of Psychology 
Building 39 
The Australian National University 
Canberra ACT 0200 
Ph: (02) 6125 8158 
Fax: (02) 6125 0499_ 
Email: R.ichard.Okearney(alan u.edu.au 
If you have any concerns regarding the way the research was conducted, please contact the 
ANlJ Human Research Ethics Committee: 
Human Ethics Officer 
Human Research Ethics Committee 
The Australian National University 
Canberra ACT 0200 
Ph: (02) 6125 7945 
Email: Human.Ethics.Officer(alanu.edu.au 
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RESEARCH CONSENT FORM 
I,---------------- ----(name of participant) 
of 
- ------
(street) (Suburb/town) ( state & postcode) 
have been asked to consent to my participation in a research project entitled: 
Early and late-onset anxiety disorders in older adults: Implications for the clinical 
presentation and management of anxiety in late-life. 
I have read the information sheet fo r this study and understand its contents, and have been 
informed of the fo llowing points: 
I. The aim of this project is to ga in a better understanding of the experience of anxiety 
and the li fe events that contribute to the development of these concerns in adults 
aged 55 and above; and to investigate responsiveness to components of a treatment 
program fo r anxiety, according to the age at wh ich individuals began experiencing 
anxiety. 
2. The results obtained from the study may or may not be o( direct benefit to my 
mental health management and treatment. 
3 . a) Participation in the research project w ill invo lve attending an interview in which I 
will be asked questions about myse lf, my family, my medica l hi story, and my 
experience of past and current anxiety problems. This interview wil l take up to 2 
hours with breaks where needed; 
b) I understand that the initial interview w ill also involve the researcher taking 
measurements of my skin conductance, blood pressure, and my height and weight; 
and 
c) I understand that I w ill be asked to complete a questionnaire package as part of 
the interv iew, which will involve answering questions about my fee lings of anxiety, 
worry, and depress ion, and how I respond to various situations. This is expected to 
take approximately 45 miuutes to complete. 
4. I understand that I may also be invited to take part in a treatment program, which 
wi ll involve attending individual treatment sessions over a I 2-week period and that 
between treatment components I will be asked to complete some of the 
questionnaires completed in the first stage of the study, as well a questionnaire 
asking me to rate my experiences of the treatment and its effectiveness. 
5. I give permiss ion to the researcher to audio and or videotape the interv iew and 
treatment sess ions. 
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6. I give permission to the researcher to contact my G.P during the course ofmy 
involvement in the research project, in order to gather information about my 
physical health status and medication use. 
7. I understand that while the results of the research may be published in the form ofa 
PhD thesis and/or a journal article, my involvement and my identity will not be 
revealed in any way. 
8. I understand that the information provided by me will be kept confidential so far as 
the law permits. This form and the questionnaires will be stored separately in a 
locked office at the Australian National University. Data entered onto a computer 
will be kept in a computer accessible only by password by the researcher 
9. I understand that I may withdraw form the research project at any stage, and that 
this will not affect my mental health care in any way, now or in the future. 
10. Should I have any concerns regarding participation, I am aware that I may contact: 
Ms. Maaria Haque 
School of Psychology 
Building 39 
The Australian National University 
Canberra ACT 0200 
Ph: (02) 6125 3972 
Fax: (02) 6125 0499 
Dr. Richard O'Kearney 
School of Psychology 
Building 39 
The Australian National University 
Canberra ACT 0200 
Ph: (02) 6125 8158 
Fax: (02) 6125 0499 
Email: Maaria.Hague(a)anu.edu.au Email: Richard .Okearney(a)anu.edu.au 
11. Should I have any other problems or queries about the way in which the study was 
conducted, and I do not feel comfortable contacting the research staff, I am aware 
that I may contact: 
Human Ethics Officer 
Human Research Ethics Committee 
The Australian National University 
Canberra ACT 0200 
Ph: (02) 6125 7945 
Email: Human.Ethics.Officer(a;anu.edu .au 
After _considering all these points, I accept the invitation to participate in this project. 
Signature (of Participant): ________ _ Date: ______ _ 
Signature (of Investigator): _______ _ Date: 
-------
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Inter-rater Reliability Rating Form 
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Date: 
Client ID number: 
Clinician's Ratings and Diagnoses 
Date of birth: 
Date of initial assessment: 
Age at initial assessment: 
Age (or year of onset) of presenting problem:~----------
AXIS I 
1. 
2. 
3. 
4. 
AXIS II 
1. 
2. 
3. 
4. 
Current DSM-IV Diagnoses 
AXIS III 
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AXIS IV Recent Significant Life Events 
Problems with primary support (specify) _ _______________ _ 
Problems related to the social environment (Specify) _____________ _ 
Educational problems (Specify) ____________________ _ 
Economic problems (Specify) ____________________ _ 
Problems with access to health care services (Specify) ____________ _ 
Problems related to interaction with the legal system/ crime (Specify) ______ _ 
Other psychosocial and environmental problems (Specify) _ _________ _ 
Past DSM-IV Diagnoses 
Diagnosis Date of Onset Date of Remission 
(Or age of client, number of years ago) 
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Things to listen for: 
• Report of the client's first subjective experience of significant anxiety (i.e. , first 
onset, be it in terms of chronological age, or year) . If client is vague with regards to 
date of onset, attempt to ascertain by linking onset to objective life events reported 
(e.g, death of a family member, birth of a child ... ) . These details may come up 
throughout the interview rather than at the time the client is initially asked about 
onset (i.e., when talking about vocation, marital history etc). 
• Report of client's first help-seeking or when they first got help for emotional 
difficulty- this may be psychological or medical (i.e. , report of taking 
antidepressant or anxiolytic medication, being treated by a prescription from a G.P, 
psychiatrist, or if they have previously sought psychological help). If client does not 
report an age of onset or year, but reports when they got help, this may be seen as 
their first significant episode. [There may be differences as clients may report 
anxiety was a problem as an adolescent, but were first treated for post-natal 
depression, in this instance the clients report of first experience takes precedent]. 
• Some participants may not have a current episode/presenting problem, but will 
describe a significant episode or episodes in the past. 
• Some participants refer to having a 'panic attack ' or 'anxiety attack ', though what 
they are describing is intense worry and anxiety that does not include symptoms of 
an actual panic attack, and use this to describe worry that is more consistent with 
GAD. 
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APPENDIXN 
Treatment Evaluation Forms 
(Following each treatment module and at six-month follow-up) 
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Date: 
Client ID: 
B tA~tu 
Having learnt controlled breathing and relaxation techniques, use the following 
scale to answer the following questions about your experience of anxiety: 
O---------- l ----------2----------3----------4----------5----------6----------7----------8 
None/ 
Not at all 
Mild Moderate Severe Very Severe/ 
Very much 
1. Since learning and using these skills, how much do you experience? 
Rating 
a. Irritability 
b. Restlessness, feeling keyed up or on edge 
c. Being easily fatigued 
d. Difficulty concentrating or mid going blank, 
e. Muscle tension, and 
f. Difficulty falling asleep/ staying asleep; 
Restless /unsatisfying sleep 
Use the same scale to answer questions 2-6: 
2. How would you rate your overall level of/experience of anxiety? _ _ _ _ 
3. How much are you bothered by your worrying thoughts? ___ _ 
4. To what degree do you believe that your worries or anticipated negative events 
will occur? 
----
5. Ho_w long, or how much of the day do you spend worrying? __ _ 
6. Have these skills led to, or helped reduce the frequency of anxiety episodes you 
experience per week? y N 
7. Has learning these skills led to, or helped reduce the intensity of anxiety you 
experience? y N 
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8. Has learning these skills helped with your worries, and anticipation of worrisome 
events occurring? y N 
Use the following rating scale to answer the following questions (9-14): 
0----------1----------2----------3----------4----------5----------6----------7 ----------8 
None 
Very little 
Some/ 
A little 
Moderate/ 
Quite a bit 
Much/ 
A lot 
Very Much/ 
9. How useful do you find these strategies in managing your anxiety? ____ _ 
10. What impact has learning and implementing these strategies had on your anxiety 
and how you feel? ___ _ 
11. What impact have these skills had on your sleep patterns ( e.g., amount and 
quality of sleep)? ___ _ 
12. To what extent has your ability to manage anxiety chang_ed as a result of learning 
these skills? 
----
13. How confident are you that these skills will be successful in managing your 
anxiety? ____ _ 
14. To what degree have these skills helped in managing your anxiety? ___ _ 
15. H<;iw would you rate your ability to cope with your anxiety/worry? 
(Please circle) 
1---------------2 ____ · ----------3---------------4---------------5 
Poor Fair Good Very Good Excellent 
Further comments 
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Date: 
Client ID: 
- ~~L•l 
Having learnt cognitive skills such as thought monitoring, identifying thinking 
errors and applying alternative beliefs; use the following scale to answer the 
following questions about your experience of anxiety: 
O---------- l ----------2----------3----------4----------5----------6----------7----------8 
None/ 
Not at all 
Mild Moderate Severe Very Severe/ 
Very much 
1. Since learning and using these skills, how much do you experience? 
a. Irritability 
b. Restlessness, feeling keyed up or on edge 
c. Being easily fatigued 
d. Difficulty concentrating or mid going blank, 
e. Muscle tension, and 
f. Difficulty falling asleep/ staying asleep; 
Restless /unsatisfying sleep 
Use the same scale to answer questions 2-6: 
Rating 
2. How would you rate your overall level of/experience of anxiety? _ _ _ _ 
3. How much are you bothered by your worrying thoughts? _ _ _ _ 
4. · To what degree do you believe that your worries or anticipated negative 
events will occur? ___ _ 
5. How long, or how much of the day do you spend worrying? __ _ 
6. Have these skills led to, or helped reduce the frequency of anxiety episodes 
you experience per week? y N 
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I 
7. Has learning these skills led to, or helped reduce the intensity of anxiety you 
experience? y N 
8. Has learning these skills helped with your worries, and anticipation of 
worrisome events occurring? y N 
Use the following rating scale to answer the following questions (9-14): 
0----------1----------2----------3----------4----------5----------6----------7 ----------8 
None 
Very little 
Some/ 
A little 
Moderate/ 
Quite a bit 
Much/ Very Much/ 
A lot 
9. How useful do you find these strategies in managing your anxiety? __ _ 
10. What impact has learning and implementing these strategies had on your 
anxiety and how you feel? __ _ 
11. What impact have these skills had on your sleep patterns ( e.g., amount and 
quality of sleep)? ___ _ 
12. To what extent has your ability to manage anxiety changed as a result of 
learning these skills? ___ _ 
13. How confident are you that these skills will be successful in managing your 
.anxiety? ____ _ 
l:l. To what degree have these skills helped in managing your anxiety?~ 
15-. How would you rate your ability to cope with your anxiety/worry? 
(Please circle) 3_ -------------4---------------5 . 1---------------2--------------- -
Poor Fair Good Very Good Excellent 
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Date: 
Client ID: 
-~~tu 
Having learnt behavioural skills, including establishment of daily structure and 
gradual exposure to worrisome or avoided events, use the following scale to 
answer the following questions about your experience of anxiety: 
O---------- l ----------2----------3----------4----------5----------6----------7----------8 
None/ 
Not at all 
Mild Moderate Severe Very Severe/ 
Very much 
1. Since learning and using these skills, how much do you experience? 
a. Irritability 
b. Restlessness, feeling keyed up or on edge 
c. Being easily fatigued 
d. Difficulty concentrating or mid going blank, 
e. Muscle tension, and 
f. Difficulty falling asleep/ staying asleep; 
Restless /unsatisfying sleep 
Use the same scale to answer questions 2-6: 
Rating 
2. How would you rate your overall level of/experience of anxiety? ___ _ 
3. How much are you bothered by your worrying thoughts? ___ _ 
4. To what degree do you believe that your worries or anticipated negative 
events will occur? 
5. How long, or how much of the day do you spend worrying? __ _ 
6. Have these skills led to, or helped reduce the frequency of anxiety episodes 
you experience per week? y N 
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7. Has learning these skills led to, or helped reduce the intensity of anxiety you 
experience? y N 
8. Has learning these skills helped with your worries, and anticipation of 
worrisome events occurring? y N 
Use the following rating scale to answer the following questions (9-14): 
0----------1----------2----------3----------4----------5----------6----------7 ----------8 
None 
Very little 
Some/ 
A little 
Moderate/ 
Quite a bit 
Much/ Very Much 
A lot 
9. How useful do you find these strategies in managing your anxiety? __ 
10. What impact has learning and implementing these strategies had on your 
anxiety and how you feel? ___ _ 
11. What impact have these skills had on your sleep patterns (e.g., amount and 
quality of sleep)? _ __ _ 
12. To what extent has your ability to manage anx iety changed as a result of 
learning these skills? ___ _ 
13 . How confident are you that these skills will be successful in managing your 
anxiety? ____ _ 
1_4. To what degree have these skills helped in managing your anxiety? __ 
15. How would you rate your ability to cope with your anxiety/worry? 
(Please circle) 
1---------------2---------------3------ ---------4---------------5 
Poor Fair Good Very Good Exce llent 
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Date: 
Client ID: 
'+'~LU THE AUSTRALIAN NATIONAL UNIVERSITY 
Having participated in the study, please use the following scale to answer the 
following questions about your current experience of anxiety: 
0----------1----------2----------3----------4----------5----------6----------7 ----------8 
None/ 
Not at all 
Mild Moderate Severe Very Severe/ 
Very much 
1. Since your participation in the study, and have learnt techniques to manage 
anxiety, how much do you experience? 
a. Irritability 
b. Restlessness, feeling keyed up or on edge 
c. Being easily fatigued 
d. Difficulty concentrating or mid going blank, 
e. Muscle tension, and 
f. Difficulty falling asleep/ staying asleep; 
Restless /unsatisfying sleep 
Use the same scale to answer questions 2-6: 
Rating 
2. How would you rate your overall level of/experience of anxiety? ___ _ 
3. How much are you bothered by your worrying thoughts?---~ 
4. To what degree do you believe that your worries or anticipated negative events 
will occur? 
----
5. How long, or how much of the day do you spend worrying? __ _ 
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6. Has the program, and the skills learnt through your participation led to, or helped 
reduce the frequency of anxiety episodes you experience per week? Y N 
7. Has participation and learning of these skills led to, or helped reduce the intensity 
of anxiety you experience? y 
8. Has participation in the program and learning of these skills helped with your 
worries and anticipation of worrisome events occurring? 
Use the following rating scale to answer the following questions (9-14): 
O---------- l ----------2----------3----------4----------5----------6----------7----------8 
None Some/ 
Very little A little 
Moderate/ Much/ 
Quite a bit 
Very Much/ 
A lot 
y 
9. How useful do you find the strategies learnt in managing your anxiety? __ 
10. What impact has participation in the study, and implementing the strategies 
learnt through the program, had on your anxiety and how you feel? ___ _ 
11. What impact has participation in the program and the skills learnt had on your 
sleep patterns ( e.g., amount and quality of sleep)? _ __ _ 
12. To :what extent has your ability to manage anxiety changed as a result of 
participating in the program and learning skills to manage anxiety? ___ _ 
13. How confident are you that the skills have been successful in managing your 
anxiety? _ ___ _ 
N 
N 
14. To what degree has participation and the skills learnt helped in managing your 
anxiety? ___ _ 
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15. How would you rate your ability to cope with your anxiety/worry? 
(Please circle) 
1---------------2---------------3---------------4---------------5 
Poor Fair Good Very Good Excellent 
16. When it comes to your health, how would you compare yourself to others your 
age? (Please circle on the following scale) 
Much better off 
Somewhat better off 2 
About the same 3 
Somewhat worse off 4 
Much worse off 5 
17. Compared to one year ago, in general, how would you rate your health now? 
Much better than one year ago 
Somewhat better than one year ago 
About the same as one year ago 
Somewhat worse than one year ago 
Much worse than one year ago 
2 
3 
4 
5 
18. To what extent did you find the programme helpful overall? 
0---------------2----------------3--------------4---------------5 ---------------6 
Not at all somewhat helpful extremely helpful 
19. What parts of the programme did you find useful? 
20. What aspects of the programme have you continued to use to help manage your 
anxiety (e.g., breathing, relaxation, monitoring your thoughts, identifying 
thinking errors, looking for evidence, activity scheduling, problem solving, 
exposure etc)? 
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21. Which of the techniques learnt have been most useful in helping to reduce your 
anxiety? 
22. Which of the techniques learnt have been most beneficial in helping you to 
manage your anxiety _ ______________________ _ 
23. To what extent has your ability to manage anxiety changed since participating in 
the study? 
0---------------2----------------3--------------4---------------5---------------6 
Got worse not at all changed a lot 
Further comments 
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Summary and Outline of Treatment Manual 
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Modules 
Late-Life Anxiety Study 
Modular CBT Treatment Manual 
Psychoeducation and Awareness Module (session 1) 
(i) Overview and introduction 
(ii) Explanation of tripartite model of anxiety (physiological, cognitive, and 
behavioral components) 
(iii) Exp lanation of treatment principles and procedures 
Relaxation Skills (sessions 2 & 3) 
(i) Training in controlled breathing 
(ii) Training in Progress ive Deep Muscle Relaxation (8-muscle exercise; 4-
muscle exercise with discrimination training; relaxation-by-recall) 
(iii) Cued relaxation 
Cognitive skills (4 sessions) 
Session 4 
(i) Explanation ofrole of thinking in anx iety and other negative emotions 
(ii) Instruction on self-monitoring of symptoms according to cognitive-behaviora l 
format. 
Downward arrow technique. 
Session 5 
(i) Identification of logica l errors/cognitive distortions (e.g. , overestimating, 
catastrophizing, etc.) and alternative explanations 
Session 6 
(i) Application of alternative beliefs 
Session 7 
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(i) Thought stopping 
(ii) Sleep hygiene (including sleep restriction, stimulus control) 
Behavioral Skills and skills application (5 sessions, including relapse 
prevention) 
Session 8 
(i) Establishment of daily schedule/structure 
(ii) Worry behavior prevention 
Sessions 9-12 
(i) Problem-solving 
Generating alternative solutions, evaluating costs/benefits, implementing 
strategies 
(ii) Exposure to avoided or anxiety-provoking situations (counter-conditioning 
model) 
(iii) Hierarchy construction; Graduated exposure plus ongoing practice (with 
application of all coping skills: relaxation, cognitive, behavioral) 
(iv) Relapse prevention (including summary of therapeutic principles, plans for 
maintaining gains, and continued practice. 
Outline of treatment procedures and basic principles underlying treatment 
There are four primary treatment modules in the manual. 
The first module consists of basic information and psychoeducation. This module is 
designed to convey the nature, processes and consequences of anxiety and worry, and to 
correct any misconceptions held by the client about anxiety. 
The second module consists of somatic control exercises in the form of progressive muscle 
relaxation training. Relaxation is included to directly target the physiological arousal and 
tension that are a core component of anxiety, particularly GAD and panic disorders. 
Moreover, relaxation has been demonstrated to be effective in terms of treating anxiety 
(Craske, Barlow & O'Leary, 1992). 
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Third, cognitive skills and cognitive restructuring are designed to foster the recognition and 
replacement of anxious, negatively skewed styles of thought. The explanation of the role of 
thinking and common logical errors are designed to impart on the client a sense that their 
way of thinking, and thus their experience of anxiety is modifiable. 
The fourth module consists of behav ioural skills intended to initiate and/or increase the 
client ' s activity, thus imparting a sense of control and mastery over ones activities and daily 
life. Problem solving is also delivered to instil a sense of manageability in regards to 
problems and issues that have arisen or may arise. Sleep hyg iene is implemented as needed 
to those having problems with sleep disturbance. 
Worry exposure for those with generalized anxiety is used to evoke, in a methodical and 
controlled fashion, the worries most sa lient to the individual. Repeated exposures and 
increasing control over the worry process focuses on replacing cognitive avoidance 
tendencies with of cognitive modi fication through approach and challenge. Further, in vivo 
exposure to situations that are being avoided or put off, and response prevention of any 
safety behaviours is inc luded. Since over-cautiousness and safety/checking behaviour are 
understood to be principally motivated by the ant icipation of some negative outcome or of 
levels of anxiety that might impair performance, cognitive restructuring and relaxation are 
emphasized and pract iced before conducting graduated exposure exercises. 
The first two treatment modules are viewed principally as sk ills for managing anxiety once 
it has been elicited. On the other hand, the worry exposure, in vivo exposure and response 
prevention modules are seen as the principal vehicles by which control over the initiation of 
the anx iety and worry processes is acquired. 
362 
Targets of treatment 
The manual is aimed at addressing cognitive biases, physiological arousal and 
avoidance behaviours. It also introduces time management and problem solving skills to 
address other issues that may, in some cases, be pertinent to the experience of anxiety, 
such as life stressors, e.g. , relationship difficulties and job loss. The manual does not 
attempt to directly address additional problems that can co-occur with anxiety, such as 
depression, however many of the same treatment techniques and skills apply so such 
problems, and may have transfer effects. 
Individual variability 
The treatment manual attempts to apply to a broad range in the extent to which an 
individual may experience worry, arousal and avoidance. Given individual variability, 
not all sections of the program will be equally relevant for every client. Some 
individuals may primarily experience excessive worry, whereas others primarily 
experience excessive arousal even though their worry is judged to be in proportion to 
their life circumstances. Thus, for some sufferers of chronic anxiety, the cognitive 
restructuring may be less relevant than the relaxation, or vice versa. Nevertheless, all 
modules should be delivered to the client 
Differentiating panic and anxiety 
The state of anxiety is differentiated from fear/panic, both theoretically and with respect 
to their three-response-mode presentation (cognitive, phys iological and behavioural). 
Anxiety is characterized by (i) perception/awareness of distant threat, (ii) chronic 
tension and hyperarousal, and (iii) cautiousness, procrastination and interference with 
performance and the ab ility to concentrate on the task at hand. 
Fear .or panic is characterized by (i) perception/awareness of immediate peril , (ii) 
sudden, automatic discharge, and (iii) strong escape or fight/flight urges . 
General Optimization Strategies 
To optimize compliance and attendance, and heighten the impact ofCBT methods, the 
following strategies are utilized for all clients, at al l applicable sessions, regardless of 
the specific module: 
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1 . Weekly reading assignments compiled from Craske, Barlow, & O'Leary's Mastery 
of Your Anxiety and Worry: Client Workbook, and Padesky and Greenberger's 
Mind over mood- Client Manual. Each week the therapist assigns readings 
corresponding the specific module currently being implemented. At the following 
session, the therapist inquires about the reading and answers any questions the client 
has. 
2. Following each session, a summary of essential points covered during the session, 
as well as the client's specific assignments for the week is given to the client. The 
subsequent session includes a point-by-point review of the previous session's 
summary sheet, including inquiry concerning the client's utilization of any cognitive 
or behavioral strategies described therein, as well as review of homework 
assigrunents. 
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Descriptive Analysis of EO and LO Participants 
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Appendix P presents the descriptive statistics for the age of onset, demographic, health, ·· 
psychiatric treatment and comorbidity, genetic and psychological characteristics of 
early- and late-onset participants who took part in the treatment study (Chapter Eleven). 
Appendix P.1 Age at onset characteristics 
Descriptive statistics fo r age at evaluation and age at onset of current and past episodes 
of illness are presented in Table P. I . Comparison of means using independent-samples 
t-tests were performed to examine the differences in age at evaluation and age at onset 
of current and past episodes of psychiatric illness between EO and LO groups using a 
Bonferroni adjustment of a= 0.0125. No differences were found between onset groups 
in mean age at evaluation or age at onset of presenting episode of GAD. Comparison of 
onset groups revealed that, on average, the EO group was significantly younger than the 
LO group at age of first onset of a DSM-IV disorder of any kind. Similarly, participants 
in the EO group were found to be significantly younger, on average, than those in the 
LO group at age of first onset ofa DSM-IV disorder of any kind. Levene ' s test for 
equality of variances was significant for these two variables, indicating non -equal 
variances for groups on these two variables. Accordingly, t values, degrees of freedom, 
and p va lues reported for these variables are based on Levene ' s. test of equality. 
Table P.1 
Mean Age at Evaluation and Mean Age at Onset of Current and Past Episodes of Illness 
for Early-and Late-Onset Participants (N = 41) 
Early Onset Late Onset Significance 
(N = 18) (N = 23) test 
Variable M SD M SD t[dD 
Age·at evaluation (years) 61.33 5.52 63.13 6.43 - 0.94[39] 
Age at onset of presenting 
58.67 6.54 59.70 5.55 - 0.54[39] 
episode (years) 
Age at first onset of any 
15.33 5.59 51.13 14.15 - 1 J.07 [30 J JJ***t 
disorder (years) 
Age at onset of first anxiety 
15.33 5.59 54.26 9.97 -15.81 [3576J***t 
disorder (years) 
* p :S 0.05 ; **p :S 0.01 ; ***p :S 0.001 
t equality of variances not assumed (Levene ' s test significant) 
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Appendix P.2 Demographic characteristics 
Descriptive statistics were conducted to investigate the demographic characteristics of 
participants, and are presented in Tables P.2 and P.3. Gender, ethnicity and marital 
status are presented in Table P.2, with x2 tests revealing no significant differences 
between onset groups. Females outnumbered males in both £0 and LO groups 2:1. The 
majority of participants were non-indigenous Australian and married and/or living with 
a partner. 
Table P.2 
Demographic Characteristic of Early-and Late Onset Participants (N = 41) 
Early Onset Late Onset Significance 
(N=l8) (N =23) test 
Variable /(%) (n) /(%) (n) X [dfJ 
Gender o.04 r1J 
Male 33.3 (6) 30.4 (7) 
Female 66.7 (12) 69.6 (I 6) 
Ethnicity 0.74[3] 
Non-indigenous Australian 66.7 (12) 73.9 (I 7) 
European 22.2 (4) 13.0 (3) 
Asian 5.6 (I) 8.7 (2) 
South American 5.6 (I) 4.3 (I) 
Marital status 0.11 [I ] 
Single 5.6 (I) 4.3 (I) 
Married/ in a relationship 83.3 (15) 87.0 (20) 
Separated or divorced 11.2 (2) 4.3 (I) 
Widowed 4.3 (I) 
*p :S 0.05;**p:S 0.0 l ; ***p :S 0.001 
The educational and occupational characteristics of EO and LO participants are 
presented in Table P .3, with x2 tests revealing no significant differences between onset 
groups. Using a cut-off of 50 years to distinguish onset groups, analysis of demographic 
characteristics revealed a significant difference between groups for occupation, (X2(1) = 
4.89, p < 0.05). Inspection of the standardised residuals for this variable reveal that 
there was a greater number of participants in the EO group in non-professional positions 
than expected, and fewer LO participants in the non-professional positions than 
expected. There were also fewer EO participants in professional positions than was 
expected and a greater number of LO participants in professional positions than 
expected. 
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Table P.3 
Education and Occupation Characteristics of ED and LO participants (N = 41) 
Early Onset Late Onset Significance 
(N = 18) (N =23) test 
Variable f(%) (n) f(%) (n) ?{df] 
Level of education 0.04[1] 
Year 8 - 'intermediate' 16.7 (3) 4.3 (I) 
Year 10- ' matriculation' 16.7 (3) 26.1 (6) 
Tafe/trade qualification II.I (2) 43.5 (10) 
University degree 50.0 (9) 17.4 (4) 
Post-graduate degree 5.6 (1) 8.7 (2) 
Occupation 1.77 (11 
Professional or associate 38.9 (7) 65 .2 (15) 
professional 44.4 (8) 26.1 (6) 
Higher administrative or clerical 5.6 ( I) 
Tradesperson II.I (2) 8.7 (2) 
Non-professional 
Employment status 0.1 711 1 
Employed 50.0 (9) 43 .5 (I 0) 
Unemployed II.I (2) 4.3 (I) 
Retired 38.9 (7) 52.2 ( 12) 
Employment intensity 2.98121 
Part-time 38.9 (7) 17.4 (4) 
Full-time I I.I (2) 26.1 (6) 
n/a 50.9 (9) 56.5 (13) 
* p :S 0.05; **p :S 0.01; ***p :S 0.001 
Appendix P.3 Health characteristics 
Appendix P.3.1 Current medical conditions 
As a group, participants had 42 different current medical disorders. Descriptive statistics 
for the more commonly reported disorders are listed in Table P.4. The most common 
medical conditions for both EO and LO groups included a pain syndrome, arthritis, high 
blood pressure, high cholesterol, and irritable bowel syndrome. A high percentage of 
both EO and LO groups reported wearing glasses for reading and/or long-distance 
v1s1on. 
368 
A series of analyses were conducted to determine whether early-and late-onset groups 
differed with regards to medical comorbidity. Analyses were not performed between 
groups for conditions where there was an expected cell count of less than five (i.e 
respiratory, cardiac and endocrine/metabolic conditions) . Overall , EO and LO groups 
were found to be similar with respect to the frequency of current health conditions 
experienced by adults with late-life GAD, as seen in Table P.4. 2x2 x2 analyses 
revealed no significant differences between groups in terms of diseases of the nervous 
system, blood pressure, cholesterol , digestive and gastrointestinal conditions, 
musculoskeletal/ connective tissue conditions, or problems with vision. Pain was found 
to be more prevalent in the LO group, however this difference was not found to be 
significant. Overall EO and LO participants reported an average of 3.7 (S.D = 2.5) and 
5.2 (S.D = 3.5) medical conditions each. An independent-samples t-test indicated that 
onset groups did not differ in the total number of conditions reported by EO and LO 
participants, on average (t (39) - -1.49, p > .005). 
Table P4 
Current Medical Conditions and Mean Number of Total Medical Conditions for Early-
and Late-Onset Participants (N = 41) 
Early onset Late onset Significance 
(N=J8) (N = 23) test 
f(%) (n) f(%) (n) ? {dj] 
Diseases of the nervous system 27.8 (5) 21.7 (5) 0.20[!] 
Cardiac conditions 16.7 (3) 21.7 (5) 
High blood pressure 55.6 (10) 43.5 (I 0) 0.59[1] 
Respiratory disease II.I (2) 26.1 (6) 
Neoplasms I I.I (2) 4.3 (I) 
Endocrine/ metabolic conditions 5.6 (1) 21.7 (5) 
High cholesterol 38.9 (7) 43.5 (I 0) 0.09[1 ] 
Digestive and gastrointestinal 38.9 (7) 47.8 (11) 0.33[! ] 
conditions 
Genito-urinary problems (urinary 5.6 (I) 8.7 (2) 
tract infection) 
Any eye/ear conditions 11.1 (2) 13. l (3) 
Problems with vision (use of 
glasses) 
100.0 (18) 87.0 (20) 2.53[1] 
Musculoskeletal/ connective tissue 44.4 (8) 56.5 ( 13) 3.68[1 ] 
conditions 
Pain syndrome 44.4 (8) 56.1 (I 7) 0.59[1] 
* p :S 0.05; **p :S 0.01; ***p :S 0.001 
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Appendix P.3.2 Current medication use 
Descriptive statistics for current prescription and non-prescription medications use by 
early- and late-onset participants are presented in Table Q.5 . Independent-samples t-
tests revealed no significant differences between onset groups in prescription, non-
prescription, or total medication (prescription and non-prescription) use. 
Table P.5 
Prescription and Non-prescription Medication Use for Early-and Late-Onset 
Participants (N = 41) 
Early onset Late onset Significance 
Variable 
Prescription medications used 
Non-prescription medications used 
Total number of medications used 
(prescription and non-prescription) 
* p :S 0.05; **p :S 0.01; ***p :S 0.001 
(N=J8) 
M 
1.4 
I.I 
2.4 
SD 
1.2 
1.3 
2.1 
(N = 23) Test 
M SD f[df] 
2.1 1.8 - 1.40[39] 
0.9 1.0 0.40[39] 
3.0 2.2 - 0.75 [39] 
Appendix P.4 Psychiatric treatment history and illness characteristics 
Descriptive statistics for mean age at help-seeking and illness characteristics such as 
illness duration and number of episodes of psychiatric illness for EO and LO groups are 
presented in Table P.6. Independent-samples t-test revea led no significant difference 
between groups in mean age at which participants report first seeking help for a 
psychiatric problem. A significant difference was found between onset groups for the 
numper of episodes of a psychiatric disorder reported, with EO participants reporting a 
significantly greater number of episodes on average. A significant difference was also 
found for time since first onset of a DSM-IV disorder of any kind, and for since first 
onset of a DSM-IV anxiety disorder. Duration, in years, of the presenting disorder was 
not however found to differ between onset groups. 
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Table P.6 
Treatment Characteristics of Early-and Late-onset Participants (N = 41) 
Early onset Late onset Significance 
(N=l8) (N= 23) test 
Variable M SD M SD t[dll 
Mean age at help seeking 46.9 (18.5) 55.7 (14.2) - 1.70[39] 
Mean number of episodes 4.0 (l .4) 2.3 (I .4) - 3.84[39]*** 
Duration of presenting episode of 
anxiety (years) 
2.67 (2.53) 3.43 ( 4.09) - 0.63 [39] 
Time since first onset of a DSM-
46.0 (7. l) 
IV anxiety disorder (years) 
8.9 (7.6) 16.0[39J*** 
Time since first onset of a DSM-
IV disorder of any kind (years) 
46.50 (7.94) 12.0 (11.45) I 0.8[J9J *** 
* p :S 0.05; **p :S 0.0 I; ***p :S 0.001 
Descriptive statistics for psychiatric treatment previously sought by EO and LO 
participants are presented in Table P. 7. Differences in psychiatric treatment history, 
including psychotropic medication use were investigated using x2 analyses. Overall, the 
two groups were found to be similar with regard to psychiatric treatment history. There 
were no significant differences between onset groups in terms of a history of 
counselling or psychotherapy, past psychotropic medication use, current psychotropic 
medication use, nor with regard to a past history of treatment of any kind. 
Table P.7 
Descriptive Statistics/or Psychiatric Treatment History of Early- and Late-onset 
participants (N = 41) 
Early onset Late onset Significance 
(N=l 8) (N = 23) test 
Variable f(¾) (n) f(¾) (n) X [dfj 
Treatment history 
Psychotherapy 27.8 (5) 26.l (6) 0.01[!] 
Medication 66.7 (12) 52.2 (I 2) 0.87[1] 
Any treatment 77.8 (14) 65.2 (15) 0,77[! ] 
(therapy and/or medications) 
Current psychotropic medication use 33.3 (6) 30.4 (7) 0.04[1] 
Type of psychotropic 
Antidepressant 16.7 (3) 21.7 (5) 
Benzodiazepine 16.7 (3) 8.7 (2) 
* p :S 0.05; **p :S 0.01 ; ***p :S 0.001 
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Appendix P.5 Psychiatric comorbidity 
Appendix P.5.1 Descriptive analysis of current and comorbid psychiatric 
conditions 
Descriptive statistics for the presenting psychiatric disorder and comorbid psychiatric 
conditions at evaluation for EO and LO groups are presented in Tabl e P.8. Table P.8 
demonstrates that over half the EO and LO groups did not meet criteria for any DSM-IV 
diagnosis other than GAD. There were a small number of participants in both onset 
groups who were diagnosed as having a primary diagnosis of GAD and secondary 
diagnoses of either PD, phobias or MOD (single episode and recurrent). 
Table P.8 
Current and comorbid psychiatric conditions for early -and late-onset participants at 
presenting episode (N = 41) 
Principal Diagnosis 
~~~ I ~~~ 
~~ ~~ 
"' 
GAD (n = 18) GAD (n=21) PD (n=2) 
·;;;
0 f% (n) f% (n) f% (n) = bl) 
"' Q No Diagnosis 55.6% (I 0) 66.7% (14) 
c GAD 100% (2) 
"' -0
= PD 11.1% (2) 14.3% (3) 0 () 
" VJ Phobias 16.7% (3) 4.8% (I) 
OCD 5.6% ( I ) 
MOD single 19.5% (2) 
MDD recurrent 11.1% (2) 4.8% (I) 
* p S 0.05 ; **p '.S 0.01 ; ***p '.S 0.001 
Appendix P.5.2 Descriptive analysis of psychiatric conditions atfirst onset of a 
DSM-IV disorder of any kind 
Descriptive statistics for psychiatric conditions at first onset of a DSM-IV disorder of 
any kind for EO and LO groups are presented in Tables P.9 and P.l 0. For both the EO 
and LO groups, the majority of participants had a principal diagnosis of GAD. A small 
number ofEO participants had OCD, PTSD and MDD (single) as their primary 
diagnosis, whilst MDD single and 'other' were the primary diagnoses for a small 
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proportion of LO participants. There were a small number ofEO participants who 
additionally had a secondary diagnosi s of GAD, PD, Phobias or MDD single. Those 
LO participants who met criteria for a secondary diagnos is presented with PD, MDD 
single and a drug-i nduced psychosis. 
Table P.9 
Psychiatric diagnoses and co morbid psychiatric conditions at onset of first DSM-IV 
disorder of any kind for EO participants (N = 18) 
Principal diagnosis 
GAD OCD PTSD MDDsingle 
,.,, (n =14) (n = 1) (n = 1) (n = 3) 
'in 
0 No diagnosis 57.1%(8) 100% (1) C: 
01) 
"' GAD 100% (I) 100% (2) i5 
c 
"' 
PD 7.1% (I) 
-a Phobias 28.6% (4) C: 
0 
u MDD single 7.1% (l) 
" VJ 
Table P.10 
Psychiatric diagnoses and comorbid psychiatric conditions at onset of first DSM-IV 
disorder of any kind for LO participants (N = 23) 
Principal Diagnoses 
,.,, GAD (n = 19) MDD single (n = 3) Other (n = 1) 
' in 
0 
,:: f% (n) f% (n) f% (n) 01) 
"' i5 No Diagnosis 78.9% (15) 33.3.3% (I) 100.0% (I) 
c PD 5.3% (I) 33.3.3% (]) 
"' -a
C: MDD single 15 .8% (3) 0 
u 
" Other* 5.3% (1) 33.3.3% (1) VJ 
*Drug-induced psychosis 
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Appendix P.5.3 Descriptive analysis of psychiatric conditions at first onset of a DSM-IV 
anxiety disorder 
Descriptive statistics for psychiatric diagnoses and comorbid psychiatric conditions at 
first onset of a DSM-IV anxiety disorder for early-and late-onset participants are 
presented in Table P.11. The majority of EO and LO participants had a principal 
diagnosis of GAD, with half of those EO participants not meeting criteria for a 
comorbid psychiatric condition. One EO participant each met the criteria for OCD and 
PTSD as their primary diagnosis, whilst two LO participants had a principal diagnosis 
of PD. A small number of participants in the EO group had either GAD, PD, phobias or 
MDD (single episode) as a secondary disorder, whilst a small number of LO 
participants had either GAD, PD or MDD (single) as a comorbid psychiatric condition. 
Table P.11 
Psychiatric diagnoses and comorbid psychiatric conditions at onset of first DSM-IV 
anxiety disorder for early-and late-onset participants (N = 41) 
GAD 
"' 
(n = 16) 
·;;; 
0 No diagnosis 50.0% (8) C: 
bl) 
"' GAD 0 
c 
"' 
PD 6.2% (I) 
-0 Phobias 25.0% (4) § 
u MDD Single 18.8% (3) (U 
C/) 
Primary Diagnosis 
Early -onset 
(n = 18) 
OCD 
(n = 1) 
I 00% (1) 
PTSD 
(n = I) 
100% (1) 
Late-onset 
(n = 23) 
GAD PD 
(n = 21) (n = 2) 
85.7% (18) 
100% (2) 
9.5% (2) 
4.8% (I) 
Descriptive statistics for participants meeting diagnostic criteria for one or more 
comorbid psychiatric condition at time of evaluation, at onset of first DSM-IV disorder 
of any kind, and at onset of first DSM-IV anxiety disorder are presented in Table P.12. 
x2 analyses revealed that onset groups were similar with regard to rates of psychiatric 
comorbidity at evaluation, at time of first onset of any DSM-IV disorder, and at first 
lifetime onset of a DSM-IV anxiety disorder. 
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Table P.12 
Frequency of psychiatric comorbidity for current and past episodes of illness onset for 
early-and late-onset participants (N = 41) 
Early Onset late Onset Significance 
(N = 18) (N = 23) test 
Variable /(%) (n) /(%) (n) X2/df] 
Comorbid psychiatric condition at 44.4 (8) 39.1 (9) 0.12 [1 ] 
time of presentation 
Comorbid psychiatric condition at 50.0 (9) 26.1 (6) 2.49[1 ] 
time of I st DSM-IV diagnosis 
Comorbid psychiatric condition at 50.0 (9) 21.7 (5) 3.59(1 ] 
time of I st anxiety disorder 
diagnosis 
* p '.S 0.05 ; **p '.S 0.01; ***p '.S 0.001 
Summary and conclusions 
As with findings for the overall sample, early-and late-onset groups were homogenous 
in terms of demographic and health characteristics, consistent with previous findings 
(Beck et al, 1996; Chou, 2009; Le Roux et al. , 2005 ; Lenze et al. , 2005). The findings 
for demographic characteristics using a cut-off of 50 were similar to findin gs using a 
cut-off of 34 with the exception of occupation. The finding revea led a greater number of 
participants in the EO group in non-professional positions, and fewer LO participants in 
non-professional positions than expected. It is possible that the chronic course of GAD 
and the long history of illness experienced by participants with EO of GAD impacted on 
these individuals ability to enter into or maintain jobs in the professional industry, 
accounting for the difference in occupational status. Occupation has not specifically 
been investigated amongst demographic characteristics analysed in studies of onset and 
late-life psychopatho logy, however the finding that onset groups differed with regard to 
occupation using a cut-off of 50 years is in contrast to the current and previous findings 
that EO and LO groups of older adults are alike with regard to demographic 
characteristics (Le Roux et al. , 2005 ; Chou, 2009). 
Early-and late-onset participants were similar in terms of the types and number of health 
conditions they suffered from, prescription and non-prescription medication use, 
inc luding the use of psychotropic medication and history of treatment sought and 
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received prior to the present investigation. Onset groups were also found to differ in the 
number of previously significant episodes of psychiatric illness and duration, in years 
since onset of their first episode of anxiety, with the EO group reporting a greater 
number of episodes and greater history of anxiety on average. These findings are as 
expected given the much younger mean age at onset of first anxiety episode for EO 
participants, and are consistent with previous findings of late-life GAD (Beck et al. , 
1996; Le Roux et al., 2005). 
Participants in both onset groups met criteria for a wide range of comorbid psychiatric 
conditions at all assessment points, namely at evaluation, at first onset of any DSM-IV 
disorder, and first onset of a DSM-JV anxiety disorder. The proportion of participants of 
participants who met criteria for one or more comorbid psychiatric condition at 
presentation and at onset of first DSM-IV anxiety disorder and disorder of any kind was 
similar for EO and LO groups. 
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APPENDIXQ 
Descriptive Analysis of Treated and Untreated Participants 
377 
Appendix Q presents the descriptive statistics for age at onset, demographic , health , 
medication, treatment history and clinical characteristics of those paiiicipants who took 
part in the treatment programme and those who were untreated (Chapter Eleven). 
Appendix Q.1 Age at onset characteristics 
Descriptive statistics for age at onset of current and past episodes of illness are 
presented in Table Q. I . The treated and untreated participants were found to be sim ilar 
in age. Comparison of means using independent-samples t-tests revealed no significant 
difference between the two groups in mean age at onset of the presenting episode, mean 
age at first onset of a DSM-IV disorder of any kind, and in age at first onset of a DSM-
IV anxiety disorder. Levene's test for equality of variances was significant for these 
latter two variables , indicating non-equal variances for groups on these two variables. 
Accordingly, t values, degrees of freedom, and p values reported for these variables are 
based on Levene's test of equality. 
Table Q.I 
Age of onset characteristics for treated and untreated participants (N = 73) 
Treated Untreated Significance 
participants participants test 
(N = 41) (N = 32) 
Variable Mean SD Mean SD t[df] 
Age at evaluation 64.41 6.17 62.34 6.04 1.441711 
Age at onset of presenting 
episode (years) 
59.24 5.95 59.03 7.15 0.14[71] 
Age at first onset of any 
35.41 21.14 40.84 17.46 I .20po 1sJ t 
disorder (years) 
Age at onset of first anxiety 
disorder (years) 37.17 21.23 44.25 17.48 1.56[70 77] i• 
*p:S 0.05 ;**p :S 0.0l;***p :S 0.001 
t equality of variances not assumed (Levene's test significant) 
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Appendix Q.2 Demographic characteristics 
Descriptive statistics conducted to investigate the demographic characteristics treated 
and untreated participants are presented in Table Q.2. In general, the two groups were 
quite similar with respect to demographic background. There were no significant 
differences between treated and untreated participant groups in terms of gender, 
education or occupation, nor in terms of employment status, or employment intensity. 
A significant difference was found between groups for marital status. Inspection of the 
standardised residuals for this variable reveal that there were significantly more single 
participants in the untreated group than expected, and significantly fewer single 
participants in the treated group than expected. Given significant findings for this 
variable an additional x2 analyses was performed to investigate whether this varied by 
onset group. This analysis was unable to be performed for the EO group due to a cell 
size of less than five. Investigation of differences in marital status for treated and 
untreated participants classified as having LO anxiety revealed a significant difference 
between groups. Inspection of the standardised residuals showed that there were 
significantly more single LO participants in the untreated group and significantly less 
single LO participants in the treated group than expected (X2(l)= 10.47, p < .005). 
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Table Q.2 
Demographic characteristics of treated and untreated participants (N = 7 3) 
Treatment Untreated Significance 
Group group Test 
(N = 41) (N =32) 
Variable f(%) (n) f(%) (n) X2/dfj 
Gender 0.87 [I] 
Male 31.7 (I 3) 21.9 (7) 
Female 68.3 (28) 78. 1 (25) 
Ethn icity 4.48[3] 
Non-indigenous Australian 70.8 (29) 87.5 (28) 
European 17.1 (7) 3.1 ( 1) 
Asian 7.3 (3) 3.1 (1) 
South American 4.9 (2) 6.2 (2) 
Marital status 12.34***p] 
Single 4.9 (2) 6.2 (2) 
Married/in a relationship 85.4 (35) 46 .9 (15) 
Separated or divorced 7.3 (3) 37.5 (12) 
Widowed 2.4 (I) 9.4 (3) 
Level of education 0.06p] 
Year 8- ' intermediate ' 9.8 (4) 25.0 (8) 
Year 10- 'matriculation' 22.0 (9) 9.4 (3) 
Tafe/trade qualification 29.3 (12) 40k (13) 
University degree 31.7 (13) 15.6 (5) 
Post-graduate degree 7.3 (3) 9.4 (3) 
Occupation l.10 [1 ] 
Professional or associate 51.3 (21) 31.3 (I 0) 
professional 39.0 (I 6) 58.9 (19) 
Higher administrative or clerical 2.4 (I) 3.1 ( I) 
Tradesperson 7.3 (3) 6.2 (2) 
Non-professional 
Employment status 3.5lpJ 
Employed 46.3 (I 9) 25.0 (8) 
Unemployed 7.3 (3) 12.5 (4) 
Retired 46.3 (19) 62.5 (20) 
Employment intensity 3.55 [2] 
Part-time 26.8 (11) 15.6 (5) 
Full-time 19.5 (8) 9.4 (3) 
n/a 53.7 (22) 75.0 (24) 
* p :S 0.05; **p :S 0.01; ***p :S 0.001 
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Appendix Q.3. Clinical characteristics/psychological variables 
The base I ine psychological variables for treated and untreated participants are presented 
in Table Q.8. A series of independent-samples !-tests were conducted to determine 
whether there were any differences between treated and untreated participants on 
baseline measures of these psychological variables. With the exception of the geriatric 
depression scale, which was completed in the initial assessment interview, five 
participants from the untreated group did not return completed questionnaires at 
baseline and were therefore omitted from analyses. As illustrated in Table Q.3, 
participants taking part in the treatment study were found to have significantly higher 
scores on measures of anxiety and anxiety sensitivity than those who did not go on to 
have treatment. On average, treated participants had higher scores on measures of 
depression, worry, and trait anxiety, and lower scores of general self-efficacy, social 
self-efficacy and perceptions of control over anxiety- related events than those who 
elected not to have treatment; however these differences were not found to be 
significant. 
Table Q.3 
Clinical characteristics of treated and untreated participants (N = 68) 
Variables Treated group Untreated group Significance 
(n=41) (n = 27) test 
M SD M SD t [df] 
Depression 4.88 3.18 4.81 3.52 -0.08[71] 
Anxiety 13.59 4.65 11.00 5.14 - 2. I 5[66J* 
Worry 62.05 9.53 57.59 I I .23 - 1.76[66] 
Trait anxiety 50.61 9.97 48.59 8.81 -0.85 [66] 
Anxiety sensitivity 33.71 13.9 24.93 12.33 -2.73[66]** 
General Self-efficacy 52.32 12.09 55.59 9.66 1.18[66] 
Social Self-efficacy 17.85 4.48 19.15 3.76 l .24[66J 
Perceived control of anxiety 69.63 17.65 71.88 17.93 0.5 I [6sJ 
* p <:: 0.05; **p <:: 0.01; ***p <:: 0.00]. 
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